data_5x4f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x4f _Structure_validation_residue.Date_analyzed 2017-08-11 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 29.8 p90 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.379 . . . . 1.33 107.278 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.932 HD13 ' HE1' ' A' ' 73' ' ' TYR . 23.6 pt -129.98 163.8 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.129 0.422 . . . . 1.64 111.123 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.742 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 134.28 55.14 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 109.506 -0.553 . . . . 3.21 109.506 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 73' ' ' TYR . 1.6 t -136.83 142.87 36.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 O-C-N 121.499 -0.751 . . . . 1.96 110.883 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 t -154.13 151.74 29.61 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.01 -0.431 . . . . 1.23 111.319 163.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.972 ' HA ' ' CB ' ' A' ' 75' ' ' VAL . 18.8 tt0 -65.96 -40.05 90.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.51 0.672 . . . . 2.97 110.734 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 8' ' ' THR . 18.6 t70 -123.02 151.03 42.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.711 -1.588 . . . . 1.14 106.711 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.32 -30.5 66.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.553 -0.906 . . . . 1.48 108.553 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.69 31.19 6.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.284 -1.325 . . . . 2.58 111.031 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 27.0 t70 -84.84 -121.53 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.28 -1.378 . . . . 0.59 107.28 167.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -122.19 92.95 48.81 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.373 -0.831 . . . . 2.18 110.455 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 56.3 Cg_endo -67.57 136.3 38.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.191 1.927 . . . . 0.64 110.997 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.497 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.86 143.94 39.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.351 -0.84 . . . . 0.58 111.461 -169.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.673 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 23.8 mt-10 -97.35 125.66 42.1 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.888 -0.412 . . . . 1.62 109.888 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 47.8 pt -140.77 139.08 19.13 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.155 -0.475 . . . . 2.06 111.527 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 7.6 Cg_exo -72.65 150.91 51.56 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.292 2.662 . . . . 1.05 112.784 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -129.47 168.41 16.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 1.54 111.019 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -75.07 145.73 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.289 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.38 -21.37 9.42 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.611 -1.177 . . . . 2.13 112.536 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 29.3 t70 -76.16 -7.04 53.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.292 1.044 . . . . 2.32 108.709 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.98 53.99 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.021 -1.631 . . . . 0.65 109.021 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.479 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.6 OUTLIER -123.44 155.92 36.51 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.447 -1.376 . . . . 1.01 110.401 -166.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -147.31 152.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 122.568 0.347 . . . . 0.52 110.811 177.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.095 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -68.9 94.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.129 -0.487 . . . . 2.59 110.468 178.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD23 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -64.6 -49.69 70.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 110.006 -0.368 . . . . 1.62 110.006 -171.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.791 ' HA ' HG23 ' A' ' 32' ' ' THR . 16.7 p -62.66 -36.22 82.16 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.829 0.824 . . . . 1.89 110.154 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.095 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.6 m -72.53 -33.6 66.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.913 -1.04 . . . . 1.71 108.512 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.832 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 8.8 t -60.95 -48.52 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.482 -1.236 . . . . 1.34 110.751 170.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -62.44 -17.7 60.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.095 0.776 . . . . 1.34 113.095 -176.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.12 38.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.71 1.374 . . . . 1.0 114.71 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.522 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 170.22 -164.72 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.194 0.998 . . . . 1.12 109.012 -173.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -107.97 92.09 8.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.938 -0.764 . . . . 1.81 108.938 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.832 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.76 6.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.86 3.707 . . . . 0.97 115.318 176.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 1.029 ' HA2' HG11 ' A' ' 75' ' ' VAL . . . 109.2 -15.6 32.99 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 109.979 -1.249 . . . . 0.68 109.979 -161.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 32' ' ' THR . . . 47.15 -91.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.984 1.314 . . . . 0.52 114.148 171.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 t -131.02 6.74 4.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.404 0.621 . . . . 1.64 110.282 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -144.69 147.8 19.2 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.341 -0.845 . . . . 0.51 111.081 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -128.25 152.97 47.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.283 -1.367 . . . . 0.82 113.093 177.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.75 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 77.7 mtt-85 -136.48 164.88 27.13 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.057 -2.201 . . . . 2.34 105.057 158.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.678 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -155.94 163.65 39.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 119.928 1.24 . . . . 1.69 112.502 168.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 72' ' ' VAL . 29.1 mmt180 -114.79 125.5 53.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 124.48 1.112 . . . . 3.18 113.329 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 1.051 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.39 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 119.935 3.309 . . . . 3.04 119.935 141.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.051 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 9.7 mt-30 . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 122.317 1.056 . . . . 4.2 111.96 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 132.19 34.67 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.464 -1.698 . . . . 1.74 111.293 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 12.4 ptp -69.52 82.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.051 0.453 . . . . 2.93 109.937 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.618 ' HD3' ' OH ' ' A' ' 43' ' ' TYR . 18.3 ttt180 -115.95 150.3 37.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.652 0.739 . . . . 2.9 110.812 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.77 165.98 24.8 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.514 -1.221 . . . . 0.44 115.243 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.637 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 70.5 t -99.43 146.19 9.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.856 -1.672 . . . . 0.95 111.01 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.733 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 11.1 mtt180 -62.01 136.27 57.89 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.707 0.803 . . . . 5.04 112.906 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.671 ' HB2' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -121.74 115.7 23.17 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.664 -0.495 . . . . 2.13 109.664 170.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.663 HG12 ' HG3' ' A' ' 58' ' ' GLU . 10.3 t -130.22 114.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.535 -0.302 . . . . 0.95 110.52 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.663 ' HG3' HG12 ' A' ' 57' ' ' VAL . 15.3 mt-10 51.2 37.19 17.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.021 0.528 . . . . 1.51 112.289 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -2.04 66.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.681 -0.771 . . . . 0.55 113.058 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -100.97 147.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.684 -0.304 . . . . 0.58 111.586 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.892 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.3 tp -103.8 114.56 28.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.836 -1.172 . . . . 1.72 107.836 169.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.733 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 9.9 t-160 -114.58 136.13 53.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.889 -0.724 . . . . 2.16 112.203 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.69 162.05 39.99 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.37 108.586 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.46 159.1 54.86 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 121.85 1.7 . . . . 1.6 110.504 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -47.38 -44.34 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.686 0.616 . . . . 3.12 112.503 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.61 28.22 0.38 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.545 -0.752 . . . . 2.45 109.813 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.14 -97.43 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.592 -0.813 . . . . 2.11 113.267 -173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 1.04 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -107.71 -81.56 0.56 Allowed 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.748 0.308 . . . . 4.47 110.543 -178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.1 -70.7 0.43 Allowed Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 119.604 -1.284 . . . . 1.78 114.709 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 11.4 p-10 -139.77 33.67 2.0 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.84 1.305 . . . . 1.48 109.724 -152.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 1.04 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -48.7 162.04 0.11 Allowed 'General case' 0 CA--C 1.477 -1.836 0 CA-C-N 112.147 -2.297 . . . . 1.22 109.242 169.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.742 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.5 p -86.33 106.36 15.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.156 -1.383 . . . . 1.09 107.284 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.932 ' HE1' HD13 ' A' ' 5' ' ' ILE . 19.8 m-85 -77.77 145.28 36.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.587 -0.733 . . . . 0.84 111.258 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 3.1 t -97.0 150.68 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.85 -1.523 . . . . 0.34 108.06 169.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 1.029 HG11 ' HA2' ' A' ' 37' ' ' GLY . 5.0 t -108.1 118.1 55.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.59 0.71 . . . . 2.4 112.186 -165.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -127.64 130.22 48.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.697 -1.138 . . . . 1.89 110.611 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.737 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 3.3 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.674 -0.679 . . . . 1.36 110.856 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 44.6 p90 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 106.779 -1.563 . . . . 1.33 106.779 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.791 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 14.8 pt -128.23 161.24 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 118.044 0.384 . . . . 1.64 111.557 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.807 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 10.1 ttt180 -119.83 132.17 55.5 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.165 -0.679 . . . . 3.21 109.165 171.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.6 p -137.28 140.46 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.632 -0.427 . . . . 1.96 111.596 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.921 HG21 ' HB3' ' A' ' 15' ' ' PRO . 4.8 t -152.81 171.23 18.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.542 -0.754 . . . . 1.23 109.754 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.812 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 21.1 mt-10 -74.72 -53.92 8.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.864 0.84 . . . . 2.97 109.091 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 8' ' ' THR . 1.8 t70 -111.49 150.4 29.96 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.304 -1.369 . . . . 1.14 107.304 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 44' ' ' ARG . 43.4 mt-10 -63.94 -22.51 66.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.264 -1.334 . . . . 1.48 109.083 -170.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -122.3 23.57 9.72 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.448 -1.251 . . . . 2.58 111.53 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.615 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.6 t70 -74.28 -112.71 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.097 -1.075 . . . . 0.59 108.097 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.2 tt0 -122.23 88.42 48.55 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.283 -0.871 . . . . 2.18 109.873 165.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.921 ' HB3' HG21 ' A' ' 8' ' ' THR . 91.4 Cg_endo -78.43 130.59 10.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.625 1.55 . . . . 0.64 110.686 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.08 133.58 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.539 -0.755 . . . . 0.58 111.841 -169.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.76 122.56 29.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.377 -0.601 . . . . 1.62 109.377 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.657 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 37.4 pt -139.04 138.83 21.7 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.99 -0.55 . . . . 2.06 110.927 -171.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 16.2 Cg_exo -68.71 124.29 11.35 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.08 2.52 . . . . 1.05 112.055 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.541 ' HG ' HG22 ' A' ' 5' ' ' ILE . 18.7 m -95.49 169.57 9.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 1.54 110.533 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.0 tp10 -64.95 136.02 56.33 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.008 -0.738 . . . . 2.77 109.008 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.63 -16.97 7.16 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.239 -0.891 . . . . 2.13 112.32 -175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -79.6 1.09 27.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.726 0.774 . . . . 2.32 109.028 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.98 49.25 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 114.258 -1.337 . . . . 0.65 110.587 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.562 ' OG1' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.19 159.46 36.77 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.32 -0.94 . . . . 1.01 110.884 -165.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.33 153.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.52 111.223 175.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.124 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -70.54 94.6 1.0 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.872 -0.604 . . . . 2.59 110.749 -178.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.678 HD23 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.46 -50.32 65.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.527 -0.545 . . . . 1.62 109.527 -173.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.808 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.6 p -61.55 -33.95 74.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.682 0.753 . . . . 1.89 110.375 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.124 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 8.6 m -75.0 -33.14 61.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.071 -0.968 . . . . 1.71 108.952 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.822 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 18.7 t -62.68 -47.62 92.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.227 -0.897 . . . . 1.34 110.537 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.808 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -64.89 -16.96 63.89 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.775 0.657 . . . . 1.34 112.775 -177.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.75 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.451 1.278 . . . . 1.0 114.451 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 170.77 -166.53 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.484 1.114 . . . . 1.12 108.787 -172.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -109.88 92.15 12.13 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.938 -0.764 . . . . 1.81 108.938 166.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.822 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -121.27 4.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.558 3.505 . . . . 0.97 115.017 176.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.41 30.95 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.167 -1.173 . . . . 0.68 110.167 -161.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.768 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.68 -88.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.764 1.394 . . . . 0.52 114.764 165.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.597 ' HG ' HG22 ' A' ' 32' ' ' THR . 15.7 m -129.58 -1.54 4.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.32 0.581 . . . . 1.64 110.966 -163.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.554 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -129.55 169.96 20.59 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.199 -1.16 . . . . 0.51 110.199 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.807 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -148.43 140.28 23.82 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.332 -0.947 . . . . 0.82 112.15 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.5 mtt180 -134.11 152.91 52.05 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 106.38 -1.711 . . . . 2.34 106.38 159.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.763 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 50.0 p90 -153.37 164.81 37.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 120.71 1.596 . . . . 1.69 113.483 169.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 11' ' ' GLU . 9.0 mtm180 -109.73 150.49 28.23 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.845 -1.525 . . . . 3.18 110.201 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 1.139 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 t30 . . . . . 0 C--O 1.219 -0.55 0 CA-C-N 114.028 -1.442 . . . . 3.04 110.508 -166.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.139 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.1 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 115.331 1.604 . . . . 4.2 115.331 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -60.97 126.04 25.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.339 -0.391 . . . . 1.74 110.243 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.83 92.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.928 0.871 . . . . 2.93 110.221 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.546 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 74.1 ttt180 -105.24 149.78 25.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.869 -1.059 . . . . 2.9 112.168 -170.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -96.53 149.22 19.25 Favored Glycine 0 C--N 1.302 -1.32 0 CA-C-N 113.941 -1.481 . . . . 0.44 114.502 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.807 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 76.0 t -98.78 143.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.514 -1.343 . . . . 0.95 110.327 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.586 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -65.85 135.49 54.9 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 112.514 0.561 . . . . 5.04 112.514 -170.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.678 ' HB2' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.05 111.22 22.16 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.192 -0.67 . . . . 2.13 109.192 169.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.786 HG13 ' HG2' ' A' ' 58' ' ' GLU . 19.3 t -129.44 118.03 44.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.153 -0.476 . . . . 0.95 110.699 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.786 ' HG2' HG13 ' A' ' 57' ' ' VAL . 3.9 mm-40 52.69 35.53 18.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.375 0.509 . . . . 1.51 112.375 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.433 ' C ' HD22 ' A' ' 28' ' ' LEU . . . 92.79 -0.87 70.55 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.588 -0.815 . . . . 0.55 113.048 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.562 HG22 ' OG1' ' A' ' 25' ' ' THR . 3.9 mt -104.08 149.35 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.796 0.332 . . . . 0.58 111.706 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.8 tp -102.51 116.5 32.73 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.92 -1.511 . . . . 1.72 106.92 166.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -115.09 133.59 55.9 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.598 0.713 . . . . 2.16 112.166 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 164.25 31.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 113.895 -1.502 . . . . 1.37 110.46 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.84 168.01 9.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.551 2.834 . . . . 1.6 110.688 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -41.99 -42.99 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.436 0.902 . . . . 3.12 113.436 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.91 -23.63 4.6 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.171 0.434 . . . . 2.45 112.171 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 136.9 8.44 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 118.98 -1.581 . . . . 2.11 114.054 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.434 ' CD2' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -81.37 -89.55 0.07 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.238 0.615 . . . . 4.47 111.373 170.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.9 48.0 0.12 Allowed Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.671 -0.776 . . . . 1.78 113.918 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.791 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 87.04 -45.18 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 114.361 -0.92 . . . . 1.48 110.28 156.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.807 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 47.07 173.2 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.964 1.364 . . . . 1.22 113.784 174.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.541 ' H ' HG12 ' A' ' 72' ' ' VAL . 2.2 p -103.02 105.05 17.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 113.422 -1.717 . . . . 1.09 109.145 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.763 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.0 m-85 -80.59 145.84 31.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.094 0.95 . . . . 0.84 112.858 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -109.16 159.18 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 112.889 -1.959 . . . . 0.34 110.151 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.812 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 p -87.93 103.78 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 2.4 112.145 -165.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -129.03 127.2 41.1 Favored 'General case' 0 C--O 1.208 -1.08 0 C-N-CA 120.111 -0.636 . . . . 1.89 109.423 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.701 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.489 -0.767 . . . . 1.36 110.322 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 35.7 p90 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.813 -0.81 . . . . 1.33 108.813 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.937 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -124.36 159.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 121.188 -0.205 . . . . 1.64 111.01 -178.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 2.9 ttt180 -120.52 134.35 55.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.756 -0.461 . . . . 3.21 109.756 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.693 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.4 p -138.16 148.5 24.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 O-C-N 121.786 -0.571 . . . . 1.96 111.57 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.908 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.5 t -152.57 171.21 18.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.494 -0.321 . . . . 1.23 110.918 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 1.068 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.4 tm-20 -83.33 -33.02 25.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.807 0.813 . . . . 2.97 110.036 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 8' ' ' THR . 19.3 t70 -132.18 150.0 52.26 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.15 -1.426 . . . . 1.14 107.15 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.62 -25.3 38.05 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.981 0.801 . . . . 1.48 109.529 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -130.52 38.01 3.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.816 -1.084 . . . . 2.58 111.898 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 8.4 t70 -77.02 -111.6 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.69 -1.596 . . . . 0.59 106.69 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 34.5 mm-40 -123.36 89.61 50.95 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.026 -0.988 . . . . 2.18 109.944 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.908 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 55.5 Cg_endo -69.18 133.1 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.231 1.287 . . . . 0.64 110.05 173.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.41 128.26 69.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.605 -0.725 . . . . 0.58 111.138 -169.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.783 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.6 mp0 -84.13 121.73 27.85 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.715 -0.675 . . . . 1.62 109.628 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 32.1 pt -140.64 143.61 33.11 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.496 -0.775 . . . . 2.06 111.537 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 2.9 Cg_exo -76.35 131.4 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.319 2.679 . . . . 1.05 112.415 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.437 ' HB3' HD13 ' A' ' 5' ' ' ILE . 7.2 p -103.59 171.35 7.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.768 -0.651 . . . . 1.54 109.799 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.26 142.57 58.23 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.444 -0.576 . . . . 2.77 109.444 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.76 -28.86 24.2 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.952 1.407 . . . . 2.13 112.347 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 6.3 p-10 -84.54 1.28 46.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.141 0.972 . . . . 2.32 108.8 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 24.31 23.05 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 113.867 -1.515 . . . . 0.65 110.234 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.469 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.35 151.81 38.74 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.827 -1.187 . . . . 1.01 111.622 -165.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.799 HG21 ' HB3' ' A' ' 61' ' ' LEU . 1.0 OUTLIER -147.31 148.7 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.667 -0.697 . . . . 0.52 109.955 170.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.013 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -64.87 102.75 0.63 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.15 0.5 . . . . 2.59 110.128 175.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.663 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.65 -50.63 68.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.45 -0.574 . . . . 1.62 109.45 -172.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.823 ' HA ' HG23 ' A' ' 32' ' ' THR . 17.9 p -68.87 -37.34 79.01 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.614 0.721 . . . . 1.89 110.201 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.013 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.5 m -70.88 -32.97 70.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.119 -0.946 . . . . 1.71 108.73 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.844 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.7 t -62.14 -44.77 99.46 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-N 114.821 -1.081 . . . . 1.34 110.47 170.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.823 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -63.4 -19.24 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.71 0.633 . . . . 1.34 112.71 -176.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.33 40.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.869 1.433 . . . . 1.0 114.869 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 169.91 -164.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.503 0.721 . . . . 1.12 109.437 -171.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -109.08 91.46 9.37 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.216 -0.661 . . . . 1.81 109.216 166.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.844 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.78 1.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.387 3.391 . . . . 0.97 115.116 175.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.651 ' HA2' ' CG2' ' A' ' 75' ' ' VAL . . . 107.69 -10.95 38.57 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 110.065 -1.214 . . . . 0.68 110.065 -161.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 32' ' ' THR . . . 51.09 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.603 1.561 . . . . 0.52 114.521 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -133.97 -36.41 0.93 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.733 0.778 . . . . 1.64 110.439 -161.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.563 ' C ' ' HB3' ' A' ' 76' ' ' ASN . . . -97.76 155.21 20.42 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-N 114.742 -1.117 . . . . 0.51 110.399 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.661 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -132.69 150.54 52.15 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.666 -1.214 . . . . 0.82 112.858 178.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 51' ' ' MET . 50.9 mtt180 -136.95 149.6 47.66 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.939 -1.875 . . . . 2.34 105.939 162.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.747 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 41.6 p90 -154.93 158.13 38.8 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 120.165 1.348 . . . . 1.69 112.635 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.491 ' HB3' HG11 ' A' ' 72' ' ' VAL . 10.2 ttp180 -114.44 132.97 56.07 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 113.687 0.995 . . . . 3.18 113.687 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.279 18.5 t30 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 117.926 2.565 . . . . 3.04 117.926 144.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.746 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 10.6 tt0 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.55 0.69 . . . . 4.2 112.348 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -105.98 136.11 46.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 1.74 109.46 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.712 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 22.4 ptt? -62.61 85.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.793 0.806 . . . . 2.93 111.125 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 57.0 ttt180 -100.54 150.29 22.83 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.494 -0.776 . . . . 2.9 110.954 -176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -90.45 160.83 28.27 Favored Glycine 0 C--N 1.293 -1.81 0 CA-C-N 115.019 -0.991 . . . . 0.44 114.796 175.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.661 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 69.2 t -99.2 142.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.417 -1.392 . . . . 0.95 109.804 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.634 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 1.2 mpt_? -66.89 133.73 50.62 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.052 0.39 . . . . 5.04 112.052 -168.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.637 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.99 115.15 28.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.26 0.552 . . . . 2.13 109.64 172.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.626 HG12 ' HG3' ' A' ' 58' ' ' GLU . 3.6 t -133.81 118.93 31.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-N 116.222 -0.445 . . . . 0.95 109.972 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.626 ' HG3' HG12 ' A' ' 57' ' ' VAL . 29.2 mt-10 56.43 36.11 27.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.82 0.343 . . . . 1.51 111.643 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.31 0.41 89.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.493 -0.861 . . . . 0.55 112.828 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 57' ' ' VAL . 4.6 mt -97.08 147.43 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 O-C-N 122.617 -0.343 . . . . 0.58 111.465 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 26' ' ' VAL . 12.7 tp -104.03 115.76 31.02 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.55 -1.278 . . . . 1.72 107.55 167.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -116.42 133.55 55.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.232 -0.587 . . . . 2.16 111.48 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.66 162.31 36.58 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.282 -1.007 . . . . 1.37 108.282 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.79 160.05 42.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 121.87 1.714 . . . . 1.6 110.921 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.5 -44.25 17.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.693 0.621 . . . . 3.12 111.89 -171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.89 32.47 0.1 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.082 -0.963 . . . . 2.45 108.854 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -88.68 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.919 -1.037 . . . . 2.11 113.935 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.673 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -103.89 -77.86 0.57 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.137 -0.69 . . . . 4.47 109.137 -172.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.02 -78.37 0.13 Allowed Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.846 -1.169 . . . . 1.78 113.462 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.937 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 3.2 p-10 -127.92 -56.95 1.26 Allowed 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 114.957 -0.622 . . . . 1.48 109.444 -169.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.795 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 56.45 167.34 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 124.694 1.247 . . . . 1.22 110.465 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' H ' HG12 ' A' ' 72' ' ' VAL . 1.9 p -95.07 104.39 15.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.858 -1.137 . . . . 1.09 108.562 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.747 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.2 m-85 -80.2 145.06 32.46 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.885 0.85 . . . . 0.84 111.845 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.3 t -108.76 154.52 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 113.519 -1.673 . . . . 0.34 109.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 1.068 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -85.61 120.13 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.163 0.506 . . . . 2.4 110.16 -167.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.563 ' HB3' ' C ' ' A' ' 40' ' ' GLY . 56.2 t30 -131.5 128.24 38.97 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.775 -0.578 . . . . 1.89 111.01 172.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.728 ' HE1' HG23 ' A' ' 75' ' ' VAL . 1.3 p90 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 118.999 -0.524 . . . . 1.36 110.648 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.773 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 15.5 p90 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 108.668 -0.864 . . . . 1.33 108.668 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.794 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 20.9 pt -116.47 163.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.646 0.26 . . . . 1.64 111.592 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.633 HH11 ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.31 131.48 56.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.853 -0.795 . . . . 3.21 108.853 179.298 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.34 146.35 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.98 -1.075 . . . . 1.96 111.365 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.933 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 t -152.25 168.56 24.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.674 -0.239 . . . . 1.23 110.413 166.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.627 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 1.7 mp0 -77.42 -33.92 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.97 111.247 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 8' ' ' THR . 1.3 t70 -133.23 152.56 51.94 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.569 -1.271 . . . . 1.14 107.569 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.588 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 4.2 mt-10 -55.29 -39.62 70.08 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 122.555 1.169 . . . . 1.48 107.966 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -106.85 25.91 10.72 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.873 -1.967 . . . . 2.58 113.057 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 4.4 t70 -81.83 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.891 -1.151 . . . . 0.59 107.891 170.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 38.6 mt-10 -122.96 91.05 50.07 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 115.754 -0.657 . . . . 2.18 110.624 168.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.933 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 58.5 Cg_endo -70.7 134.65 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.551 1.501 . . . . 0.64 110.379 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.29 153.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.364 -0.835 . . . . 0.58 110.864 -169.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.773 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.8 mp0 -108.5 122.48 47.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.2 -0.454 . . . . 1.62 110.849 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.63 138.67 17.54 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.902 -0.59 . . . . 2.06 112.006 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.04 148.34 21.71 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.957 2.438 . . . . 1.05 112.231 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.9 m -122.6 169.24 11.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 1.54 111.281 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -66.49 150.71 48.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.485 0.66 . . . . 2.77 111.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -52.38 -28.39 19.43 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.438 -1.71 . . . . 2.13 111.903 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 33.6 t70 -77.74 -7.21 56.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.379 1.085 . . . . 2.32 108.79 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.81 25.98 36.44 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 108.357 -1.897 . . . . 0.65 108.357 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.18 151.08 39.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.874 -1.663 . . . . 1.01 112.179 -160.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.908 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 147.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.393 -0.821 . . . . 0.52 110.519 173.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.046 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -65.19 96.51 0.22 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.258 0.623 . . . . 2.59 110.247 178.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.63 -49.57 70.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.563 -0.289 . . . . 1.62 110.254 -168.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.692 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.5 p -70.2 -34.35 72.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.002 0.906 . . . . 1.89 109.895 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.046 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 15.8 m -70.81 -32.78 69.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.742 -1.117 . . . . 1.71 108.085 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.863 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.5 t -65.12 -42.15 93.63 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 CA-C-N 114.11 -1.404 . . . . 1.34 110.846 171.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -64.4 -20.32 66.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.855 -0.528 . . . . 1.34 111.95 -175.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.15 -163.3 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 123.211 0.604 . . . . 1.12 109.988 -173.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -106.96 92.59 7.8 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.719 -0.845 . . . . 1.81 108.719 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.863 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -122.34 2.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.201 3.267 . . . . 0.97 114.867 173.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 106.92 -16.15 39.78 Favored Glycine 0 C--O 1.217 -0.923 0 N-CA-C 109.917 -1.273 . . . . 0.68 109.917 -162.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.718 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 52.75 -92.12 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.907 1.283 . . . . 0.52 113.542 172.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.9 m -122.69 4.16 9.52 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.672 0.749 . . . . 1.64 110.243 -166.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.533 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -136.65 174.65 21.47 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 110.085 -1.206 . . . . 0.51 110.085 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -153.19 143.71 22.58 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 120.128 -0.629 . . . . 0.82 110.692 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.4 mtt180 -134.64 150.84 50.7 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 105.739 -1.949 . . . . 2.34 105.739 160.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.659 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 45.9 p90 -152.54 165.23 35.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 121.181 1.809 . . . . 1.69 113.125 170.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.588 ' HD2' ' OE2' ' A' ' 11' ' ' GLU . 35.1 mtp85 -106.91 134.34 50.22 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.159 -1.837 . . . . 3.18 108.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 1.042 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 56.8 t30 . . . . . 0 C--O 1.219 -0.544 0 CA-C-N 114.575 -1.193 . . . . 3.04 111.136 -164.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.042 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 5.0 tt0 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 114.936 1.458 . . . . 4.2 114.936 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -60.97 130.03 44.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.992 -0.373 . . . . 1.74 109.992 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -64.85 87.58 0.06 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.357 0.598 . . . . 2.93 109.804 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 21.0 ttt180 -101.21 147.63 26.04 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.684 0.754 . . . . 2.9 112.288 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -93.7 154.61 21.74 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 113.715 -1.584 . . . . 0.44 114.279 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.563 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 46.4 t -100.04 143.7 13.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 113.746 -1.227 . . . . 0.95 111.525 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HD2' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -62.52 138.04 58.39 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 124.477 1.111 . . . . 5.04 113.517 -175.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.4 pp -115.74 124.22 50.26 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.041 -0.264 . . . . 2.13 110.405 169.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.587 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.3 t -134.94 122.95 39.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.125 0 CA-C-O 118.846 -0.597 . . . . 0.95 109.609 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.587 ' HG3' HG12 ' A' ' 57' ' ' VAL . 35.1 mt-10 56.88 36.46 27.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.651 0.659 . . . . 1.51 112.093 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.29 8.69 87.03 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.549 -0.834 . . . . 0.55 112.408 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 57' ' ' VAL . 5.8 mt -104.04 149.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 122.351 0.26 . . . . 0.58 110.785 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.908 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.8 tp -102.08 116.02 31.78 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.974 -1.121 . . . . 1.72 107.974 170.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.16 122.56 46.16 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.106 0.479 . . . . 2.16 111.734 -175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.01 163.6 22.41 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.148 -0.933 . . . . 1.37 110.381 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.17 166.55 12.5 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.112 2.541 . . . . 1.6 111.875 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.78 -45.65 4.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.233 0.827 . . . . 3.12 113.233 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.99 -29.96 7.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 2.45 110.935 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.79 128.64 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 122.04 0.8 . . . . 2.11 113.375 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -84.2 -42.66 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.391 1.091 . . . . 4.47 108.877 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.79 -79.82 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 113.359 -1.746 . . . . 1.78 111.446 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.794 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.69 -59.07 0.48 Allowed 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 114.423 -0.888 . . . . 1.48 109.36 -172.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER 58.08 151.25 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.799 1.312 . . . . 1.22 110.425 -177.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.6 p -91.33 106.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.395 -0.82 . . . . 1.09 108.806 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.705 ' HE1' HD13 ' A' ' 5' ' ' ILE . 18.1 m-85 -78.63 144.16 35.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.141 -0.936 . . . . 0.84 112.012 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.7 t -109.19 159.88 8.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.179 -1.828 . . . . 0.34 109.625 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.679 HG23 ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -91.95 113.09 26.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.76 0.791 . . . . 2.4 111.257 -169.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -130.54 126.34 36.53 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.075 -0.966 . . . . 1.89 108.922 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.691 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 118.23 -0.89 . . . . 1.36 110.4 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.863 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 23.4 p90 . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 107.985 -1.117 . . . . 1.33 107.985 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 1.004 ' HA ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -135.23 162.33 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.222 0.465 . . . . 1.64 111.473 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 1.086 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -117.98 132.67 56.37 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 119.715 -0.794 . . . . 3.21 109.889 -176.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 3.3 p -138.85 148.44 24.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.941 -0.474 . . . . 1.96 111.405 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 1.034 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -153.98 164.01 39.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.353 -0.385 . . . . 1.23 109.99 165.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.703 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.4 mp0 -67.94 -32.95 73.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 2.97 111.504 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.833 ' O ' HG22 ' A' ' 8' ' ' THR . 14.2 t70 -132.48 149.44 52.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.613 -1.625 . . . . 1.14 106.613 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 3.0 mt-10 -54.44 -34.22 61.03 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 122.01 0.91 . . . . 1.48 108.653 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -110.19 28.65 8.42 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.502 -1.681 . . . . 2.58 111.867 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.641 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.3 t70 -83.7 -117.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.895 -0.78 . . . . 0.59 108.895 171.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -121.4 89.61 47.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.555 -0.748 . . . . 2.18 110.429 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.034 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 74.4 Cg_endo -75.06 140.56 25.42 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 C-N-CA 123.107 2.538 . . . . 0.64 113.506 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.09 125.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 115.448 -0.796 . . . . 0.58 110.509 -175.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.086 ' HG2' ' HG3' ' A' ' 6' ' ' ARG . 25.0 mt-10 -86.12 120.6 27.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.223 -0.658 . . . . 1.62 109.223 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 19.7 pt -142.03 144.41 31.89 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.303 -0.862 . . . . 2.06 111.454 -168.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 72.2 Cg_endo -74.64 145.29 32.74 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.867 2.378 . . . . 1.05 113.34 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.486 ' OG ' HD13 ' A' ' 5' ' ' ILE . 8.5 m -104.42 170.26 8.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.54 110.232 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.01 141.12 54.97 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.987 -0.746 . . . . 2.77 108.987 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.66 -19.14 5.52 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.354 1.034 . . . . 2.13 112.689 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.666 ' HB2' ' HB ' ' A' ' 25' ' ' THR . 7.4 m-20 -75.95 -5.17 44.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.124 0.964 . . . . 2.32 108.775 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.21 23.99 60.13 Favored Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 108.74 -1.744 . . . . 0.65 108.74 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -122.38 154.03 38.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.1 -1.55 . . . . 1.01 111.238 -162.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.811 HG21 ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -146.68 143.12 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.526 -0.761 . . . . 0.52 109.741 172.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.692 HD22 ' CB ' ' A' ' 30' ' ' THR . 3.5 mp -68.53 116.92 9.62 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.786 -0.45 . . . . 2.59 109.786 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.669 ' O ' HG21 ' A' ' 32' ' ' THR . 15.6 tp -60.02 -51.36 69.96 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.206 0.316 . . . . 1.62 110.697 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.799 ' HA ' HG23 ' A' ' 32' ' ' THR . 7.9 m -71.78 -44.86 63.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.428 -0.805 . . . . 1.89 110.859 -174.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.692 ' CB ' HD22 ' A' ' 27' ' ' LEU . 2.7 m -63.67 -32.19 73.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.955 -0.566 . . . . 1.71 109.721 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.828 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -59.43 -48.47 87.07 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.908 -0.587 . . . . 1.34 110.262 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.799 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.11 -17.76 63.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.043 0.757 . . . . 1.34 113.043 -176.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.63 37.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 171.48 -165.71 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.967 0.907 . . . . 1.12 108.993 -173.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -109.31 92.79 12.06 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 109.233 -0.654 . . . . 1.81 109.233 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.828 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.92 8.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.52 3.48 . . . . 0.97 113.928 173.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.905 ' HA2' ' HB ' ' A' ' 75' ' ' VAL . . . 107.83 -26.7 16.79 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 110.078 -1.209 . . . . 0.68 110.078 -162.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 77' ' ' TYR . . . 61.1 -81.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.987 1.106 . . . . 0.52 113.987 167.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.529 ' HA ' HD13 ' A' ' 28' ' ' LEU . 36.5 t -120.28 -12.9 8.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.524 0.678 . . . . 1.64 109.443 -165.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.65 157.51 24.15 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.897 -1.047 . . . . 0.51 112.344 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -127.94 153.01 47.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.174 -0.61 . . . . 0.82 111.502 174.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 95.1 mtt180 -138.52 146.52 42.06 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 106.743 -1.577 . . . . 2.34 106.743 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.81 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 47.4 p90 -154.67 166.92 31.89 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 117.903 -1.519 . . . . 1.69 113.946 169.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.779 ' HB3' HG11 ' A' ' 72' ' ' VAL . 73.8 ttt180 -102.32 137.69 40.23 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 113.857 -1.519 . . . . 3.18 107.853 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.829 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.4 t-20 . . . . . 0 C--O 1.211 -0.927 0 N-CA-C 113.219 0.822 . . . . 3.04 113.219 -158.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.829 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 5.9 mt-30 . . . . . 0 CA--C 1.515 -0.369 0 N-CA-C 113.426 0.898 . . . . 4.2 113.426 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -57.33 133.96 55.58 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.124 -0.944 . . . . 1.74 109.973 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -63.42 88.22 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.672 0.748 . . . . 2.93 110.073 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -102.41 145.03 30.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.382 -0.826 . . . . 2.9 111.623 -173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 167.28 21.28 Favored Glycine 0 C--N 1.299 -1.512 0 CA-C-N 114.092 -1.413 . . . . 0.44 114.216 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 55.9 t -97.43 140.16 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.036 -1.082 . . . . 0.95 111.058 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.0 mpt_? -67.33 135.86 53.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.58 -0.736 . . . . 5.04 112.402 -174.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.773 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -108.11 120.51 42.53 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.935 -0.706 . . . . 2.13 110.563 171.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 60' ' ' ILE . 32.5 t -130.16 115.81 34.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 115.686 -0.688 . . . . 0.95 109.774 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.575 ' HG3' HG13 ' A' ' 57' ' ' VAL . 16.4 mt-10 52.59 35.42 17.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.766 0.317 . . . . 1.51 111.504 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.87 4.65 75.11 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.835 -0.698 . . . . 0.55 113.066 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 5.1 mt -100.64 148.98 6.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 O-C-N 122.586 -0.361 . . . . 0.58 111.496 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.811 ' HB2' HG21 ' A' ' 26' ' ' VAL . 56.2 mt -101.36 118.17 36.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.253 -1.017 . . . . 1.72 108.253 167.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 128.96 55.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.331 -0.547 . . . . 2.16 111.832 -174.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 161.35 57.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.83 -1.544 . . . . 1.37 106.83 161.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 12.7 Cg_exo -69.19 146.69 64.54 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.624 1.549 . . . . 1.6 111.145 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -45.78 17.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.804 0.811 . . . . 3.12 111.629 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.79 24.26 5.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.38 -1.282 . . . . 2.45 109.356 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 64' ' ' PRO . . . -77.3 -119.48 0.19 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.707 -0.759 . . . . 2.11 112.715 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.746 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.49 -172.94 2.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.454 -0.573 . . . . 4.47 109.454 -175.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -175.13 86.47 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.861 -1.162 . . . . 1.78 112.042 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.004 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 3.5 t30 102.19 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 124.808 2.242 . . . . 1.48 108.946 171.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -86.72 -177.48 6.13 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 109.517 -3.492 . . . . 1.22 106.396 167.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG11 ' HB3' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -99.28 101.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 124.546 1.154 . . . . 1.09 108.697 176.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.81 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 19.5 m-85 -84.2 141.27 31.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.704 1.002 . . . . 0.84 113.704 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.8 t -109.2 163.91 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 112.564 -2.107 . . . . 0.34 107.593 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.905 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 21.5 m -118.9 127.74 75.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.59 -0.694 . . . . 2.4 111.407 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.91 128.35 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.751 -0.78 . . . . 1.89 110.341 169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.679 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.047 -0.977 . . . . 1.36 110.306 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.636 ' O ' ' HB3' ' A' ' 70' ' ' ASN . 38.8 p90 . . . . . 0 N--CA 1.441 -0.882 0 N-CA-C 108.591 -0.892 . . . . 1.33 108.591 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.843 HD13 ' HE1' ' A' ' 73' ' ' TYR . 15.0 pt -127.52 165.78 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 122.611 0.365 . . . . 1.64 110.792 -170.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.613 ' NH1' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -114.46 132.76 56.16 Favored 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 108.952 -0.758 . . . . 3.21 108.952 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG22 ' HD1' ' A' ' 73' ' ' TYR . 2.3 t -135.89 143.5 36.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 O-C-N 121.113 -0.992 . . . . 1.96 110.296 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.967 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 t -153.55 167.41 29.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.039 -0.356 . . . . 1.23 110.039 162.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.921 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -72.48 -54.18 10.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.023 0.916 . . . . 2.97 109.2 173.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 8' ' ' THR . 13.1 t70 -112.63 148.13 35.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.639 -1.245 . . . . 1.14 107.639 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HG2' HG23 ' A' ' 74' ' ' VAL . 3.8 mt-10 -58.55 -26.38 63.5 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.869 -1.06 . . . . 1.48 108.414 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -119.8 29.19 7.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.636 -1.62 . . . . 2.58 111.158 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 4.4 t70 -84.31 -117.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.07 -1.085 . . . . 0.59 108.07 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 31.0 mt-10 -121.52 90.87 48.19 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.136 -0.938 . . . . 2.18 110.218 168.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.967 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.8 Cg_endo -72.47 134.21 22.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.649 1.566 . . . . 0.64 110.82 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.511 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -129.72 144.2 38.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.269 -0.878 . . . . 0.58 110.983 -168.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 16.9 mt-10 -90.76 122.12 33.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.768 -0.456 . . . . 1.62 109.768 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.736 HD12 ' HD2' ' A' ' 19' ' ' PRO . 7.1 tp -140.85 131.73 13.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.469 -0.787 . . . . 2.06 111.175 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.736 ' HD2' HD12 ' A' ' 18' ' ' ILE . 55.4 Cg_endo -71.88 137.71 30.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.652 2.235 . . . . 1.05 112.764 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.0 p -106.32 170.46 7.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 1.54 110.297 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -65.46 140.83 58.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.963 -0.384 . . . . 2.77 109.963 178.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' GLY . 3.5 m-20 -54.99 -19.91 7.9 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.617 -1.174 . . . . 2.13 111.987 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.78 0.92 13.79 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.866 0.841 . . . . 2.32 108.8 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.09 24.64 73.19 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.687 -1.365 . . . . 0.65 109.687 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 1.036 ' HG1' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.74 166.15 23.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.143 -1.028 . . . . 1.01 109.963 -168.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.951 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -146.18 148.21 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.415 -0.357 . . . . 0.52 110.384 175.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.047 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -65.56 94.55 0.19 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.148 -0.478 . . . . 2.59 109.861 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.715 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.61 -49.08 74.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.664 -0.495 . . . . 1.62 109.664 -168.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.626 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.4 p -65.5 -35.6 81.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.5 0.667 . . . . 1.89 110.349 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.047 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 3.4 m -72.35 -33.72 67.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.316 -0.856 . . . . 1.71 108.7 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.858 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 45.7 t -63.72 -39.71 86.37 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 115.159 -0.928 . . . . 1.34 110.383 170.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.715 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.6 p -64.87 -20.15 66.27 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.785 -0.572 . . . . 1.34 112.142 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 41.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.56 1.319 . . . . 1.0 114.56 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.08 -163.88 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.258 0.623 . . . . 1.12 110.021 -173.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.7 92.83 7.77 Favored Pre-proline 0 N--CA 1.436 -1.132 0 N-CA-C 108.649 -0.871 . . . . 1.81 108.649 165.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -122.25 3.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.639 2.892 . . . . 0.97 114.561 171.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.809 ' HA2' HG21 ' A' ' 75' ' ' VAL . . . 106.99 -23.77 26.73 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 109.806 -1.317 . . . . 0.68 109.806 -161.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.749 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.49 -89.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.031 1.333 . . . . 0.52 114.106 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 32.1 t -125.4 -13.34 6.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.45 0.643 . . . . 1.64 110.846 -161.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -114.43 156.23 15.79 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 109.633 -1.387 . . . . 0.51 109.633 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -133.05 139.75 47.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.963 -1.095 . . . . 0.82 111.871 175.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 67.6 mtt180 -132.69 154.2 50.39 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 106.313 -1.736 . . . . 2.34 106.313 162.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.721 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.1 p90 -154.69 165.47 36.44 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 120.121 1.328 . . . . 1.69 113.234 170.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 97.1 mtt180 -97.28 133.31 42.07 Favored 'General case' 0 C--O 1.253 1.268 0 O-C-N 125.684 1.865 . . . . 3.18 109.142 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 1.048 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 2.8 t-20 . . . . . 0 C--O 1.22 -0.483 0 CA-C-N 114.081 -1.418 . . . . 3.04 110.848 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.048 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.5 tt0 . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 115.132 1.53 . . . . 4.2 115.132 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -62.07 121.17 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.244 -0.889 . . . . 1.74 109.017 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 59.3 mtm -68.44 77.82 0.27 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.65 -0.87 . . . . 2.93 108.65 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.591 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 14.0 ttt180 -103.88 156.78 17.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.469 -0.787 . . . . 2.9 111.54 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.591 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -98.16 158.21 20.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.496 -1.229 . . . . 0.44 114.766 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.621 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 87.9 t -98.86 143.93 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.325 -1.437 . . . . 0.95 109.854 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.505 ' NH2' ' HA ' ' A' ' 64' ' ' PRO . 82.0 mtt180 -64.48 135.25 55.87 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 111.56 0.207 . . . . 5.04 111.56 -171.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -113.7 114.98 27.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.873 0.368 . . . . 2.13 110.031 170.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 58' ' ' GLU . 4.6 t -128.32 115.09 36.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.472 -0.331 . . . . 0.95 110.296 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 57' ' ' VAL . 23.0 mt-10 53.44 36.55 23.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.999 0.52 . . . . 1.51 112.383 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.1 0.91 73.39 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.402 -0.904 . . . . 0.55 112.689 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 1.036 HG22 ' HG1' ' A' ' 25' ' ' THR . 1.9 mt -104.34 148.04 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 122.681 -0.305 . . . . 0.58 111.163 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.951 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.3 tp -102.39 114.95 29.58 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.797 -1.186 . . . . 1.72 107.797 169.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -115.66 142.2 47.06 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.2 0.524 . . . . 2.16 111.891 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.28 160.85 29.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.091 -0.958 . . . . 1.37 110.301 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.505 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 24.2 Cg_exo -64.16 166.06 17.8 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.912 3.075 . . . . 1.6 112.602 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.01 -46.57 5.56 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.908 0.861 . . . . 3.12 112.804 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.18 -44.25 8.44 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.987 -1.46 . . . . 2.45 110.043 -175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.2 133.64 0.48 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.369 -0.832 . . . . 2.11 112.427 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.601 ' CG ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.52 -77.39 0.07 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.091 -0.555 . . . . 4.47 109.787 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 5' ' ' ILE . . . 176.24 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.663 -0.698 . . . . 1.78 112.101 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.642 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 4.9 p-10 -156.38 54.84 0.56 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.199 1.0 . . . . 1.48 109.697 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.601 HD13 ' CG ' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -52.92 162.51 0.61 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-N 113.465 -1.698 . . . . 1.22 110.028 165.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.689 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 1.6 p -96.42 107.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 114.297 -1.319 . . . . 1.09 108.656 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.843 ' HE1' HD13 ' A' ' 5' ' ' ILE . 17.1 m-85 -80.03 146.95 31.7 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.121 -0.945 . . . . 0.84 112.638 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -110.28 158.8 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 113.386 -1.734 . . . . 0.34 110.039 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.921 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 6.4 p -97.61 109.06 22.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.594 0.711 . . . . 2.4 112.422 -165.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.459 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 0.9 OUTLIER -130.62 128.51 41.14 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 120.144 -0.623 . . . . 1.89 111.399 165.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.725 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.764 0 CA-C-O 119.129 -0.462 . . . . 1.36 110.652 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 20.5 p90 . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 107.613 -1.254 . . . . 1.33 107.613 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 21.7 pt -121.45 162.38 20.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 120.645 0.26 . . . . 1.64 110.589 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.847 ' HG3' ' HA ' ' A' ' 72' ' ' VAL . 1.4 tpp85 -118.81 131.96 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.0 -1.111 . . . . 3.21 108.0 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.85 146.95 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 O-C-N 121.218 -0.926 . . . . 1.96 110.763 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 1.105 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -152.26 148.87 28.07 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.666 -0.243 . . . . 1.23 110.408 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 1.081 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 47.9 mp0 -60.8 -36.21 78.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.145 0.498 . . . . 2.97 111.593 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 t0 -128.35 153.41 47.06 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.972 -1.492 . . . . 1.14 106.972 174.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.24 -30.67 64.82 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.718 0.771 . . . . 1.48 108.927 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -119.76 31.66 6.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.366 -1.288 . . . . 2.58 110.972 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 3.8 t70 -79.98 -118.26 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.26 -1.385 . . . . 0.59 107.26 168.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 21.9 tt0 -120.45 91.88 47.04 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.72 -0.673 . . . . 2.18 110.01 168.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.105 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 64.1 Cg_endo -71.56 133.45 22.34 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.201 1.934 . . . . 0.64 111.555 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.52 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.44 -0.8 . . . . 0.58 110.885 -170.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 26.6 mt-10 -97.77 121.98 40.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.053 -0.522 . . . . 1.62 110.123 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 41.4 pt -141.28 143.36 30.21 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.843 -0.617 . . . . 2.06 111.295 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 8.2 Cg_exo -72.6 160.15 47.18 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.184 2.589 . . . . 1.05 112.422 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.4 m -132.37 171.67 13.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.9 -0.591 . . . . 1.54 110.001 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.03 142.09 58.54 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.262 -0.644 . . . . 2.77 109.262 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.21 -24.21 17.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 124.503 1.127 . . . . 2.13 111.951 -168.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 16.0 t70 -74.38 -8.64 56.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.34 1.067 . . . . 2.32 108.905 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.26 41.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.741 -1.744 . . . . 0.65 108.741 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -120.62 154.89 34.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.052 -1.574 . . . . 1.01 111.518 -165.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.861 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -147.61 140.01 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.161 -0.927 . . . . 0.52 109.138 169.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 30' ' ' THR . 2.8 mp -64.43 111.86 2.85 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.927 -0.768 . . . . 2.59 108.927 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.756 ' O ' HG21 ' A' ' 32' ' ' THR . 30.0 tp -58.14 -51.71 68.58 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 120.756 0.313 . . . . 1.62 110.193 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -67.18 -47.5 70.76 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.564 -0.744 . . . . 1.89 110.626 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.681 ' CB ' HD22 ' A' ' 27' ' ' LEU . 3.0 m -65.55 -32.65 74.36 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 115.563 -0.744 . . . . 1.71 109.81 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.853 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -61.48 -45.12 99.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 115.907 -0.588 . . . . 1.34 110.478 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.756 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.5 p -64.36 -19.21 65.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.207 0.447 . . . . 1.34 112.207 -176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.1 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 171.22 -164.35 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 123.406 0.682 . . . . 1.12 109.835 -173.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -107.79 92.81 9.42 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.55 -0.75 . . . . 1.81 109.214 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.853 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -120.32 6.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.322 3.348 . . . . 0.97 113.924 171.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 1.059 ' HA2' HG12 ' A' ' 75' ' ' VAL . . . 107.47 -25.54 21.14 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.097 -1.201 . . . . 0.68 110.097 -161.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 77' ' ' TYR . . . 56.61 -91.81 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.029 1.332 . . . . 0.52 113.735 173.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.437 ' HA ' HD13 ' A' ' 28' ' ' LEU . 19.5 m -115.78 -21.71 9.48 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.546 0.689 . . . . 1.64 110.135 -160.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.57 147.8 18.74 Favored Glycine 0 N--CA 1.418 -2.557 0 CA-C-N 114.783 -1.099 . . . . 0.51 111.005 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.757 HD13 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -128.22 142.34 51.19 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.335 -0.946 . . . . 0.82 110.606 172.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.715 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 96.0 mtt180 -132.24 161.78 32.58 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.841 -1.911 . . . . 2.34 105.841 165.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.72 ' HD2' ' HE2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -157.4 166.66 32.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.038 -1.065 . . . . 1.69 112.369 168.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.56 ' HB2' HG21 ' A' ' 72' ' ' VAL . 46.4 mtp180 -111.08 139.28 46.57 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.347 1.655 . . . . 3.18 108.282 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.863 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.209 -1.033 0 CA-C-N 115.343 -0.844 . . . . 3.04 111.636 -161.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.863 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 6.2 mt-30 . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 113.494 0.924 . . . . 4.2 113.494 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -46.88 121.68 3.8 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.262 -0.881 . . . . 1.74 110.207 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 15.8 ptm -63.6 86.21 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 2.93 109.21 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 10.6 ttt180 -124.67 151.03 45.46 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.709 0.766 . . . . 2.9 111.079 -172.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.51 165.52 24.87 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 114.194 -1.366 . . . . 0.44 115.124 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.675 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 78.5 t -83.73 141.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 112.879 -1.661 . . . . 0.95 109.696 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mpt_? -64.96 134.53 54.12 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.485 0.18 . . . . 5.04 111.485 -171.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.8 pp -110.62 114.08 27.2 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.59 -0.444 . . . . 2.13 110.065 172.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.639 HG12 ' HG3' ' A' ' 58' ' ' GLU . 13.9 t -125.1 113.79 37.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 109.916 -0.401 . . . . 0.95 109.916 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.639 ' HG3' HG12 ' A' ' 57' ' ' VAL . 19.9 mt-10 52.19 36.6 19.68 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.837 0.455 . . . . 1.51 111.711 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.79 -1.71 75.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.38 -0.914 . . . . 0.55 112.891 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -95.69 145.49 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 117.342 0.571 . . . . 0.58 110.688 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.861 ' HB3' HG21 ' A' ' 26' ' ' VAL . 11.9 tp -104.38 115.82 31.05 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.65 -1.241 . . . . 1.72 107.65 170.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 2.5 t-80 -116.05 133.57 55.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.162 -0.615 . . . . 2.16 112.081 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 162.24 37.23 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 107.684 -1.228 . . . . 1.37 107.684 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.09 153.19 72.41 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.491 1.46 . . . . 1.6 110.835 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -46.92 -44.14 19.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.588 0.709 . . . . 3.12 111.472 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.64 36.43 0.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.428 -1.26 . . . . 2.45 108.646 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.34 -103.53 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.99 -1.005 . . . . 2.11 113.885 -172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.615 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -86.57 -58.18 2.71 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.969 -0.752 . . . . 4.47 108.969 -173.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.58 -69.71 0.34 Allowed Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.57 -1.196 . . . . 1.78 113.195 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -139.39 -56.06 0.58 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 114.628 -0.786 . . . . 1.48 109.107 -168.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.668 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.3 OUTLIER 55.25 161.78 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.72 0 O-C-N 124.375 1.047 . . . . 1.22 110.544 -177.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.847 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 16.3 m -93.63 104.27 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 108.174 -1.047 . . . . 1.09 108.174 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.757 ' HB3' HD13 ' A' ' 41' ' ' LEU . 22.5 m-85 -78.58 138.91 38.6 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.884 -0.598 . . . . 0.84 111.504 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -96.85 151.94 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.456 -1.247 . . . . 0.34 108.687 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 1.081 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 4.0 t -114.86 115.23 48.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.342 0.591 . . . . 2.4 112.265 -163.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.715 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -128.63 129.14 45.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.497 -0.774 . . . . 1.89 111.351 178.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.735 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.658 -0.687 . . . . 1.36 110.552 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.917 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 32.6 p90 . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 109.272 -0.64 . . . . 1.33 109.272 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.963 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 25.4 pt -124.06 160.71 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.234 0.333 . . . . 1.64 110.516 -174.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.778 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 22.1 ttm180 -118.73 135.61 54.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.976 -0.69 . . . . 3.21 110.146 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.1 t -130.02 145.94 34.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 O-C-N 122.044 -0.41 . . . . 1.96 110.638 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.814 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.3 t -151.4 163.02 39.91 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.297 -0.252 . . . . 1.23 110.417 163.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 1.016 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -68.87 -39.05 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.925 -0.71 . . . . 2.97 111.011 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.26 154.84 50.78 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.875 -0.787 . . . . 1.14 108.875 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -52.6 -39.34 61.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.454 1.121 . . . . 1.48 108.257 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.57 7.97 33.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.366 -1.743 . . . . 2.58 112.939 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.61 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 2.7 t70 -85.79 -127.01 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 118.861 -1.136 . . . . 0.59 108.218 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.46 92.13 48.55 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.566 -0.743 . . . . 2.18 110.315 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.814 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.1 Cg_endo -70.57 132.96 23.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.726 1.617 . . . . 0.64 111.094 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.19 125.82 64.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.173 -0.921 . . . . 0.58 110.692 -169.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.917 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 23.4 mt-10 -85.1 120.98 27.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.966 -0.561 . . . . 1.62 110.453 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 21.4 pt -143.07 145.2 31.92 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.07 -0.968 . . . . 2.06 111.748 -171.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 16.5 Cg_exo -69.54 133.68 26.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.112 2.542 . . . . 1.05 113.084 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 p -108.53 172.23 6.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.809 -0.632 . . . . 1.54 110.647 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.73 138.41 58.37 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.044 0.45 . . . . 2.77 110.018 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -53.48 -31.49 45.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.954 -1.476 . . . . 2.13 112.183 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.537 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.4 p-10 -85.45 2.3 45.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.877 0.846 . . . . 2.32 108.9 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 25.47 18.28 Favored Glycine 0 CA--C 1.497 -1.07 0 CA-C-N 114.336 -1.302 . . . . 0.65 109.976 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.537 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.01 155.42 29.23 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.004 -1.098 . . . . 1.01 112.254 -165.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.781 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 138.49 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.121 -0.945 . . . . 0.52 108.994 169.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.703 HD22 ' CB ' ' A' ' 30' ' ' THR . 2.6 mp -64.08 112.09 2.83 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.942 -0.762 . . . . 2.59 108.942 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.702 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.34 -50.01 69.44 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.193 -0.669 . . . . 1.62 109.193 -174.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.8 p -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 1.89 111.171 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.703 ' CB ' HD22 ' A' ' 27' ' ' LEU . 3.6 m -68.43 -32.95 73.34 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.181 -0.674 . . . . 1.71 109.181 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.84 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.3 t -58.61 -53.41 47.41 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 CA-C-N 115.199 -0.91 . . . . 1.34 110.383 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -61.94 -16.64 52.59 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.351 0.871 . . . . 1.34 113.351 -175.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.375 1.25 . . . . 1.0 114.375 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.588 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 172.32 -164.26 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.014 0.926 . . . . 1.12 109.259 -173.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -108.96 91.88 9.85 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 109.073 -0.714 . . . . 1.81 109.073 164.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.84 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.13 8.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.801 3.667 . . . . 0.97 114.466 175.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.844 ' HA2' HG12 ' A' ' 75' ' ' VAL . . . 108.27 -21.16 29.39 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.137 -1.185 . . . . 0.68 110.137 -163.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB2' ' HB3' ' A' ' 77' ' ' TYR . . . 58.51 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.755 1.02 . . . . 0.52 113.755 170.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.9 m -130.77 -5.33 4.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.52 0.676 . . . . 1.64 110.472 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -132.0 155.27 21.37 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 115.14 -0.936 . . . . 0.51 111.86 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -132.41 154.59 49.67 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 119.8 -0.76 . . . . 0.82 111.466 174.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.2 mtt180 -140.41 151.82 45.22 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.706 -1.961 . . . . 2.34 105.706 161.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.664 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 36.3 p90 -157.63 165.03 36.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 120.188 1.358 . . . . 1.69 112.699 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 45.3 mtm180 -110.89 150.38 29.27 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 125.601 1.813 . . . . 3.18 109.554 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.814 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 23.4 t-20 . . . . . 0 C--O 1.214 -0.806 0 CA-C-N 114.148 -1.387 . . . . 3.04 111.115 -162.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.814 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 10.2 mt-30 . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 113.901 1.075 . . . . 4.2 113.901 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.71 115.9 1.3 Allowed 'General case' 0 C--N 1.308 -1.223 0 O-C-N 123.813 0.696 . . . . 1.74 110.739 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 4.8 ptt? -62.43 92.43 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.378 0.608 . . . . 2.93 110.222 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 7.6 ptp85 -122.31 161.42 23.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.573 -0.74 . . . . 2.9 109.691 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -116.13 167.26 12.43 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.085 -1.055 . . . . 0.44 115.391 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.654 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 99.5 t -83.96 141.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.345 -1.427 . . . . 0.95 111.391 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.497 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 3.3 mpt_? -72.29 135.64 46.03 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.643 -0.708 . . . . 5.04 112.221 -171.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp -98.84 117.68 33.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.103 -0.639 . . . . 2.13 109.888 172.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.645 HG12 ' HG3' ' A' ' 58' ' ' GLU . 9.5 t -132.95 114.7 22.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 109.87 -0.419 . . . . 0.95 109.87 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.645 ' HG3' HG12 ' A' ' 57' ' ' VAL . 25.3 mt-10 53.9 39.5 30.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.092 0.405 . . . . 1.51 112.092 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 87.04 -1.37 86.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.42 -0.895 . . . . 0.55 112.646 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.3 mt -100.75 149.33 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 122.734 -0.274 . . . . 0.58 111.073 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.781 ' HB3' HG21 ' A' ' 26' ' ' VAL . 6.4 tp -102.09 114.83 29.3 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.507 -1.664 . . . . 1.72 106.507 165.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -115.57 134.69 54.81 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.269 0.557 . . . . 2.16 112.322 -165.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB1' ' CH2' ' A' ' 68' ' ' TRP . . . -103.65 163.02 18.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.591 -1.186 . . . . 1.37 108.572 170.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.82 163.76 15.33 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.687 2.258 . . . . 1.6 111.683 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.2 -45.79 8.59 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.71 0.766 . . . . 3.12 112.834 -173.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.38 -39.12 8.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.296 -1.32 . . . . 2.45 110.336 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.88 149.06 4.48 Favored Glycine 0 N--CA 1.426 -2.029 0 C-N-CA 120.556 -0.831 . . . . 2.11 112.298 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.623 ' HB2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.85 -52.43 36.82 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.934 -1.135 . . . . 4.47 107.934 175.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 5' ' ' ILE . . . 166.98 -83.76 0.1 OUTLIER Glycine 0 N--CA 1.417 -2.58 0 CA-C-N 113.79 -1.55 . . . . 1.78 111.427 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.963 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.2 p30 -142.25 -62.11 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 0 CA-C-N 114.58 -0.81 . . . . 1.48 109.922 -170.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 54.01 176.4 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.35 1.071 . . . . 1.22 111.297 -177.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.54 ' H ' HG12 ' A' ' 72' ' ' VAL . 2.1 p -102.91 104.54 16.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 113.326 -1.761 . . . . 1.09 108.427 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.786 ' HE1' HD13 ' A' ' 5' ' ' ILE . 20.4 m-85 -80.82 146.5 30.89 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.701 0.763 . . . . 0.84 112.157 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -107.6 158.21 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.499 -1.682 . . . . 0.34 107.933 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 1.016 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 t -113.93 110.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.56 0.695 . . . . 2.4 111.383 -164.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -126.35 129.4 48.74 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.122 -0.945 . . . . 1.89 110.684 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.696 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.835 0 CA-C-O 118.587 -0.72 . . . . 1.36 110.116 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 23.0 p90 . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.594 -1.632 . . . . 1.33 106.594 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.919 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -127.49 160.76 36.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.984 -0.286 . . . . 1.64 110.661 -172.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 5.2 ttt180 -119.4 132.77 55.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.758 -0.777 . . . . 3.21 109.279 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.776 HG23 ' HD1' ' A' ' 73' ' ' TYR . 3.5 t -132.63 144.2 37.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 121.923 -0.485 . . . . 1.96 110.396 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.992 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 5.4 t -152.85 168.33 26.11 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.369 0.128 . . . . 1.23 110.768 166.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.776 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 tm-20 -72.92 -56.4 5.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.058 0.932 . . . . 2.97 108.624 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 8' ' ' THR . 14.0 t70 -110.01 148.31 31.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.822 -1.177 . . . . 1.14 107.822 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.631 ' HG2' HG23 ' A' ' 74' ' ' VAL . 1.5 mt-10 -63.11 -17.82 62.73 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.347 -1.297 . . . . 1.48 108.577 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.64 33.55 4.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.996 -1.456 . . . . 2.58 110.657 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 7.3 t70 -83.55 -118.09 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.697 -1.223 . . . . 0.59 107.697 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -121.5 90.76 48.1 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.067 -0.97 . . . . 2.18 110.184 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.992 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 72.7 Cg_endo -74.69 133.43 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.056 1.837 . . . . 0.64 110.879 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.28 136.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.021 -0.536 . . . . 0.58 111.338 -169.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 34.2 mt-10 -86.07 122.0 29.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.84 -0.43 . . . . 1.62 109.84 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 25.4 pt -140.49 141.1 24.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.789 -0.641 . . . . 2.06 111.031 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 47.6 Cg_endo -69.69 136.29 32.81 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.713 2.275 . . . . 1.05 112.425 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.768 ' HB3' HD13 ' A' ' 5' ' ' ILE . 8.2 p -112.14 169.36 8.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 1.54 110.518 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.91 136.73 53.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.333 -0.618 . . . . 2.77 109.333 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 24' ' ' GLY . 1.2 m-20 -55.1 -17.4 4.01 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.195 0.998 . . . . 2.13 112.555 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -74.55 0.71 13.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.009 0.909 . . . . 2.32 108.645 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.31 23.98 74.38 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 113.866 -1.516 . . . . 0.65 110.973 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.925 ' HG1' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -132.43 166.74 21.32 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.406 -0.397 . . . . 1.01 110.775 -169.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.849 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -147.5 146.35 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.598 -0.728 . . . . 0.52 110.04 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.809 ' HG ' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -67.62 109.71 3.4 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.007 -0.738 . . . . 2.59 109.007 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.525 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -65.77 -48.95 70.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.17 -0.923 . . . . 1.62 110.009 -169.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.5 m -58.86 -39.23 80.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.14 -0.936 . . . . 1.89 110.771 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.809 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 2.5 t -68.61 -33.19 73.61 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.602 -1.259 . . . . 1.71 107.602 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.842 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 19.8 t -66.89 -42.54 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 CA-C-N 114.292 -1.322 . . . . 1.34 109.864 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.684 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -65.8 -19.09 65.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.366 0.506 . . . . 1.34 112.366 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.7 41.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.51 1.3 . . . . 1.0 114.51 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 173.51 -164.29 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 123.968 0.907 . . . . 1.12 108.981 -173.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.04 92.16 10.44 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 108.849 -0.797 . . . . 1.81 108.849 166.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.842 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -118.53 1.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.287 3.325 . . . . 0.97 114.369 173.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.882 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . 107.61 -20.09 32.61 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 110.1 -1.2 . . . . 0.68 110.1 -161.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 63.45 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.226 1.01 . . . . 0.52 113.504 170.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.4 t -128.87 -21.49 3.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.317 0.58 . . . . 1.64 110.415 -165.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.507 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -112.97 155.51 16.24 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.485 -1.046 . . . . 0.51 110.485 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.59 151.01 51.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 118.736 -1.186 . . . . 0.82 112.984 176.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 mtt180 -133.82 161.0 35.92 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.187 -1.783 . . . . 2.34 106.187 158.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.833 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.6 p90 -156.91 165.57 35.83 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 119.396 0.998 . . . . 1.69 111.892 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB2' HG11 ' A' ' 72' ' ' VAL . 53.6 mtt180 -110.07 143.64 39.83 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 125.088 1.493 . . . . 3.18 109.138 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 1.047 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 35.0 t30 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 114.995 -1.002 . . . . 3.04 111.343 -169.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.047 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 115.28 1.585 . . . . 4.2 115.28 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.56 118.67 12.72 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.088 -0.96 . . . . 1.74 111.01 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 5.9 ptm -64.23 87.26 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.074 -0.713 . . . . 2.93 109.074 170.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 7.3 ttt180 -121.19 156.21 32.88 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.934 -0.575 . . . . 2.9 110.432 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -100.48 164.81 19.04 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 121.975 0.764 . . . . 0.44 113.951 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.634 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 91.0 t -98.53 140.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.545 -1.327 . . . . 0.95 109.867 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.6 ' HD2' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -63.27 134.72 56.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.648 -0.705 . . . . 5.04 112.642 -175.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.34 121.77 46.1 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.533 -0.467 . . . . 2.13 109.925 165.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.667 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.7 t -126.17 113.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.739 -0.467 . . . . 0.95 109.739 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.667 ' HG3' HG12 ' A' ' 57' ' ' VAL . 12.1 mt-10 51.13 36.5 15.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.067 0.547 . . . . 1.51 112.445 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.458 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . 95.35 -3.23 66.04 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.729 -0.748 . . . . 0.55 112.932 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.925 HG22 ' HG1' ' A' ' 25' ' ' THR . 2.3 mt -100.81 148.16 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.726 -0.279 . . . . 0.58 110.443 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.849 ' HB3' HG21 ' A' ' 26' ' ' VAL . 16.4 tp -102.44 114.58 28.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.134 -1.061 . . . . 1.72 108.134 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -111.65 122.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.711 0.767 . . . . 2.16 111.616 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.67 162.47 62.83 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 106.838 -1.541 . . . . 1.37 106.838 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 22.2 Cg_exo -63.41 149.89 89.97 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 120.421 1.186 . . . . 1.6 109.594 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -45.95 -43.68 14.2 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.195 0.934 . . . . 3.12 111.924 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.17 32.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.484 -0.932 . . . . 2.45 108.484 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.11 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.004 -0.998 . . . . 2.11 113.885 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.708 ' CD1' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.34 -76.93 0.6 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.538 0.685 . . . . 4.47 109.897 -172.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.33 -76.49 0.12 Allowed Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 114.95 -1.023 . . . . 1.78 113.757 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.919 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -133.42 -59.03 0.88 Allowed 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.101 -0.549 . . . . 1.48 109.737 -167.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 51.06 172.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.439 1.087 . . . . 1.22 111.648 -176.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 44' ' ' ARG . 2.0 p -99.56 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 113.99 -1.459 . . . . 1.09 108.492 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.833 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.6 m-85 -79.86 144.81 33.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.827 0.822 . . . . 0.84 112.671 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.631 HG23 ' HG2' ' A' ' 11' ' ' GLU . 3.5 t -110.38 164.11 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.356 -1.747 . . . . 0.34 109.548 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.882 HG22 ' HA2' ' A' ' 37' ' ' GLY . 9.8 p -98.95 114.67 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.671 0.619 . . . . 2.4 112.671 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 1.1 p30 -133.54 128.2 34.78 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 118.638 -1.225 . . . . 1.89 110.533 158.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.702 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.38 -0.819 . . . . 1.36 109.957 167.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.618 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 16.8 p90 . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 107.258 -1.386 . . . . 1.33 107.258 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.799 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -121.86 162.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.88 0.309 . . . . 1.64 111.223 -172.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 1.015 ' HD2' ' HB2' ' A' ' 15' ' ' PRO . 1.9 tpp85 -117.83 132.45 56.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.152 -0.684 . . . . 3.21 109.152 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 2.7 p -138.81 147.2 25.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 O-C-N 121.411 -0.806 . . . . 1.96 111.503 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.961 HG21 ' HB3' ' A' ' 15' ' ' PRO . 2.1 t -153.49 171.13 19.18 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.494 -0.928 . . . . 1.23 108.494 166.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.0 mt-10 -75.33 -54.9 6.3 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.834 -1.147 . . . . 2.97 108.142 171.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 12.0 m-20 -103.38 142.11 34.78 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.845 -1.169 . . . . 1.14 107.845 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 74' ' ' VAL . 4.3 mt-10 -57.71 -25.76 60.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 1.48 109.078 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.64 39.33 3.89 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.677 -1.601 . . . . 2.58 110.868 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.4 t70 -80.86 -114.48 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.042 -1.466 . . . . 0.59 107.042 165.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -123.14 90.16 50.52 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.274 -0.875 . . . . 2.18 109.668 165.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.015 ' HB2' ' HD2' ' A' ' 6' ' ' ARG . 72.5 Cg_endo -72.55 135.96 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.397 2.065 . . . . 0.64 111.376 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -126.86 147.01 31.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.804 -0.635 . . . . 0.58 110.928 -168.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 13.8 mt-10 -95.62 124.53 39.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.113 -0.494 . . . . 1.62 110.857 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 35.8 pt -141.2 150.9 60.19 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.715 -0.675 . . . . 2.06 111.047 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.48 159.73 14.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.938 2.426 . . . . 1.05 112.421 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.516 ' OG ' HD13 ' A' ' 5' ' ' ILE . 16.4 m -119.06 169.59 9.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 1.54 110.277 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.15 145.31 55.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.054 -0.721 . . . . 2.77 109.054 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -23.74 14.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.281 -1.327 . . . . 2.13 111.952 -171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 22.5 t70 -78.26 -8.46 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.213 1.006 . . . . 2.32 109.171 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.1 31.67 Favored Glycine 0 CA--C 1.5 -0.873 0 N-CA-C 108.681 -1.767 . . . . 0.65 108.681 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -117.56 149.81 40.02 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 112.893 -1.654 . . . . 1.01 110.915 -166.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.787 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -144.42 148.03 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.225 -0.443 . . . . 0.52 110.725 173.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.026 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -70.61 94.69 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 2.59 110.48 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.679 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.58 -49.77 69.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.017 -0.538 . . . . 1.62 110.461 -170.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.698 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.7 m -69.77 -31.04 68.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.618 0.723 . . . . 1.89 109.719 -177.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.026 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.5 m -73.46 -32.36 64.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.233 -0.894 . . . . 1.71 108.758 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.801 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 17.5 t -64.33 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 115.175 -0.921 . . . . 1.34 110.273 168.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.698 HG23 ' HA ' ' A' ' 29' ' ' SER . 1.3 p -65.03 -18.8 65.61 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.042 -0.411 . . . . 1.34 111.887 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.95 40.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 170.76 -166.61 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 124.054 0.941 . . . . 1.12 108.846 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -109.62 92.32 11.91 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.89 -0.781 . . . . 1.81 108.89 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.801 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 2.4 Cg_endo -120.42 5.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.199 3.266 . . . . 0.97 114.661 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 107.31 -26.98 16.91 Favored Glycine 0 C--O 1.222 -0.602 0 N-CA-C 109.716 -1.353 . . . . 0.68 109.716 -161.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.721 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 62.57 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.509 1.3 . . . . 0.52 114.509 165.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -122.41 -10.17 8.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.612 0.72 . . . . 1.64 110.482 -159.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -120.4 154.06 16.54 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.489 -1.445 . . . . 0.51 109.489 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -130.47 138.9 50.51 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 118.716 -1.194 . . . . 0.82 111.893 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.745 ' HE ' ' HB3' ' A' ' 51' ' ' MET . 20.1 mtp180 -126.35 157.94 37.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.381 -1.34 . . . . 2.34 107.381 159.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.795 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 25.4 p90 -154.34 160.21 41.59 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.435 -1.306 . . . . 1.69 111.845 165.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.564 ' HB3' HG11 ' A' ' 72' ' ' VAL . 15.0 ttm180 -107.57 136.24 47.68 Favored 'General case' 0 C--O 1.253 1.267 0 O-C-N 125.758 1.911 . . . . 3.18 109.228 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.6 m120 . . . . . 0 C--O 1.211 -0.946 0 O-C-N 124.292 0.995 . . . . 3.04 111.908 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 35.7 mt-30 . . . . . 0 CA--C 1.507 -0.673 0 N-CA-C 113.879 1.066 . . . . 4.2 113.879 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -67.88 124.56 23.68 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.877 -1.51 . . . . 1.74 108.861 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.745 ' HB3' ' HE ' ' A' ' 42' ' ' ARG . 18.2 mmt -69.67 80.05 0.43 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.997 -1.112 . . . . 2.93 107.997 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 15.1 ttt180 -101.79 152.88 20.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.565 -1.198 . . . . 2.9 110.991 -166.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.476 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -99.33 161.02 19.83 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.288 -1.324 . . . . 0.44 114.54 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.661 ' CG1' ' HG ' ' A' ' 61' ' ' LEU . 86.0 t -99.09 142.16 15.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 113.416 -1.392 . . . . 0.95 110.158 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -64.4 136.2 56.87 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 112.05 0.389 . . . . 5.04 112.05 -172.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.67 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -117.1 111.91 20.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.123 0.487 . . . . 2.13 110.567 175.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 60' ' ' ILE . 35.6 t -127.97 117.25 45.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 116.26 -0.427 . . . . 0.95 110.059 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 57' ' ' VAL . 22.0 mt-10 54.83 35.7 24.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.687 0.28 . . . . 1.51 111.689 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.7 3.1 86.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.41 -0.9 . . . . 0.55 112.933 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.1 mt -96.29 146.62 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 117.114 0.457 . . . . 0.58 110.814 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.787 ' HB3' HG21 ' A' ' 26' ' ' VAL . 6.8 tp -103.83 117.89 35.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.268 -1.382 . . . . 1.72 107.268 169.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -116.44 137.37 52.21 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.107 -0.637 . . . . 2.16 112.365 -169.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.48 163.74 17.6 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 114.564 -1.198 . . . . 1.37 109.899 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.3 167.4 6.16 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.672 2.914 . . . . 1.6 111.79 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -44.1 3.58 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.821 0.701 . . . . 3.12 112.66 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 -21.02 7.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.125 -0.943 . . . . 2.45 110.93 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 153.53 19.73 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.567 -1.302 . . . . 2.11 112.378 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.728 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.71 -49.89 35.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.441 -1.318 . . . . 4.47 107.441 169.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.1 -81.48 0.08 OUTLIER Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 112.781 -2.009 . . . . 1.78 110.261 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.799 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.5 p30 -147.04 -61.73 0.29 Allowed 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.559 -0.821 . . . . 1.48 109.354 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 68' ' ' TRP . 1.2 mm? 56.24 166.95 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.664 0 O-C-N 124.276 0.985 . . . . 1.22 110.959 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.605 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 1.8 p -100.3 107.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 114.26 -1.336 . . . . 1.09 109.493 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.842 ' HB3' HD11 ' A' ' 41' ' ' LEU . 19.0 m-85 -77.1 142.2 39.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.109 -0.95 . . . . 0.84 112.041 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.718 HG23 ' HG2' ' A' ' 11' ' ' GLU . 3.3 t -110.88 167.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 113.629 -1.623 . . . . 0.34 110.6 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 5.7 p -99.03 105.02 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 112.641 0.608 . . . . 2.4 112.641 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 0.3 OUTLIER -130.36 124.9 33.3 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 118.692 -1.203 . . . . 1.89 111.506 163.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.687 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.294 -0.86 . . . . 1.36 109.545 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.986 -0.375 . . . . 6.22 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -120.23 101.28 7.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 3.03 110.977 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.7 136.79 34.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.678 -0.49 . . . . 2.5 109.678 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 29.8 p90 -139.66 176.01 9.09 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.379 . . . . 1.33 107.278 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.932 HD13 ' HE1' ' A' ' 73' ' ' TYR . 23.6 pt -129.98 163.8 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.129 0.422 . . . . 1.64 111.123 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.742 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 134.28 55.14 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 109.506 -0.553 . . . . 3.21 109.506 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 73' ' ' TYR . 1.6 t -136.83 142.87 36.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 O-C-N 121.499 -0.751 . . . . 1.96 110.883 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 t -154.13 151.74 29.61 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.01 -0.431 . . . . 1.23 111.319 163.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.972 ' HA ' ' CB ' ' A' ' 75' ' ' VAL . 18.8 tt0 -65.96 -40.05 90.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.51 0.672 . . . . 2.97 110.734 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 8' ' ' THR . 18.6 t70 -123.02 151.03 42.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.711 -1.588 . . . . 1.14 106.711 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.32 -30.5 66.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.553 -0.906 . . . . 1.48 108.553 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.69 31.19 6.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.284 -1.325 . . . . 2.58 111.031 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 27.0 t70 -84.84 -121.53 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.28 -1.378 . . . . 0.59 107.28 167.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -122.19 92.95 48.81 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.373 -0.831 . . . . 2.18 110.455 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 56.3 Cg_endo -67.57 136.3 38.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.191 1.927 . . . . 0.64 110.997 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.497 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.86 143.94 39.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.351 -0.84 . . . . 0.58 111.461 -169.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.673 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 23.8 mt-10 -97.35 125.66 42.1 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.888 -0.412 . . . . 1.62 109.888 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 47.8 pt -140.77 139.08 19.13 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.155 -0.475 . . . . 2.06 111.527 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 7.6 Cg_exo -72.65 150.91 51.56 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.292 2.662 . . . . 1.05 112.784 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -129.47 168.41 16.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 1.54 111.019 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -75.07 145.73 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.289 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.38 -21.37 9.42 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.611 -1.177 . . . . 2.13 112.536 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 29.3 t70 -76.16 -7.04 53.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.292 1.044 . . . . 2.32 108.709 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.98 53.99 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.021 -1.631 . . . . 0.65 109.021 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.479 HG23 ' CG2' ' A' ' 60' ' ' ILE . 0.6 OUTLIER -123.44 155.92 36.51 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.447 -1.376 . . . . 1.01 110.401 -166.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -147.31 152.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 122.568 0.347 . . . . 0.52 110.811 177.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.095 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -68.9 94.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.129 -0.487 . . . . 2.59 110.468 178.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD23 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -64.6 -49.69 70.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 110.006 -0.368 . . . . 1.62 110.006 -171.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.791 ' HA ' HG23 ' A' ' 32' ' ' THR . 16.7 p -62.66 -36.22 82.16 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.829 0.824 . . . . 1.89 110.154 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.095 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.6 m -72.53 -33.6 66.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.913 -1.04 . . . . 1.71 108.512 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.832 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 8.8 t -60.95 -48.52 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.482 -1.236 . . . . 1.34 110.751 170.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -62.44 -17.7 60.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.095 0.776 . . . . 1.34 113.095 -176.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.12 38.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.71 1.374 . . . . 1.0 114.71 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.522 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 170.22 -164.72 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.194 0.998 . . . . 1.12 109.012 -173.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -107.97 92.09 8.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.938 -0.764 . . . . 1.81 108.938 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.832 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.76 6.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.86 3.707 . . . . 0.97 115.318 176.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 1.029 ' HA2' HG11 ' A' ' 75' ' ' VAL . . . 109.2 -15.6 32.99 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 109.979 -1.249 . . . . 0.68 109.979 -161.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 32' ' ' THR . . . 47.15 -91.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.984 1.314 . . . . 0.52 114.148 171.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 t -131.02 6.74 4.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.404 0.621 . . . . 1.64 110.282 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -144.69 147.8 19.2 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.341 -0.845 . . . . 0.51 111.081 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -128.25 152.97 47.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.283 -1.367 . . . . 0.82 113.093 177.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.75 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 77.7 mtt-85 -136.48 164.88 27.13 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.057 -2.201 . . . . 2.34 105.057 158.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.678 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -155.94 163.65 39.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 119.928 1.24 . . . . 1.69 112.502 168.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 29.1 mmt180 -114.79 125.5 53.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 124.48 1.112 . . . . 3.18 113.329 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 1.051 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.39 0.7 OUTLIER 98.66 -60.28 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.223 0 N-CA-C 119.935 3.309 . . . . 3.04 119.935 141.231 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.719 ' HB2' HD13 ' A' ' 71' ' ' LEU . 39.5 Cg_exo -61.94 -1.29 2.1 Favored 'Trans proline' 0 C--N 1.363 1.298 0 CA-C-N 123.82 2.4 . . . . 3.71 113.787 -170.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.813 HG11 ' H ' ' A' ' 48' ' ' SER . 2.5 p -98.32 -101.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.322 -0.621 . . . . 5.02 109.322 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.813 ' H ' HG11 ' A' ' 47' ' ' VAL . 37.7 m -111.86 14.13 20.97 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 116.109 -0.496 . . . . 3.64 111.26 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.051 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 9.7 mt-30 62.45 22.3 13.16 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.317 1.056 . . . . 4.2 111.96 -171.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 132.19 34.67 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.464 -1.698 . . . . 1.74 111.293 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 12.4 ptp -69.52 82.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.051 0.453 . . . . 2.93 109.937 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.618 ' HD3' ' OH ' ' A' ' 43' ' ' TYR . 18.3 ttt180 -115.95 150.3 37.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.652 0.739 . . . . 2.9 110.812 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.77 165.98 24.8 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.514 -1.221 . . . . 0.44 115.243 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.637 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 70.5 t -99.43 146.19 9.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.856 -1.672 . . . . 0.95 111.01 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.733 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 11.1 mtt180 -62.01 136.27 57.89 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.707 0.803 . . . . 5.04 112.906 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.671 ' HB2' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -121.74 115.7 23.17 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.664 -0.495 . . . . 2.13 109.664 170.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.663 HG12 ' HG3' ' A' ' 58' ' ' GLU . 10.3 t -130.22 114.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.535 -0.302 . . . . 0.95 110.52 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.663 ' HG3' HG12 ' A' ' 57' ' ' VAL . 15.3 mt-10 51.2 37.19 17.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.021 0.528 . . . . 1.51 112.289 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -2.04 66.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.681 -0.771 . . . . 0.55 113.058 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -100.97 147.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.684 -0.304 . . . . 0.58 111.586 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.892 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.3 tp -103.8 114.56 28.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.836 -1.172 . . . . 1.72 107.836 169.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.733 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 9.9 t-160 -114.58 136.13 53.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.889 -0.724 . . . . 2.16 112.203 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.69 162.05 39.99 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 1.37 108.586 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.46 159.1 54.86 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 121.85 1.7 . . . . 1.6 110.504 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -47.38 -44.34 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.686 0.616 . . . . 3.12 112.503 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.61 28.22 0.38 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.545 -0.752 . . . . 2.45 109.813 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.14 -97.43 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.592 -0.813 . . . . 2.11 113.267 -173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 1.04 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -107.71 -81.56 0.56 Allowed 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.748 0.308 . . . . 4.47 110.543 -178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.1 -70.7 0.43 Allowed Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 119.604 -1.284 . . . . 1.78 114.709 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 11.4 p-10 -139.77 33.67 2.0 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.84 1.305 . . . . 1.48 109.724 -152.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 1.04 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -48.7 162.04 0.11 Allowed 'General case' 0 CA--C 1.477 -1.836 0 CA-C-N 112.147 -2.297 . . . . 1.22 109.242 169.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.742 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.5 p -86.33 106.36 15.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.156 -1.383 . . . . 1.09 107.284 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.932 ' HE1' HD13 ' A' ' 5' ' ' ILE . 19.8 m-85 -77.77 145.28 36.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.587 -0.733 . . . . 0.84 111.258 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.75 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 3.1 t -97.0 150.68 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.85 -1.523 . . . . 0.34 108.06 169.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 1.029 HG11 ' HA2' ' A' ' 37' ' ' GLY . 5.0 t -108.1 118.1 55.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.59 0.71 . . . . 2.4 112.186 -165.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -127.64 130.22 48.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.697 -1.138 . . . . 1.89 110.611 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.737 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 3.3 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.674 -0.679 . . . . 1.36 110.856 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.038 -0.726 . . . . 6.22 109.038 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m 62.26 79.3 0.26 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.319 -0.993 . . . . 3.03 108.319 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.48 152.19 28.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.718 -0.674 . . . . 2.5 111.258 -168.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 44.6 p90 -130.21 176.23 8.27 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.779 -1.563 . . . . 1.33 106.779 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.791 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 14.8 pt -128.23 161.24 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 118.044 0.384 . . . . 1.64 111.557 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.807 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 10.1 ttt180 -119.83 132.17 55.5 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.165 -0.679 . . . . 3.21 109.165 171.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.6 p -137.28 140.46 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.632 -0.427 . . . . 1.96 111.596 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.921 HG21 ' HB3' ' A' ' 15' ' ' PRO . 4.8 t -152.81 171.23 18.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.542 -0.754 . . . . 1.23 109.754 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.812 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 21.1 mt-10 -74.72 -53.92 8.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.864 0.84 . . . . 2.97 109.091 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 8' ' ' THR . 1.8 t70 -111.49 150.4 29.96 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.304 -1.369 . . . . 1.14 107.304 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 44' ' ' ARG . 43.4 mt-10 -63.94 -22.51 66.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.264 -1.334 . . . . 1.48 109.083 -170.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -122.3 23.57 9.72 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.448 -1.251 . . . . 2.58 111.53 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.615 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.6 t70 -74.28 -112.71 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.097 -1.075 . . . . 0.59 108.097 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.2 tt0 -122.23 88.42 48.55 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.283 -0.871 . . . . 2.18 109.873 165.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.921 ' HB3' HG21 ' A' ' 8' ' ' THR . 91.4 Cg_endo -78.43 130.59 10.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.625 1.55 . . . . 0.64 110.686 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.08 133.58 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.539 -0.755 . . . . 0.58 111.841 -169.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.76 122.56 29.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.377 -0.601 . . . . 1.62 109.377 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.657 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 37.4 pt -139.04 138.83 21.7 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.99 -0.55 . . . . 2.06 110.927 -171.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 16.2 Cg_exo -68.71 124.29 11.35 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.08 2.52 . . . . 1.05 112.055 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.541 ' HG ' HG22 ' A' ' 5' ' ' ILE . 18.7 m -95.49 169.57 9.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 1.54 110.533 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.0 tp10 -64.95 136.02 56.33 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.008 -0.738 . . . . 2.77 109.008 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.63 -16.97 7.16 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.239 -0.891 . . . . 2.13 112.32 -175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -79.6 1.09 27.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.726 0.774 . . . . 2.32 109.028 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.98 49.25 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 114.258 -1.337 . . . . 0.65 110.587 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.562 ' OG1' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.19 159.46 36.77 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.32 -0.94 . . . . 1.01 110.884 -165.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.33 153.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.52 111.223 175.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.124 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -70.54 94.6 1.0 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.872 -0.604 . . . . 2.59 110.749 -178.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.678 HD23 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.46 -50.32 65.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.527 -0.545 . . . . 1.62 109.527 -173.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.808 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.6 p -61.55 -33.95 74.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.682 0.753 . . . . 1.89 110.375 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.124 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 8.6 m -75.0 -33.14 61.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.071 -0.968 . . . . 1.71 108.952 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.822 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 18.7 t -62.68 -47.62 92.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.227 -0.897 . . . . 1.34 110.537 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.808 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -64.89 -16.96 63.89 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.775 0.657 . . . . 1.34 112.775 -177.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.75 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.451 1.278 . . . . 1.0 114.451 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 170.77 -166.53 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.484 1.114 . . . . 1.12 108.787 -172.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -109.88 92.15 12.13 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.938 -0.764 . . . . 1.81 108.938 166.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.822 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -121.27 4.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.558 3.505 . . . . 0.97 115.017 176.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.41 30.95 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.167 -1.173 . . . . 0.68 110.167 -161.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.68 -88.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.764 1.394 . . . . 0.52 114.764 165.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.597 ' HG ' HG22 ' A' ' 32' ' ' THR . 15.7 m -129.58 -1.54 4.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.32 0.581 . . . . 1.64 110.966 -163.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.554 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -129.55 169.96 20.59 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.199 -1.16 . . . . 0.51 110.199 -177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.807 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -148.43 140.28 23.82 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.332 -0.947 . . . . 0.82 112.15 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.5 mtt180 -134.11 152.91 52.05 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 106.38 -1.711 . . . . 2.34 106.38 159.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.763 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 50.0 p90 -153.37 164.81 37.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 120.71 1.596 . . . . 1.69 113.483 169.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 11' ' ' GLU . 9.0 mtm180 -109.73 150.49 28.23 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.845 -1.525 . . . . 3.18 110.201 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 1.139 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 t30 -147.57 126.28 6.2 Favored Pre-proline 0 C--O 1.219 -0.55 0 CA-C-N 114.028 -1.442 . . . . 3.04 110.508 -166.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.81 9.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.757 2.971 . . . . 3.71 116.585 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.877 HG11 ' H ' ' A' ' 48' ' ' SER . 2.8 p -111.34 -94.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.544 -0.722 . . . . 5.02 111.566 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.877 ' H ' HG11 ' A' ' 47' ' ' VAL . 82.7 p -93.53 -11.63 31.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.5 0.667 . . . . 3.64 109.427 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.139 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.1 tt0 51.8 28.01 4.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.331 1.604 . . . . 4.2 115.331 167.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -60.97 126.04 25.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.339 -0.391 . . . . 1.74 110.243 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.83 92.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.928 0.871 . . . . 2.93 110.221 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.546 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 74.1 ttt180 -105.24 149.78 25.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.869 -1.059 . . . . 2.9 112.168 -170.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -96.53 149.22 19.25 Favored Glycine 0 C--N 1.302 -1.32 0 CA-C-N 113.941 -1.481 . . . . 0.44 114.502 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.807 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 76.0 t -98.78 143.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.514 -1.343 . . . . 0.95 110.327 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.586 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -65.85 135.49 54.9 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 112.514 0.561 . . . . 5.04 112.514 -170.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.678 ' HB2' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.05 111.22 22.16 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.192 -0.67 . . . . 2.13 109.192 169.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.786 HG13 ' HG2' ' A' ' 58' ' ' GLU . 19.3 t -129.44 118.03 44.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.153 -0.476 . . . . 0.95 110.699 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.786 ' HG2' HG13 ' A' ' 57' ' ' VAL . 3.9 mm-40 52.69 35.53 18.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.375 0.509 . . . . 1.51 112.375 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.433 ' C ' HD22 ' A' ' 28' ' ' LEU . . . 92.79 -0.87 70.55 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.588 -0.815 . . . . 0.55 113.048 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.562 HG22 ' OG1' ' A' ' 25' ' ' THR . 3.9 mt -104.08 149.35 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.796 0.332 . . . . 0.58 111.706 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.8 tp -102.51 116.5 32.73 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.92 -1.511 . . . . 1.72 106.92 166.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -115.09 133.59 55.9 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.598 0.713 . . . . 2.16 112.166 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 164.25 31.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 113.895 -1.502 . . . . 1.37 110.46 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.84 168.01 9.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.551 2.834 . . . . 1.6 110.688 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -41.99 -42.99 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.436 0.902 . . . . 3.12 113.436 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.91 -23.63 4.6 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.171 0.434 . . . . 2.45 112.171 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 136.9 8.44 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 118.98 -1.581 . . . . 2.11 114.054 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.434 ' CD2' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -81.37 -89.55 0.07 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.238 0.615 . . . . 4.47 111.373 170.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.9 48.0 0.12 Allowed Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.671 -0.776 . . . . 1.78 113.918 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.791 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 87.04 -45.18 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 114.361 -0.92 . . . . 1.48 110.28 156.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.807 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 47.07 173.2 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.964 1.364 . . . . 1.22 113.784 174.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.541 ' H ' HG12 ' A' ' 72' ' ' VAL . 2.2 p -103.02 105.05 17.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 113.422 -1.717 . . . . 1.09 109.145 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.763 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.0 m-85 -80.59 145.84 31.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.094 0.95 . . . . 0.84 112.858 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -109.16 159.18 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 112.889 -1.959 . . . . 0.34 110.151 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.812 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 p -87.93 103.78 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 2.4 112.145 -165.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -129.03 127.2 41.1 Favored 'General case' 0 C--O 1.208 -1.08 0 C-N-CA 120.111 -0.636 . . . . 1.89 109.423 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.701 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.489 -0.767 . . . . 1.36 110.322 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.066 -0.346 . . . . 6.22 110.066 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m 65.84 -178.41 0.19 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.712 0.632 . . . . 3.03 111.465 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.76 152.6 25.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.09 -0.504 . . . . 2.5 110.007 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 35.7 p90 -135.06 172.92 12.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.813 -0.81 . . . . 1.33 108.813 -172.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.937 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -124.36 159.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 121.188 -0.205 . . . . 1.64 111.01 -178.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 2.9 ttt180 -120.52 134.35 55.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.756 -0.461 . . . . 3.21 109.756 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.693 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.4 p -138.16 148.5 24.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 O-C-N 121.786 -0.571 . . . . 1.96 111.57 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.908 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.5 t -152.57 171.21 18.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.494 -0.321 . . . . 1.23 110.918 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 1.068 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.4 tm-20 -83.33 -33.02 25.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.807 0.813 . . . . 2.97 110.036 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 8' ' ' THR . 19.3 t70 -132.18 150.0 52.26 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.15 -1.426 . . . . 1.14 107.15 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.62 -25.3 38.05 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.981 0.801 . . . . 1.48 109.529 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -130.52 38.01 3.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.816 -1.084 . . . . 2.58 111.898 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 8.4 t70 -77.02 -111.6 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.69 -1.596 . . . . 0.59 106.69 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 34.5 mm-40 -123.36 89.61 50.95 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.026 -0.988 . . . . 2.18 109.944 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.908 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 55.5 Cg_endo -69.18 133.1 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.231 1.287 . . . . 0.64 110.05 173.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.41 128.26 69.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.605 -0.725 . . . . 0.58 111.138 -169.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.783 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.6 mp0 -84.13 121.73 27.85 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.715 -0.675 . . . . 1.62 109.628 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 32.1 pt -140.64 143.61 33.11 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.496 -0.775 . . . . 2.06 111.537 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 2.9 Cg_exo -76.35 131.4 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.319 2.679 . . . . 1.05 112.415 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.437 ' HB3' HD13 ' A' ' 5' ' ' ILE . 7.2 p -103.59 171.35 7.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.768 -0.651 . . . . 1.54 109.799 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.26 142.57 58.23 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.444 -0.576 . . . . 2.77 109.444 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.76 -28.86 24.2 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.952 1.407 . . . . 2.13 112.347 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 6.3 p-10 -84.54 1.28 46.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.141 0.972 . . . . 2.32 108.8 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 24.31 23.05 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 113.867 -1.515 . . . . 0.65 110.234 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.469 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.35 151.81 38.74 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.827 -1.187 . . . . 1.01 111.622 -165.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.799 HG21 ' HB3' ' A' ' 61' ' ' LEU . 1.0 OUTLIER -147.31 148.7 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.667 -0.697 . . . . 0.52 109.955 170.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.013 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -64.87 102.75 0.63 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.15 0.5 . . . . 2.59 110.128 175.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.663 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.65 -50.63 68.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.45 -0.574 . . . . 1.62 109.45 -172.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.823 ' HA ' HG23 ' A' ' 32' ' ' THR . 17.9 p -68.87 -37.34 79.01 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.614 0.721 . . . . 1.89 110.201 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.013 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.5 m -70.88 -32.97 70.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.119 -0.946 . . . . 1.71 108.73 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.844 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.7 t -62.14 -44.77 99.46 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-N 114.821 -1.081 . . . . 1.34 110.47 170.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.823 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -63.4 -19.24 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.71 0.633 . . . . 1.34 112.71 -176.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.33 40.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.869 1.433 . . . . 1.0 114.869 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 169.91 -164.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.503 0.721 . . . . 1.12 109.437 -171.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -109.08 91.46 9.37 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.216 -0.661 . . . . 1.81 109.216 166.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.844 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.78 1.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.387 3.391 . . . . 0.97 115.116 175.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.651 ' HA2' ' CG2' ' A' ' 75' ' ' VAL . . . 107.69 -10.95 38.57 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 110.065 -1.214 . . . . 0.68 110.065 -161.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 32' ' ' THR . . . 51.09 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.603 1.561 . . . . 0.52 114.521 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -133.97 -36.41 0.93 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.733 0.778 . . . . 1.64 110.439 -161.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.563 ' C ' ' HB3' ' A' ' 76' ' ' ASN . . . -97.76 155.21 20.42 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-N 114.742 -1.117 . . . . 0.51 110.399 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.661 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -132.69 150.54 52.15 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.666 -1.214 . . . . 0.82 112.858 178.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 51' ' ' MET . 50.9 mtt180 -136.95 149.6 47.66 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.939 -1.875 . . . . 2.34 105.939 162.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.747 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 41.6 p90 -154.93 158.13 38.8 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 120.165 1.348 . . . . 1.69 112.635 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.491 ' HB3' HG11 ' A' ' 72' ' ' VAL . 10.2 ttp180 -114.44 132.97 56.07 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 113.687 0.995 . . . . 3.18 113.687 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.279 18.5 t30 105.88 -75.84 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 117.926 2.565 . . . . 3.04 117.926 144.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 71' ' ' LEU . 56.0 Cg_exo -55.41 -3.23 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.132 1.888 . . . . 3.71 114.484 -171.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.953 HG11 ' H ' ' A' ' 48' ' ' SER . 3.6 p -105.35 -94.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.663 -0.495 . . . . 5.02 109.663 168.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.953 ' H ' HG11 ' A' ' 47' ' ' VAL . 17.6 t -110.89 7.01 21.62 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.326 -0.397 . . . . 3.64 111.702 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.746 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 10.6 tt0 52.4 25.55 3.57 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-O 121.55 0.69 . . . . 4.2 112.348 -168.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -105.98 136.11 46.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 1.74 109.46 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.712 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 22.4 ptt? -62.61 85.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.793 0.806 . . . . 2.93 111.125 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 57.0 ttt180 -100.54 150.29 22.83 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.494 -0.776 . . . . 2.9 110.954 -176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -90.45 160.83 28.27 Favored Glycine 0 C--N 1.293 -1.81 0 CA-C-N 115.019 -0.991 . . . . 0.44 114.796 175.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.661 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 69.2 t -99.2 142.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.417 -1.392 . . . . 0.95 109.804 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.634 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 1.2 mpt_? -66.89 133.73 50.62 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.052 0.39 . . . . 5.04 112.052 -168.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.637 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.99 115.15 28.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.26 0.552 . . . . 2.13 109.64 172.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.626 HG12 ' HG3' ' A' ' 58' ' ' GLU . 3.6 t -133.81 118.93 31.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-N 116.222 -0.445 . . . . 0.95 109.972 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.626 ' HG3' HG12 ' A' ' 57' ' ' VAL . 29.2 mt-10 56.43 36.11 27.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.82 0.343 . . . . 1.51 111.643 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.31 0.41 89.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.493 -0.861 . . . . 0.55 112.828 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 57' ' ' VAL . 4.6 mt -97.08 147.43 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 O-C-N 122.617 -0.343 . . . . 0.58 111.465 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 26' ' ' VAL . 12.7 tp -104.03 115.76 31.02 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.55 -1.278 . . . . 1.72 107.55 167.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -116.42 133.55 55.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.232 -0.587 . . . . 2.16 111.48 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.66 162.31 36.58 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.282 -1.007 . . . . 1.37 108.282 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.79 160.05 42.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 121.87 1.714 . . . . 1.6 110.921 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.5 -44.25 17.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.693 0.621 . . . . 3.12 111.89 -171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.89 32.47 0.1 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.082 -0.963 . . . . 2.45 108.854 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -88.68 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.919 -1.037 . . . . 2.11 113.935 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.673 ' HB2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -103.89 -77.86 0.57 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.137 -0.69 . . . . 4.47 109.137 -172.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.02 -78.37 0.13 Allowed Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.846 -1.169 . . . . 1.78 113.462 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.937 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 3.2 p-10 -127.92 -56.95 1.26 Allowed 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 114.957 -0.622 . . . . 1.48 109.444 -169.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.795 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.1 OUTLIER 56.45 167.34 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 124.694 1.247 . . . . 1.22 110.465 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' H ' HG12 ' A' ' 72' ' ' VAL . 1.9 p -95.07 104.39 15.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.858 -1.137 . . . . 1.09 108.562 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.747 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.2 m-85 -80.2 145.06 32.46 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.885 0.85 . . . . 0.84 111.845 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.3 t -108.76 154.52 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 113.519 -1.673 . . . . 0.34 109.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 1.068 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -85.61 120.13 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.163 0.506 . . . . 2.4 110.16 -167.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.563 ' HB3' ' C ' ' A' ' 40' ' ' GLY . 56.2 t30 -131.5 128.24 38.97 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.775 -0.578 . . . . 1.89 111.01 172.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.728 ' HE1' HG23 ' A' ' 75' ' ' VAL . 1.3 p90 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 118.999 -0.524 . . . . 1.36 110.648 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.751 -0.463 . . . . 6.22 109.751 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m 60.08 84.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.229 -0.656 . . . . 3.03 109.229 -173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -80.84 152.5 28.16 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.497 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.773 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 15.5 p90 -126.12 171.82 10.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.668 -0.864 . . . . 1.33 108.668 -174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.794 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 20.9 pt -116.47 163.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.646 0.26 . . . . 1.64 111.592 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.633 HH11 ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.31 131.48 56.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.853 -0.795 . . . . 3.21 108.853 179.298 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.34 146.35 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.98 -1.075 . . . . 1.96 111.365 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.933 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 t -152.25 168.56 24.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.674 -0.239 . . . . 1.23 110.413 166.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.627 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 1.7 mp0 -77.42 -33.92 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.97 111.247 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 8' ' ' THR . 1.3 t70 -133.23 152.56 51.94 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.569 -1.271 . . . . 1.14 107.569 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.588 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 4.2 mt-10 -55.29 -39.62 70.08 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 122.555 1.169 . . . . 1.48 107.966 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -106.85 25.91 10.72 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.873 -1.967 . . . . 2.58 113.057 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 4.4 t70 -81.83 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.891 -1.151 . . . . 0.59 107.891 170.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 38.6 mt-10 -122.96 91.05 50.07 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 115.754 -0.657 . . . . 2.18 110.624 168.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.933 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 58.5 Cg_endo -70.7 134.65 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.551 1.501 . . . . 0.64 110.379 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.29 153.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.364 -0.835 . . . . 0.58 110.864 -169.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.773 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.8 mp0 -108.5 122.48 47.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.2 -0.454 . . . . 1.62 110.849 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.63 138.67 17.54 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.902 -0.59 . . . . 2.06 112.006 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.04 148.34 21.71 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.957 2.438 . . . . 1.05 112.231 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.9 m -122.6 169.24 11.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 1.54 111.281 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -66.49 150.71 48.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.485 0.66 . . . . 2.77 111.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -52.38 -28.39 19.43 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.438 -1.71 . . . . 2.13 111.903 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 33.6 t70 -77.74 -7.21 56.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.379 1.085 . . . . 2.32 108.79 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.81 25.98 36.44 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 108.357 -1.897 . . . . 0.65 108.357 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.18 151.08 39.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.874 -1.663 . . . . 1.01 112.179 -160.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.908 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 147.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.393 -0.821 . . . . 0.52 110.519 173.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.046 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -65.19 96.51 0.22 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.258 0.623 . . . . 2.59 110.247 178.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.63 -49.57 70.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.563 -0.289 . . . . 1.62 110.254 -168.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.692 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.5 p -70.2 -34.35 72.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.002 0.906 . . . . 1.89 109.895 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.046 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 15.8 m -70.81 -32.78 69.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.742 -1.117 . . . . 1.71 108.085 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.863 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.5 t -65.12 -42.15 93.63 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 CA-C-N 114.11 -1.404 . . . . 1.34 110.846 171.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -64.4 -20.32 66.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.855 -0.528 . . . . 1.34 111.95 -175.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.15 -163.3 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 123.211 0.604 . . . . 1.12 109.988 -173.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -106.96 92.59 7.8 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.719 -0.845 . . . . 1.81 108.719 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.863 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -122.34 2.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.201 3.267 . . . . 0.97 114.867 173.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 106.92 -16.15 39.78 Favored Glycine 0 C--O 1.217 -0.923 0 N-CA-C 109.917 -1.273 . . . . 0.68 109.917 -162.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.718 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 52.75 -92.12 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.907 1.283 . . . . 0.52 113.542 172.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.9 m -122.69 4.16 9.52 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.672 0.749 . . . . 1.64 110.243 -166.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -136.65 174.65 21.47 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 110.085 -1.206 . . . . 0.51 110.085 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -153.19 143.71 22.58 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 120.128 -0.629 . . . . 0.82 110.692 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.4 mtt180 -134.64 150.84 50.7 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 105.739 -1.949 . . . . 2.34 105.739 160.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.659 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 45.9 p90 -152.54 165.23 35.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 121.181 1.809 . . . . 1.69 113.125 170.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.588 ' HD2' ' OE2' ' A' ' 11' ' ' GLU . 35.1 mtp85 -106.91 134.34 50.22 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.159 -1.837 . . . . 3.18 108.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 1.042 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 56.8 t30 -133.7 128.45 19.93 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 114.575 -1.193 . . . . 3.04 111.136 -164.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' OD1' ' A' ' 45' ' ' ASN . 86.9 Cg_exo -50.16 -13.04 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.802 3.001 . . . . 3.71 115.996 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.874 HG11 ' H ' ' A' ' 48' ' ' SER . 2.8 p -94.73 -91.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 118.403 0.547 . . . . 5.02 111.129 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.874 ' H ' HG11 ' A' ' 47' ' ' VAL . 80.0 p -97.26 -9.9 26.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.396 0.617 . . . . 3.64 109.709 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.042 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 5.0 tt0 50.88 27.63 3.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.936 1.458 . . . . 4.2 114.936 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -60.97 130.03 44.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.992 -0.373 . . . . 1.74 109.992 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -64.85 87.58 0.06 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.357 0.598 . . . . 2.93 109.804 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 21.0 ttt180 -101.21 147.63 26.04 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.684 0.754 . . . . 2.9 112.288 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -93.7 154.61 21.74 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 113.715 -1.584 . . . . 0.44 114.279 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.563 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 46.4 t -100.04 143.7 13.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 113.746 -1.227 . . . . 0.95 111.525 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HD2' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -62.52 138.04 58.39 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 124.477 1.111 . . . . 5.04 113.517 -175.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.4 pp -115.74 124.22 50.26 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.041 -0.264 . . . . 2.13 110.405 169.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.587 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.3 t -134.94 122.95 39.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.125 0 CA-C-O 118.846 -0.597 . . . . 0.95 109.609 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.587 ' HG3' HG12 ' A' ' 57' ' ' VAL . 35.1 mt-10 56.88 36.46 27.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.651 0.659 . . . . 1.51 112.093 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.29 8.69 87.03 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.549 -0.834 . . . . 0.55 112.408 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 57' ' ' VAL . 5.8 mt -104.04 149.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 122.351 0.26 . . . . 0.58 110.785 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.908 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.8 tp -102.08 116.02 31.78 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.974 -1.121 . . . . 1.72 107.974 170.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.16 122.56 46.16 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.106 0.479 . . . . 2.16 111.734 -175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.01 163.6 22.41 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.148 -0.933 . . . . 1.37 110.381 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.17 166.55 12.5 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.112 2.541 . . . . 1.6 111.875 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.78 -45.65 4.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.233 0.827 . . . . 3.12 113.233 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.99 -29.96 7.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 2.45 110.935 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.79 128.64 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 122.04 0.8 . . . . 2.11 113.375 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -84.2 -42.66 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.391 1.091 . . . . 4.47 108.877 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.79 -79.82 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 113.359 -1.746 . . . . 1.78 111.446 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.794 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.69 -59.07 0.48 Allowed 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 114.423 -0.888 . . . . 1.48 109.36 -172.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER 58.08 151.25 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.799 1.312 . . . . 1.22 110.425 -177.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.6 p -91.33 106.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.395 -0.82 . . . . 1.09 108.806 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.705 ' HE1' HD13 ' A' ' 5' ' ' ILE . 18.1 m-85 -78.63 144.16 35.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.141 -0.936 . . . . 0.84 112.012 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.7 t -109.19 159.88 8.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.179 -1.828 . . . . 0.34 109.625 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.679 HG23 ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -91.95 113.09 26.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.76 0.791 . . . . 2.4 111.257 -169.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -130.54 126.34 36.53 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.075 -0.966 . . . . 1.89 108.922 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.691 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 118.23 -0.89 . . . . 1.36 110.4 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.876 -0.416 . . . . 6.22 109.876 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -93.82 114.94 27.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.074 -0.713 . . . . 3.03 109.074 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.28 147.5 28.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.088 0.471 . . . . 2.5 111.189 -172.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.863 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 23.4 p90 -138.69 174.73 10.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.985 -1.117 . . . . 1.33 107.985 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 1.004 ' HA ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -135.23 162.33 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.222 0.465 . . . . 1.64 111.473 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 1.086 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -117.98 132.67 56.37 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 119.715 -0.794 . . . . 3.21 109.889 -176.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 3.3 p -138.85 148.44 24.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.941 -0.474 . . . . 1.96 111.405 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 1.034 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -153.98 164.01 39.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.353 -0.385 . . . . 1.23 109.99 165.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.703 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.4 mp0 -67.94 -32.95 73.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 2.97 111.504 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.833 ' O ' HG22 ' A' ' 8' ' ' THR . 14.2 t70 -132.48 149.44 52.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.613 -1.625 . . . . 1.14 106.613 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.447 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 3.0 mt-10 -54.44 -34.22 61.03 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 122.01 0.91 . . . . 1.48 108.653 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -110.19 28.65 8.42 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.502 -1.681 . . . . 2.58 111.867 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.641 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.3 t70 -83.7 -117.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.895 -0.78 . . . . 0.59 108.895 171.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -121.4 89.61 47.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.555 -0.748 . . . . 2.18 110.429 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.034 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 74.4 Cg_endo -75.06 140.56 25.42 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 C-N-CA 123.107 2.538 . . . . 0.64 113.506 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.09 125.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 115.448 -0.796 . . . . 0.58 110.509 -175.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.086 ' HG2' ' HG3' ' A' ' 6' ' ' ARG . 25.0 mt-10 -86.12 120.6 27.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.223 -0.658 . . . . 1.62 109.223 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 19.7 pt -142.03 144.41 31.89 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.303 -0.862 . . . . 2.06 111.454 -168.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 72.2 Cg_endo -74.64 145.29 32.74 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.867 2.378 . . . . 1.05 113.34 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.486 ' OG ' HD13 ' A' ' 5' ' ' ILE . 8.5 m -104.42 170.26 8.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 1.54 110.232 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.01 141.12 54.97 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.987 -0.746 . . . . 2.77 108.987 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.66 -19.14 5.52 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.354 1.034 . . . . 2.13 112.689 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.666 ' HB2' ' HB ' ' A' ' 25' ' ' THR . 7.4 m-20 -75.95 -5.17 44.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.124 0.964 . . . . 2.32 108.775 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.21 23.99 60.13 Favored Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 108.74 -1.744 . . . . 0.65 108.74 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -122.38 154.03 38.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.1 -1.55 . . . . 1.01 111.238 -162.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.811 HG21 ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -146.68 143.12 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.526 -0.761 . . . . 0.52 109.741 172.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.692 HD22 ' CB ' ' A' ' 30' ' ' THR . 3.5 mp -68.53 116.92 9.62 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.786 -0.45 . . . . 2.59 109.786 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.669 ' O ' HG21 ' A' ' 32' ' ' THR . 15.6 tp -60.02 -51.36 69.96 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.206 0.316 . . . . 1.62 110.697 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.799 ' HA ' HG23 ' A' ' 32' ' ' THR . 7.9 m -71.78 -44.86 63.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.428 -0.805 . . . . 1.89 110.859 -174.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.692 ' CB ' HD22 ' A' ' 27' ' ' LEU . 2.7 m -63.67 -32.19 73.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.955 -0.566 . . . . 1.71 109.721 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.828 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -59.43 -48.47 87.07 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.908 -0.587 . . . . 1.34 110.262 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.799 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.11 -17.76 63.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.043 0.757 . . . . 1.34 113.043 -176.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.63 37.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.534 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 171.48 -165.71 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.967 0.907 . . . . 1.12 108.993 -173.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -109.31 92.79 12.06 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 109.233 -0.654 . . . . 1.81 109.233 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.828 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.92 8.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.52 3.48 . . . . 0.97 113.928 173.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.905 ' HA2' ' HB ' ' A' ' 75' ' ' VAL . . . 107.83 -26.7 16.79 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 110.078 -1.209 . . . . 0.68 110.078 -162.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 77' ' ' TYR . . . 61.1 -81.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.987 1.106 . . . . 0.52 113.987 167.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.529 ' HA ' HD13 ' A' ' 28' ' ' LEU . 36.5 t -120.28 -12.9 8.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.524 0.678 . . . . 1.64 109.443 -165.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.65 157.51 24.15 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.897 -1.047 . . . . 0.51 112.344 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -127.94 153.01 47.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.174 -0.61 . . . . 0.82 111.502 174.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 95.1 mtt180 -138.52 146.52 42.06 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 106.743 -1.577 . . . . 2.34 106.743 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.81 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 47.4 p90 -154.67 166.92 31.89 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 117.903 -1.519 . . . . 1.69 113.946 169.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.779 ' HB3' HG11 ' A' ' 72' ' ' VAL . 73.8 ttt180 -102.32 137.69 40.23 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 113.857 -1.519 . . . . 3.18 107.853 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.829 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.4 t-20 -142.68 111.95 5.83 Favored Pre-proline 0 C--O 1.211 -0.927 0 N-CA-C 113.219 0.822 . . . . 3.04 113.219 -158.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' HD13 ' A' ' 71' ' ' LEU . 31.7 Cg_exo -20.89 -35.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.269 1 C-N-CA 126.783 4.989 . . . . 3.71 118.105 -175.421 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' A' ' 48' ' ' SER . 2.1 p -81.69 -83.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 118.871 0.759 . . . . 5.02 110.821 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.591 ' H ' ' CG1' ' A' ' 47' ' ' VAL . 87.5 p -103.76 -9.64 18.92 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.109 -0.496 . . . . 3.64 110.486 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.829 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 5.9 mt-30 50.66 25.59 2.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.961 -1.018 . . . . 4.2 113.426 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -57.33 133.96 55.58 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.124 -0.944 . . . . 1.74 109.973 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -63.42 88.22 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.672 0.748 . . . . 2.93 110.073 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -102.41 145.03 30.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.382 -0.826 . . . . 2.9 111.623 -173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 167.28 21.28 Favored Glycine 0 C--N 1.299 -1.512 0 CA-C-N 114.092 -1.413 . . . . 0.44 114.216 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 55.9 t -97.43 140.16 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.036 -1.082 . . . . 0.95 111.058 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.0 mpt_? -67.33 135.86 53.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.58 -0.736 . . . . 5.04 112.402 -174.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.773 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -108.11 120.51 42.53 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.935 -0.706 . . . . 2.13 110.563 171.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 60' ' ' ILE . 32.5 t -130.16 115.81 34.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 115.686 -0.688 . . . . 0.95 109.774 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.575 ' HG3' HG13 ' A' ' 57' ' ' VAL . 16.4 mt-10 52.59 35.42 17.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.766 0.317 . . . . 1.51 111.504 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.87 4.65 75.11 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.835 -0.698 . . . . 0.55 113.066 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 5.1 mt -100.64 148.98 6.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 O-C-N 122.586 -0.361 . . . . 0.58 111.496 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.811 ' HB2' HG21 ' A' ' 26' ' ' VAL . 56.2 mt -101.36 118.17 36.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.253 -1.017 . . . . 1.72 108.253 167.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 128.96 55.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.331 -0.547 . . . . 2.16 111.832 -174.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 161.35 57.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.83 -1.544 . . . . 1.37 106.83 161.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 12.7 Cg_exo -69.19 146.69 64.54 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.624 1.549 . . . . 1.6 111.145 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -45.78 17.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.804 0.811 . . . . 3.12 111.629 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.79 24.26 5.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.38 -1.282 . . . . 2.45 109.356 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 64' ' ' PRO . . . -77.3 -119.48 0.19 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.707 -0.759 . . . . 2.11 112.715 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.746 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.49 -172.94 2.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.454 -0.573 . . . . 4.47 109.454 -175.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -175.13 86.47 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.861 -1.162 . . . . 1.78 112.042 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.004 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 3.5 t30 102.19 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 124.808 2.242 . . . . 1.48 108.946 171.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -86.72 -177.48 6.13 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 109.517 -3.492 . . . . 1.22 106.396 167.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG11 ' HB3' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -99.28 101.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 124.546 1.154 . . . . 1.09 108.697 176.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.81 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 19.5 m-85 -84.2 141.27 31.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.704 1.002 . . . . 0.84 113.704 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.8 t -109.2 163.91 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 112.564 -2.107 . . . . 0.34 107.593 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.905 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 21.5 m -118.9 127.74 75.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.59 -0.694 . . . . 2.4 111.407 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.91 128.35 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.751 -0.78 . . . . 1.89 110.341 169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.679 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.047 -0.977 . . . . 1.36 110.306 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.921 -0.4 . . . . 6.22 109.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 61.59 92.22 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.312 -0.625 . . . . 3.03 109.312 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -78.86 140.51 38.14 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.068 -0.514 . . . . 2.5 110.862 -166.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.636 ' O ' ' HB3' ' A' ' 70' ' ' ASN . 38.8 p90 -133.6 172.2 13.07 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.591 -0.892 . . . . 1.33 108.591 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.843 HD13 ' HE1' ' A' ' 73' ' ' TYR . 15.0 pt -127.52 165.78 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 122.611 0.365 . . . . 1.64 110.792 -170.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.613 ' NH1' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -114.46 132.76 56.16 Favored 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 108.952 -0.758 . . . . 3.21 108.952 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG22 ' HD1' ' A' ' 73' ' ' TYR . 2.3 t -135.89 143.5 36.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 O-C-N 121.113 -0.992 . . . . 1.96 110.296 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.967 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 t -153.55 167.41 29.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.039 -0.356 . . . . 1.23 110.039 162.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.921 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -72.48 -54.18 10.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.023 0.916 . . . . 2.97 109.2 173.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 8' ' ' THR . 13.1 t70 -112.63 148.13 35.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.639 -1.245 . . . . 1.14 107.639 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HG2' HG23 ' A' ' 74' ' ' VAL . 3.8 mt-10 -58.55 -26.38 63.5 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.869 -1.06 . . . . 1.48 108.414 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -119.8 29.19 7.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.636 -1.62 . . . . 2.58 111.158 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 4.4 t70 -84.31 -117.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.07 -1.085 . . . . 0.59 108.07 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 31.0 mt-10 -121.52 90.87 48.19 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.136 -0.938 . . . . 2.18 110.218 168.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.967 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.8 Cg_endo -72.47 134.21 22.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.649 1.566 . . . . 0.64 110.82 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.511 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -129.72 144.2 38.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.269 -0.878 . . . . 0.58 110.983 -168.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 16.9 mt-10 -90.76 122.12 33.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.768 -0.456 . . . . 1.62 109.768 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.736 HD12 ' HD2' ' A' ' 19' ' ' PRO . 7.1 tp -140.85 131.73 13.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.469 -0.787 . . . . 2.06 111.175 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.736 ' HD2' HD12 ' A' ' 18' ' ' ILE . 55.4 Cg_endo -71.88 137.71 30.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.652 2.235 . . . . 1.05 112.764 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.0 p -106.32 170.46 7.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 1.54 110.297 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -65.46 140.83 58.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.963 -0.384 . . . . 2.77 109.963 178.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 24' ' ' GLY . 3.5 m-20 -54.99 -19.91 7.9 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.617 -1.174 . . . . 2.13 111.987 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.78 0.92 13.79 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.866 0.841 . . . . 2.32 108.8 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.09 24.64 73.19 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.687 -1.365 . . . . 0.65 109.687 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 1.036 ' HG1' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.74 166.15 23.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.143 -1.028 . . . . 1.01 109.963 -168.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.951 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -146.18 148.21 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.415 -0.357 . . . . 0.52 110.384 175.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.047 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -65.56 94.55 0.19 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.148 -0.478 . . . . 2.59 109.861 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.715 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.61 -49.08 74.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.664 -0.495 . . . . 1.62 109.664 -168.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.626 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.4 p -65.5 -35.6 81.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.5 0.667 . . . . 1.89 110.349 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.047 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 3.4 m -72.35 -33.72 67.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.316 -0.856 . . . . 1.71 108.7 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.858 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 45.7 t -63.72 -39.71 86.37 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 115.159 -0.928 . . . . 1.34 110.383 170.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.715 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.6 p -64.87 -20.15 66.27 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.785 -0.572 . . . . 1.34 112.142 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 41.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.56 1.319 . . . . 1.0 114.56 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.08 -163.88 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.258 0.623 . . . . 1.12 110.021 -173.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.7 92.83 7.77 Favored Pre-proline 0 N--CA 1.436 -1.132 0 N-CA-C 108.649 -0.871 . . . . 1.81 108.649 165.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -122.25 3.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.639 2.892 . . . . 0.97 114.561 171.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.809 ' HA2' HG21 ' A' ' 75' ' ' VAL . . . 106.99 -23.77 26.73 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 109.806 -1.317 . . . . 0.68 109.806 -161.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.749 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.49 -89.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.031 1.333 . . . . 0.52 114.106 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 32.1 t -125.4 -13.34 6.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.45 0.643 . . . . 1.64 110.846 -161.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -114.43 156.23 15.79 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 109.633 -1.387 . . . . 0.51 109.633 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -133.05 139.75 47.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.963 -1.095 . . . . 0.82 111.871 175.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 67.6 mtt180 -132.69 154.2 50.39 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 106.313 -1.736 . . . . 2.34 106.313 162.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.721 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.1 p90 -154.69 165.47 36.44 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 120.121 1.328 . . . . 1.69 113.234 170.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 97.1 mtt180 -97.28 133.31 42.07 Favored 'General case' 0 C--O 1.253 1.268 0 O-C-N 125.684 1.865 . . . . 3.18 109.142 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 1.048 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 2.8 t-20 -128.54 122.53 21.79 Favored Pre-proline 0 C--O 1.22 -0.483 0 CA-C-N 114.081 -1.418 . . . . 3.04 110.848 -170.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HD2' HD21 ' A' ' 45' ' ' ASN . 77.5 Cg_exo -51.74 -15.42 2.93 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.027 3.151 . . . . 3.71 116.467 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.682 HG22 ' N ' ' A' ' 48' ' ' SER . 0.8 OUTLIER -91.29 -90.47 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 118.792 0.724 . . . . 5.02 111.383 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.682 ' N ' HG22 ' A' ' 47' ' ' VAL . 3.4 m -101.99 -2.57 29.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.746 0.784 . . . . 3.64 110.765 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.048 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.5 tt0 51.02 47.91 24.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 115.132 1.53 . . . . 4.2 115.132 171.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -62.07 121.17 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.244 -0.889 . . . . 1.74 109.017 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 59.3 mtm -68.44 77.82 0.27 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.65 -0.87 . . . . 2.93 108.65 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.591 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 14.0 ttt180 -103.88 156.78 17.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.469 -0.787 . . . . 2.9 111.54 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.591 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -98.16 158.21 20.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.496 -1.229 . . . . 0.44 114.766 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.621 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 87.9 t -98.86 143.93 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.325 -1.437 . . . . 0.95 109.854 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.505 ' NH2' ' HA ' ' A' ' 64' ' ' PRO . 82.0 mtt180 -64.48 135.25 55.87 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 111.56 0.207 . . . . 5.04 111.56 -171.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -113.7 114.98 27.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.873 0.368 . . . . 2.13 110.031 170.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 58' ' ' GLU . 4.6 t -128.32 115.09 36.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.472 -0.331 . . . . 0.95 110.296 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 57' ' ' VAL . 23.0 mt-10 53.44 36.55 23.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.999 0.52 . . . . 1.51 112.383 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.1 0.91 73.39 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.402 -0.904 . . . . 0.55 112.689 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 1.036 HG22 ' HG1' ' A' ' 25' ' ' THR . 1.9 mt -104.34 148.04 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 122.681 -0.305 . . . . 0.58 111.163 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.951 ' HB3' HG21 ' A' ' 26' ' ' VAL . 13.3 tp -102.39 114.95 29.58 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.797 -1.186 . . . . 1.72 107.797 169.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -115.66 142.2 47.06 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.2 0.524 . . . . 2.16 111.891 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.28 160.85 29.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.091 -0.958 . . . . 1.37 110.301 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.505 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 24.2 Cg_exo -64.16 166.06 17.8 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.912 3.075 . . . . 1.6 112.602 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.01 -46.57 5.56 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.908 0.861 . . . . 3.12 112.804 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.18 -44.25 8.44 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.987 -1.46 . . . . 2.45 110.043 -175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.2 133.64 0.48 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.369 -0.832 . . . . 2.11 112.427 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.601 ' CG ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.52 -77.39 0.07 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.091 -0.555 . . . . 4.47 109.787 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 5' ' ' ILE . . . 176.24 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.663 -0.698 . . . . 1.78 112.101 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.642 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 4.9 p-10 -156.38 54.84 0.56 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.199 1.0 . . . . 1.48 109.697 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.601 HD13 ' CG ' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -52.92 162.51 0.61 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-N 113.465 -1.698 . . . . 1.22 110.028 165.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.689 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 1.6 p -96.42 107.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 114.297 -1.319 . . . . 1.09 108.656 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.843 ' HE1' HD13 ' A' ' 5' ' ' ILE . 17.1 m-85 -80.03 146.95 31.7 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.121 -0.945 . . . . 0.84 112.638 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -110.28 158.8 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 113.386 -1.734 . . . . 0.34 110.039 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.921 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 6.4 p -97.61 109.06 22.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.594 0.711 . . . . 2.4 112.422 -165.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.459 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 0.9 OUTLIER -130.62 128.51 41.14 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 120.144 -0.623 . . . . 1.89 111.399 165.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.725 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.764 0 CA-C-O 119.129 -0.462 . . . . 1.36 110.652 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 110.276 -0.268 . . . . 6.22 110.276 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t 71.48 125.33 0.03 OUTLIER 'General case' 0 C--O 1.235 0.292 0 O-C-N 124.087 0.867 . . . . 3.03 110.397 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -80.83 153.16 27.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.848 -0.615 . . . . 2.5 109.596 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 20.5 p90 -120.51 166.84 13.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.613 -1.254 . . . . 1.33 107.613 -176.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 21.7 pt -121.45 162.38 20.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 120.645 0.26 . . . . 1.64 110.589 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.847 ' HG3' ' HA ' ' A' ' 72' ' ' VAL . 1.4 tpp85 -118.81 131.96 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.0 -1.111 . . . . 3.21 108.0 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -139.85 146.95 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 O-C-N 121.218 -0.926 . . . . 1.96 110.763 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 1.105 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -152.26 148.87 28.07 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.666 -0.243 . . . . 1.23 110.408 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 1.081 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 47.9 mp0 -60.8 -36.21 78.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.145 0.498 . . . . 2.97 111.593 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 t0 -128.35 153.41 47.06 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.972 -1.492 . . . . 1.14 106.972 174.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.24 -30.67 64.82 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.718 0.771 . . . . 1.48 108.927 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -119.76 31.66 6.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.366 -1.288 . . . . 2.58 110.972 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 3.8 t70 -79.98 -118.26 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.26 -1.385 . . . . 0.59 107.26 168.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 21.9 tt0 -120.45 91.88 47.04 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.72 -0.673 . . . . 2.18 110.01 168.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.105 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 64.1 Cg_endo -71.56 133.45 22.34 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.201 1.934 . . . . 0.64 111.555 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.52 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.44 -0.8 . . . . 0.58 110.885 -170.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 26.6 mt-10 -97.77 121.98 40.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.053 -0.522 . . . . 1.62 110.123 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 41.4 pt -141.28 143.36 30.21 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.843 -0.617 . . . . 2.06 111.295 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 8.2 Cg_exo -72.6 160.15 47.18 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.184 2.589 . . . . 1.05 112.422 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.4 m -132.37 171.67 13.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.9 -0.591 . . . . 1.54 110.001 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.03 142.09 58.54 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.262 -0.644 . . . . 2.77 109.262 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.21 -24.21 17.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 124.503 1.127 . . . . 2.13 111.951 -168.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 16.0 t70 -74.38 -8.64 56.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.34 1.067 . . . . 2.32 108.905 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.26 41.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.741 -1.744 . . . . 0.65 108.741 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -120.62 154.89 34.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.052 -1.574 . . . . 1.01 111.518 -165.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.861 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -147.61 140.01 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.161 -0.927 . . . . 0.52 109.138 169.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 30' ' ' THR . 2.8 mp -64.43 111.86 2.85 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.927 -0.768 . . . . 2.59 108.927 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.756 ' O ' HG21 ' A' ' 32' ' ' THR . 30.0 tp -58.14 -51.71 68.58 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 120.756 0.313 . . . . 1.62 110.193 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -67.18 -47.5 70.76 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.564 -0.744 . . . . 1.89 110.626 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.681 ' CB ' HD22 ' A' ' 27' ' ' LEU . 3.0 m -65.55 -32.65 74.36 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 115.563 -0.744 . . . . 1.71 109.81 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.853 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -61.48 -45.12 99.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 115.907 -0.588 . . . . 1.34 110.478 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.756 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.5 p -64.36 -19.21 65.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.207 0.447 . . . . 1.34 112.207 -176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.1 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 171.22 -164.35 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 123.406 0.682 . . . . 1.12 109.835 -173.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -107.79 92.81 9.42 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.55 -0.75 . . . . 1.81 109.214 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.853 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -120.32 6.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.322 3.348 . . . . 0.97 113.924 171.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 1.059 ' HA2' HG12 ' A' ' 75' ' ' VAL . . . 107.47 -25.54 21.14 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.097 -1.201 . . . . 0.68 110.097 -161.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 77' ' ' TYR . . . 56.61 -91.81 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.029 1.332 . . . . 0.52 113.735 173.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.437 ' HA ' HD13 ' A' ' 28' ' ' LEU . 19.5 m -115.78 -21.71 9.48 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.546 0.689 . . . . 1.64 110.135 -160.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.57 147.8 18.74 Favored Glycine 0 N--CA 1.418 -2.557 0 CA-C-N 114.783 -1.099 . . . . 0.51 111.005 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD13 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -128.22 142.34 51.19 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.335 -0.946 . . . . 0.82 110.606 172.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.715 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 96.0 mtt180 -132.24 161.78 32.58 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.841 -1.911 . . . . 2.34 105.841 165.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.72 ' HD2' ' HE2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -157.4 166.66 32.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.038 -1.065 . . . . 1.69 112.369 168.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.56 ' HB2' HG21 ' A' ' 72' ' ' VAL . 46.4 mtp180 -111.08 139.28 46.57 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.347 1.655 . . . . 3.18 108.282 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.863 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -137.49 120.82 11.6 Favored Pre-proline 0 C--O 1.209 -1.033 0 CA-C-N 115.343 -0.844 . . . . 3.04 111.636 -161.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.484 ' N ' HD21 ' A' ' 45' ' ' ASN . 82.1 Cg_exo -49.58 5.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 124.653 3.569 . . . . 3.71 116.869 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.924 HG11 ' H ' ' A' ' 48' ' ' SER . 2.7 p -100.62 -86.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 121.797 -0.564 . . . . 5.02 110.25 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.924 ' H ' HG11 ' A' ' 47' ' ' VAL . 68.5 p -107.28 -8.12 16.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.977 -0.556 . . . . 3.64 110.911 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.863 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 6.2 mt-30 51.77 28.02 4.61 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 124.482 1.113 . . . . 4.2 113.494 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -46.88 121.68 3.8 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.262 -0.881 . . . . 1.74 110.207 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 15.8 ptm -63.6 86.21 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 2.93 109.21 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 10.6 ttt180 -124.67 151.03 45.46 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.709 0.766 . . . . 2.9 111.079 -172.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.51 165.52 24.87 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 114.194 -1.366 . . . . 0.44 115.124 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.675 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 78.5 t -83.73 141.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 112.879 -1.661 . . . . 0.95 109.696 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mpt_? -64.96 134.53 54.12 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.485 0.18 . . . . 5.04 111.485 -171.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.8 pp -110.62 114.08 27.2 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.59 -0.444 . . . . 2.13 110.065 172.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.639 HG12 ' HG3' ' A' ' 58' ' ' GLU . 13.9 t -125.1 113.79 37.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 109.916 -0.401 . . . . 0.95 109.916 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.639 ' HG3' HG12 ' A' ' 57' ' ' VAL . 19.9 mt-10 52.19 36.6 19.68 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.837 0.455 . . . . 1.51 111.711 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.79 -1.71 75.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.38 -0.914 . . . . 0.55 112.891 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -95.69 145.49 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 117.342 0.571 . . . . 0.58 110.688 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.861 ' HB3' HG21 ' A' ' 26' ' ' VAL . 11.9 tp -104.38 115.82 31.05 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.65 -1.241 . . . . 1.72 107.65 170.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.405 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 2.5 t-80 -116.05 133.57 55.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.162 -0.615 . . . . 2.16 112.081 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 162.24 37.23 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 107.684 -1.228 . . . . 1.37 107.684 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.09 153.19 72.41 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.491 1.46 . . . . 1.6 110.835 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -46.92 -44.14 19.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.588 0.709 . . . . 3.12 111.472 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.64 36.43 0.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.428 -1.26 . . . . 2.45 108.646 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.34 -103.53 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.99 -1.005 . . . . 2.11 113.885 -172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.615 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -86.57 -58.18 2.71 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.969 -0.752 . . . . 4.47 108.969 -173.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.58 -69.71 0.34 Allowed Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.57 -1.196 . . . . 1.78 113.195 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -139.39 -56.06 0.58 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 114.628 -0.786 . . . . 1.48 109.107 -168.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.668 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.3 OUTLIER 55.25 161.78 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.72 0 O-C-N 124.375 1.047 . . . . 1.22 110.544 -177.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.847 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 16.3 m -93.63 104.27 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 108.174 -1.047 . . . . 1.09 108.174 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.757 ' HB3' HD13 ' A' ' 41' ' ' LEU . 22.5 m-85 -78.58 138.91 38.6 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.884 -0.598 . . . . 0.84 111.504 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -96.85 151.94 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.456 -1.247 . . . . 0.34 108.687 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 1.081 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 4.0 t -114.86 115.23 48.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.342 0.591 . . . . 2.4 112.265 -163.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.715 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -128.63 129.14 45.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.497 -0.774 . . . . 1.89 111.351 178.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.735 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.658 -0.687 . . . . 1.36 110.552 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.639 0.257 . . . . 6.22 110.651 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -87.8 119.02 27.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.848 -0.427 . . . . 3.03 109.848 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.75 134.18 35.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.65 -0.5 . . . . 2.5 109.65 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.917 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 32.6 p90 -141.19 172.9 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.272 -0.64 . . . . 1.33 109.272 -170.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.963 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 25.4 pt -124.06 160.71 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.234 0.333 . . . . 1.64 110.516 -174.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.778 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 22.1 ttm180 -118.73 135.61 54.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.976 -0.69 . . . . 3.21 110.146 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.679 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.1 t -130.02 145.94 34.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 O-C-N 122.044 -0.41 . . . . 1.96 110.638 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.814 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.3 t -151.4 163.02 39.91 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.297 -0.252 . . . . 1.23 110.417 163.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 1.016 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -68.87 -39.05 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.925 -0.71 . . . . 2.97 111.011 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.26 154.84 50.78 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.875 -0.787 . . . . 1.14 108.875 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -52.6 -39.34 61.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.454 1.121 . . . . 1.48 108.257 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.57 7.97 33.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.366 -1.743 . . . . 2.58 112.939 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.61 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 2.7 t70 -85.79 -127.01 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 118.861 -1.136 . . . . 0.59 108.218 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.46 92.13 48.55 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.566 -0.743 . . . . 2.18 110.315 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.814 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.1 Cg_endo -70.57 132.96 23.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.726 1.617 . . . . 0.64 111.094 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.19 125.82 64.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.173 -0.921 . . . . 0.58 110.692 -169.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.917 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 23.4 mt-10 -85.1 120.98 27.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.966 -0.561 . . . . 1.62 110.453 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 21.4 pt -143.07 145.2 31.92 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.07 -0.968 . . . . 2.06 111.748 -171.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 16.5 Cg_exo -69.54 133.68 26.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.112 2.542 . . . . 1.05 113.084 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 p -108.53 172.23 6.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.809 -0.632 . . . . 1.54 110.647 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.73 138.41 58.37 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.044 0.45 . . . . 2.77 110.018 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -53.48 -31.49 45.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.954 -1.476 . . . . 2.13 112.183 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.4 p-10 -85.45 2.3 45.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.877 0.846 . . . . 2.32 108.9 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 25.47 18.28 Favored Glycine 0 CA--C 1.497 -1.07 0 CA-C-N 114.336 -1.302 . . . . 0.65 109.976 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.537 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.01 155.42 29.23 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.004 -1.098 . . . . 1.01 112.254 -165.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.781 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 138.49 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.121 -0.945 . . . . 0.52 108.994 169.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.703 HD22 ' CB ' ' A' ' 30' ' ' THR . 2.6 mp -64.08 112.09 2.83 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.942 -0.762 . . . . 2.59 108.942 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.702 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.34 -50.01 69.44 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.193 -0.669 . . . . 1.62 109.193 -174.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.8 p -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 1.89 111.171 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.703 ' CB ' HD22 ' A' ' 27' ' ' LEU . 3.6 m -68.43 -32.95 73.34 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.181 -0.674 . . . . 1.71 109.181 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.84 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.3 t -58.61 -53.41 47.41 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 CA-C-N 115.199 -0.91 . . . . 1.34 110.383 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -61.94 -16.64 52.59 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.351 0.871 . . . . 1.34 113.351 -175.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.375 1.25 . . . . 1.0 114.375 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.588 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 172.32 -164.26 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.014 0.926 . . . . 1.12 109.259 -173.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -108.96 91.88 9.85 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 109.073 -0.714 . . . . 1.81 109.073 164.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.84 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.13 8.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.801 3.667 . . . . 0.97 114.466 175.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.844 ' HA2' HG12 ' A' ' 75' ' ' VAL . . . 108.27 -21.16 29.39 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.137 -1.185 . . . . 0.68 110.137 -163.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB2' ' HB3' ' A' ' 77' ' ' TYR . . . 58.51 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.755 1.02 . . . . 0.52 113.755 170.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.9 m -130.77 -5.33 4.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.52 0.676 . . . . 1.64 110.472 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -132.0 155.27 21.37 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 115.14 -0.936 . . . . 0.51 111.86 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -132.41 154.59 49.67 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 119.8 -0.76 . . . . 0.82 111.466 174.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.2 mtt180 -140.41 151.82 45.22 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.706 -1.961 . . . . 2.34 105.706 161.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.664 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 36.3 p90 -157.63 165.03 36.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 120.188 1.358 . . . . 1.69 112.699 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 45.3 mtm180 -110.89 150.38 29.27 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 125.601 1.813 . . . . 3.18 109.554 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.814 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 23.4 t-20 -146.21 116.53 4.75 Favored Pre-proline 0 C--O 1.214 -0.806 0 CA-C-N 114.148 -1.387 . . . . 3.04 111.115 -162.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HD2' HD13 ' A' ' 71' ' ' LEU . 14.2 Cg_exo -25.6 -27.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 126.569 4.846 . . . . 3.71 118.311 -172.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.8 HG11 ' H ' ' A' ' 48' ' ' SER . 2.5 p -83.9 -84.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 118.957 0.799 . . . . 5.02 110.855 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.8 ' H ' HG11 ' A' ' 47' ' ' VAL . 22.7 t -107.12 -9.01 16.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.021 -0.536 . . . . 3.64 110.151 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.814 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 10.2 mt-30 50.61 26.97 2.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 113.901 1.075 . . . . 4.2 113.901 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.71 115.9 1.3 Allowed 'General case' 0 C--N 1.308 -1.223 0 O-C-N 123.813 0.696 . . . . 1.74 110.739 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 4.8 ptt? -62.43 92.43 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.378 0.608 . . . . 2.93 110.222 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 7.6 ptp85 -122.31 161.42 23.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.573 -0.74 . . . . 2.9 109.691 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -116.13 167.26 12.43 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.085 -1.055 . . . . 0.44 115.391 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.654 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 99.5 t -83.96 141.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.345 -1.427 . . . . 0.95 111.391 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.497 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 3.3 mpt_? -72.29 135.64 46.03 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.643 -0.708 . . . . 5.04 112.221 -171.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp -98.84 117.68 33.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.103 -0.639 . . . . 2.13 109.888 172.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.645 HG12 ' HG3' ' A' ' 58' ' ' GLU . 9.5 t -132.95 114.7 22.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 109.87 -0.419 . . . . 0.95 109.87 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.645 ' HG3' HG12 ' A' ' 57' ' ' VAL . 25.3 mt-10 53.9 39.5 30.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.092 0.405 . . . . 1.51 112.092 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 87.04 -1.37 86.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.42 -0.895 . . . . 0.55 112.646 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.3 mt -100.75 149.33 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 122.734 -0.274 . . . . 0.58 111.073 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.781 ' HB3' HG21 ' A' ' 26' ' ' VAL . 6.4 tp -102.09 114.83 29.3 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.507 -1.664 . . . . 1.72 106.507 165.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -115.57 134.69 54.81 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.269 0.557 . . . . 2.16 112.322 -165.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB1' ' CH2' ' A' ' 68' ' ' TRP . . . -103.65 163.02 18.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.591 -1.186 . . . . 1.37 108.572 170.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.82 163.76 15.33 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.687 2.258 . . . . 1.6 111.683 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.2 -45.79 8.59 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.71 0.766 . . . . 3.12 112.834 -173.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.38 -39.12 8.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.296 -1.32 . . . . 2.45 110.336 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.88 149.06 4.48 Favored Glycine 0 N--CA 1.426 -2.029 0 C-N-CA 120.556 -0.831 . . . . 2.11 112.298 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.623 ' HB2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.85 -52.43 36.82 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.934 -1.135 . . . . 4.47 107.934 175.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 5' ' ' ILE . . . 166.98 -83.76 0.1 OUTLIER Glycine 0 N--CA 1.417 -2.58 0 CA-C-N 113.79 -1.55 . . . . 1.78 111.427 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.963 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.2 p30 -142.25 -62.11 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 0 CA-C-N 114.58 -0.81 . . . . 1.48 109.922 -170.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 54.01 176.4 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.35 1.071 . . . . 1.22 111.297 -177.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.54 ' H ' HG12 ' A' ' 72' ' ' VAL . 2.1 p -102.91 104.54 16.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 113.326 -1.761 . . . . 1.09 108.427 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.786 ' HE1' HD13 ' A' ' 5' ' ' ILE . 20.4 m-85 -80.82 146.5 30.89 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.701 0.763 . . . . 0.84 112.157 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -107.6 158.21 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.499 -1.682 . . . . 0.34 107.933 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 1.016 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 t -113.93 110.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.56 0.695 . . . . 2.4 111.383 -164.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -126.35 129.4 48.74 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.122 -0.945 . . . . 1.89 110.684 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.696 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.835 0 CA-C-O 118.587 -0.72 . . . . 1.36 110.116 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.863 0.363 . . . . 6.22 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p -112.24 -81.05 0.59 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.965 0.412 . . . . 3.03 110.59 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -111.8 153.74 26.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.309 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.487 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 23.0 p90 -131.67 163.87 27.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.594 -1.632 . . . . 1.33 106.594 173.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.919 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -127.49 160.76 36.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.984 -0.286 . . . . 1.64 110.661 -172.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 5.2 ttt180 -119.4 132.77 55.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.758 -0.777 . . . . 3.21 109.279 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.776 HG23 ' HD1' ' A' ' 73' ' ' TYR . 3.5 t -132.63 144.2 37.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 121.923 -0.485 . . . . 1.96 110.396 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.992 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 5.4 t -152.85 168.33 26.11 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.369 0.128 . . . . 1.23 110.768 166.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.776 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 tm-20 -72.92 -56.4 5.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.058 0.932 . . . . 2.97 108.624 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 8' ' ' THR . 14.0 t70 -110.01 148.31 31.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.822 -1.177 . . . . 1.14 107.822 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.631 ' HG2' HG23 ' A' ' 74' ' ' VAL . 1.5 mt-10 -63.11 -17.82 62.73 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.347 -1.297 . . . . 1.48 108.577 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.64 33.55 4.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.996 -1.456 . . . . 2.58 110.657 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 7.3 t70 -83.55 -118.09 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.697 -1.223 . . . . 0.59 107.697 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -121.5 90.76 48.1 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.067 -0.97 . . . . 2.18 110.184 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.992 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 72.7 Cg_endo -74.69 133.43 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.056 1.837 . . . . 0.64 110.879 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.28 136.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.021 -0.536 . . . . 0.58 111.338 -169.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 34.2 mt-10 -86.07 122.0 29.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.84 -0.43 . . . . 1.62 109.84 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 25.4 pt -140.49 141.1 24.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.789 -0.641 . . . . 2.06 111.031 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 47.6 Cg_endo -69.69 136.29 32.81 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.713 2.275 . . . . 1.05 112.425 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.768 ' HB3' HD13 ' A' ' 5' ' ' ILE . 8.2 p -112.14 169.36 8.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 1.54 110.518 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.91 136.73 53.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.333 -0.618 . . . . 2.77 109.333 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 24' ' ' GLY . 1.2 m-20 -55.1 -17.4 4.01 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.195 0.998 . . . . 2.13 112.555 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -74.55 0.71 13.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.009 0.909 . . . . 2.32 108.645 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.31 23.98 74.38 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 113.866 -1.516 . . . . 0.65 110.973 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.925 ' HG1' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -132.43 166.74 21.32 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.406 -0.397 . . . . 1.01 110.775 -169.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.849 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -147.5 146.35 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.598 -0.728 . . . . 0.52 110.04 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.809 ' HG ' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -67.62 109.71 3.4 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.007 -0.738 . . . . 2.59 109.007 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -65.77 -48.95 70.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.17 -0.923 . . . . 1.62 110.009 -169.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.684 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.5 m -58.86 -39.23 80.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.14 -0.936 . . . . 1.89 110.771 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.809 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 2.5 t -68.61 -33.19 73.61 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.602 -1.259 . . . . 1.71 107.602 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.842 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 19.8 t -66.89 -42.54 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 CA-C-N 114.292 -1.322 . . . . 1.34 109.864 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.684 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -65.8 -19.09 65.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.366 0.506 . . . . 1.34 112.366 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.7 41.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.51 1.3 . . . . 1.0 114.51 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 173.51 -164.29 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 123.968 0.907 . . . . 1.12 108.981 -173.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.04 92.16 10.44 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 108.849 -0.797 . . . . 1.81 108.849 166.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.842 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -118.53 1.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.287 3.325 . . . . 0.97 114.369 173.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.882 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . 107.61 -20.09 32.61 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 110.1 -1.2 . . . . 0.68 110.1 -161.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 63.45 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.226 1.01 . . . . 0.52 113.504 170.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.4 t -128.87 -21.49 3.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.317 0.58 . . . . 1.64 110.415 -165.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -112.97 155.51 16.24 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.485 -1.046 . . . . 0.51 110.485 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.59 151.01 51.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 118.736 -1.186 . . . . 0.82 112.984 176.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.605 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 mtt180 -133.82 161.0 35.92 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.187 -1.783 . . . . 2.34 106.187 158.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.833 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.6 p90 -156.91 165.57 35.83 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 119.396 0.998 . . . . 1.69 111.892 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB2' HG11 ' A' ' 72' ' ' VAL . 53.6 mtt180 -110.07 143.64 39.83 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 125.088 1.493 . . . . 3.18 109.138 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 1.047 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 35.0 t30 -128.04 123.84 22.85 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.995 -1.002 . . . . 3.04 111.343 -169.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HD2' HD13 ' A' ' 71' ' ' LEU . 48.8 Cg_exo -38.01 -28.59 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.966 3.777 . . . . 3.71 116.305 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.566 ' CG1' ' H ' ' A' ' 48' ' ' SER . 2.1 p -96.54 -90.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.074 0.397 . . . . 5.02 111.461 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.566 ' H ' ' CG1' ' A' ' 47' ' ' VAL . 33.8 p -90.33 -8.83 49.82 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.666 0.746 . . . . 3.64 110.798 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.047 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER 50.43 49.27 21.02 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 115.28 1.585 . . . . 4.2 115.28 169.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.56 118.67 12.72 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.088 -0.96 . . . . 1.74 111.01 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 5.9 ptm -64.23 87.26 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.074 -0.713 . . . . 2.93 109.074 170.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 7.3 ttt180 -121.19 156.21 32.88 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.934 -0.575 . . . . 2.9 110.432 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -100.48 164.81 19.04 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 121.975 0.764 . . . . 0.44 113.951 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.634 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 91.0 t -98.53 140.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.545 -1.327 . . . . 0.95 109.867 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.6 ' HD2' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -63.27 134.72 56.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.648 -0.705 . . . . 5.04 112.642 -175.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.34 121.77 46.1 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.533 -0.467 . . . . 2.13 109.925 165.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.667 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.7 t -126.17 113.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.739 -0.467 . . . . 0.95 109.739 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.667 ' HG3' HG12 ' A' ' 57' ' ' VAL . 12.1 mt-10 51.13 36.5 15.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.067 0.547 . . . . 1.51 112.445 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.458 ' HA2' HD22 ' A' ' 28' ' ' LEU . . . 95.35 -3.23 66.04 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.729 -0.748 . . . . 0.55 112.932 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.925 HG22 ' HG1' ' A' ' 25' ' ' THR . 2.3 mt -100.81 148.16 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.726 -0.279 . . . . 0.58 110.443 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.849 ' HB3' HG21 ' A' ' 26' ' ' VAL . 16.4 tp -102.44 114.58 28.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.134 -1.061 . . . . 1.72 108.134 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -111.65 122.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.711 0.767 . . . . 2.16 111.616 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.67 162.47 62.83 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 106.838 -1.541 . . . . 1.37 106.838 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 22.2 Cg_exo -63.41 149.89 89.97 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 120.421 1.186 . . . . 1.6 109.594 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -45.95 -43.68 14.2 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.195 0.934 . . . . 3.12 111.924 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.17 32.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.484 -0.932 . . . . 2.45 108.484 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.11 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.004 -0.998 . . . . 2.11 113.885 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.708 ' CD1' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.34 -76.93 0.6 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.538 0.685 . . . . 4.47 109.897 -172.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.33 -76.49 0.12 Allowed Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 114.95 -1.023 . . . . 1.78 113.757 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.919 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -133.42 -59.03 0.88 Allowed 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.101 -0.549 . . . . 1.48 109.737 -167.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 51.06 172.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.439 1.087 . . . . 1.22 111.648 -176.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 44' ' ' ARG . 2.0 p -99.56 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 113.99 -1.459 . . . . 1.09 108.492 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.833 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.6 m-85 -79.86 144.81 33.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.827 0.822 . . . . 0.84 112.671 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.631 HG23 ' HG2' ' A' ' 11' ' ' GLU . 3.5 t -110.38 164.11 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.356 -1.747 . . . . 0.34 109.548 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.882 HG22 ' HA2' ' A' ' 37' ' ' GLY . 9.8 p -98.95 114.67 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.671 0.619 . . . . 2.4 112.671 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 1.1 p30 -133.54 128.2 34.78 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 118.638 -1.225 . . . . 1.89 110.533 158.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.702 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.38 -0.819 . . . . 1.36 109.957 167.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.614 0.245 . . . . 6.22 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -80.91 73.69 7.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.364 0.602 . . . . 3.03 109.553 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -82.73 141.72 32.18 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.635 -0.711 . . . . 2.5 109.755 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.618 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 16.8 p90 -138.64 162.54 34.36 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.258 -1.386 . . . . 1.33 107.258 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.799 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -121.86 162.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.88 0.309 . . . . 1.64 111.223 -172.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 1.015 ' HD2' ' HB2' ' A' ' 15' ' ' PRO . 1.9 tpp85 -117.83 132.45 56.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.152 -0.684 . . . . 3.21 109.152 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 2.7 p -138.81 147.2 25.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 O-C-N 121.411 -0.806 . . . . 1.96 111.503 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.961 HG21 ' HB3' ' A' ' 15' ' ' PRO . 2.1 t -153.49 171.13 19.18 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.494 -0.928 . . . . 1.23 108.494 166.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.0 mt-10 -75.33 -54.9 6.3 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.834 -1.147 . . . . 2.97 108.142 171.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 12.0 m-20 -103.38 142.11 34.78 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.845 -1.169 . . . . 1.14 107.845 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 74' ' ' VAL . 4.3 mt-10 -57.71 -25.76 60.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 1.48 109.078 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.64 39.33 3.89 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.677 -1.601 . . . . 2.58 110.868 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.4 t70 -80.86 -114.48 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.042 -1.466 . . . . 0.59 107.042 165.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -123.14 90.16 50.52 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.274 -0.875 . . . . 2.18 109.668 165.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.015 ' HB2' ' HD2' ' A' ' 6' ' ' ARG . 72.5 Cg_endo -72.55 135.96 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.397 2.065 . . . . 0.64 111.376 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -126.86 147.01 31.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.804 -0.635 . . . . 0.58 110.928 -168.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 13.8 mt-10 -95.62 124.53 39.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.113 -0.494 . . . . 1.62 110.857 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 35.8 pt -141.2 150.9 60.19 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.715 -0.675 . . . . 2.06 111.047 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.48 159.73 14.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.938 2.426 . . . . 1.05 112.421 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.516 ' OG ' HD13 ' A' ' 5' ' ' ILE . 16.4 m -119.06 169.59 9.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 1.54 110.277 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.15 145.31 55.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.054 -0.721 . . . . 2.77 109.054 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -23.74 14.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.281 -1.327 . . . . 2.13 111.952 -171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 22.5 t70 -78.26 -8.46 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.213 1.006 . . . . 2.32 109.171 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.1 31.67 Favored Glycine 0 CA--C 1.5 -0.873 0 N-CA-C 108.681 -1.767 . . . . 0.65 108.681 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -117.56 149.81 40.02 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 112.893 -1.654 . . . . 1.01 110.915 -166.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.787 HG21 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -144.42 148.03 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.225 -0.443 . . . . 0.52 110.725 173.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.026 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -70.61 94.69 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 2.59 110.48 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.679 ' O ' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.58 -49.77 69.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.017 -0.538 . . . . 1.62 110.461 -170.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.698 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.7 m -69.77 -31.04 68.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.618 0.723 . . . . 1.89 109.719 -177.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.026 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.5 m -73.46 -32.36 64.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.233 -0.894 . . . . 1.71 108.758 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.801 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 17.5 t -64.33 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 115.175 -0.921 . . . . 1.34 110.273 168.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.698 HG23 ' HA ' ' A' ' 29' ' ' SER . 1.3 p -65.03 -18.8 65.61 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.042 -0.411 . . . . 1.34 111.887 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.95 40.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 170.76 -166.61 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 124.054 0.941 . . . . 1.12 108.846 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -109.62 92.32 11.91 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.89 -0.781 . . . . 1.81 108.89 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.801 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 2.4 Cg_endo -120.42 5.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.199 3.266 . . . . 0.97 114.661 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 107.31 -26.98 16.91 Favored Glycine 0 C--O 1.222 -0.602 0 N-CA-C 109.716 -1.353 . . . . 0.68 109.716 -161.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.721 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 62.57 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.509 1.3 . . . . 0.52 114.509 165.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -122.41 -10.17 8.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.612 0.72 . . . . 1.64 110.482 -159.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -120.4 154.06 16.54 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.489 -1.445 . . . . 0.51 109.489 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -130.47 138.9 50.51 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 118.716 -1.194 . . . . 0.82 111.893 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.745 ' HE ' ' HB3' ' A' ' 51' ' ' MET . 20.1 mtp180 -126.35 157.94 37.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.381 -1.34 . . . . 2.34 107.381 159.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.795 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 25.4 p90 -154.34 160.21 41.59 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.435 -1.306 . . . . 1.69 111.845 165.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.564 ' HB3' HG11 ' A' ' 72' ' ' VAL . 15.0 ttm180 -107.57 136.24 47.68 Favored 'General case' 0 C--O 1.253 1.267 0 O-C-N 125.758 1.911 . . . . 3.18 109.228 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.6 m120 -115.58 176.89 1.34 Allowed Pre-proline 0 C--O 1.211 -0.946 0 O-C-N 124.292 0.995 . . . . 3.04 111.908 -169.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' CD ' ' HB3' ' A' ' 45' ' ' ASN . 2.2 Cg_endo -94.53 1.93 2.83 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.206 2.604 . . . . 3.71 112.594 167.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.876 HG11 ' H ' ' A' ' 48' ' ' SER . 2.4 p -103.42 -96.27 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.892 0.377 . . . . 5.02 111.709 -174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.876 ' H ' HG11 ' A' ' 47' ' ' VAL . 6.2 m -104.7 -4.29 22.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.687 0.756 . . . . 3.64 109.868 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 35.7 mt-30 52.88 42.62 32.05 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 113.976 -1.466 . . . . 4.2 113.879 170.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -67.88 124.56 23.68 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.877 -1.51 . . . . 1.74 108.861 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.745 ' HB3' ' HE ' ' A' ' 42' ' ' ARG . 18.2 mmt -69.67 80.05 0.43 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.997 -1.112 . . . . 2.93 107.997 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 15.1 ttt180 -101.79 152.88 20.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.565 -1.198 . . . . 2.9 110.991 -166.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.476 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -99.33 161.02 19.83 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.288 -1.324 . . . . 0.44 114.54 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.661 ' CG1' ' HG ' ' A' ' 61' ' ' LEU . 86.0 t -99.09 142.16 15.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 113.416 -1.392 . . . . 0.95 110.158 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -64.4 136.2 56.87 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 112.05 0.389 . . . . 5.04 112.05 -172.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.67 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -117.1 111.91 20.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.123 0.487 . . . . 2.13 110.567 175.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 60' ' ' ILE . 35.6 t -127.97 117.25 45.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 116.26 -0.427 . . . . 0.95 110.059 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 57' ' ' VAL . 22.0 mt-10 54.83 35.7 24.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.687 0.28 . . . . 1.51 111.689 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.7 3.1 86.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.41 -0.9 . . . . 0.55 112.933 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.1 mt -96.29 146.62 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 117.114 0.457 . . . . 0.58 110.814 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.787 ' HB3' HG21 ' A' ' 26' ' ' VAL . 6.8 tp -103.83 117.89 35.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.268 -1.382 . . . . 1.72 107.268 169.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -116.44 137.37 52.21 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.107 -0.637 . . . . 2.16 112.365 -169.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.48 163.74 17.6 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 114.564 -1.198 . . . . 1.37 109.899 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.3 167.4 6.16 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.672 2.914 . . . . 1.6 111.79 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -44.1 3.58 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.821 0.701 . . . . 3.12 112.66 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 -21.02 7.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.125 -0.943 . . . . 2.45 110.93 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 153.53 19.73 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.567 -1.302 . . . . 2.11 112.378 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.728 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.71 -49.89 35.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.441 -1.318 . . . . 4.47 107.441 169.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.1 -81.48 0.08 OUTLIER Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 112.781 -2.009 . . . . 1.78 110.261 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.799 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.5 p30 -147.04 -61.73 0.29 Allowed 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.559 -0.821 . . . . 1.48 109.354 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 68' ' ' TRP . 1.2 mm? 56.24 166.95 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.664 0 O-C-N 124.276 0.985 . . . . 1.22 110.959 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.605 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 1.8 p -100.3 107.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 114.26 -1.336 . . . . 1.09 109.493 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.842 ' HB3' HD11 ' A' ' 41' ' ' LEU . 19.0 m-85 -77.1 142.2 39.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.109 -0.95 . . . . 0.84 112.041 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.718 HG23 ' HG2' ' A' ' 11' ' ' GLU . 3.3 t -110.88 167.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 113.629 -1.623 . . . . 0.34 110.6 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 5.7 p -99.03 105.02 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 112.641 0.608 . . . . 2.4 112.641 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 0.3 OUTLIER -130.36 124.9 33.3 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 118.692 -1.203 . . . . 1.89 111.506 163.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.687 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.294 -0.86 . . . . 1.36 109.545 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 29.8 p90 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.379 . . . . 1.1699999999999999 107.278 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.955 HD12 ' HE1' ' A' ' 73' ' ' TYR . 23.6 pt -129.98 163.8 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.129 0.422 . . . . 1.0 111.123 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 134.28 55.14 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 109.506 -0.553 . . . . 2.73 109.506 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.652 HG13 ' HB2' ' A' ' 73' ' ' TYR . 1.6 t -136.83 142.87 36.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 O-C-N 121.499 -0.751 . . . . 1.45 110.883 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.898 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 t -154.13 151.74 29.61 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.01 -0.431 . . . . 0.56000000000000005 111.319 163.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.99 ' HA ' ' CB ' ' A' ' 75' ' ' VAL . 18.8 tt0 -65.96 -40.05 90.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.51 0.672 . . . . 2.9700000000000002 110.734 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -123.02 151.03 42.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.711 -1.588 . . . . 1.1399999999999999 106.711 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 11' ' ' GLU . 2.5 mt-10 -58.32 -30.5 66.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.553 -0.906 . . . . 1.48 108.553 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.69 31.19 6.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.284 -1.325 . . . . 2.02 111.031 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 27.0 t70 -84.84 -121.53 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.28 -1.378 . . . . 0.58999999999999997 107.28 167.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -122.19 92.95 48.81 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.373 -0.831 . . . . 2.1800000000000002 110.455 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.898 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 56.3 Cg_endo -67.57 136.3 38.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 110.997 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.511 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.86 143.94 39.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.351 -0.84 . . . . 0.51000000000000001 111.461 -169.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.676 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 23.8 mt-10 -97.35 125.66 42.1 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.888 -0.412 . . . . 1.6200000000000001 109.888 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 47.8 pt -140.77 139.08 19.13 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.155 -0.475 . . . . 1.52 111.527 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 7.6 Cg_exo -72.65 150.91 51.56 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.292 2.662 . . . . 0.67000000000000004 112.784 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -129.47 168.41 16.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.96999999999999997 111.019 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' THR . 26.8 tt0 -75.07 145.73 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.289 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.38 -21.37 9.42 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.611 -1.177 . . . . 2.1299999999999999 112.536 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 29.3 t70 -76.16 -7.04 53.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.292 1.044 . . . . 2.3199999999999998 108.709 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.98 53.99 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.021 -1.631 . . . . 0.56000000000000005 109.021 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -123.44 155.92 36.51 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.447 -1.376 . . . . 0.62 110.401 -166.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -147.31 152.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 122.568 0.347 . . . . 0.46999999999999997 110.811 177.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.103 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -68.9 94.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.129 -0.487 . . . . 1.9399999999999999 110.468 178.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -64.6 -49.69 70.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 110.006 -0.368 . . . . 0.96999999999999997 110.006 -171.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 32' ' ' THR . 16.7 p -62.66 -36.22 82.16 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.829 0.824 . . . . 1.4299999999999999 110.154 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.103 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.6 m -72.53 -33.6 66.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.913 -1.04 . . . . 1.4199999999999999 108.512 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.85 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 8.8 t -60.95 -48.52 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.482 -1.236 . . . . 0.67000000000000004 110.751 170.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -62.44 -17.7 60.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.095 0.776 . . . . 0.71999999999999997 113.095 -176.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.12 38.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.71 1.374 . . . . 0.93000000000000005 114.71 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER 170.22 -164.72 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.194 0.998 . . . . 1.05 109.012 -173.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -107.97 92.09 8.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.85 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.76 6.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.86 3.707 . . . . 0.84999999999999998 115.318 176.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 1.126 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 109.2 -15.6 32.99 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 109.979 -1.249 . . . . 0.67000000000000004 109.979 -161.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 47.15 -91.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.984 1.314 . . . . 0.45000000000000001 114.148 171.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 t -131.02 6.74 4.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.404 0.621 . . . . 1.1100000000000001 110.282 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -144.69 147.8 19.2 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.341 -0.845 . . . . 0.39000000000000001 111.081 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -128.25 152.97 47.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.283 -1.367 . . . . 0.56000000000000005 113.093 177.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.811 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 77.7 mtt-85 -136.48 164.88 27.13 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.057 -2.201 . . . . 1.9399999999999999 105.057 158.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -155.94 163.65 39.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 119.928 1.24 . . . . 1.1399999999999999 112.502 168.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -114.79 125.5 53.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 124.48 1.112 . . . . 2.7200000000000002 113.329 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.39 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 119.935 3.309 . . . . 3.04 119.935 141.231 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 3.5 mt-30 . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 122.317 1.056 . . . . 4.2000000000000002 111.96 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 132.19 34.67 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.464 -1.698 . . . . 1.72 111.293 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 12.4 ptp -69.52 82.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.051 0.453 . . . . 2.3500000000000001 109.937 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HD3' ' OH ' ' A' ' 43' ' ' TYR . 18.3 ttt180 -115.95 150.3 37.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.652 0.739 . . . . 2.48 110.812 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.77 165.98 24.8 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.514 -1.221 . . . . 0.40999999999999998 115.243 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.7 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 70.5 t -99.43 146.19 9.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.856 -1.672 . . . . 0.42999999999999999 111.01 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 11.1 mtt180 -62.01 136.27 57.89 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.707 0.803 . . . . 4.1100000000000003 112.906 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -121.74 115.7 23.17 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.664 -0.495 . . . . 1.53 109.664 170.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 58' ' ' GLU . 10.3 t -130.22 114.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.535 -0.302 . . . . 0.53000000000000003 110.52 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 57' ' ' VAL . 15.3 mt-10 51.2 37.19 17.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.021 0.528 . . . . 1.51 112.289 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -2.04 66.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.681 -0.771 . . . . 0.51000000000000001 113.058 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -100.97 147.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.684 -0.304 . . . . 0.48999999999999999 111.586 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.997 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -103.8 114.56 28.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.836 -1.172 . . . . 1.0700000000000001 107.836 169.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.751 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 9.9 t-160 -114.58 136.13 53.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.889 -0.724 . . . . 1.5 112.203 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.69 162.05 39.99 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 0.82999999999999996 108.586 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.46 159.1 54.86 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 121.85 1.7 . . . . 1.29 110.504 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -47.38 -44.34 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.686 0.616 . . . . 3.1200000000000001 112.503 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.61 28.22 0.38 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.545 -0.752 . . . . 2.1400000000000001 109.813 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.14 -97.43 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.592 -0.813 . . . . 1.5600000000000001 113.267 -173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 1.016 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -107.71 -81.56 0.56 Allowed 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.748 0.308 . . . . 3.6899999999999999 110.543 -178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.1 -70.7 0.43 Allowed Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 119.604 -1.284 . . . . 1.78 114.709 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 11.4 p-10 -139.77 33.67 2.0 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.84 1.305 . . . . 1.48 109.724 -152.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -48.7 162.04 0.11 Allowed 'General case' 0 CA--C 1.477 -1.836 0 CA-C-N 112.147 -2.297 . . . . 0.90000000000000002 109.242 169.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.775 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.5 p -86.33 106.36 15.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.156 -1.383 . . . . 0.81999999999999995 107.284 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.955 ' HE1' HD12 ' A' ' 5' ' ' ILE . 19.8 m-85 -77.77 145.28 36.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.587 -0.733 . . . . 0.41999999999999998 111.258 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 3.1 t -97.0 150.68 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.85 -1.523 . . . . 0.34000000000000002 108.06 169.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.126 HG13 ' HA2' ' A' ' 37' ' ' GLY . 5.0 t -108.1 118.1 55.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.59 0.71 . . . . 1.8400000000000001 112.186 -165.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -127.64 130.22 48.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.697 -1.138 . . . . 1.8799999999999999 110.611 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 3.3 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.674 -0.679 . . . . 1.3600000000000001 110.856 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 44.6 p90 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 106.779 -1.563 . . . . 1.1699999999999999 106.779 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 14.8 pt -128.23 161.24 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 118.044 0.384 . . . . 1.0 111.557 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 10.1 ttt180 -119.83 132.17 55.5 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.165 -0.679 . . . . 2.73 109.165 171.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.516 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.6 p -137.28 140.46 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.632 -0.427 . . . . 1.45 111.596 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.757 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.8 t -152.81 171.23 18.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.542 -0.754 . . . . 0.56000000000000005 109.754 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.82 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 21.1 mt-10 -74.72 -53.92 8.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.864 0.84 . . . . 2.9700000000000002 109.091 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.49 150.4 29.96 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.304 -1.369 . . . . 1.1399999999999999 107.304 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 44' ' ' ARG . 43.4 mt-10 -63.94 -22.51 66.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.264 -1.334 . . . . 1.48 109.083 -170.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -122.3 23.57 9.72 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.448 -1.251 . . . . 2.02 111.53 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.6 t70 -74.28 -112.71 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.097 -1.075 . . . . 0.58999999999999997 108.097 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' HD13 ' A' ' 16' ' ' ILE . 33.2 tt0 -122.23 88.42 48.55 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.283 -0.871 . . . . 2.1800000000000002 109.873 165.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 91.4 Cg_endo -78.43 130.59 10.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.625 1.55 . . . . 0.57999999999999996 110.686 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.08 133.58 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.539 -0.755 . . . . 0.51000000000000001 111.841 -169.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.76 122.56 29.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.377 -0.601 . . . . 1.6200000000000001 109.377 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 37.4 pt -139.04 138.83 21.7 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.99 -0.55 . . . . 1.52 110.927 -171.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 16.2 Cg_exo -68.71 124.29 11.35 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.08 2.52 . . . . 0.67000000000000004 112.055 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -95.49 169.57 9.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 0.96999999999999997 110.533 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.0 tp10 -64.95 136.02 56.33 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.008 -0.738 . . . . 2.77 109.008 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.63 -16.97 7.16 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.239 -0.891 . . . . 2.1299999999999999 112.32 -175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -79.6 1.09 27.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.726 0.774 . . . . 2.3199999999999998 109.028 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.98 49.25 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 114.258 -1.337 . . . . 0.56000000000000005 110.587 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.19 159.46 36.77 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.32 -0.94 . . . . 0.62 110.884 -165.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.942 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.33 153.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 111.223 175.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -70.54 94.6 1.0 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.872 -0.604 . . . . 1.9399999999999999 110.749 -178.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.46 -50.32 65.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.527 -0.545 . . . . 0.96999999999999997 109.527 -173.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.718 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.6 p -61.55 -33.95 74.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.682 0.753 . . . . 1.4299999999999999 110.375 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.099 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 8.6 m -75.0 -33.14 61.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.071 -0.968 . . . . 1.4199999999999999 108.952 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.838 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 18.7 t -62.68 -47.62 92.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.227 -0.897 . . . . 0.67000000000000004 110.537 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -64.89 -16.96 63.89 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.775 0.657 . . . . 0.71999999999999997 112.775 -177.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.75 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.451 1.278 . . . . 0.93000000000000005 114.451 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER 170.77 -166.53 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.484 1.114 . . . . 1.05 108.787 -172.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HD2' ' HH ' ' A' ' 77' ' ' TYR . 11.0 m-85 -109.88 92.15 12.13 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.838 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -121.27 4.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.558 3.505 . . . . 0.84999999999999998 115.017 176.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.41 30.95 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.167 -1.173 . . . . 0.67000000000000004 110.167 -161.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.68 -88.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.764 1.394 . . . . 0.45000000000000001 114.764 165.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 15.7 m -129.58 -1.54 4.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 110.966 -163.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.55 169.96 20.59 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.199 -1.16 . . . . 0.39000000000000001 110.199 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.814 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -148.43 140.28 23.82 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.332 -0.947 . . . . 0.56000000000000005 112.15 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.595 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.5 mtt180 -134.11 152.91 52.05 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 106.38 -1.711 . . . . 1.9399999999999999 106.38 159.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.797 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 50.0 p90 -153.37 164.81 37.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 120.71 1.596 . . . . 1.1399999999999999 113.483 169.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 11' ' ' GLU . 9.0 mtm180 -109.73 150.49 28.23 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.845 -1.525 . . . . 2.7200000000000002 110.201 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.02 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 t30 . . . . . 0 C--O 1.219 -0.55 0 CA-C-N 114.028 -1.442 . . . . 3.04 110.508 -166.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.02 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 1.5 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 115.331 1.604 . . . . 4.2000000000000002 115.331 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -60.97 126.04 25.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.339 -0.391 . . . . 1.72 110.243 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.83 92.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.928 0.871 . . . . 2.3500000000000001 110.221 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 74.1 ttt180 -105.24 149.78 25.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.869 -1.059 . . . . 2.48 112.168 -170.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -96.53 149.22 19.25 Favored Glycine 0 C--N 1.302 -1.32 0 CA-C-N 113.941 -1.481 . . . . 0.40999999999999998 114.502 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.814 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 76.0 t -98.78 143.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.514 -1.343 . . . . 0.42999999999999999 110.327 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.665 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -65.85 135.49 54.9 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 112.514 0.561 . . . . 4.1100000000000003 112.514 -170.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.05 111.22 22.16 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.192 -0.67 . . . . 1.53 109.192 169.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 58' ' ' GLU . 19.3 t -129.44 118.03 44.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.153 -0.476 . . . . 0.53000000000000003 110.699 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.944 ' HG2' HG12 ' A' ' 57' ' ' VAL . 3.9 mm-40 52.69 35.53 18.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.375 0.509 . . . . 1.51 112.375 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' C ' HD23 ' A' ' 28' ' ' LEU . . . 92.79 -0.87 70.55 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.588 -0.815 . . . . 0.51000000000000001 113.048 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -104.08 149.35 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.796 0.332 . . . . 0.48999999999999999 111.706 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.942 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.51 116.5 32.73 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.92 -1.511 . . . . 1.0700000000000001 106.92 166.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -115.09 133.59 55.9 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.598 0.713 . . . . 1.5 112.166 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 164.25 31.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 113.895 -1.502 . . . . 0.82999999999999996 110.46 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.84 168.01 9.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.551 2.834 . . . . 1.29 110.688 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -41.99 -42.99 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.436 0.902 . . . . 3.1200000000000001 113.436 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.91 -23.63 4.6 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.171 0.434 . . . . 2.1400000000000001 112.171 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 136.9 8.44 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 118.98 -1.581 . . . . 1.5600000000000001 114.054 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.434 ' CD2' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -81.37 -89.55 0.07 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.238 0.615 . . . . 3.6899999999999999 111.373 170.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.9 48.0 0.12 Allowed Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.671 -0.776 . . . . 1.78 113.918 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.851 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 87.04 -45.18 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 114.361 -0.92 . . . . 1.48 110.28 156.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.806 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 47.07 173.2 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.964 1.364 . . . . 0.90000000000000002 113.784 174.219 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -103.02 105.05 17.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 113.422 -1.717 . . . . 0.81999999999999995 109.145 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.797 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.0 m-85 -80.59 145.84 31.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.094 0.95 . . . . 0.41999999999999998 112.858 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -109.16 159.18 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 112.889 -1.959 . . . . 0.34000000000000002 110.151 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.82 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 p -87.93 103.78 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 1.8400000000000001 112.145 -165.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -129.03 127.2 41.1 Favored 'General case' 0 C--O 1.208 -1.08 0 C-N-CA 120.111 -0.636 . . . . 1.8799999999999999 109.423 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.489 -0.767 . . . . 1.3600000000000001 110.322 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.78 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 35.7 p90 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.813 -0.81 . . . . 1.1699999999999999 108.813 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.958 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -124.36 159.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 121.188 -0.205 . . . . 1.0 111.01 -178.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.79 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 2.9 ttt180 -120.52 134.35 55.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.756 -0.461 . . . . 2.73 109.756 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.688 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.4 p -138.16 148.5 24.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 O-C-N 121.786 -0.571 . . . . 1.45 111.57 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.5 t -152.57 171.21 18.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.494 -0.321 . . . . 0.56000000000000005 110.918 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 1.035 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.4 tm-20 -83.33 -33.02 25.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.807 0.813 . . . . 2.9700000000000002 110.036 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -132.18 150.0 52.26 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.15 -1.426 . . . . 1.1399999999999999 107.15 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' HH21 ' A' ' 44' ' ' ARG . 7.4 mm-40 -55.62 -25.3 38.05 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.981 0.801 . . . . 1.48 109.529 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -130.52 38.01 3.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.816 -1.084 . . . . 2.02 111.898 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 8.4 t70 -77.02 -111.6 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.69 -1.596 . . . . 0.58999999999999997 106.69 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -123.36 89.61 50.95 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.026 -0.988 . . . . 2.1800000000000002 109.944 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.857 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 55.5 Cg_endo -69.18 133.1 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.231 1.287 . . . . 0.57999999999999996 110.05 173.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.41 128.26 69.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.605 -0.725 . . . . 0.51000000000000001 111.138 -169.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.78 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.6 mp0 -84.13 121.73 27.85 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.715 -0.675 . . . . 1.6200000000000001 109.628 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 32.1 pt -140.64 143.61 33.11 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.496 -0.775 . . . . 1.52 111.537 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 2.9 Cg_exo -76.35 131.4 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.319 2.679 . . . . 0.67000000000000004 112.415 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 5' ' ' ILE . 7.2 p -103.59 171.35 7.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.768 -0.651 . . . . 0.96999999999999997 109.799 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.26 142.57 58.23 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.444 -0.576 . . . . 2.77 109.444 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.76 -28.86 24.2 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.952 1.407 . . . . 2.1299999999999999 112.347 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 6.3 p-10 -84.54 1.28 46.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.141 0.972 . . . . 2.3199999999999998 108.8 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 24.31 23.05 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 113.867 -1.515 . . . . 0.56000000000000005 110.234 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.48 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.35 151.81 38.74 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.827 -1.187 . . . . 0.62 111.622 -165.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.834 HG23 ' HB3' ' A' ' 61' ' ' LEU . 1.0 OUTLIER -147.31 148.7 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.667 -0.697 . . . . 0.46999999999999997 109.955 170.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.012 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -64.87 102.75 0.63 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.15 0.5 . . . . 1.9399999999999999 110.128 175.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -63.65 -50.63 68.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.45 -0.574 . . . . 0.96999999999999997 109.45 -172.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.69 ' HA ' HG23 ' A' ' 32' ' ' THR . 17.9 p -68.87 -37.34 79.01 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.614 0.721 . . . . 1.4299999999999999 110.201 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.5 m -70.88 -32.97 70.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 108.73 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.858 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.7 t -62.14 -44.77 99.46 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-N 114.821 -1.081 . . . . 0.67000000000000004 110.47 170.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -63.4 -19.24 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.71 0.633 . . . . 0.71999999999999997 112.71 -176.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.33 40.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.869 1.433 . . . . 0.93000000000000005 114.869 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER 169.91 -164.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.503 0.721 . . . . 1.05 109.437 -171.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -109.08 91.46 9.37 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.216 -0.661 . . . . 1.5 109.216 166.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.78 1.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.387 3.391 . . . . 0.84999999999999998 115.116 175.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CG2' ' A' ' 75' ' ' VAL . . . 107.69 -10.95 38.57 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 110.065 -1.214 . . . . 0.67000000000000004 110.065 -161.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 51.09 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.603 1.561 . . . . 0.45000000000000001 114.521 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -133.97 -36.41 0.93 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.733 0.778 . . . . 1.1100000000000001 110.439 -161.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 76' ' ' ASN . . . -97.76 155.21 20.42 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-N 114.742 -1.117 . . . . 0.39000000000000001 110.399 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.718 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -132.69 150.54 52.15 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.666 -1.214 . . . . 0.56000000000000005 112.858 178.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB2' ' A' ' 51' ' ' MET . 50.9 mtt180 -136.95 149.6 47.66 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.939 -1.875 . . . . 1.9399999999999999 105.939 162.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.79 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 41.6 p90 -154.93 158.13 38.8 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 120.165 1.348 . . . . 1.1399999999999999 112.635 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HG2' ' HB2' ' A' ' 45' ' ' ASN . 10.2 ttp180 -114.44 132.97 56.07 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 113.687 0.995 . . . . 2.7200000000000002 113.687 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.279 18.5 t30 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 117.926 2.565 . . . . 3.04 117.926 144.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 6.7 tt0 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.55 0.69 . . . . 4.2000000000000002 112.348 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -105.98 136.11 46.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 1.72 109.46 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.73 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 22.4 ptt? -62.61 85.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.793 0.806 . . . . 2.3500000000000001 111.125 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 57.0 ttt180 -100.54 150.29 22.83 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.494 -0.776 . . . . 2.48 110.954 -176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -90.45 160.83 28.27 Favored Glycine 0 C--N 1.293 -1.81 0 CA-C-N 115.019 -0.991 . . . . 0.40999999999999998 114.796 175.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.718 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 69.2 t -99.2 142.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.417 -1.392 . . . . 0.42999999999999999 109.804 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.731 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 1.2 mpt_? -66.89 133.73 50.62 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.052 0.39 . . . . 4.1100000000000003 112.052 -168.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.655 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.99 115.15 28.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.26 0.552 . . . . 1.53 109.64 172.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.623 HG12 ' HG3' ' A' ' 58' ' ' GLU . 3.6 t -133.81 118.93 31.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-N 116.222 -0.445 . . . . 0.53000000000000003 109.972 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 57' ' ' VAL . 29.2 mt-10 56.43 36.11 27.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.82 0.343 . . . . 1.51 111.643 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.31 0.41 89.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.493 -0.861 . . . . 0.51000000000000001 112.828 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 mt -97.08 147.43 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 O-C-N 122.617 -0.343 . . . . 0.48999999999999999 111.465 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.834 ' HB3' HG23 ' A' ' 26' ' ' VAL . 12.7 tp -104.03 115.76 31.02 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.55 -1.278 . . . . 1.0700000000000001 107.55 167.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -116.42 133.55 55.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.232 -0.587 . . . . 1.5 111.48 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.66 162.31 36.58 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.282 -1.007 . . . . 0.82999999999999996 108.282 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.79 160.05 42.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 121.87 1.714 . . . . 1.29 110.921 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.5 -44.25 17.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.693 0.621 . . . . 3.1200000000000001 111.89 -171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.89 32.47 0.1 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.082 -0.963 . . . . 2.1400000000000001 108.854 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -88.68 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.919 -1.037 . . . . 1.5600000000000001 113.935 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.855 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -103.89 -77.86 0.57 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.137 -0.69 . . . . 3.6899999999999999 109.137 -172.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.02 -78.37 0.13 Allowed Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.846 -1.169 . . . . 1.78 113.462 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.958 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 3.2 p-10 -127.92 -56.95 1.26 Allowed 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 114.957 -0.622 . . . . 1.48 109.444 -169.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER 56.45 167.34 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 124.694 1.247 . . . . 0.90000000000000002 110.465 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 72' ' ' VAL . 1.9 p -95.07 104.39 15.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.858 -1.137 . . . . 0.81999999999999995 108.562 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.79 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.2 m-85 -80.2 145.06 32.46 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.885 0.85 . . . . 0.41999999999999998 111.845 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.3 t -108.76 154.52 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 113.519 -1.673 . . . . 0.34000000000000002 109.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.035 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -85.61 120.13 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.163 0.506 . . . . 1.8400000000000001 110.16 -167.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.579 ' HB3' ' C ' ' A' ' 40' ' ' GLY . 56.2 t30 -131.5 128.24 38.97 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.775 -0.578 . . . . 1.8799999999999999 111.01 172.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 118.999 -0.524 . . . . 1.3600000000000001 110.648 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 15.5 p90 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 108.668 -0.864 . . . . 1.1699999999999999 108.668 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 20.9 pt -116.47 163.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.646 0.26 . . . . 1.0 111.592 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.657 HH11 ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.31 131.48 56.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.853 -0.795 . . . . 2.73 108.853 179.298 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.34 146.35 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.98 -1.075 . . . . 1.45 111.365 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.891 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 t -152.25 168.56 24.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.674 -0.239 . . . . 0.56000000000000005 110.413 166.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.657 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 1.7 mp0 -77.42 -33.92 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.9700000000000002 111.247 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.23 152.56 51.94 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.569 -1.271 . . . . 1.1399999999999999 107.569 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 4.2 mt-10 -55.29 -39.62 70.08 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 122.555 1.169 . . . . 1.48 107.966 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -106.85 25.91 10.72 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.873 -1.967 . . . . 2.02 113.057 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -81.83 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.891 -1.151 . . . . 0.58999999999999997 107.891 170.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.96 91.05 50.07 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 115.754 -0.657 . . . . 2.1800000000000002 110.624 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.891 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 58.5 Cg_endo -70.7 134.65 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.551 1.501 . . . . 0.57999999999999996 110.379 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.29 153.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.364 -0.835 . . . . 0.51000000000000001 110.864 -169.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.775 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.8 mp0 -108.5 122.48 47.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.2 -0.454 . . . . 1.6200000000000001 110.849 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.63 138.67 17.54 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.902 -0.59 . . . . 1.52 112.006 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.04 148.34 21.71 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.957 2.438 . . . . 0.67000000000000004 112.231 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.9 m -122.6 169.24 11.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 0.96999999999999997 111.281 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -66.49 150.71 48.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.485 0.66 . . . . 2.77 111.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -52.38 -28.39 19.43 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.438 -1.71 . . . . 2.1299999999999999 111.903 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 33.6 t70 -77.74 -7.21 56.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.379 1.085 . . . . 2.3199999999999998 108.79 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.81 25.98 36.44 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 108.357 -1.897 . . . . 0.56000000000000005 108.357 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.18 151.08 39.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.874 -1.663 . . . . 0.62 112.179 -160.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 147.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.393 -0.821 . . . . 0.46999999999999997 110.519 173.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.077 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -65.19 96.51 0.22 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.258 0.623 . . . . 1.9399999999999999 110.247 178.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.63 -49.57 70.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.563 -0.289 . . . . 0.96999999999999997 110.254 -168.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.5 p -70.2 -34.35 72.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.002 0.906 . . . . 1.4299999999999999 109.895 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.077 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 15.8 m -70.81 -32.78 69.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.742 -1.117 . . . . 1.4199999999999999 108.085 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.877 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.5 t -65.12 -42.15 93.63 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 CA-C-N 114.11 -1.404 . . . . 0.67000000000000004 110.846 171.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -64.4 -20.32 66.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.855 -0.528 . . . . 0.71999999999999997 111.95 -175.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.826 1.417 . . . . 0.93000000000000005 114.826 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER 172.15 -163.3 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 123.211 0.604 . . . . 1.05 109.988 -173.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -106.96 92.59 7.8 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.719 -0.845 . . . . 1.5 108.719 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.877 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -122.34 2.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.201 3.267 . . . . 0.84999999999999998 114.867 173.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . 106.92 -16.15 39.78 Favored Glycine 0 C--O 1.217 -0.923 0 N-CA-C 109.917 -1.273 . . . . 0.67000000000000004 109.917 -162.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 52.75 -92.12 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.907 1.283 . . . . 0.45000000000000001 113.542 172.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.9 m -122.69 4.16 9.52 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.672 0.749 . . . . 1.1100000000000001 110.243 -166.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.65 174.65 21.47 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 110.085 -1.206 . . . . 0.39000000000000001 110.085 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -153.19 143.71 22.58 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 120.128 -0.629 . . . . 0.56000000000000005 110.692 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.554 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.4 mtt180 -134.64 150.84 50.7 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 105.739 -1.949 . . . . 1.9399999999999999 105.739 160.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.69 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 45.9 p90 -152.54 165.23 35.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 121.181 1.809 . . . . 1.1399999999999999 113.125 170.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 11' ' ' GLU . 35.1 mtp85 -106.91 134.34 50.22 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.159 -1.837 . . . . 2.7200000000000002 108.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.141 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 56.8 t30 . . . . . 0 C--O 1.219 -0.544 0 CA-C-N 114.575 -1.193 . . . . 3.04 111.136 -164.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.141 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 5.0 tt0 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 114.936 1.458 . . . . 4.2000000000000002 114.936 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -60.97 130.03 44.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.992 -0.373 . . . . 1.72 109.992 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -64.85 87.58 0.06 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.357 0.598 . . . . 2.3500000000000001 109.804 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 21.0 ttt180 -101.21 147.63 26.04 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.684 0.754 . . . . 2.48 112.288 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -93.7 154.61 21.74 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 113.715 -1.584 . . . . 0.40999999999999998 114.279 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 46.4 t -100.04 143.7 13.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 113.746 -1.227 . . . . 0.42999999999999999 111.525 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -62.52 138.04 58.39 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 124.477 1.111 . . . . 4.1100000000000003 113.517 -175.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.4 pp -115.74 124.22 50.26 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.041 -0.264 . . . . 1.53 110.405 169.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.609 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.3 t -134.94 122.95 39.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.125 0 CA-C-O 118.846 -0.597 . . . . 0.53000000000000003 109.609 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HG3' HG12 ' A' ' 57' ' ' VAL . 35.1 mt-10 56.88 36.46 27.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.651 0.659 . . . . 1.51 112.093 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.29 8.69 87.03 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.549 -0.834 . . . . 0.51000000000000001 112.408 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 57' ' ' VAL . 5.8 mt -104.04 149.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 122.351 0.26 . . . . 0.48999999999999999 110.785 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.08 116.02 31.78 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.974 -1.121 . . . . 1.0700000000000001 107.974 170.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.16 122.56 46.16 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.106 0.479 . . . . 1.5 111.734 -175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.01 163.6 22.41 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.82999999999999996 110.381 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.17 166.55 12.5 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.112 2.541 . . . . 1.29 111.875 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.78 -45.65 4.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.233 0.827 . . . . 3.1200000000000001 113.233 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.99 -29.96 7.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 2.1400000000000001 110.935 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.79 128.64 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 122.04 0.8 . . . . 1.5600000000000001 113.375 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.535 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 m95 -84.2 -42.66 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.391 1.091 . . . . 3.6899999999999999 108.877 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.79 -79.82 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 113.359 -1.746 . . . . 1.78 111.446 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.69 -59.07 0.48 Allowed 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 114.423 -0.888 . . . . 1.48 109.36 -172.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER 58.08 151.25 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.799 1.312 . . . . 0.90000000000000002 110.425 -177.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.6 p -91.33 106.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.395 -0.82 . . . . 0.81999999999999995 108.806 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.69 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.1 m-85 -78.63 144.16 35.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.141 -0.936 . . . . 0.41999999999999998 112.012 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.7 t -109.19 159.88 8.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.179 -1.828 . . . . 0.34000000000000002 109.625 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.657 ' HB ' ' O ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -91.95 113.09 26.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.76 0.791 . . . . 1.8400000000000001 111.257 -169.163 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -130.54 126.34 36.53 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.075 -0.966 . . . . 1.8799999999999999 108.922 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 118.23 -0.89 . . . . 1.3600000000000001 110.4 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 23.4 p90 . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 107.985 -1.117 . . . . 1.1699999999999999 107.985 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.021 ' HA ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -135.23 162.33 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.222 0.465 . . . . 1.0 111.473 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 1.077 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -117.98 132.67 56.37 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 119.715 -0.794 . . . . 2.73 109.889 -176.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 3.3 p -138.85 148.44 24.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.941 -0.474 . . . . 1.45 111.405 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.985 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -153.98 164.01 39.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.353 -0.385 . . . . 0.56000000000000005 109.99 165.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.4 mp0 -67.94 -32.95 73.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 2.9700000000000002 111.504 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' THR . 14.2 t70 -132.48 149.44 52.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.613 -1.625 . . . . 1.1399999999999999 106.613 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 3.0 mt-10 -54.44 -34.22 61.03 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 122.01 0.91 . . . . 1.48 108.653 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -110.19 28.65 8.42 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.502 -1.681 . . . . 2.02 111.867 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.668 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.3 t70 -83.7 -117.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.895 -0.78 . . . . 0.58999999999999997 108.895 171.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -121.4 89.61 47.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.555 -0.748 . . . . 2.1800000000000002 110.429 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.985 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 74.4 Cg_endo -75.06 140.56 25.42 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 C-N-CA 123.107 2.538 . . . . 0.57999999999999996 113.506 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.09 125.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 115.448 -0.796 . . . . 0.51000000000000001 110.509 -175.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.077 ' HG2' ' HG3' ' A' ' 6' ' ' ARG . 25.0 mt-10 -86.12 120.6 27.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.223 -0.658 . . . . 1.6200000000000001 109.223 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 19.7 pt -142.03 144.41 31.89 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.303 -0.862 . . . . 1.52 111.454 -168.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 72.2 Cg_endo -74.64 145.29 32.74 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.867 2.378 . . . . 0.67000000000000004 113.34 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.503 ' OG ' HD12 ' A' ' 5' ' ' ILE . 8.5 m -104.42 170.26 8.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 110.232 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.01 141.12 54.97 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.987 -0.746 . . . . 2.77 108.987 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.66 -19.14 5.52 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.354 1.034 . . . . 2.1299999999999999 112.689 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' A' ' 25' ' ' THR . 7.4 m-20 -75.95 -5.17 44.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.124 0.964 . . . . 2.3199999999999998 108.775 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.21 23.99 60.13 Favored Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 108.74 -1.744 . . . . 0.56000000000000005 108.74 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -122.38 154.03 38.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.1 -1.55 . . . . 0.62 111.238 -162.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -146.68 143.12 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.526 -0.761 . . . . 0.46999999999999997 109.741 172.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 3.5 mp -68.53 116.92 9.62 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.786 -0.45 . . . . 1.9399999999999999 109.786 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD13 HD21 ' A' ' 61' ' ' LEU . 15.6 tp -60.02 -51.36 69.96 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.206 0.316 . . . . 0.96999999999999997 110.697 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.706 ' HA ' HG23 ' A' ' 32' ' ' THR . 7.9 m -71.78 -44.86 63.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.428 -0.805 . . . . 1.4299999999999999 110.859 -174.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 2.7 m -63.67 -32.19 73.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.955 -0.566 . . . . 1.4199999999999999 109.721 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.848 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -59.43 -48.47 87.07 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.908 -0.587 . . . . 0.67000000000000004 110.262 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.11 -17.76 63.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.043 0.757 . . . . 0.71999999999999997 113.043 -176.297 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.63 37.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.542 1.312 . . . . 0.93000000000000005 114.542 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.7 OUTLIER 171.48 -165.71 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.967 0.907 . . . . 1.05 108.993 -173.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -109.31 92.79 12.06 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 109.233 -0.654 . . . . 1.5 109.233 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.848 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.92 8.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.52 3.48 . . . . 0.84999999999999998 113.928 173.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.929 ' HA2' ' HB ' ' A' ' 75' ' ' VAL . . . 107.83 -26.7 16.79 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 110.078 -1.209 . . . . 0.67000000000000004 110.078 -162.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.72 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 61.1 -81.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.987 1.106 . . . . 0.45000000000000001 113.987 167.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 28' ' ' LEU . 36.5 t -120.28 -12.9 8.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.524 0.678 . . . . 1.1100000000000001 109.443 -165.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.65 157.51 24.15 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.897 -1.047 . . . . 0.39000000000000001 112.344 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -127.94 153.01 47.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.174 -0.61 . . . . 0.56000000000000005 111.502 174.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 95.1 mtt180 -138.52 146.52 42.06 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 106.743 -1.577 . . . . 1.9399999999999999 106.743 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.841 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 47.4 p90 -154.67 166.92 31.89 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 117.903 -1.519 . . . . 1.1399999999999999 113.946 169.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.64 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 73.8 ttt180 -102.32 137.69 40.23 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 113.857 -1.519 . . . . 2.7200000000000002 107.853 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.853 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.4 t30 . . . . . 0 C--O 1.211 -0.927 0 N-CA-C 113.219 0.822 . . . . 3.04 113.219 -158.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.853 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 5.9 mt-30 . . . . . 0 CA--C 1.515 -0.369 0 N-CA-C 113.426 0.898 . . . . 4.2000000000000002 113.426 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -57.33 133.96 55.58 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.124 -0.944 . . . . 1.72 109.973 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -63.42 88.22 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.672 0.748 . . . . 2.3500000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -102.41 145.03 30.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.382 -0.826 . . . . 2.48 111.623 -173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 167.28 21.28 Favored Glycine 0 C--N 1.299 -1.512 0 CA-C-N 114.092 -1.413 . . . . 0.40999999999999998 114.216 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 55.9 t -97.43 140.16 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.036 -1.082 . . . . 0.42999999999999999 111.058 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.0 mpt_? -67.33 135.86 53.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.58 -0.736 . . . . 4.1100000000000003 112.402 -174.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.788 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -108.11 120.51 42.53 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.935 -0.706 . . . . 1.53 110.563 171.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.749 HG12 ' HG3' ' A' ' 58' ' ' GLU . 32.5 t -130.16 115.81 34.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 115.686 -0.688 . . . . 0.53000000000000003 109.774 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.749 ' HG3' HG12 ' A' ' 57' ' ' VAL . 16.4 mt-10 52.59 35.42 17.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.766 0.317 . . . . 1.51 111.504 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.87 4.65 75.11 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.835 -0.698 . . . . 0.51000000000000001 113.066 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.788 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 5.1 mt -100.64 148.98 6.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 O-C-N 122.586 -0.361 . . . . 0.48999999999999999 111.496 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.852 ' HB2' HG23 ' A' ' 26' ' ' VAL . 56.2 mt -101.36 118.17 36.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.253 -1.017 . . . . 1.0700000000000001 108.253 167.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 128.96 55.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.331 -0.547 . . . . 1.5 111.832 -174.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 161.35 57.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.83 -1.544 . . . . 0.82999999999999996 106.83 161.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 12.7 Cg_exo -69.19 146.69 64.54 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.624 1.549 . . . . 1.29 111.145 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -45.78 17.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.804 0.811 . . . . 3.1200000000000001 111.629 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.79 24.26 5.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.38 -1.282 . . . . 2.1400000000000001 109.356 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 64' ' ' PRO . . . -77.3 -119.48 0.19 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.707 -0.759 . . . . 1.5600000000000001 112.715 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.821 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.49 -172.94 2.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.454 -0.573 . . . . 3.6899999999999999 109.454 -175.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -175.13 86.47 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.861 -1.162 . . . . 1.78 112.042 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.021 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 3.5 t30 102.19 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 124.808 2.242 . . . . 1.48 108.946 171.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -86.72 -177.48 6.13 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 109.517 -3.492 . . . . 0.90000000000000002 106.396 167.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -99.28 101.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 124.546 1.154 . . . . 0.81999999999999995 108.697 176.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 19.5 m-85 -84.2 141.27 31.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.704 1.002 . . . . 0.41999999999999998 113.704 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.8 t -109.2 163.91 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 112.564 -2.107 . . . . 0.34000000000000002 107.593 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.929 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 21.5 m -118.9 127.74 75.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.59 -0.694 . . . . 1.8400000000000001 111.407 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.91 128.35 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.751 -0.78 . . . . 1.8799999999999999 110.341 169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.717 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.047 -0.977 . . . . 1.3600000000000001 110.306 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 70' ' ' ASN . 38.8 p90 . . . . . 0 N--CA 1.441 -0.882 0 N-CA-C 108.591 -0.892 . . . . 1.1699999999999999 108.591 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.849 HD12 ' HE1' ' A' ' 73' ' ' TYR . 15.0 pt -127.52 165.78 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 122.611 0.365 . . . . 1.0 110.792 -170.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.611 ' NH1' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -114.46 132.76 56.16 Favored 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 108.952 -0.758 . . . . 2.73 108.952 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG22 ' HD1' ' A' ' 73' ' ' TYR . 2.3 t -135.89 143.5 36.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 O-C-N 121.113 -0.992 . . . . 1.45 110.296 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.966 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 t -153.55 167.41 29.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.039 -0.356 . . . . 0.56000000000000005 110.039 162.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.927 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -72.48 -54.18 10.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.023 0.916 . . . . 2.9700000000000002 109.2 173.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 13.1 t70 -112.63 148.13 35.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.639 -1.245 . . . . 1.1399999999999999 107.639 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 74' ' ' VAL . 3.8 mt-10 -58.55 -26.38 63.5 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.869 -1.06 . . . . 1.48 108.414 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -119.8 29.19 7.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.636 -1.62 . . . . 2.02 111.158 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.483 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -84.31 -117.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.07 -1.085 . . . . 0.58999999999999997 108.07 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 31.0 mt-10 -121.52 90.87 48.19 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.136 -0.938 . . . . 2.1800000000000002 110.218 168.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.966 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.8 Cg_endo -72.47 134.21 22.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.649 1.566 . . . . 0.57999999999999996 110.82 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.526 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -129.72 144.2 38.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.269 -0.878 . . . . 0.51000000000000001 110.983 -168.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 16.9 mt-10 -90.76 122.12 33.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.768 -0.456 . . . . 1.6200000000000001 109.768 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.75 HD12 ' HD2' ' A' ' 19' ' ' PRO . 7.1 tp -140.85 131.73 13.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.469 -0.787 . . . . 1.52 111.175 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.75 ' HD2' HD12 ' A' ' 18' ' ' ILE . 55.4 Cg_endo -71.88 137.71 30.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.652 2.235 . . . . 0.67000000000000004 112.764 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.0 p -106.32 170.46 7.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.96999999999999997 110.297 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -65.46 140.83 58.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.963 -0.384 . . . . 2.77 109.963 178.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 24' ' ' GLY . 3.5 m-20 -54.99 -19.91 7.9 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.617 -1.174 . . . . 2.1299999999999999 111.987 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.78 0.92 13.79 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.866 0.841 . . . . 2.3199999999999998 108.8 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.09 24.64 73.19 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.687 -1.365 . . . . 0.56000000000000005 109.687 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -134.74 166.15 23.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.143 -1.028 . . . . 0.62 109.963 -168.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -146.18 148.21 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.415 -0.357 . . . . 0.46999999999999997 110.384 175.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -65.56 94.55 0.19 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.148 -0.478 . . . . 1.9399999999999999 109.861 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.61 -49.08 74.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.664 -0.495 . . . . 0.96999999999999997 109.664 -168.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.558 ' N ' ' HG ' ' A' ' 28' ' ' LEU . 5.4 p -65.5 -35.6 81.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.5 0.667 . . . . 1.4299999999999999 110.349 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.044 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 3.4 m -72.35 -33.72 67.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.316 -0.856 . . . . 1.4199999999999999 108.7 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.88 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 45.7 t -63.72 -39.71 86.37 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 115.159 -0.928 . . . . 0.67000000000000004 110.383 170.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.6 p -64.87 -20.15 66.27 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 112.142 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 41.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.56 1.319 . . . . 0.93000000000000005 114.56 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER 172.08 -163.88 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.258 0.623 . . . . 1.05 110.021 -173.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.7 92.83 7.77 Favored Pre-proline 0 N--CA 1.436 -1.132 0 N-CA-C 108.649 -0.871 . . . . 1.5 108.649 165.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.88 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -122.25 3.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.639 2.892 . . . . 0.84999999999999998 114.561 171.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.826 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 106.99 -23.77 26.73 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 109.806 -1.317 . . . . 0.67000000000000004 109.806 -161.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.82 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.49 -89.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.031 1.333 . . . . 0.45000000000000001 114.106 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 32.1 t -125.4 -13.34 6.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.45 0.643 . . . . 1.1100000000000001 110.846 -161.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.23 15.79 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 109.633 -1.387 . . . . 0.39000000000000001 109.633 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -133.05 139.75 47.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.963 -1.095 . . . . 0.56000000000000005 111.871 175.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 67.6 mtt180 -132.69 154.2 50.39 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 106.313 -1.736 . . . . 1.9399999999999999 106.313 162.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.1 p90 -154.69 165.47 36.44 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 120.121 1.328 . . . . 1.1399999999999999 113.234 170.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.77 ' HB2' HG13 ' A' ' 72' ' ' VAL . 97.1 mtt180 -97.28 133.31 42.07 Favored 'General case' 0 C--O 1.253 1.268 0 O-C-N 125.684 1.865 . . . . 2.7200000000000002 109.142 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.117 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 38.4 t30 . . . . . 0 C--O 1.22 -0.483 0 CA-C-N 114.081 -1.418 . . . . 3.04 110.848 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.117 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.0 tt0 . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 115.132 1.53 . . . . 4.2000000000000002 115.132 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -62.07 121.17 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.244 -0.889 . . . . 1.72 109.017 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 59.3 mtm -68.44 77.82 0.27 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.65 -0.87 . . . . 2.3500000000000001 108.65 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 14.0 ttt180 -103.88 156.78 17.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.469 -0.787 . . . . 2.48 111.54 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.589 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -98.16 158.21 20.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.496 -1.229 . . . . 0.40999999999999998 114.766 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.635 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 87.9 t -98.86 143.93 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.325 -1.437 . . . . 0.42999999999999999 109.854 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' A' ' 64' ' ' PRO . 82.0 mtt180 -64.48 135.25 55.87 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 111.56 0.207 . . . . 4.1100000000000003 111.56 -171.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -113.7 114.98 27.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.873 0.368 . . . . 1.53 110.031 170.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 60' ' ' ILE . 4.6 t -128.32 115.09 36.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.472 -0.331 . . . . 0.53000000000000003 110.296 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.634 ' HG3' HG12 ' A' ' 57' ' ' VAL . 23.0 mt-10 53.44 36.55 23.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.999 0.52 . . . . 1.51 112.383 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.1 0.91 73.39 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.402 -0.904 . . . . 0.51000000000000001 112.689 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 57' ' ' VAL . 1.9 mt -104.34 148.04 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 122.681 -0.305 . . . . 0.48999999999999999 111.163 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.952 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -102.39 114.95 29.58 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.797 -1.186 . . . . 1.0700000000000001 107.797 169.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -115.66 142.2 47.06 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.2 0.524 . . . . 1.5 111.891 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.28 160.85 29.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.091 -0.958 . . . . 0.82999999999999996 110.301 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 24.2 Cg_exo -64.16 166.06 17.8 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.912 3.075 . . . . 1.29 112.602 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.01 -46.57 5.56 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.908 0.861 . . . . 3.1200000000000001 112.804 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.18 -44.25 8.44 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.987 -1.46 . . . . 2.1400000000000001 110.043 -175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.2 133.64 0.48 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.369 -0.832 . . . . 1.5600000000000001 112.427 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.624 ' CG ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.52 -77.39 0.07 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.091 -0.555 . . . . 3.6899999999999999 109.787 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 176.24 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.663 -0.698 . . . . 1.78 112.101 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 4.9 p-10 -156.38 54.84 0.56 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.199 1.0 . . . . 1.48 109.697 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.624 HD11 ' CG ' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -52.92 162.51 0.61 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-N 113.465 -1.698 . . . . 0.90000000000000002 110.028 165.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.77 HG13 ' HB2' ' A' ' 44' ' ' ARG . 1.6 p -96.42 107.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 114.297 -1.319 . . . . 0.81999999999999995 108.656 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.849 ' HE1' HD12 ' A' ' 5' ' ' ILE . 17.1 m-85 -80.03 146.95 31.7 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.121 -0.945 . . . . 0.41999999999999998 112.638 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -110.28 158.8 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 113.386 -1.734 . . . . 0.34000000000000002 110.039 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.927 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 6.4 p -97.61 109.06 22.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.594 0.711 . . . . 1.8400000000000001 112.422 -165.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.453 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 0.9 OUTLIER -130.62 128.51 41.14 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 120.144 -0.623 . . . . 1.8799999999999999 111.399 165.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.764 0 CA-C-O 119.129 -0.462 . . . . 1.3600000000000001 110.652 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.517 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 20.5 p90 . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 107.613 -1.254 . . . . 1.1699999999999999 107.613 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 21.7 pt -121.45 162.38 20.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 120.645 0.26 . . . . 1.0 110.589 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.892 ' HG3' ' HA ' ' A' ' 72' ' ' VAL . 1.4 tpp85 -118.81 131.96 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.0 -1.111 . . . . 2.73 108.0 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.409 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.5 p -139.85 146.95 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 O-C-N 121.218 -0.926 . . . . 1.45 110.763 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 1.044 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -152.26 148.87 28.07 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.666 -0.243 . . . . 0.56000000000000005 110.408 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 1.07 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 47.9 mp0 -60.8 -36.21 78.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.145 0.498 . . . . 2.9700000000000002 111.593 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -128.35 153.41 47.06 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.972 -1.492 . . . . 1.1399999999999999 106.972 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.24 -30.67 64.82 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.718 0.771 . . . . 1.48 108.927 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -119.76 31.66 6.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.366 -1.288 . . . . 2.02 110.972 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 3.8 t70 -79.98 -118.26 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.26 -1.385 . . . . 0.58999999999999997 107.26 168.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 21.9 tt0 -120.45 91.88 47.04 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.72 -0.673 . . . . 2.1800000000000002 110.01 168.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.044 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 64.1 Cg_endo -71.56 133.45 22.34 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.201 1.934 . . . . 0.57999999999999996 111.555 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.52 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.44 -0.8 . . . . 0.51000000000000001 110.885 -170.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 26.6 mt-10 -97.77 121.98 40.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.053 -0.522 . . . . 1.6200000000000001 110.123 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 41.4 pt -141.28 143.36 30.21 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.843 -0.617 . . . . 1.52 111.295 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 8.2 Cg_exo -72.6 160.15 47.18 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.184 2.589 . . . . 0.67000000000000004 112.422 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.4 m -132.37 171.67 13.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 110.001 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' THR . 28.8 tt0 -64.03 142.09 58.54 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.262 -0.644 . . . . 2.77 109.262 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.21 -24.21 17.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 124.503 1.127 . . . . 2.1299999999999999 111.951 -168.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 16.0 t70 -74.38 -8.64 56.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.34 1.067 . . . . 2.3199999999999998 108.905 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.26 41.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.741 -1.744 . . . . 0.56000000000000005 108.741 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -120.62 154.89 34.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.052 -1.574 . . . . 0.62 111.518 -165.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -147.61 140.01 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.161 -0.927 . . . . 0.46999999999999997 109.138 169.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.8 mp -64.43 111.86 2.85 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.927 -0.768 . . . . 1.9399999999999999 108.927 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' THR . 30.0 tp -58.14 -51.71 68.58 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 120.756 0.313 . . . . 0.96999999999999997 110.193 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -67.18 -47.5 70.76 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.564 -0.744 . . . . 1.4299999999999999 110.626 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.632 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.0 m -65.55 -32.65 74.36 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 115.563 -0.744 . . . . 1.4199999999999999 109.81 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.872 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -61.48 -45.12 99.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 115.907 -0.588 . . . . 0.67000000000000004 110.478 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.5 p -64.36 -19.21 65.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.207 0.447 . . . . 0.71999999999999997 112.207 -176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.1 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.364 1.246 . . . . 0.93000000000000005 114.364 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER 171.22 -164.35 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 123.406 0.682 . . . . 1.05 109.835 -173.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -107.79 92.81 9.42 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.55 -0.75 . . . . 1.5 109.214 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.872 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -120.32 6.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.322 3.348 . . . . 0.84999999999999998 113.924 171.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 1.068 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 107.47 -25.54 21.14 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.097 -1.201 . . . . 0.67000000000000004 110.097 -161.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 56.61 -91.81 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.029 1.332 . . . . 0.45000000000000001 113.735 173.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.469 ' HA ' HD11 ' A' ' 28' ' ' LEU . 19.5 m -115.78 -21.71 9.48 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 110.135 -160.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA3' ' ND2' ' A' ' 76' ' ' ASN . . . -117.57 147.8 18.74 Favored Glycine 0 N--CA 1.418 -2.557 0 CA-C-N 114.783 -1.099 . . . . 0.39000000000000001 111.005 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -128.22 142.34 51.19 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.335 -0.946 . . . . 0.56000000000000005 110.606 172.328 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.651 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 96.0 mtt180 -132.24 161.78 32.58 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.841 -1.911 . . . . 1.9399999999999999 105.841 165.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -157.4 166.66 32.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.038 -1.065 . . . . 1.1399999999999999 112.369 168.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 46.4 mtp180 -111.08 139.28 46.57 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.347 1.655 . . . . 2.7200000000000002 108.282 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.892 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.4 t-20 . . . . . 0 C--O 1.209 -1.033 0 CA-C-N 115.343 -0.844 . . . . 3.04 111.636 -161.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.892 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 6.2 mt-30 . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 113.494 0.924 . . . . 4.2000000000000002 113.494 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -46.88 121.68 3.8 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.262 -0.881 . . . . 1.72 110.207 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 15.8 ptm -63.6 86.21 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 2.3500000000000001 109.21 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 10.6 ttt180 -124.67 151.03 45.46 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.709 0.766 . . . . 2.48 111.079 -172.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.51 165.52 24.87 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 114.194 -1.366 . . . . 0.40999999999999998 115.124 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.685 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 78.5 t -83.73 141.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 112.879 -1.661 . . . . 0.42999999999999999 109.696 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mpt_? -64.96 134.53 54.12 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.485 0.18 . . . . 4.1100000000000003 111.485 -171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.8 pp -110.62 114.08 27.2 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.59 -0.444 . . . . 1.53 110.065 172.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.591 HG12 ' HG3' ' A' ' 58' ' ' GLU . 13.9 t -125.1 113.79 37.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 109.916 -0.401 . . . . 0.53000000000000003 109.916 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 57' ' ' VAL . 19.9 mt-10 52.19 36.6 19.68 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.837 0.455 . . . . 1.51 111.711 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.79 -1.71 75.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.38 -0.914 . . . . 0.51000000000000001 112.891 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -95.69 145.49 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 117.342 0.571 . . . . 0.48999999999999999 110.688 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 11.9 tp -104.38 115.82 31.05 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.65 -1.241 . . . . 1.0700000000000001 107.65 170.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.422 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 2.5 t-80 -116.05 133.57 55.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.162 -0.615 . . . . 1.5 112.081 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 162.24 37.23 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 107.684 -1.228 . . . . 0.82999999999999996 107.684 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.09 153.19 72.41 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.491 1.46 . . . . 1.29 110.835 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -46.92 -44.14 19.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.588 0.709 . . . . 3.1200000000000001 111.472 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.64 36.43 0.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.428 -1.26 . . . . 2.1400000000000001 108.646 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.34 -103.53 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.99 -1.005 . . . . 1.5600000000000001 113.885 -172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HD1' HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -86.57 -58.18 2.71 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.969 -0.752 . . . . 3.6899999999999999 108.969 -173.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.58 -69.71 0.34 Allowed Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.57 -1.196 . . . . 1.78 113.195 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -139.39 -56.06 0.58 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 114.628 -0.786 . . . . 1.48 109.107 -168.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.631 HD21 ' HD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER 55.25 161.78 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.72 0 O-C-N 124.375 1.047 . . . . 0.90000000000000002 110.544 -177.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.892 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 16.3 m -93.63 104.27 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 108.174 -1.047 . . . . 0.81999999999999995 108.174 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.754 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m-85 -78.58 138.91 38.6 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.884 -0.598 . . . . 0.41999999999999998 111.504 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -96.85 151.94 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.456 -1.247 . . . . 0.34000000000000002 108.687 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.07 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 4.0 t -114.86 115.23 48.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.342 0.591 . . . . 1.8400000000000001 112.265 -163.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.559 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 3.1 p-10 -128.63 129.14 45.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.497 -0.774 . . . . 1.8799999999999999 111.351 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.658 -0.687 . . . . 1.3600000000000001 110.552 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.933 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 32.6 p90 . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 109.272 -0.64 . . . . 1.1699999999999999 109.272 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.985 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 25.4 pt -124.06 160.71 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.234 0.333 . . . . 1.0 110.516 -174.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.782 ' HD3' ' HB2' ' A' ' 15' ' ' PRO . 22.1 ttm180 -118.73 135.61 54.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.976 -0.69 . . . . 2.73 110.146 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.663 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.1 t -130.02 145.94 34.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 O-C-N 122.044 -0.41 . . . . 1.45 110.638 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.78 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.3 t -151.4 163.02 39.91 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.297 -0.252 . . . . 0.56000000000000005 110.417 163.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 1.047 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -68.87 -39.05 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.925 -0.71 . . . . 2.9700000000000002 111.011 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.26 154.84 50.78 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.875 -0.787 . . . . 1.1399999999999999 108.875 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -52.6 -39.34 61.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.454 1.121 . . . . 1.48 108.257 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.57 7.97 33.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.366 -1.743 . . . . 2.02 112.939 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 2.7 t70 -85.79 -127.01 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 118.861 -1.136 . . . . 0.58999999999999997 108.218 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.46 92.13 48.55 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.566 -0.743 . . . . 2.1800000000000002 110.315 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 60.1 Cg_endo -70.57 132.96 23.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.726 1.617 . . . . 0.57999999999999996 111.094 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.19 125.82 64.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.173 -0.921 . . . . 0.51000000000000001 110.692 -169.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.933 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 23.4 mt-10 -85.1 120.98 27.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.966 -0.561 . . . . 1.6200000000000001 110.453 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 21.4 pt -143.07 145.2 31.92 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.07 -0.968 . . . . 1.52 111.748 -171.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 16.5 Cg_exo -69.54 133.68 26.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.112 2.542 . . . . 0.67000000000000004 113.084 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 p -108.53 172.23 6.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 110.647 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.73 138.41 58.37 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.044 0.45 . . . . 2.77 110.018 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -53.48 -31.49 45.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.954 -1.476 . . . . 2.1299999999999999 112.183 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.4 p-10 -85.45 2.3 45.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.877 0.846 . . . . 2.3199999999999998 108.9 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 25.47 18.28 Favored Glycine 0 CA--C 1.497 -1.07 0 CA-C-N 114.336 -1.302 . . . . 0.56000000000000005 109.976 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.544 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.01 155.42 29.23 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.004 -1.098 . . . . 0.62 112.254 -165.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 138.49 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.121 -0.945 . . . . 0.46999999999999997 108.994 169.251 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.6 mp -64.08 112.09 2.83 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.942 -0.762 . . . . 1.9399999999999999 108.942 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.34 -50.01 69.44 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.193 -0.669 . . . . 0.96999999999999997 109.193 -174.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.8 p -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 1.4299999999999999 111.171 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.714 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.6 m -68.43 -32.95 73.34 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.181 -0.674 . . . . 1.4199999999999999 109.181 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.861 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.3 t -58.61 -53.41 47.41 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 CA-C-N 115.199 -0.91 . . . . 0.67000000000000004 110.383 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -61.94 -16.64 52.59 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.351 0.871 . . . . 0.71999999999999997 113.351 -175.454 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.375 1.25 . . . . 0.93000000000000005 114.375 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER 172.32 -164.26 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.014 0.926 . . . . 1.05 109.259 -173.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -108.96 91.88 9.85 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 109.073 -0.714 . . . . 1.5 109.073 164.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.861 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.13 8.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.801 3.667 . . . . 0.84999999999999998 114.466 175.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.866 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 108.27 -21.16 29.39 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.137 -1.185 . . . . 0.67000000000000004 110.137 -163.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 58.51 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.755 1.02 . . . . 0.45000000000000001 113.755 170.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.9 m -130.77 -5.33 4.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.52 0.676 . . . . 1.1100000000000001 110.472 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.0 155.27 21.37 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 115.14 -0.936 . . . . 0.39000000000000001 111.86 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -132.41 154.59 49.67 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 119.8 -0.76 . . . . 0.56000000000000005 111.466 174.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.2 mtt180 -140.41 151.82 45.22 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.706 -1.961 . . . . 1.9399999999999999 105.706 161.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.698 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 36.3 p90 -157.63 165.03 36.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 120.188 1.358 . . . . 1.1399999999999999 112.699 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 45.3 mtm180 -110.89 150.38 29.27 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 125.601 1.813 . . . . 2.7200000000000002 109.554 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.837 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.8 t30 . . . . . 0 C--O 1.214 -0.806 0 CA-C-N 114.148 -1.387 . . . . 3.04 111.115 -162.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.837 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 15.0 mt-30 . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 113.901 1.075 . . . . 4.2000000000000002 113.901 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.71 115.9 1.3 Allowed 'General case' 0 C--N 1.308 -1.223 0 O-C-N 123.813 0.696 . . . . 1.72 110.739 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 4.8 ptt? -62.43 92.43 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.378 0.608 . . . . 2.3500000000000001 110.222 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 7.6 ptp85 -122.31 161.42 23.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.573 -0.74 . . . . 2.48 109.691 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -116.13 167.26 12.43 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.085 -1.055 . . . . 0.40999999999999998 115.391 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.705 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 99.5 t -83.96 141.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.345 -1.427 . . . . 0.42999999999999999 111.391 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 3.3 mpt_? -72.29 135.64 46.03 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.643 -0.708 . . . . 4.1100000000000003 112.221 -171.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp -98.84 117.68 33.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.103 -0.639 . . . . 1.53 109.888 172.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.61 HG12 ' HG3' ' A' ' 58' ' ' GLU . 9.5 t -132.95 114.7 22.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 109.87 -0.419 . . . . 0.53000000000000003 109.87 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HG3' HG12 ' A' ' 57' ' ' VAL . 25.3 mt-10 53.9 39.5 30.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.092 0.405 . . . . 1.51 112.092 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 87.04 -1.37 86.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.42 -0.895 . . . . 0.51000000000000001 112.646 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.3 mt -100.75 149.33 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 122.734 -0.274 . . . . 0.48999999999999999 111.073 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.4 tp -102.09 114.83 29.3 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.507 -1.664 . . . . 1.0700000000000001 106.507 165.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -115.57 134.69 54.81 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.269 0.557 . . . . 1.5 112.322 -165.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.65 163.02 18.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.591 -1.186 . . . . 0.82999999999999996 108.572 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.82 163.76 15.33 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.687 2.258 . . . . 1.29 111.683 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.2 -45.79 8.59 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.71 0.766 . . . . 3.1200000000000001 112.834 -173.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.38 -39.12 8.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.296 -1.32 . . . . 2.1400000000000001 110.336 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.88 149.06 4.48 Favored Glycine 0 N--CA 1.426 -2.029 0 C-N-CA 120.556 -0.831 . . . . 1.5600000000000001 112.298 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.85 -52.43 36.82 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.934 -1.135 . . . . 3.6899999999999999 107.934 175.265 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 166.98 -83.76 0.1 OUTLIER Glycine 0 N--CA 1.417 -2.58 0 CA-C-N 113.79 -1.55 . . . . 1.78 111.427 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.985 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.2 p30 -142.25 -62.11 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 0 CA-C-N 114.58 -0.81 . . . . 1.48 109.922 -170.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 54.01 176.4 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.35 1.071 . . . . 0.90000000000000002 111.297 -177.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 72' ' ' VAL . 2.1 p -102.91 104.54 16.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 113.326 -1.761 . . . . 0.81999999999999995 108.427 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.8 ' HE1' HD12 ' A' ' 5' ' ' ILE . 20.4 m-85 -80.82 146.5 30.89 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.701 0.763 . . . . 0.41999999999999998 112.157 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -107.6 158.21 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.499 -1.682 . . . . 0.34000000000000002 107.933 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.047 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 t -113.93 110.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.56 0.695 . . . . 1.8400000000000001 111.383 -164.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -126.35 129.4 48.74 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.684 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.835 0 CA-C-O 118.587 -0.72 . . . . 1.3600000000000001 110.116 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 23.0 p90 . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.594 -1.632 . . . . 1.1699999999999999 106.594 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -127.49 160.76 36.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.661 -172.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 5.2 ttt180 -119.4 132.77 55.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.758 -0.777 . . . . 2.73 109.279 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.787 HG22 ' HD1' ' A' ' 73' ' ' TYR . 3.5 t -132.63 144.2 37.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 121.923 -0.485 . . . . 1.45 110.396 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.961 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 5.4 t -152.85 168.33 26.11 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.369 0.128 . . . . 0.56000000000000005 110.768 166.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.793 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 tm-20 -72.92 -56.4 5.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.058 0.932 . . . . 2.9700000000000002 108.624 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 14.0 t70 -110.01 148.31 31.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.822 -1.177 . . . . 1.1399999999999999 107.822 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 74' ' ' VAL . 1.5 mt-10 -63.11 -17.82 62.73 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.347 -1.297 . . . . 1.48 108.577 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.64 33.55 4.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.996 -1.456 . . . . 2.02 110.657 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 7.3 t70 -83.55 -118.09 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.697 -1.223 . . . . 0.58999999999999997 107.697 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 6.1 tp10 -121.5 90.76 48.1 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.067 -0.97 . . . . 2.1800000000000002 110.184 167.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 72.7 Cg_endo -74.69 133.43 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.056 1.837 . . . . 0.57999999999999996 110.879 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.28 136.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.021 -0.536 . . . . 0.51000000000000001 111.338 -169.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 34.2 mt-10 -86.07 122.0 29.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.84 -0.43 . . . . 1.6200000000000001 109.84 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 25.4 pt -140.49 141.1 24.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.789 -0.641 . . . . 1.52 111.031 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 47.6 Cg_endo -69.69 136.29 32.81 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.713 2.275 . . . . 0.67000000000000004 112.425 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.778 ' HB3' HD12 ' A' ' 5' ' ' ILE . 8.2 p -112.14 169.36 8.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.96999999999999997 110.518 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.91 136.73 53.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.333 -0.618 . . . . 2.77 109.333 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' GLY . 1.2 m-20 -55.1 -17.4 4.01 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.195 0.998 . . . . 2.1299999999999999 112.555 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -74.55 0.71 13.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.009 0.909 . . . . 2.3199999999999998 108.645 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.31 23.98 74.38 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 113.866 -1.516 . . . . 0.56000000000000005 110.973 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.43 166.74 21.32 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.406 -0.397 . . . . 0.62 110.775 -169.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -147.5 146.35 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.598 -0.728 . . . . 0.46999999999999997 110.04 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -67.62 109.71 3.4 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.007 -0.738 . . . . 1.9399999999999999 109.007 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -65.77 -48.95 70.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.17 -0.923 . . . . 0.96999999999999997 110.009 -169.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.567 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.5 m -58.86 -39.23 80.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.14 -0.936 . . . . 1.4299999999999999 110.771 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.776 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 2.5 t -68.61 -33.19 73.61 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.602 -1.259 . . . . 1.4199999999999999 107.602 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.856 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 19.8 t -66.89 -42.54 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 CA-C-N 114.292 -1.322 . . . . 0.67000000000000004 109.864 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -65.8 -19.09 65.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.366 0.506 . . . . 0.71999999999999997 112.366 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.7 41.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.51 1.3 . . . . 0.93000000000000005 114.51 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER 173.51 -164.29 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 123.968 0.907 . . . . 1.05 108.981 -173.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.04 92.16 10.44 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 108.849 -0.797 . . . . 1.5 108.849 166.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.878 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -118.53 1.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.287 3.325 . . . . 0.84999999999999998 114.369 173.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 107.61 -20.09 32.61 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 110.1 -1.2 . . . . 0.67000000000000004 110.1 -161.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.878 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 63.45 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.226 1.01 . . . . 0.45000000000000001 113.504 170.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.4 t -128.87 -21.49 3.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.317 0.58 . . . . 1.1100000000000001 110.415 -165.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.508 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -112.97 155.51 16.24 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.485 -1.046 . . . . 0.39000000000000001 110.485 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.706 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.59 151.01 51.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 118.736 -1.186 . . . . 0.56000000000000005 112.984 176.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 mtt180 -133.82 161.0 35.92 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.187 -1.783 . . . . 1.9399999999999999 106.187 158.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.872 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.6 p90 -156.91 165.57 35.83 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 119.396 0.998 . . . . 1.1399999999999999 111.892 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -110.07 143.64 39.83 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 125.088 1.493 . . . . 2.7200000000000002 109.138 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.106 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 35.0 t30 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 114.995 -1.002 . . . . 3.04 111.343 -169.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.106 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 115.28 1.585 . . . . 4.2000000000000002 115.28 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.56 118.67 12.72 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.088 -0.96 . . . . 1.72 111.01 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 5.9 ptm -64.23 87.26 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.074 -0.713 . . . . 2.3500000000000001 109.074 170.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 7.3 ttt180 -121.19 156.21 32.88 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.934 -0.575 . . . . 2.48 110.432 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -100.48 164.81 19.04 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 121.975 0.764 . . . . 0.40999999999999998 113.951 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.694 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 91.0 t -98.53 140.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.545 -1.327 . . . . 0.42999999999999999 109.867 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -63.27 134.72 56.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.648 -0.705 . . . . 4.1100000000000003 112.642 -175.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.34 121.77 46.1 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.533 -0.467 . . . . 1.53 109.925 165.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.662 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.7 t -126.17 113.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.739 -0.467 . . . . 0.53000000000000003 109.739 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HG3' HG12 ' A' ' 57' ' ' VAL . 12.1 mt-10 51.13 36.5 15.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.067 0.547 . . . . 1.51 112.445 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 95.35 -3.23 66.04 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.729 -0.748 . . . . 0.51000000000000001 112.932 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.3 mt -100.81 148.16 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.726 -0.279 . . . . 0.48999999999999999 110.443 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' VAL . 16.4 tp -102.44 114.58 28.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.134 -1.061 . . . . 1.0700000000000001 108.134 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -111.65 122.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.711 0.767 . . . . 1.5 111.616 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.67 162.47 62.83 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 106.838 -1.541 . . . . 0.82999999999999996 106.838 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 22.2 Cg_exo -63.41 149.89 89.97 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 120.421 1.186 . . . . 1.29 109.594 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -45.95 -43.68 14.2 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.195 0.934 . . . . 3.1200000000000001 111.924 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.17 32.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.484 -0.932 . . . . 2.1400000000000001 108.484 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.11 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.004 -0.998 . . . . 1.5600000000000001 113.885 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.775 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.34 -76.93 0.6 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.538 0.685 . . . . 3.6899999999999999 109.897 -172.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.33 -76.49 0.12 Allowed Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 114.95 -1.023 . . . . 1.78 113.757 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.935 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -133.42 -59.03 0.88 Allowed 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.101 -0.549 . . . . 1.48 109.737 -167.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 51.06 172.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.439 1.087 . . . . 0.90000000000000002 111.648 -176.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 6' ' ' ARG . 2.0 p -99.56 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 113.99 -1.459 . . . . 0.81999999999999995 108.492 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.872 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.6 m-85 -79.86 144.81 33.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.827 0.822 . . . . 0.41999999999999998 112.671 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.715 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.5 t -110.38 164.11 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.356 -1.747 . . . . 0.34000000000000002 109.548 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.902 HG23 ' HA2' ' A' ' 37' ' ' GLY . 9.8 p -98.95 114.67 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.671 0.619 . . . . 1.8400000000000001 112.671 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.457 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 1.1 p30 -133.54 128.2 34.78 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 118.638 -1.225 . . . . 1.8799999999999999 110.533 158.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.38 -0.819 . . . . 1.3600000000000001 109.957 167.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 16.8 p90 . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 107.258 -1.386 . . . . 1.1699999999999999 107.258 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -121.86 162.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.88 0.309 . . . . 1.0 111.223 -172.41 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 1.081 ' HD2' ' HB2' ' A' ' 15' ' ' PRO . 1.9 tpp85 -117.83 132.45 56.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 2.7 p -138.81 147.2 25.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 O-C-N 121.411 -0.806 . . . . 1.45 111.503 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 2.1 t -153.49 171.13 19.18 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.494 -0.928 . . . . 0.56000000000000005 108.494 166.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.0 mt-10 -75.33 -54.9 6.3 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.834 -1.147 . . . . 2.9700000000000002 108.142 171.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 12.0 m-20 -103.38 142.11 34.78 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.845 -1.169 . . . . 1.1399999999999999 107.845 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 74' ' ' VAL . 4.3 mt-10 -57.71 -25.76 60.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 1.48 109.078 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.64 39.33 3.89 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.677 -1.601 . . . . 2.02 110.868 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.4 t70 -80.86 -114.48 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.042 -1.466 . . . . 0.58999999999999997 107.042 165.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -123.14 90.16 50.52 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.274 -0.875 . . . . 2.1800000000000002 109.668 165.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.081 ' HB2' ' HD2' ' A' ' 6' ' ' ARG . 72.5 Cg_endo -72.55 135.96 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.397 2.065 . . . . 0.57999999999999996 111.376 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -126.86 147.01 31.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.804 -0.635 . . . . 0.51000000000000001 110.928 -168.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.608 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 13.8 mt-10 -95.62 124.53 39.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.113 -0.494 . . . . 1.6200000000000001 110.857 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 35.8 pt -141.2 150.9 60.19 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.715 -0.675 . . . . 1.52 111.047 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.48 159.73 14.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.938 2.426 . . . . 0.67000000000000004 112.421 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.523 ' OG ' HD12 ' A' ' 5' ' ' ILE . 16.4 m -119.06 169.59 9.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.96999999999999997 110.277 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.15 145.31 55.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.054 -0.721 . . . . 2.77 109.054 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -23.74 14.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.281 -1.327 . . . . 2.1299999999999999 111.952 -171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 22.5 t70 -78.26 -8.46 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.213 1.006 . . . . 2.3199999999999998 109.171 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.1 31.67 Favored Glycine 0 CA--C 1.5 -0.873 0 N-CA-C 108.681 -1.767 . . . . 0.56000000000000005 108.681 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.56 149.81 40.02 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 112.893 -1.654 . . . . 0.62 110.915 -166.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.811 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -144.42 148.03 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.225 -0.443 . . . . 0.46999999999999997 110.725 173.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.071 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -70.61 94.69 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.48 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.58 -49.77 69.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.017 -0.538 . . . . 0.96999999999999997 110.461 -170.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.633 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.7 m -69.77 -31.04 68.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.618 0.723 . . . . 1.4299999999999999 109.719 -177.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.071 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.5 m -73.46 -32.36 64.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.233 -0.894 . . . . 1.4199999999999999 108.758 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.819 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 17.5 t -64.33 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 115.175 -0.921 . . . . 0.67000000000000004 110.273 168.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.3 p -65.03 -18.8 65.61 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.042 -0.411 . . . . 0.71999999999999997 111.887 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.95 40.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.384 1.253 . . . . 0.93000000000000005 114.384 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER 170.76 -166.61 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 124.054 0.941 . . . . 1.05 108.846 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -109.62 92.32 11.91 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.89 -0.781 . . . . 1.5 108.89 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.819 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 2.4 Cg_endo -120.42 5.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.199 3.266 . . . . 0.84999999999999998 114.661 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' O ' ' HD1' ' A' ' 77' ' ' TYR . . . 107.31 -26.98 16.91 Favored Glycine 0 C--O 1.222 -0.602 0 N-CA-C 109.716 -1.353 . . . . 0.67000000000000004 109.716 -161.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.792 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 62.57 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.509 1.3 . . . . 0.45000000000000001 114.509 165.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -122.41 -10.17 8.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.612 0.72 . . . . 1.1100000000000001 110.482 -159.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.4 154.06 16.54 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.489 -1.445 . . . . 0.39000000000000001 109.489 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -130.47 138.9 50.51 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 118.716 -1.194 . . . . 0.56000000000000005 111.893 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.79 ' HE ' ' HB3' ' A' ' 51' ' ' MET . 20.1 mtp180 -126.35 157.94 37.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.381 -1.34 . . . . 1.9399999999999999 107.381 159.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 25.4 p90 -154.34 160.21 41.59 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.435 -1.306 . . . . 1.1399999999999999 111.845 165.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 72' ' ' VAL . 15.0 ttm180 -107.57 136.24 47.68 Favored 'General case' 0 C--O 1.253 1.267 0 O-C-N 125.758 1.911 . . . . 2.7200000000000002 109.228 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.6 m120 . . . . . 0 C--O 1.211 -0.946 0 O-C-N 124.292 0.995 . . . . 3.04 111.908 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 32.4 mt-30 . . . . . 0 CA--C 1.507 -0.673 0 N-CA-C 113.879 1.066 . . . . 4.2000000000000002 113.879 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -67.88 124.56 23.68 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.877 -1.51 . . . . 1.72 108.861 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.79 ' HB3' ' HE ' ' A' ' 42' ' ' ARG . 18.2 mmt -69.67 80.05 0.43 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.997 -1.112 . . . . 2.3500000000000001 107.997 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 15.1 ttt180 -101.79 152.88 20.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.565 -1.198 . . . . 2.48 110.991 -166.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 161.02 19.83 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.288 -1.324 . . . . 0.40999999999999998 114.54 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.67 ' CG1' ' HG ' ' A' ' 61' ' ' LEU . 86.0 t -99.09 142.16 15.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 113.416 -1.392 . . . . 0.42999999999999999 110.158 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -64.4 136.2 56.87 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 112.05 0.389 . . . . 4.1100000000000003 112.05 -172.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -117.1 111.91 20.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.123 0.487 . . . . 1.53 110.567 175.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.748 HG12 ' HG3' ' A' ' 58' ' ' GLU . 35.6 t -127.97 117.25 45.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 116.26 -0.427 . . . . 0.53000000000000003 110.059 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.748 ' HG3' HG12 ' A' ' 57' ' ' VAL . 22.0 mt-10 54.83 35.7 24.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.687 0.28 . . . . 1.51 111.689 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.7 3.1 86.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.41 -0.9 . . . . 0.51000000000000001 112.933 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.1 mt -96.29 146.62 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 117.114 0.457 . . . . 0.48999999999999999 110.814 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.811 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.8 tp -103.83 117.89 35.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.268 -1.382 . . . . 1.0700000000000001 107.268 169.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -116.44 137.37 52.21 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.107 -0.637 . . . . 1.5 112.365 -169.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.48 163.74 17.6 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 114.564 -1.198 . . . . 0.82999999999999996 109.899 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.3 167.4 6.16 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.672 2.914 . . . . 1.29 111.79 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -44.1 3.58 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.821 0.701 . . . . 3.1200000000000001 112.66 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 -21.02 7.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.125 -0.943 . . . . 2.1400000000000001 110.93 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 153.53 19.73 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.567 -1.302 . . . . 1.5600000000000001 112.378 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.871 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.71 -49.89 35.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.441 -1.318 . . . . 3.6899999999999999 107.441 169.347 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.1 -81.48 0.08 OUTLIER Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 112.781 -2.009 . . . . 1.78 110.261 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.827 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.5 p30 -147.04 -61.73 0.29 Allowed 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.559 -0.821 . . . . 1.48 109.354 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.871 HD21 ' HB2' ' A' ' 68' ' ' TRP . 1.2 mm? 56.24 166.95 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.664 0 O-C-N 124.276 0.985 . . . . 0.90000000000000002 110.959 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 1.8 p -100.3 107.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 114.26 -1.336 . . . . 0.81999999999999995 109.493 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.846 ' HB3' HD11 ' A' ' 41' ' ' LEU . 19.0 m-85 -77.1 142.2 39.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.109 -0.95 . . . . 0.41999999999999998 112.041 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.725 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.3 t -110.88 167.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 113.629 -1.623 . . . . 0.34000000000000002 110.6 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' VAL . 5.7 p -99.03 105.02 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 112.641 0.608 . . . . 1.8400000000000001 112.641 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 0.3 OUTLIER -130.36 124.9 33.3 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 118.692 -1.203 . . . . 1.8799999999999999 111.506 163.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.294 -0.86 . . . . 1.3600000000000001 109.545 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.986 -0.375 . . . . 5.8600000000000003 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -120.23 101.28 7.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 2.73 110.977 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.7 136.79 34.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.678 -0.49 . . . . 2.5 109.678 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 29.8 p90 -139.66 176.01 9.09 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.379 . . . . 1.1699999999999999 107.278 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.955 HD12 ' HE1' ' A' ' 73' ' ' TYR . 23.6 pt -129.98 163.8 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.129 0.422 . . . . 1.0 111.123 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 134.28 55.14 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 109.506 -0.553 . . . . 2.73 109.506 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.652 HG13 ' HB2' ' A' ' 73' ' ' TYR . 1.6 t -136.83 142.87 36.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 O-C-N 121.499 -0.751 . . . . 1.45 110.883 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.898 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 t -154.13 151.74 29.61 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.01 -0.431 . . . . 0.56000000000000005 111.319 163.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.99 ' HA ' ' CB ' ' A' ' 75' ' ' VAL . 18.8 tt0 -65.96 -40.05 90.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.51 0.672 . . . . 2.9700000000000002 110.734 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -123.02 151.03 42.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.711 -1.588 . . . . 1.1399999999999999 106.711 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 11' ' ' GLU . 2.5 mt-10 -58.32 -30.5 66.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.553 -0.906 . . . . 1.48 108.553 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.69 31.19 6.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.284 -1.325 . . . . 2.02 111.031 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 27.0 t70 -84.84 -121.53 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.28 -1.378 . . . . 0.58999999999999997 107.28 167.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -122.19 92.95 48.81 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.373 -0.831 . . . . 2.1800000000000002 110.455 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.898 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 56.3 Cg_endo -67.57 136.3 38.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 110.997 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.511 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.86 143.94 39.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.351 -0.84 . . . . 0.51000000000000001 111.461 -169.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.676 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 23.8 mt-10 -97.35 125.66 42.1 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.888 -0.412 . . . . 1.6200000000000001 109.888 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 47.8 pt -140.77 139.08 19.13 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.155 -0.475 . . . . 1.52 111.527 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 7.6 Cg_exo -72.65 150.91 51.56 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.292 2.662 . . . . 0.67000000000000004 112.784 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -129.47 168.41 16.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.96999999999999997 111.019 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' THR . 26.8 tt0 -75.07 145.73 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.289 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.38 -21.37 9.42 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.611 -1.177 . . . . 2.1299999999999999 112.536 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 29.3 t70 -76.16 -7.04 53.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.292 1.044 . . . . 2.3199999999999998 108.709 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.98 53.99 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.021 -1.631 . . . . 0.56000000000000005 109.021 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -123.44 155.92 36.51 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.447 -1.376 . . . . 0.62 110.401 -166.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -147.31 152.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 122.568 0.347 . . . . 0.46999999999999997 110.811 177.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.103 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -68.9 94.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.129 -0.487 . . . . 1.9399999999999999 110.468 178.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -64.6 -49.69 70.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 110.006 -0.368 . . . . 0.96999999999999997 110.006 -171.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 32' ' ' THR . 16.7 p -62.66 -36.22 82.16 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.829 0.824 . . . . 1.4299999999999999 110.154 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.103 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.6 m -72.53 -33.6 66.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.913 -1.04 . . . . 1.4199999999999999 108.512 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.85 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 8.8 t -60.95 -48.52 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.482 -1.236 . . . . 0.67000000000000004 110.751 170.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -62.44 -17.7 60.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.095 0.776 . . . . 0.71999999999999997 113.095 -176.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.12 38.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.71 1.374 . . . . 0.93000000000000005 114.71 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER 170.22 -164.72 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.194 0.998 . . . . 1.05 109.012 -173.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -107.97 92.09 8.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.85 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.76 6.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.86 3.707 . . . . 0.84999999999999998 115.318 176.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 1.126 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 109.2 -15.6 32.99 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 109.979 -1.249 . . . . 0.67000000000000004 109.979 -161.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 47.15 -91.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.984 1.314 . . . . 0.45000000000000001 114.148 171.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 t -131.02 6.74 4.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.404 0.621 . . . . 1.1100000000000001 110.282 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -144.69 147.8 19.2 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.341 -0.845 . . . . 0.39000000000000001 111.081 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -128.25 152.97 47.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.283 -1.367 . . . . 0.56000000000000005 113.093 177.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.811 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 77.7 mtt-85 -136.48 164.88 27.13 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.057 -2.201 . . . . 1.9399999999999999 105.057 158.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -155.94 163.65 39.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 119.928 1.24 . . . . 1.1399999999999999 112.502 168.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.618 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 29.1 mmt180 -114.79 125.5 53.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 124.48 1.112 . . . . 2.7200000000000002 113.329 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.39 0.7 OUTLIER 98.66 -60.28 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.223 0 N-CA-C 119.935 3.309 . . . . 3.04 119.935 141.231 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.749 ' HB2' HD12 ' A' ' 71' ' ' LEU . 39.5 Cg_exo -61.94 -1.29 2.1 Favored 'Trans proline' 0 C--N 1.363 1.298 0 CA-C-N 123.82 2.4 . . . . 3.6200000000000001 113.787 -170.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.826 HG13 ' H ' ' A' ' 48' ' ' SER . 2.5 p -98.32 -101.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.322 -0.621 . . . . 4.4199999999999999 109.322 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.826 ' H ' HG13 ' A' ' 47' ' ' VAL . 37.7 m -111.86 14.13 20.97 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 116.109 -0.496 . . . . 3.3199999999999998 111.26 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 3.5 mt-30 62.45 22.3 13.16 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.317 1.056 . . . . 4.2000000000000002 111.96 -171.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 132.19 34.67 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.464 -1.698 . . . . 1.72 111.293 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 12.4 ptp -69.52 82.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.051 0.453 . . . . 2.3500000000000001 109.937 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HD3' ' OH ' ' A' ' 43' ' ' TYR . 18.3 ttt180 -115.95 150.3 37.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.652 0.739 . . . . 2.48 110.812 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.77 165.98 24.8 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.514 -1.221 . . . . 0.40999999999999998 115.243 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.7 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 70.5 t -99.43 146.19 9.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.856 -1.672 . . . . 0.42999999999999999 111.01 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 11.1 mtt180 -62.01 136.27 57.89 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.707 0.803 . . . . 4.1100000000000003 112.906 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -121.74 115.7 23.17 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.664 -0.495 . . . . 1.53 109.664 170.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 58' ' ' GLU . 10.3 t -130.22 114.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.535 -0.302 . . . . 0.53000000000000003 110.52 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 57' ' ' VAL . 15.3 mt-10 51.2 37.19 17.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.021 0.528 . . . . 1.51 112.289 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -2.04 66.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.681 -0.771 . . . . 0.51000000000000001 113.058 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -100.97 147.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.684 -0.304 . . . . 0.48999999999999999 111.586 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.997 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -103.8 114.56 28.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.836 -1.172 . . . . 1.0700000000000001 107.836 169.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.751 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 9.9 t-160 -114.58 136.13 53.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.889 -0.724 . . . . 1.5 112.203 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.69 162.05 39.99 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 0.82999999999999996 108.586 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.46 159.1 54.86 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 121.85 1.7 . . . . 1.29 110.504 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -47.38 -44.34 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.686 0.616 . . . . 3.1200000000000001 112.503 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.61 28.22 0.38 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.545 -0.752 . . . . 2.1400000000000001 109.813 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.14 -97.43 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.592 -0.813 . . . . 1.5600000000000001 113.267 -173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 1.016 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -107.71 -81.56 0.56 Allowed 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.748 0.308 . . . . 3.6899999999999999 110.543 -178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.1 -70.7 0.43 Allowed Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 119.604 -1.284 . . . . 1.78 114.709 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 11.4 p-10 -139.77 33.67 2.0 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.84 1.305 . . . . 1.48 109.724 -152.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -48.7 162.04 0.11 Allowed 'General case' 0 CA--C 1.477 -1.836 0 CA-C-N 112.147 -2.297 . . . . 0.90000000000000002 109.242 169.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.775 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.5 p -86.33 106.36 15.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.156 -1.383 . . . . 0.81999999999999995 107.284 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.955 ' HE1' HD12 ' A' ' 5' ' ' ILE . 19.8 m-85 -77.77 145.28 36.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.587 -0.733 . . . . 0.41999999999999998 111.258 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 3.1 t -97.0 150.68 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.85 -1.523 . . . . 0.34000000000000002 108.06 169.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.126 HG13 ' HA2' ' A' ' 37' ' ' GLY . 5.0 t -108.1 118.1 55.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.59 0.71 . . . . 1.8400000000000001 112.186 -165.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -127.64 130.22 48.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.697 -1.138 . . . . 1.8799999999999999 110.611 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 3.3 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.674 -0.679 . . . . 1.3600000000000001 110.856 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.038 -0.726 . . . . 5.8600000000000003 109.038 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m 62.26 79.3 0.26 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.319 -0.993 . . . . 2.73 108.319 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.48 152.19 28.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.718 -0.674 . . . . 2.5 111.258 -168.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 44.6 p90 -130.21 176.23 8.27 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.779 -1.563 . . . . 1.1699999999999999 106.779 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 14.8 pt -128.23 161.24 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 118.044 0.384 . . . . 1.0 111.557 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 10.1 ttt180 -119.83 132.17 55.5 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.165 -0.679 . . . . 2.73 109.165 171.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.6 p -137.28 140.46 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.632 -0.427 . . . . 1.45 111.596 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.757 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.8 t -152.81 171.23 18.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.542 -0.754 . . . . 0.56000000000000005 109.754 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.82 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 21.1 mt-10 -74.72 -53.92 8.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.864 0.84 . . . . 2.9700000000000002 109.091 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.49 150.4 29.96 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.304 -1.369 . . . . 1.1399999999999999 107.304 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 44' ' ' ARG . 43.4 mt-10 -63.94 -22.51 66.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.264 -1.334 . . . . 1.48 109.083 -170.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -122.3 23.57 9.72 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.448 -1.251 . . . . 2.02 111.53 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.6 t70 -74.28 -112.71 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.097 -1.075 . . . . 0.58999999999999997 108.097 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' HD13 ' A' ' 16' ' ' ILE . 33.2 tt0 -122.23 88.42 48.55 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.283 -0.871 . . . . 2.1800000000000002 109.873 165.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 91.4 Cg_endo -78.43 130.59 10.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.625 1.55 . . . . 0.57999999999999996 110.686 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.08 133.58 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.539 -0.755 . . . . 0.51000000000000001 111.841 -169.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.76 122.56 29.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.377 -0.601 . . . . 1.6200000000000001 109.377 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 37.4 pt -139.04 138.83 21.7 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.99 -0.55 . . . . 1.52 110.927 -171.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 16.2 Cg_exo -68.71 124.29 11.35 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.08 2.52 . . . . 0.67000000000000004 112.055 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -95.49 169.57 9.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 0.96999999999999997 110.533 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.0 tp10 -64.95 136.02 56.33 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.008 -0.738 . . . . 2.77 109.008 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.63 -16.97 7.16 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.239 -0.891 . . . . 2.1299999999999999 112.32 -175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -79.6 1.09 27.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.726 0.774 . . . . 2.3199999999999998 109.028 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.98 49.25 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 114.258 -1.337 . . . . 0.56000000000000005 110.587 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.19 159.46 36.77 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.32 -0.94 . . . . 0.62 110.884 -165.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.942 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.33 153.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 111.223 175.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -70.54 94.6 1.0 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.872 -0.604 . . . . 1.9399999999999999 110.749 -178.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.46 -50.32 65.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.527 -0.545 . . . . 0.96999999999999997 109.527 -173.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.718 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.6 p -61.55 -33.95 74.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.682 0.753 . . . . 1.4299999999999999 110.375 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.099 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 8.6 m -75.0 -33.14 61.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.071 -0.968 . . . . 1.4199999999999999 108.952 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.838 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 18.7 t -62.68 -47.62 92.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.227 -0.897 . . . . 0.67000000000000004 110.537 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -64.89 -16.96 63.89 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.775 0.657 . . . . 0.71999999999999997 112.775 -177.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.75 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.451 1.278 . . . . 0.93000000000000005 114.451 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER 170.77 -166.53 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.484 1.114 . . . . 1.05 108.787 -172.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HD2' ' HH ' ' A' ' 77' ' ' TYR . 11.0 m-85 -109.88 92.15 12.13 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.838 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -121.27 4.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.558 3.505 . . . . 0.84999999999999998 115.017 176.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.41 30.95 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.167 -1.173 . . . . 0.67000000000000004 110.167 -161.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.68 -88.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.764 1.394 . . . . 0.45000000000000001 114.764 165.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 15.7 m -129.58 -1.54 4.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 110.966 -163.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.55 169.96 20.59 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.199 -1.16 . . . . 0.39000000000000001 110.199 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.814 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -148.43 140.28 23.82 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.332 -0.947 . . . . 0.56000000000000005 112.15 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.595 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.5 mtt180 -134.11 152.91 52.05 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 106.38 -1.711 . . . . 1.9399999999999999 106.38 159.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.797 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 50.0 p90 -153.37 164.81 37.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 120.71 1.596 . . . . 1.1399999999999999 113.483 169.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 11' ' ' GLU . 9.0 mtm180 -109.73 150.49 28.23 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.845 -1.525 . . . . 2.7200000000000002 110.201 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.02 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 t30 -147.57 126.28 6.2 Favored Pre-proline 0 C--O 1.219 -0.55 0 CA-C-N 114.028 -1.442 . . . . 3.04 110.508 -166.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 45' ' ' ASN . 52.1 Cg_exo -57.81 9.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.757 2.971 . . . . 3.6200000000000001 116.585 -173.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 48' ' ' SER . 2.8 p -111.34 -94.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.544 -0.722 . . . . 4.4199999999999999 111.566 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.974 ' H ' HG13 ' A' ' 47' ' ' VAL . 82.7 p -93.53 -11.63 31.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.5 0.667 . . . . 3.3199999999999998 109.427 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.02 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 1.5 tt0 51.8 28.01 4.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.331 1.604 . . . . 4.2000000000000002 115.331 167.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -60.97 126.04 25.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.339 -0.391 . . . . 1.72 110.243 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.83 92.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.928 0.871 . . . . 2.3500000000000001 110.221 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 74.1 ttt180 -105.24 149.78 25.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.869 -1.059 . . . . 2.48 112.168 -170.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -96.53 149.22 19.25 Favored Glycine 0 C--N 1.302 -1.32 0 CA-C-N 113.941 -1.481 . . . . 0.40999999999999998 114.502 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.814 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 76.0 t -98.78 143.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.514 -1.343 . . . . 0.42999999999999999 110.327 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.665 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -65.85 135.49 54.9 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 112.514 0.561 . . . . 4.1100000000000003 112.514 -170.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.05 111.22 22.16 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.192 -0.67 . . . . 1.53 109.192 169.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 58' ' ' GLU . 19.3 t -129.44 118.03 44.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.153 -0.476 . . . . 0.53000000000000003 110.699 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.944 ' HG2' HG12 ' A' ' 57' ' ' VAL . 3.9 mm-40 52.69 35.53 18.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.375 0.509 . . . . 1.51 112.375 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' C ' HD23 ' A' ' 28' ' ' LEU . . . 92.79 -0.87 70.55 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.588 -0.815 . . . . 0.51000000000000001 113.048 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -104.08 149.35 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.796 0.332 . . . . 0.48999999999999999 111.706 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.942 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.51 116.5 32.73 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.92 -1.511 . . . . 1.0700000000000001 106.92 166.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -115.09 133.59 55.9 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.598 0.713 . . . . 1.5 112.166 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 164.25 31.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 113.895 -1.502 . . . . 0.82999999999999996 110.46 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.84 168.01 9.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.551 2.834 . . . . 1.29 110.688 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -41.99 -42.99 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.436 0.902 . . . . 3.1200000000000001 113.436 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.91 -23.63 4.6 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.171 0.434 . . . . 2.1400000000000001 112.171 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 136.9 8.44 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 118.98 -1.581 . . . . 1.5600000000000001 114.054 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.434 ' CD2' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -81.37 -89.55 0.07 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.238 0.615 . . . . 3.6899999999999999 111.373 170.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.9 48.0 0.12 Allowed Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.671 -0.776 . . . . 1.78 113.918 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.851 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 87.04 -45.18 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 114.361 -0.92 . . . . 1.48 110.28 156.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.806 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 47.07 173.2 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.964 1.364 . . . . 0.90000000000000002 113.784 174.219 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -103.02 105.05 17.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 113.422 -1.717 . . . . 0.81999999999999995 109.145 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.797 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.0 m-85 -80.59 145.84 31.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.094 0.95 . . . . 0.41999999999999998 112.858 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -109.16 159.18 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 112.889 -1.959 . . . . 0.34000000000000002 110.151 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.82 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 p -87.93 103.78 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 1.8400000000000001 112.145 -165.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -129.03 127.2 41.1 Favored 'General case' 0 C--O 1.208 -1.08 0 C-N-CA 120.111 -0.636 . . . . 1.8799999999999999 109.423 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.489 -0.767 . . . . 1.3600000000000001 110.322 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.066 -0.346 . . . . 5.8600000000000003 110.066 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m 65.84 -178.41 0.19 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.712 0.632 . . . . 2.73 111.465 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.76 152.6 25.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.09 -0.504 . . . . 2.5 110.007 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.78 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 35.7 p90 -135.06 172.92 12.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.813 -0.81 . . . . 1.1699999999999999 108.813 -172.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.958 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -124.36 159.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 121.188 -0.205 . . . . 1.0 111.01 -178.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.79 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 2.9 ttt180 -120.52 134.35 55.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.756 -0.461 . . . . 2.73 109.756 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.688 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.4 p -138.16 148.5 24.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 O-C-N 121.786 -0.571 . . . . 1.45 111.57 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.5 t -152.57 171.21 18.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.494 -0.321 . . . . 0.56000000000000005 110.918 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 1.035 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.4 tm-20 -83.33 -33.02 25.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.807 0.813 . . . . 2.9700000000000002 110.036 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -132.18 150.0 52.26 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.15 -1.426 . . . . 1.1399999999999999 107.15 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' HH21 ' A' ' 44' ' ' ARG . 7.4 mm-40 -55.62 -25.3 38.05 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.981 0.801 . . . . 1.48 109.529 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -130.52 38.01 3.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.816 -1.084 . . . . 2.02 111.898 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 8.4 t70 -77.02 -111.6 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.69 -1.596 . . . . 0.58999999999999997 106.69 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -123.36 89.61 50.95 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.026 -0.988 . . . . 2.1800000000000002 109.944 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.857 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 55.5 Cg_endo -69.18 133.1 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.231 1.287 . . . . 0.57999999999999996 110.05 173.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.41 128.26 69.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.605 -0.725 . . . . 0.51000000000000001 111.138 -169.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.78 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.6 mp0 -84.13 121.73 27.85 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.715 -0.675 . . . . 1.6200000000000001 109.628 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 32.1 pt -140.64 143.61 33.11 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.496 -0.775 . . . . 1.52 111.537 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 2.9 Cg_exo -76.35 131.4 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.319 2.679 . . . . 0.67000000000000004 112.415 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 5' ' ' ILE . 7.2 p -103.59 171.35 7.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.768 -0.651 . . . . 0.96999999999999997 109.799 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.26 142.57 58.23 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.444 -0.576 . . . . 2.77 109.444 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.76 -28.86 24.2 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.952 1.407 . . . . 2.1299999999999999 112.347 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 6.3 p-10 -84.54 1.28 46.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.141 0.972 . . . . 2.3199999999999998 108.8 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 24.31 23.05 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 113.867 -1.515 . . . . 0.56000000000000005 110.234 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.48 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.35 151.81 38.74 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.827 -1.187 . . . . 0.62 111.622 -165.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.834 HG23 ' HB3' ' A' ' 61' ' ' LEU . 1.0 OUTLIER -147.31 148.7 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.667 -0.697 . . . . 0.46999999999999997 109.955 170.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.012 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -64.87 102.75 0.63 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.15 0.5 . . . . 1.9399999999999999 110.128 175.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -63.65 -50.63 68.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.45 -0.574 . . . . 0.96999999999999997 109.45 -172.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.69 ' HA ' HG23 ' A' ' 32' ' ' THR . 17.9 p -68.87 -37.34 79.01 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.614 0.721 . . . . 1.4299999999999999 110.201 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.5 m -70.88 -32.97 70.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 108.73 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.858 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.7 t -62.14 -44.77 99.46 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-N 114.821 -1.081 . . . . 0.67000000000000004 110.47 170.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -63.4 -19.24 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.71 0.633 . . . . 0.71999999999999997 112.71 -176.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.33 40.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.869 1.433 . . . . 0.93000000000000005 114.869 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER 169.91 -164.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.503 0.721 . . . . 1.05 109.437 -171.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -109.08 91.46 9.37 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.216 -0.661 . . . . 1.5 109.216 166.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.78 1.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.387 3.391 . . . . 0.84999999999999998 115.116 175.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CG2' ' A' ' 75' ' ' VAL . . . 107.69 -10.95 38.57 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 110.065 -1.214 . . . . 0.67000000000000004 110.065 -161.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 51.09 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.603 1.561 . . . . 0.45000000000000001 114.521 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -133.97 -36.41 0.93 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.733 0.778 . . . . 1.1100000000000001 110.439 -161.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 76' ' ' ASN . . . -97.76 155.21 20.42 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-N 114.742 -1.117 . . . . 0.39000000000000001 110.399 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.718 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -132.69 150.54 52.15 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.666 -1.214 . . . . 0.56000000000000005 112.858 178.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB2' ' A' ' 51' ' ' MET . 50.9 mtt180 -136.95 149.6 47.66 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.939 -1.875 . . . . 1.9399999999999999 105.939 162.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.79 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 41.6 p90 -154.93 158.13 38.8 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 120.165 1.348 . . . . 1.1399999999999999 112.635 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HG2' ' HB2' ' A' ' 45' ' ' ASN . 10.2 ttp180 -114.44 132.97 56.07 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 113.687 0.995 . . . . 2.7200000000000002 113.687 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.279 18.5 t30 105.88 -75.84 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 117.926 2.565 . . . . 3.04 117.926 144.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.603 ' CG ' HD12 ' A' ' 71' ' ' LEU . 56.0 Cg_exo -55.41 -3.23 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.132 1.888 . . . . 3.6200000000000001 114.484 -171.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.001 HG13 ' H ' ' A' ' 48' ' ' SER . 3.6 p -105.35 -94.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.663 -0.495 . . . . 4.4199999999999999 109.663 168.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 1.001 ' H ' HG13 ' A' ' 47' ' ' VAL . 17.6 t -110.89 7.01 21.62 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.326 -0.397 . . . . 3.3199999999999998 111.702 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 6.7 tt0 52.4 25.55 3.57 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-O 121.55 0.69 . . . . 4.2000000000000002 112.348 -168.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -105.98 136.11 46.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 1.72 109.46 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.73 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 22.4 ptt? -62.61 85.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.793 0.806 . . . . 2.3500000000000001 111.125 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 57.0 ttt180 -100.54 150.29 22.83 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.494 -0.776 . . . . 2.48 110.954 -176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -90.45 160.83 28.27 Favored Glycine 0 C--N 1.293 -1.81 0 CA-C-N 115.019 -0.991 . . . . 0.40999999999999998 114.796 175.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.718 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 69.2 t -99.2 142.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.417 -1.392 . . . . 0.42999999999999999 109.804 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.731 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 1.2 mpt_? -66.89 133.73 50.62 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.052 0.39 . . . . 4.1100000000000003 112.052 -168.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.655 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.99 115.15 28.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.26 0.552 . . . . 1.53 109.64 172.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.623 HG12 ' HG3' ' A' ' 58' ' ' GLU . 3.6 t -133.81 118.93 31.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-N 116.222 -0.445 . . . . 0.53000000000000003 109.972 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 57' ' ' VAL . 29.2 mt-10 56.43 36.11 27.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.82 0.343 . . . . 1.51 111.643 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.31 0.41 89.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.493 -0.861 . . . . 0.51000000000000001 112.828 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 mt -97.08 147.43 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 O-C-N 122.617 -0.343 . . . . 0.48999999999999999 111.465 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.834 ' HB3' HG23 ' A' ' 26' ' ' VAL . 12.7 tp -104.03 115.76 31.02 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.55 -1.278 . . . . 1.0700000000000001 107.55 167.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -116.42 133.55 55.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.232 -0.587 . . . . 1.5 111.48 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.66 162.31 36.58 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.282 -1.007 . . . . 0.82999999999999996 108.282 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.79 160.05 42.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 121.87 1.714 . . . . 1.29 110.921 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.5 -44.25 17.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.693 0.621 . . . . 3.1200000000000001 111.89 -171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.89 32.47 0.1 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.082 -0.963 . . . . 2.1400000000000001 108.854 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -88.68 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.919 -1.037 . . . . 1.5600000000000001 113.935 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.855 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -103.89 -77.86 0.57 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.137 -0.69 . . . . 3.6899999999999999 109.137 -172.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.02 -78.37 0.13 Allowed Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.846 -1.169 . . . . 1.78 113.462 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.958 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 3.2 p-10 -127.92 -56.95 1.26 Allowed 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 114.957 -0.622 . . . . 1.48 109.444 -169.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER 56.45 167.34 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 124.694 1.247 . . . . 0.90000000000000002 110.465 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 72' ' ' VAL . 1.9 p -95.07 104.39 15.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.858 -1.137 . . . . 0.81999999999999995 108.562 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.79 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.2 m-85 -80.2 145.06 32.46 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.885 0.85 . . . . 0.41999999999999998 111.845 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.3 t -108.76 154.52 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 113.519 -1.673 . . . . 0.34000000000000002 109.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.035 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -85.61 120.13 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.163 0.506 . . . . 1.8400000000000001 110.16 -167.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.579 ' HB3' ' C ' ' A' ' 40' ' ' GLY . 56.2 t30 -131.5 128.24 38.97 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.775 -0.578 . . . . 1.8799999999999999 111.01 172.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 118.999 -0.524 . . . . 1.3600000000000001 110.648 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.751 -0.463 . . . . 5.8600000000000003 109.751 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m 60.08 84.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.229 -0.656 . . . . 2.73 109.229 -173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -80.84 152.5 28.16 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.497 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 15.5 p90 -126.12 171.82 10.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.668 -0.864 . . . . 1.1699999999999999 108.668 -174.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 20.9 pt -116.47 163.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.646 0.26 . . . . 1.0 111.592 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.657 HH11 ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.31 131.48 56.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.853 -0.795 . . . . 2.73 108.853 179.298 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.34 146.35 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.98 -1.075 . . . . 1.45 111.365 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.891 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 t -152.25 168.56 24.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.674 -0.239 . . . . 0.56000000000000005 110.413 166.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.657 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 1.7 mp0 -77.42 -33.92 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.9700000000000002 111.247 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.23 152.56 51.94 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.569 -1.271 . . . . 1.1399999999999999 107.569 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 4.2 mt-10 -55.29 -39.62 70.08 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 122.555 1.169 . . . . 1.48 107.966 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -106.85 25.91 10.72 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.873 -1.967 . . . . 2.02 113.057 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -81.83 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.891 -1.151 . . . . 0.58999999999999997 107.891 170.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.96 91.05 50.07 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 115.754 -0.657 . . . . 2.1800000000000002 110.624 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.891 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 58.5 Cg_endo -70.7 134.65 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.551 1.501 . . . . 0.57999999999999996 110.379 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.29 153.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.364 -0.835 . . . . 0.51000000000000001 110.864 -169.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.775 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.8 mp0 -108.5 122.48 47.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.2 -0.454 . . . . 1.6200000000000001 110.849 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.63 138.67 17.54 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.902 -0.59 . . . . 1.52 112.006 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.04 148.34 21.71 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.957 2.438 . . . . 0.67000000000000004 112.231 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.9 m -122.6 169.24 11.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 0.96999999999999997 111.281 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -66.49 150.71 48.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.485 0.66 . . . . 2.77 111.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -52.38 -28.39 19.43 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.438 -1.71 . . . . 2.1299999999999999 111.903 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 33.6 t70 -77.74 -7.21 56.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.379 1.085 . . . . 2.3199999999999998 108.79 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.81 25.98 36.44 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 108.357 -1.897 . . . . 0.56000000000000005 108.357 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.18 151.08 39.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.874 -1.663 . . . . 0.62 112.179 -160.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 147.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.393 -0.821 . . . . 0.46999999999999997 110.519 173.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.077 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -65.19 96.51 0.22 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.258 0.623 . . . . 1.9399999999999999 110.247 178.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.63 -49.57 70.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.563 -0.289 . . . . 0.96999999999999997 110.254 -168.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.5 p -70.2 -34.35 72.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.002 0.906 . . . . 1.4299999999999999 109.895 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.077 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 15.8 m -70.81 -32.78 69.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.742 -1.117 . . . . 1.4199999999999999 108.085 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.877 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.5 t -65.12 -42.15 93.63 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 CA-C-N 114.11 -1.404 . . . . 0.67000000000000004 110.846 171.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -64.4 -20.32 66.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.855 -0.528 . . . . 0.71999999999999997 111.95 -175.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.826 1.417 . . . . 0.93000000000000005 114.826 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER 172.15 -163.3 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 123.211 0.604 . . . . 1.05 109.988 -173.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -106.96 92.59 7.8 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.719 -0.845 . . . . 1.5 108.719 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.877 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -122.34 2.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.201 3.267 . . . . 0.84999999999999998 114.867 173.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . 106.92 -16.15 39.78 Favored Glycine 0 C--O 1.217 -0.923 0 N-CA-C 109.917 -1.273 . . . . 0.67000000000000004 109.917 -162.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 52.75 -92.12 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.907 1.283 . . . . 0.45000000000000001 113.542 172.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.9 m -122.69 4.16 9.52 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.672 0.749 . . . . 1.1100000000000001 110.243 -166.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.65 174.65 21.47 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 110.085 -1.206 . . . . 0.39000000000000001 110.085 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -153.19 143.71 22.58 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 120.128 -0.629 . . . . 0.56000000000000005 110.692 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.554 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.4 mtt180 -134.64 150.84 50.7 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 105.739 -1.949 . . . . 1.9399999999999999 105.739 160.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.69 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 45.9 p90 -152.54 165.23 35.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 121.181 1.809 . . . . 1.1399999999999999 113.125 170.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 11' ' ' GLU . 35.1 mtp85 -106.91 134.34 50.22 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.159 -1.837 . . . . 2.7200000000000002 108.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.141 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 56.8 t30 -133.7 128.45 19.93 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 114.575 -1.193 . . . . 3.04 111.136 -164.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' A' ' 45' ' ' ASN . 86.9 Cg_exo -50.16 -13.04 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.802 3.001 . . . . 3.6200000000000001 115.996 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.002 HG13 ' H ' ' A' ' 48' ' ' SER . 2.8 p -94.73 -91.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 118.403 0.547 . . . . 4.4199999999999999 111.129 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 1.002 ' H ' HG13 ' A' ' 47' ' ' VAL . 80.0 p -97.26 -9.9 26.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.396 0.617 . . . . 3.3199999999999998 109.709 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.141 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 5.0 tt0 50.88 27.63 3.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.936 1.458 . . . . 4.2000000000000002 114.936 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -60.97 130.03 44.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.992 -0.373 . . . . 1.72 109.992 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -64.85 87.58 0.06 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.357 0.598 . . . . 2.3500000000000001 109.804 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 21.0 ttt180 -101.21 147.63 26.04 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.684 0.754 . . . . 2.48 112.288 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -93.7 154.61 21.74 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 113.715 -1.584 . . . . 0.40999999999999998 114.279 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 46.4 t -100.04 143.7 13.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 113.746 -1.227 . . . . 0.42999999999999999 111.525 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -62.52 138.04 58.39 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 124.477 1.111 . . . . 4.1100000000000003 113.517 -175.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.4 pp -115.74 124.22 50.26 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.041 -0.264 . . . . 1.53 110.405 169.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.3 t -134.94 122.95 39.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.125 0 CA-C-O 118.846 -0.597 . . . . 0.53000000000000003 109.609 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HG3' HG12 ' A' ' 57' ' ' VAL . 35.1 mt-10 56.88 36.46 27.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.651 0.659 . . . . 1.51 112.093 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.29 8.69 87.03 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.549 -0.834 . . . . 0.51000000000000001 112.408 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 57' ' ' VAL . 5.8 mt -104.04 149.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 122.351 0.26 . . . . 0.48999999999999999 110.785 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.08 116.02 31.78 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.974 -1.121 . . . . 1.0700000000000001 107.974 170.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.16 122.56 46.16 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.106 0.479 . . . . 1.5 111.734 -175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.01 163.6 22.41 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.82999999999999996 110.381 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.17 166.55 12.5 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.112 2.541 . . . . 1.29 111.875 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.78 -45.65 4.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.233 0.827 . . . . 3.1200000000000001 113.233 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.99 -29.96 7.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 2.1400000000000001 110.935 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.79 128.64 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 122.04 0.8 . . . . 1.5600000000000001 113.375 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.535 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 m95 -84.2 -42.66 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.391 1.091 . . . . 3.6899999999999999 108.877 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.79 -79.82 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 113.359 -1.746 . . . . 1.78 111.446 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.69 -59.07 0.48 Allowed 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 114.423 -0.888 . . . . 1.48 109.36 -172.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER 58.08 151.25 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.799 1.312 . . . . 0.90000000000000002 110.425 -177.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.6 p -91.33 106.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.395 -0.82 . . . . 0.81999999999999995 108.806 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.69 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.1 m-85 -78.63 144.16 35.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.141 -0.936 . . . . 0.41999999999999998 112.012 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.7 t -109.19 159.88 8.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.179 -1.828 . . . . 0.34000000000000002 109.625 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.657 ' HB ' ' O ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -91.95 113.09 26.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.76 0.791 . . . . 1.8400000000000001 111.257 -169.163 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -130.54 126.34 36.53 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.075 -0.966 . . . . 1.8799999999999999 108.922 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 118.23 -0.89 . . . . 1.3600000000000001 110.4 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.876 -0.416 . . . . 5.8600000000000003 109.876 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -93.82 114.94 27.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.074 -0.713 . . . . 2.73 109.074 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.28 147.5 28.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.088 0.471 . . . . 2.5 111.189 -172.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 23.4 p90 -138.69 174.73 10.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.985 -1.117 . . . . 1.1699999999999999 107.985 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.021 ' HA ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -135.23 162.33 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.222 0.465 . . . . 1.0 111.473 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 1.077 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -117.98 132.67 56.37 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 119.715 -0.794 . . . . 2.73 109.889 -176.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 3.3 p -138.85 148.44 24.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.941 -0.474 . . . . 1.45 111.405 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.985 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -153.98 164.01 39.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.353 -0.385 . . . . 0.56000000000000005 109.99 165.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.4 mp0 -67.94 -32.95 73.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 2.9700000000000002 111.504 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' THR . 14.2 t70 -132.48 149.44 52.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.613 -1.625 . . . . 1.1399999999999999 106.613 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 3.0 mt-10 -54.44 -34.22 61.03 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 122.01 0.91 . . . . 1.48 108.653 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -110.19 28.65 8.42 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.502 -1.681 . . . . 2.02 111.867 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.668 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.3 t70 -83.7 -117.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.895 -0.78 . . . . 0.58999999999999997 108.895 171.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -121.4 89.61 47.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.555 -0.748 . . . . 2.1800000000000002 110.429 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.985 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 74.4 Cg_endo -75.06 140.56 25.42 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 C-N-CA 123.107 2.538 . . . . 0.57999999999999996 113.506 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.09 125.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 115.448 -0.796 . . . . 0.51000000000000001 110.509 -175.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.077 ' HG2' ' HG3' ' A' ' 6' ' ' ARG . 25.0 mt-10 -86.12 120.6 27.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.223 -0.658 . . . . 1.6200000000000001 109.223 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 19.7 pt -142.03 144.41 31.89 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.303 -0.862 . . . . 1.52 111.454 -168.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 72.2 Cg_endo -74.64 145.29 32.74 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.867 2.378 . . . . 0.67000000000000004 113.34 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.503 ' OG ' HD12 ' A' ' 5' ' ' ILE . 8.5 m -104.42 170.26 8.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 110.232 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.01 141.12 54.97 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.987 -0.746 . . . . 2.77 108.987 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.66 -19.14 5.52 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.354 1.034 . . . . 2.1299999999999999 112.689 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' A' ' 25' ' ' THR . 7.4 m-20 -75.95 -5.17 44.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.124 0.964 . . . . 2.3199999999999998 108.775 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.21 23.99 60.13 Favored Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 108.74 -1.744 . . . . 0.56000000000000005 108.74 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -122.38 154.03 38.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.1 -1.55 . . . . 0.62 111.238 -162.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -146.68 143.12 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.526 -0.761 . . . . 0.46999999999999997 109.741 172.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 3.5 mp -68.53 116.92 9.62 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.786 -0.45 . . . . 1.9399999999999999 109.786 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD13 HD21 ' A' ' 61' ' ' LEU . 15.6 tp -60.02 -51.36 69.96 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.206 0.316 . . . . 0.96999999999999997 110.697 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.706 ' HA ' HG23 ' A' ' 32' ' ' THR . 7.9 m -71.78 -44.86 63.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.428 -0.805 . . . . 1.4299999999999999 110.859 -174.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 2.7 m -63.67 -32.19 73.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.955 -0.566 . . . . 1.4199999999999999 109.721 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.848 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -59.43 -48.47 87.07 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.908 -0.587 . . . . 0.67000000000000004 110.262 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.11 -17.76 63.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.043 0.757 . . . . 0.71999999999999997 113.043 -176.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.63 37.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.542 1.312 . . . . 0.93000000000000005 114.542 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.7 OUTLIER 171.48 -165.71 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.967 0.907 . . . . 1.05 108.993 -173.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -109.31 92.79 12.06 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 109.233 -0.654 . . . . 1.5 109.233 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.848 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.92 8.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.52 3.48 . . . . 0.84999999999999998 113.928 173.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.929 ' HA2' ' HB ' ' A' ' 75' ' ' VAL . . . 107.83 -26.7 16.79 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 110.078 -1.209 . . . . 0.67000000000000004 110.078 -162.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.72 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 61.1 -81.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.987 1.106 . . . . 0.45000000000000001 113.987 167.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 28' ' ' LEU . 36.5 t -120.28 -12.9 8.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.524 0.678 . . . . 1.1100000000000001 109.443 -165.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.65 157.51 24.15 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.897 -1.047 . . . . 0.39000000000000001 112.344 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -127.94 153.01 47.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.174 -0.61 . . . . 0.56000000000000005 111.502 174.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 95.1 mtt180 -138.52 146.52 42.06 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 106.743 -1.577 . . . . 1.9399999999999999 106.743 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.841 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 47.4 p90 -154.67 166.92 31.89 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 117.903 -1.519 . . . . 1.1399999999999999 113.946 169.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.64 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 73.8 ttt180 -102.32 137.69 40.23 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 113.857 -1.519 . . . . 2.7200000000000002 107.853 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.853 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.4 t30 -142.68 111.95 5.83 Favored Pre-proline 0 C--O 1.211 -0.927 0 N-CA-C 113.219 0.822 . . . . 3.04 113.219 -158.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HD2' HD12 ' A' ' 71' ' ' LEU . 31.7 Cg_exo -20.89 -35.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.269 1 C-N-CA 126.783 4.989 . . . . 3.6200000000000001 118.105 -175.421 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.895 HG13 ' H ' ' A' ' 48' ' ' SER . 2.1 p -81.69 -83.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 118.871 0.759 . . . . 4.4199999999999999 110.821 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.895 ' H ' HG13 ' A' ' 47' ' ' VAL . 87.5 p -103.76 -9.64 18.92 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.109 -0.496 . . . . 3.3199999999999998 110.486 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.853 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 5.9 mt-30 50.66 25.59 2.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.961 -1.018 . . . . 4.2000000000000002 113.426 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -57.33 133.96 55.58 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.124 -0.944 . . . . 1.72 109.973 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -63.42 88.22 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.672 0.748 . . . . 2.3500000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -102.41 145.03 30.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.382 -0.826 . . . . 2.48 111.623 -173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 167.28 21.28 Favored Glycine 0 C--N 1.299 -1.512 0 CA-C-N 114.092 -1.413 . . . . 0.40999999999999998 114.216 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 55.9 t -97.43 140.16 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.036 -1.082 . . . . 0.42999999999999999 111.058 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.0 mpt_? -67.33 135.86 53.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.58 -0.736 . . . . 4.1100000000000003 112.402 -174.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.788 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -108.11 120.51 42.53 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.935 -0.706 . . . . 1.53 110.563 171.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.749 HG12 ' HG3' ' A' ' 58' ' ' GLU . 32.5 t -130.16 115.81 34.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 115.686 -0.688 . . . . 0.53000000000000003 109.774 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.749 ' HG3' HG12 ' A' ' 57' ' ' VAL . 16.4 mt-10 52.59 35.42 17.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.766 0.317 . . . . 1.51 111.504 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.87 4.65 75.11 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.835 -0.698 . . . . 0.51000000000000001 113.066 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.788 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 5.1 mt -100.64 148.98 6.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 O-C-N 122.586 -0.361 . . . . 0.48999999999999999 111.496 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.852 ' HB2' HG23 ' A' ' 26' ' ' VAL . 56.2 mt -101.36 118.17 36.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.253 -1.017 . . . . 1.0700000000000001 108.253 167.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 128.96 55.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.331 -0.547 . . . . 1.5 111.832 -174.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 161.35 57.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.83 -1.544 . . . . 0.82999999999999996 106.83 161.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 12.7 Cg_exo -69.19 146.69 64.54 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.624 1.549 . . . . 1.29 111.145 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -45.78 17.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.804 0.811 . . . . 3.1200000000000001 111.629 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.79 24.26 5.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.38 -1.282 . . . . 2.1400000000000001 109.356 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 64' ' ' PRO . . . -77.3 -119.48 0.19 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.707 -0.759 . . . . 1.5600000000000001 112.715 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.821 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.49 -172.94 2.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.454 -0.573 . . . . 3.6899999999999999 109.454 -175.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -175.13 86.47 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.861 -1.162 . . . . 1.78 112.042 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.021 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 3.5 t30 102.19 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 124.808 2.242 . . . . 1.48 108.946 171.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -86.72 -177.48 6.13 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 109.517 -3.492 . . . . 0.90000000000000002 106.396 167.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -99.28 101.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 124.546 1.154 . . . . 0.81999999999999995 108.697 176.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 19.5 m-85 -84.2 141.27 31.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.704 1.002 . . . . 0.41999999999999998 113.704 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.8 t -109.2 163.91 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 112.564 -2.107 . . . . 0.34000000000000002 107.593 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.929 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 21.5 m -118.9 127.74 75.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.59 -0.694 . . . . 1.8400000000000001 111.407 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.91 128.35 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.751 -0.78 . . . . 1.8799999999999999 110.341 169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.717 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.047 -0.977 . . . . 1.3600000000000001 110.306 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.921 -0.4 . . . . 5.8600000000000003 109.921 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 61.59 92.22 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.312 -0.625 . . . . 2.73 109.312 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -78.86 140.51 38.14 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.068 -0.514 . . . . 2.5 110.862 -166.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 70' ' ' ASN . 38.8 p90 -133.6 172.2 13.07 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.591 -0.892 . . . . 1.1699999999999999 108.591 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.849 HD12 ' HE1' ' A' ' 73' ' ' TYR . 15.0 pt -127.52 165.78 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 122.611 0.365 . . . . 1.0 110.792 -170.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.611 ' NH1' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -114.46 132.76 56.16 Favored 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 108.952 -0.758 . . . . 2.73 108.952 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG22 ' HD1' ' A' ' 73' ' ' TYR . 2.3 t -135.89 143.5 36.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 O-C-N 121.113 -0.992 . . . . 1.45 110.296 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.966 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 t -153.55 167.41 29.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.039 -0.356 . . . . 0.56000000000000005 110.039 162.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.927 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -72.48 -54.18 10.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.023 0.916 . . . . 2.9700000000000002 109.2 173.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 13.1 t70 -112.63 148.13 35.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.639 -1.245 . . . . 1.1399999999999999 107.639 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 74' ' ' VAL . 3.8 mt-10 -58.55 -26.38 63.5 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.869 -1.06 . . . . 1.48 108.414 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -119.8 29.19 7.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.636 -1.62 . . . . 2.02 111.158 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.483 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -84.31 -117.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.07 -1.085 . . . . 0.58999999999999997 108.07 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 31.0 mt-10 -121.52 90.87 48.19 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.136 -0.938 . . . . 2.1800000000000002 110.218 168.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.966 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.8 Cg_endo -72.47 134.21 22.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.649 1.566 . . . . 0.57999999999999996 110.82 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.526 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -129.72 144.2 38.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.269 -0.878 . . . . 0.51000000000000001 110.983 -168.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 16.9 mt-10 -90.76 122.12 33.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.768 -0.456 . . . . 1.6200000000000001 109.768 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.75 HD12 ' HD2' ' A' ' 19' ' ' PRO . 7.1 tp -140.85 131.73 13.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.469 -0.787 . . . . 1.52 111.175 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.75 ' HD2' HD12 ' A' ' 18' ' ' ILE . 55.4 Cg_endo -71.88 137.71 30.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.652 2.235 . . . . 0.67000000000000004 112.764 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.0 p -106.32 170.46 7.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.96999999999999997 110.297 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -65.46 140.83 58.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.963 -0.384 . . . . 2.77 109.963 178.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 24' ' ' GLY . 3.5 m-20 -54.99 -19.91 7.9 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.617 -1.174 . . . . 2.1299999999999999 111.987 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.78 0.92 13.79 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.866 0.841 . . . . 2.3199999999999998 108.8 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.09 24.64 73.19 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.687 -1.365 . . . . 0.56000000000000005 109.687 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -134.74 166.15 23.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.143 -1.028 . . . . 0.62 109.963 -168.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -146.18 148.21 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.415 -0.357 . . . . 0.46999999999999997 110.384 175.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -65.56 94.55 0.19 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.148 -0.478 . . . . 1.9399999999999999 109.861 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.61 -49.08 74.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.664 -0.495 . . . . 0.96999999999999997 109.664 -168.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.558 ' N ' ' HG ' ' A' ' 28' ' ' LEU . 5.4 p -65.5 -35.6 81.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.5 0.667 . . . . 1.4299999999999999 110.349 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.044 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 3.4 m -72.35 -33.72 67.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.316 -0.856 . . . . 1.4199999999999999 108.7 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.88 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 45.7 t -63.72 -39.71 86.37 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 115.159 -0.928 . . . . 0.67000000000000004 110.383 170.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.6 p -64.87 -20.15 66.27 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 112.142 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 41.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.56 1.319 . . . . 0.93000000000000005 114.56 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER 172.08 -163.88 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.258 0.623 . . . . 1.05 110.021 -173.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.7 92.83 7.77 Favored Pre-proline 0 N--CA 1.436 -1.132 0 N-CA-C 108.649 -0.871 . . . . 1.5 108.649 165.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.88 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -122.25 3.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.639 2.892 . . . . 0.84999999999999998 114.561 171.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.826 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 106.99 -23.77 26.73 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 109.806 -1.317 . . . . 0.67000000000000004 109.806 -161.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.82 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.49 -89.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.031 1.333 . . . . 0.45000000000000001 114.106 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 32.1 t -125.4 -13.34 6.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.45 0.643 . . . . 1.1100000000000001 110.846 -161.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.23 15.79 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 109.633 -1.387 . . . . 0.39000000000000001 109.633 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -133.05 139.75 47.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.963 -1.095 . . . . 0.56000000000000005 111.871 175.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 67.6 mtt180 -132.69 154.2 50.39 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 106.313 -1.736 . . . . 1.9399999999999999 106.313 162.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.1 p90 -154.69 165.47 36.44 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 120.121 1.328 . . . . 1.1399999999999999 113.234 170.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.77 ' HB2' HG13 ' A' ' 72' ' ' VAL . 97.1 mtt180 -97.28 133.31 42.07 Favored 'General case' 0 C--O 1.253 1.268 0 O-C-N 125.684 1.865 . . . . 2.7200000000000002 109.142 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.117 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 38.4 t30 -128.54 122.53 21.79 Favored Pre-proline 0 C--O 1.22 -0.483 0 CA-C-N 114.081 -1.418 . . . . 3.04 110.848 -170.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' ASN . 77.5 Cg_exo -51.74 -15.42 2.93 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.027 3.151 . . . . 3.6200000000000001 116.467 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 48' ' ' SER . 0.8 OUTLIER -91.29 -90.47 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 118.792 0.724 . . . . 4.4199999999999999 111.383 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.646 ' N ' HG22 ' A' ' 47' ' ' VAL . 3.4 m -101.99 -2.57 29.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.746 0.784 . . . . 3.3199999999999998 110.765 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.117 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.0 tt0 51.02 47.91 24.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 115.132 1.53 . . . . 4.2000000000000002 115.132 171.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -62.07 121.17 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.244 -0.889 . . . . 1.72 109.017 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 59.3 mtm -68.44 77.82 0.27 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.65 -0.87 . . . . 2.3500000000000001 108.65 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 14.0 ttt180 -103.88 156.78 17.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.469 -0.787 . . . . 2.48 111.54 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.589 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -98.16 158.21 20.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.496 -1.229 . . . . 0.40999999999999998 114.766 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.635 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 87.9 t -98.86 143.93 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.325 -1.437 . . . . 0.42999999999999999 109.854 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' A' ' 64' ' ' PRO . 82.0 mtt180 -64.48 135.25 55.87 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 111.56 0.207 . . . . 4.1100000000000003 111.56 -171.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -113.7 114.98 27.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.873 0.368 . . . . 1.53 110.031 170.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 60' ' ' ILE . 4.6 t -128.32 115.09 36.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.472 -0.331 . . . . 0.53000000000000003 110.296 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.634 ' HG3' HG12 ' A' ' 57' ' ' VAL . 23.0 mt-10 53.44 36.55 23.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.999 0.52 . . . . 1.51 112.383 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.1 0.91 73.39 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.402 -0.904 . . . . 0.51000000000000001 112.689 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 57' ' ' VAL . 1.9 mt -104.34 148.04 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 122.681 -0.305 . . . . 0.48999999999999999 111.163 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.952 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -102.39 114.95 29.58 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.797 -1.186 . . . . 1.0700000000000001 107.797 169.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -115.66 142.2 47.06 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.2 0.524 . . . . 1.5 111.891 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.28 160.85 29.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.091 -0.958 . . . . 0.82999999999999996 110.301 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 24.2 Cg_exo -64.16 166.06 17.8 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.912 3.075 . . . . 1.29 112.602 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.01 -46.57 5.56 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.908 0.861 . . . . 3.1200000000000001 112.804 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.18 -44.25 8.44 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.987 -1.46 . . . . 2.1400000000000001 110.043 -175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.2 133.64 0.48 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.369 -0.832 . . . . 1.5600000000000001 112.427 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.624 ' CG ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.52 -77.39 0.07 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.091 -0.555 . . . . 3.6899999999999999 109.787 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 176.24 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.663 -0.698 . . . . 1.78 112.101 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 4.9 p-10 -156.38 54.84 0.56 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.199 1.0 . . . . 1.48 109.697 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.624 HD11 ' CG ' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -52.92 162.51 0.61 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-N 113.465 -1.698 . . . . 0.90000000000000002 110.028 165.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.77 HG13 ' HB2' ' A' ' 44' ' ' ARG . 1.6 p -96.42 107.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 114.297 -1.319 . . . . 0.81999999999999995 108.656 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.849 ' HE1' HD12 ' A' ' 5' ' ' ILE . 17.1 m-85 -80.03 146.95 31.7 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.121 -0.945 . . . . 0.41999999999999998 112.638 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -110.28 158.8 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 113.386 -1.734 . . . . 0.34000000000000002 110.039 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.927 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 6.4 p -97.61 109.06 22.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.594 0.711 . . . . 1.8400000000000001 112.422 -165.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.453 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 0.9 OUTLIER -130.62 128.51 41.14 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 120.144 -0.623 . . . . 1.8799999999999999 111.399 165.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.764 0 CA-C-O 119.129 -0.462 . . . . 1.3600000000000001 110.652 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 110.276 -0.268 . . . . 5.8600000000000003 110.276 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t 71.48 125.33 0.03 OUTLIER 'General case' 0 C--O 1.235 0.292 0 O-C-N 124.087 0.867 . . . . 2.73 110.397 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -80.83 153.16 27.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.848 -0.615 . . . . 2.5 109.596 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.517 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 20.5 p90 -120.51 166.84 13.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.613 -1.254 . . . . 1.1699999999999999 107.613 -176.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 21.7 pt -121.45 162.38 20.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 120.645 0.26 . . . . 1.0 110.589 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.892 ' HG3' ' HA ' ' A' ' 72' ' ' VAL . 1.4 tpp85 -118.81 131.96 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.0 -1.111 . . . . 2.73 108.0 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.5 p -139.85 146.95 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 O-C-N 121.218 -0.926 . . . . 1.45 110.763 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 1.044 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -152.26 148.87 28.07 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.666 -0.243 . . . . 0.56000000000000005 110.408 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 1.07 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 47.9 mp0 -60.8 -36.21 78.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.145 0.498 . . . . 2.9700000000000002 111.593 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -128.35 153.41 47.06 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.972 -1.492 . . . . 1.1399999999999999 106.972 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.24 -30.67 64.82 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.718 0.771 . . . . 1.48 108.927 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -119.76 31.66 6.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.366 -1.288 . . . . 2.02 110.972 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 3.8 t70 -79.98 -118.26 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.26 -1.385 . . . . 0.58999999999999997 107.26 168.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 21.9 tt0 -120.45 91.88 47.04 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.72 -0.673 . . . . 2.1800000000000002 110.01 168.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.044 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 64.1 Cg_endo -71.56 133.45 22.34 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.201 1.934 . . . . 0.57999999999999996 111.555 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.52 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.44 -0.8 . . . . 0.51000000000000001 110.885 -170.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 26.6 mt-10 -97.77 121.98 40.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.053 -0.522 . . . . 1.6200000000000001 110.123 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 41.4 pt -141.28 143.36 30.21 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.843 -0.617 . . . . 1.52 111.295 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 8.2 Cg_exo -72.6 160.15 47.18 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.184 2.589 . . . . 0.67000000000000004 112.422 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.4 m -132.37 171.67 13.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 110.001 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' THR . 28.8 tt0 -64.03 142.09 58.54 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.262 -0.644 . . . . 2.77 109.262 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.21 -24.21 17.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 124.503 1.127 . . . . 2.1299999999999999 111.951 -168.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 16.0 t70 -74.38 -8.64 56.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.34 1.067 . . . . 2.3199999999999998 108.905 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.26 41.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.741 -1.744 . . . . 0.56000000000000005 108.741 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -120.62 154.89 34.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.052 -1.574 . . . . 0.62 111.518 -165.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -147.61 140.01 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.161 -0.927 . . . . 0.46999999999999997 109.138 169.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.8 mp -64.43 111.86 2.85 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.927 -0.768 . . . . 1.9399999999999999 108.927 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' THR . 30.0 tp -58.14 -51.71 68.58 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 120.756 0.313 . . . . 0.96999999999999997 110.193 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -67.18 -47.5 70.76 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.564 -0.744 . . . . 1.4299999999999999 110.626 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.632 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.0 m -65.55 -32.65 74.36 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 115.563 -0.744 . . . . 1.4199999999999999 109.81 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.872 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -61.48 -45.12 99.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 115.907 -0.588 . . . . 0.67000000000000004 110.478 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.5 p -64.36 -19.21 65.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.207 0.447 . . . . 0.71999999999999997 112.207 -176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.1 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.364 1.246 . . . . 0.93000000000000005 114.364 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER 171.22 -164.35 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 123.406 0.682 . . . . 1.05 109.835 -173.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -107.79 92.81 9.42 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.55 -0.75 . . . . 1.5 109.214 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.872 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -120.32 6.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.322 3.348 . . . . 0.84999999999999998 113.924 171.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 1.068 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 107.47 -25.54 21.14 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.097 -1.201 . . . . 0.67000000000000004 110.097 -161.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 56.61 -91.81 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.029 1.332 . . . . 0.45000000000000001 113.735 173.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.469 ' HA ' HD11 ' A' ' 28' ' ' LEU . 19.5 m -115.78 -21.71 9.48 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 110.135 -160.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA3' ' ND2' ' A' ' 76' ' ' ASN . . . -117.57 147.8 18.74 Favored Glycine 0 N--CA 1.418 -2.557 0 CA-C-N 114.783 -1.099 . . . . 0.39000000000000001 111.005 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -128.22 142.34 51.19 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.335 -0.946 . . . . 0.56000000000000005 110.606 172.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.651 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 96.0 mtt180 -132.24 161.78 32.58 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.841 -1.911 . . . . 1.9399999999999999 105.841 165.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -157.4 166.66 32.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.038 -1.065 . . . . 1.1399999999999999 112.369 168.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 46.4 mtp180 -111.08 139.28 46.57 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.347 1.655 . . . . 2.7200000000000002 108.282 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.892 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.4 t-20 -137.49 120.82 11.6 Favored Pre-proline 0 C--O 1.209 -1.033 0 CA-C-N 115.343 -0.844 . . . . 3.04 111.636 -161.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.58 5.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 124.653 3.569 . . . . 3.6200000000000001 116.869 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.998 HG13 ' H ' ' A' ' 48' ' ' SER . 2.7 p -100.62 -86.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 121.797 -0.564 . . . . 4.4199999999999999 110.25 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.998 ' H ' HG13 ' A' ' 47' ' ' VAL . 68.5 p -107.28 -8.12 16.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.977 -0.556 . . . . 3.3199999999999998 110.911 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.892 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 6.2 mt-30 51.77 28.02 4.61 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 124.482 1.113 . . . . 4.2000000000000002 113.494 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -46.88 121.68 3.8 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.262 -0.881 . . . . 1.72 110.207 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 15.8 ptm -63.6 86.21 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 2.3500000000000001 109.21 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 10.6 ttt180 -124.67 151.03 45.46 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.709 0.766 . . . . 2.48 111.079 -172.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.51 165.52 24.87 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 114.194 -1.366 . . . . 0.40999999999999998 115.124 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.685 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 78.5 t -83.73 141.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 112.879 -1.661 . . . . 0.42999999999999999 109.696 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mpt_? -64.96 134.53 54.12 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.485 0.18 . . . . 4.1100000000000003 111.485 -171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.8 pp -110.62 114.08 27.2 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.59 -0.444 . . . . 1.53 110.065 172.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.591 HG12 ' HG3' ' A' ' 58' ' ' GLU . 13.9 t -125.1 113.79 37.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 109.916 -0.401 . . . . 0.53000000000000003 109.916 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 57' ' ' VAL . 19.9 mt-10 52.19 36.6 19.68 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.837 0.455 . . . . 1.51 111.711 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.79 -1.71 75.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.38 -0.914 . . . . 0.51000000000000001 112.891 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -95.69 145.49 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 117.342 0.571 . . . . 0.48999999999999999 110.688 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 11.9 tp -104.38 115.82 31.05 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.65 -1.241 . . . . 1.0700000000000001 107.65 170.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.422 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 2.5 t-80 -116.05 133.57 55.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.162 -0.615 . . . . 1.5 112.081 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 162.24 37.23 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 107.684 -1.228 . . . . 0.82999999999999996 107.684 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.09 153.19 72.41 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.491 1.46 . . . . 1.29 110.835 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -46.92 -44.14 19.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.588 0.709 . . . . 3.1200000000000001 111.472 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.64 36.43 0.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.428 -1.26 . . . . 2.1400000000000001 108.646 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.34 -103.53 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.99 -1.005 . . . . 1.5600000000000001 113.885 -172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HD1' HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -86.57 -58.18 2.71 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.969 -0.752 . . . . 3.6899999999999999 108.969 -173.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.58 -69.71 0.34 Allowed Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.57 -1.196 . . . . 1.78 113.195 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -139.39 -56.06 0.58 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 114.628 -0.786 . . . . 1.48 109.107 -168.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.631 HD21 ' HD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER 55.25 161.78 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.72 0 O-C-N 124.375 1.047 . . . . 0.90000000000000002 110.544 -177.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.892 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 16.3 m -93.63 104.27 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 108.174 -1.047 . . . . 0.81999999999999995 108.174 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.754 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m-85 -78.58 138.91 38.6 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.884 -0.598 . . . . 0.41999999999999998 111.504 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -96.85 151.94 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.456 -1.247 . . . . 0.34000000000000002 108.687 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.07 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 4.0 t -114.86 115.23 48.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.342 0.591 . . . . 1.8400000000000001 112.265 -163.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.559 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 3.1 p-10 -128.63 129.14 45.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.497 -0.774 . . . . 1.8799999999999999 111.351 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.658 -0.687 . . . . 1.3600000000000001 110.552 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.639 0.257 . . . . 5.8600000000000003 110.651 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -87.8 119.02 27.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.848 -0.427 . . . . 2.73 109.848 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.75 134.18 35.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.65 -0.5 . . . . 2.5 109.65 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.933 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 32.6 p90 -141.19 172.9 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.272 -0.64 . . . . 1.1699999999999999 109.272 -170.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.985 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 25.4 pt -124.06 160.71 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.234 0.333 . . . . 1.0 110.516 -174.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.782 ' HD3' ' HB2' ' A' ' 15' ' ' PRO . 22.1 ttm180 -118.73 135.61 54.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.976 -0.69 . . . . 2.73 110.146 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.663 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.1 t -130.02 145.94 34.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 O-C-N 122.044 -0.41 . . . . 1.45 110.638 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.78 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.3 t -151.4 163.02 39.91 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.297 -0.252 . . . . 0.56000000000000005 110.417 163.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 1.047 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -68.87 -39.05 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.925 -0.71 . . . . 2.9700000000000002 111.011 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.26 154.84 50.78 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.875 -0.787 . . . . 1.1399999999999999 108.875 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -52.6 -39.34 61.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.454 1.121 . . . . 1.48 108.257 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.57 7.97 33.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.366 -1.743 . . . . 2.02 112.939 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 2.7 t70 -85.79 -127.01 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 118.861 -1.136 . . . . 0.58999999999999997 108.218 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.46 92.13 48.55 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.566 -0.743 . . . . 2.1800000000000002 110.315 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 60.1 Cg_endo -70.57 132.96 23.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.726 1.617 . . . . 0.57999999999999996 111.094 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.19 125.82 64.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.173 -0.921 . . . . 0.51000000000000001 110.692 -169.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.933 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 23.4 mt-10 -85.1 120.98 27.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.966 -0.561 . . . . 1.6200000000000001 110.453 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 21.4 pt -143.07 145.2 31.92 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.07 -0.968 . . . . 1.52 111.748 -171.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 16.5 Cg_exo -69.54 133.68 26.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.112 2.542 . . . . 0.67000000000000004 113.084 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 p -108.53 172.23 6.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 110.647 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.73 138.41 58.37 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.044 0.45 . . . . 2.77 110.018 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -53.48 -31.49 45.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.954 -1.476 . . . . 2.1299999999999999 112.183 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.4 p-10 -85.45 2.3 45.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.877 0.846 . . . . 2.3199999999999998 108.9 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 25.47 18.28 Favored Glycine 0 CA--C 1.497 -1.07 0 CA-C-N 114.336 -1.302 . . . . 0.56000000000000005 109.976 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.544 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.01 155.42 29.23 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.004 -1.098 . . . . 0.62 112.254 -165.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 138.49 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.121 -0.945 . . . . 0.46999999999999997 108.994 169.251 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.6 mp -64.08 112.09 2.83 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.942 -0.762 . . . . 1.9399999999999999 108.942 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.34 -50.01 69.44 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.193 -0.669 . . . . 0.96999999999999997 109.193 -174.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.8 p -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 1.4299999999999999 111.171 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.714 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.6 m -68.43 -32.95 73.34 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.181 -0.674 . . . . 1.4199999999999999 109.181 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.861 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.3 t -58.61 -53.41 47.41 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 CA-C-N 115.199 -0.91 . . . . 0.67000000000000004 110.383 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -61.94 -16.64 52.59 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.351 0.871 . . . . 0.71999999999999997 113.351 -175.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.375 1.25 . . . . 0.93000000000000005 114.375 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER 172.32 -164.26 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.014 0.926 . . . . 1.05 109.259 -173.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -108.96 91.88 9.85 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 109.073 -0.714 . . . . 1.5 109.073 164.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.861 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.13 8.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.801 3.667 . . . . 0.84999999999999998 114.466 175.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.866 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 108.27 -21.16 29.39 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.137 -1.185 . . . . 0.67000000000000004 110.137 -163.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 58.51 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.755 1.02 . . . . 0.45000000000000001 113.755 170.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.9 m -130.77 -5.33 4.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.52 0.676 . . . . 1.1100000000000001 110.472 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.0 155.27 21.37 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 115.14 -0.936 . . . . 0.39000000000000001 111.86 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -132.41 154.59 49.67 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 119.8 -0.76 . . . . 0.56000000000000005 111.466 174.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.2 mtt180 -140.41 151.82 45.22 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.706 -1.961 . . . . 1.9399999999999999 105.706 161.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.698 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 36.3 p90 -157.63 165.03 36.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 120.188 1.358 . . . . 1.1399999999999999 112.699 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 45.3 mtm180 -110.89 150.38 29.27 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 125.601 1.813 . . . . 2.7200000000000002 109.554 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.837 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 23.4 t-20 -146.21 116.53 4.75 Favored Pre-proline 0 C--O 1.214 -0.806 0 CA-C-N 114.148 -1.387 . . . . 3.04 111.115 -162.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 71' ' ' LEU . 14.2 Cg_exo -25.6 -27.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 126.569 4.846 . . . . 3.6200000000000001 118.311 -172.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.982 HG13 ' H ' ' A' ' 48' ' ' SER . 2.5 p -83.9 -84.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 118.957 0.799 . . . . 4.4199999999999999 110.855 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.982 ' H ' HG13 ' A' ' 47' ' ' VAL . 22.7 t -107.12 -9.01 16.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.021 -0.536 . . . . 3.3199999999999998 110.151 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.837 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 15.0 mt-30 50.61 26.97 2.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 113.901 1.075 . . . . 4.2000000000000002 113.901 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.71 115.9 1.3 Allowed 'General case' 0 C--N 1.308 -1.223 0 O-C-N 123.813 0.696 . . . . 1.72 110.739 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 4.8 ptt? -62.43 92.43 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.378 0.608 . . . . 2.3500000000000001 110.222 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 7.6 ptp85 -122.31 161.42 23.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.573 -0.74 . . . . 2.48 109.691 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -116.13 167.26 12.43 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.085 -1.055 . . . . 0.40999999999999998 115.391 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.705 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 99.5 t -83.96 141.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.345 -1.427 . . . . 0.42999999999999999 111.391 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 3.3 mpt_? -72.29 135.64 46.03 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.643 -0.708 . . . . 4.1100000000000003 112.221 -171.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp -98.84 117.68 33.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.103 -0.639 . . . . 1.53 109.888 172.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.61 HG12 ' HG3' ' A' ' 58' ' ' GLU . 9.5 t -132.95 114.7 22.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 109.87 -0.419 . . . . 0.53000000000000003 109.87 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HG3' HG12 ' A' ' 57' ' ' VAL . 25.3 mt-10 53.9 39.5 30.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.092 0.405 . . . . 1.51 112.092 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 87.04 -1.37 86.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.42 -0.895 . . . . 0.51000000000000001 112.646 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.3 mt -100.75 149.33 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 122.734 -0.274 . . . . 0.48999999999999999 111.073 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.4 tp -102.09 114.83 29.3 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.507 -1.664 . . . . 1.0700000000000001 106.507 165.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -115.57 134.69 54.81 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.269 0.557 . . . . 1.5 112.322 -165.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.65 163.02 18.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.591 -1.186 . . . . 0.82999999999999996 108.572 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.82 163.76 15.33 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.687 2.258 . . . . 1.29 111.683 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.2 -45.79 8.59 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.71 0.766 . . . . 3.1200000000000001 112.834 -173.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.38 -39.12 8.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.296 -1.32 . . . . 2.1400000000000001 110.336 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.88 149.06 4.48 Favored Glycine 0 N--CA 1.426 -2.029 0 C-N-CA 120.556 -0.831 . . . . 1.5600000000000001 112.298 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.85 -52.43 36.82 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.934 -1.135 . . . . 3.6899999999999999 107.934 175.265 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 166.98 -83.76 0.1 OUTLIER Glycine 0 N--CA 1.417 -2.58 0 CA-C-N 113.79 -1.55 . . . . 1.78 111.427 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.985 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.2 p30 -142.25 -62.11 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 0 CA-C-N 114.58 -0.81 . . . . 1.48 109.922 -170.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 54.01 176.4 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.35 1.071 . . . . 0.90000000000000002 111.297 -177.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 72' ' ' VAL . 2.1 p -102.91 104.54 16.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 113.326 -1.761 . . . . 0.81999999999999995 108.427 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.8 ' HE1' HD12 ' A' ' 5' ' ' ILE . 20.4 m-85 -80.82 146.5 30.89 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.701 0.763 . . . . 0.41999999999999998 112.157 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -107.6 158.21 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.499 -1.682 . . . . 0.34000000000000002 107.933 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.047 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 t -113.93 110.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.56 0.695 . . . . 1.8400000000000001 111.383 -164.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -126.35 129.4 48.74 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.684 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.835 0 CA-C-O 118.587 -0.72 . . . . 1.3600000000000001 110.116 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.863 0.363 . . . . 5.8600000000000003 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p -112.24 -81.05 0.59 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.965 0.412 . . . . 2.73 110.59 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -111.8 153.74 26.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.309 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 23.0 p90 -131.67 163.87 27.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.594 -1.632 . . . . 1.1699999999999999 106.594 173.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -127.49 160.76 36.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.661 -172.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 5.2 ttt180 -119.4 132.77 55.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.758 -0.777 . . . . 2.73 109.279 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.787 HG22 ' HD1' ' A' ' 73' ' ' TYR . 3.5 t -132.63 144.2 37.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 121.923 -0.485 . . . . 1.45 110.396 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.961 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 5.4 t -152.85 168.33 26.11 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.369 0.128 . . . . 0.56000000000000005 110.768 166.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.793 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 tm-20 -72.92 -56.4 5.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.058 0.932 . . . . 2.9700000000000002 108.624 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 14.0 t70 -110.01 148.31 31.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.822 -1.177 . . . . 1.1399999999999999 107.822 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 74' ' ' VAL . 1.5 mt-10 -63.11 -17.82 62.73 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.347 -1.297 . . . . 1.48 108.577 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.64 33.55 4.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.996 -1.456 . . . . 2.02 110.657 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 7.3 t70 -83.55 -118.09 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.697 -1.223 . . . . 0.58999999999999997 107.697 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 6.1 tp10 -121.5 90.76 48.1 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.067 -0.97 . . . . 2.1800000000000002 110.184 167.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 72.7 Cg_endo -74.69 133.43 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.056 1.837 . . . . 0.57999999999999996 110.879 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.28 136.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.021 -0.536 . . . . 0.51000000000000001 111.338 -169.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 34.2 mt-10 -86.07 122.0 29.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.84 -0.43 . . . . 1.6200000000000001 109.84 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 25.4 pt -140.49 141.1 24.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.789 -0.641 . . . . 1.52 111.031 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 47.6 Cg_endo -69.69 136.29 32.81 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.713 2.275 . . . . 0.67000000000000004 112.425 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.778 ' HB3' HD12 ' A' ' 5' ' ' ILE . 8.2 p -112.14 169.36 8.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.96999999999999997 110.518 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.91 136.73 53.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.333 -0.618 . . . . 2.77 109.333 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' GLY . 1.2 m-20 -55.1 -17.4 4.01 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.195 0.998 . . . . 2.1299999999999999 112.555 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -74.55 0.71 13.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.009 0.909 . . . . 2.3199999999999998 108.645 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.31 23.98 74.38 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 113.866 -1.516 . . . . 0.56000000000000005 110.973 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.43 166.74 21.32 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.406 -0.397 . . . . 0.62 110.775 -169.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -147.5 146.35 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.598 -0.728 . . . . 0.46999999999999997 110.04 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -67.62 109.71 3.4 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.007 -0.738 . . . . 1.9399999999999999 109.007 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -65.77 -48.95 70.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.17 -0.923 . . . . 0.96999999999999997 110.009 -169.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.567 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.5 m -58.86 -39.23 80.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.14 -0.936 . . . . 1.4299999999999999 110.771 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.776 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 2.5 t -68.61 -33.19 73.61 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.602 -1.259 . . . . 1.4199999999999999 107.602 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.856 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 19.8 t -66.89 -42.54 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 CA-C-N 114.292 -1.322 . . . . 0.67000000000000004 109.864 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -65.8 -19.09 65.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.366 0.506 . . . . 0.71999999999999997 112.366 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.7 41.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.51 1.3 . . . . 0.93000000000000005 114.51 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.6 OUTLIER 173.51 -164.29 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 123.968 0.907 . . . . 1.05 108.981 -173.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.04 92.16 10.44 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 108.849 -0.797 . . . . 1.5 108.849 166.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.878 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -118.53 1.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.287 3.325 . . . . 0.84999999999999998 114.369 173.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 107.61 -20.09 32.61 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 110.1 -1.2 . . . . 0.67000000000000004 110.1 -161.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.878 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 63.45 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.226 1.01 . . . . 0.45000000000000001 113.504 170.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.4 t -128.87 -21.49 3.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.317 0.58 . . . . 1.1100000000000001 110.415 -165.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.508 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -112.97 155.51 16.24 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.485 -1.046 . . . . 0.39000000000000001 110.485 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.706 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.59 151.01 51.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 118.736 -1.186 . . . . 0.56000000000000005 112.984 176.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 mtt180 -133.82 161.0 35.92 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.187 -1.783 . . . . 1.9399999999999999 106.187 158.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.872 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.6 p90 -156.91 165.57 35.83 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 119.396 0.998 . . . . 1.1399999999999999 111.892 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -110.07 143.64 39.83 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 125.088 1.493 . . . . 2.7200000000000002 109.138 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.106 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 35.0 t30 -128.04 123.84 22.85 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.995 -1.002 . . . . 3.04 111.343 -169.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 71' ' ' LEU . 48.8 Cg_exo -38.01 -28.59 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.966 3.777 . . . . 3.6200000000000001 116.305 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.857 HG13 ' H ' ' A' ' 48' ' ' SER . 2.1 p -96.54 -90.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.074 0.397 . . . . 4.4199999999999999 111.461 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.857 ' H ' HG13 ' A' ' 47' ' ' VAL . 33.8 p -90.33 -8.83 49.82 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.666 0.746 . . . . 3.3199999999999998 110.798 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.106 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER 50.43 49.27 21.02 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 115.28 1.585 . . . . 4.2000000000000002 115.28 169.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.56 118.67 12.72 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.088 -0.96 . . . . 1.72 111.01 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 5.9 ptm -64.23 87.26 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.074 -0.713 . . . . 2.3500000000000001 109.074 170.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 7.3 ttt180 -121.19 156.21 32.88 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.934 -0.575 . . . . 2.48 110.432 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -100.48 164.81 19.04 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 121.975 0.764 . . . . 0.40999999999999998 113.951 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.694 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 91.0 t -98.53 140.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.545 -1.327 . . . . 0.42999999999999999 109.867 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -63.27 134.72 56.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.648 -0.705 . . . . 4.1100000000000003 112.642 -175.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.34 121.77 46.1 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.533 -0.467 . . . . 1.53 109.925 165.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.662 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.7 t -126.17 113.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.739 -0.467 . . . . 0.53000000000000003 109.739 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HG3' HG12 ' A' ' 57' ' ' VAL . 12.1 mt-10 51.13 36.5 15.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.067 0.547 . . . . 1.51 112.445 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 95.35 -3.23 66.04 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.729 -0.748 . . . . 0.51000000000000001 112.932 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.3 mt -100.81 148.16 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.726 -0.279 . . . . 0.48999999999999999 110.443 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' VAL . 16.4 tp -102.44 114.58 28.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.134 -1.061 . . . . 1.0700000000000001 108.134 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -111.65 122.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.711 0.767 . . . . 1.5 111.616 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.67 162.47 62.83 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 106.838 -1.541 . . . . 0.82999999999999996 106.838 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 22.2 Cg_exo -63.41 149.89 89.97 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 120.421 1.186 . . . . 1.29 109.594 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -45.95 -43.68 14.2 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.195 0.934 . . . . 3.1200000000000001 111.924 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.17 32.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.484 -0.932 . . . . 2.1400000000000001 108.484 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.11 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.004 -0.998 . . . . 1.5600000000000001 113.885 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.775 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.34 -76.93 0.6 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.538 0.685 . . . . 3.6899999999999999 109.897 -172.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.33 -76.49 0.12 Allowed Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 114.95 -1.023 . . . . 1.78 113.757 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.935 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -133.42 -59.03 0.88 Allowed 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.101 -0.549 . . . . 1.48 109.737 -167.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 51.06 172.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.439 1.087 . . . . 0.90000000000000002 111.648 -176.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 6' ' ' ARG . 2.0 p -99.56 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 113.99 -1.459 . . . . 0.81999999999999995 108.492 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.872 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.6 m-85 -79.86 144.81 33.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.827 0.822 . . . . 0.41999999999999998 112.671 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.715 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.5 t -110.38 164.11 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.356 -1.747 . . . . 0.34000000000000002 109.548 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.902 HG23 ' HA2' ' A' ' 37' ' ' GLY . 9.8 p -98.95 114.67 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.671 0.619 . . . . 1.8400000000000001 112.671 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.457 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 1.1 p30 -133.54 128.2 34.78 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 118.638 -1.225 . . . . 1.8799999999999999 110.533 158.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.38 -0.819 . . . . 1.3600000000000001 109.957 167.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.614 0.245 . . . . 5.8600000000000003 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -80.91 73.69 7.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.364 0.602 . . . . 2.73 109.553 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -82.73 141.72 32.18 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.635 -0.711 . . . . 2.5 109.755 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 16.8 p90 -138.64 162.54 34.36 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.258 -1.386 . . . . 1.1699999999999999 107.258 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -121.86 162.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.88 0.309 . . . . 1.0 111.223 -172.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 1.081 ' HD2' ' HB2' ' A' ' 15' ' ' PRO . 1.9 tpp85 -117.83 132.45 56.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 2.7 p -138.81 147.2 25.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 O-C-N 121.411 -0.806 . . . . 1.45 111.503 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 2.1 t -153.49 171.13 19.18 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.494 -0.928 . . . . 0.56000000000000005 108.494 166.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.0 mt-10 -75.33 -54.9 6.3 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.834 -1.147 . . . . 2.9700000000000002 108.142 171.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 12.0 m-20 -103.38 142.11 34.78 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.845 -1.169 . . . . 1.1399999999999999 107.845 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 74' ' ' VAL . 4.3 mt-10 -57.71 -25.76 60.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 1.48 109.078 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.64 39.33 3.89 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.677 -1.601 . . . . 2.02 110.868 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.4 t70 -80.86 -114.48 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.042 -1.466 . . . . 0.58999999999999997 107.042 165.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -123.14 90.16 50.52 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.274 -0.875 . . . . 2.1800000000000002 109.668 165.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.081 ' HB2' ' HD2' ' A' ' 6' ' ' ARG . 72.5 Cg_endo -72.55 135.96 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.397 2.065 . . . . 0.57999999999999996 111.376 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -126.86 147.01 31.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.804 -0.635 . . . . 0.51000000000000001 110.928 -168.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.608 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 13.8 mt-10 -95.62 124.53 39.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.113 -0.494 . . . . 1.6200000000000001 110.857 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 35.8 pt -141.2 150.9 60.19 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.715 -0.675 . . . . 1.52 111.047 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.48 159.73 14.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.938 2.426 . . . . 0.67000000000000004 112.421 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.523 ' OG ' HD12 ' A' ' 5' ' ' ILE . 16.4 m -119.06 169.59 9.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.96999999999999997 110.277 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.15 145.31 55.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.054 -0.721 . . . . 2.77 109.054 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -23.74 14.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.281 -1.327 . . . . 2.1299999999999999 111.952 -171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 22.5 t70 -78.26 -8.46 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.213 1.006 . . . . 2.3199999999999998 109.171 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.1 31.67 Favored Glycine 0 CA--C 1.5 -0.873 0 N-CA-C 108.681 -1.767 . . . . 0.56000000000000005 108.681 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.56 149.81 40.02 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 112.893 -1.654 . . . . 0.62 110.915 -166.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.811 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -144.42 148.03 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.225 -0.443 . . . . 0.46999999999999997 110.725 173.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.071 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -70.61 94.69 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.48 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.58 -49.77 69.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.017 -0.538 . . . . 0.96999999999999997 110.461 -170.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.633 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.7 m -69.77 -31.04 68.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.618 0.723 . . . . 1.4299999999999999 109.719 -177.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.071 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.5 m -73.46 -32.36 64.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.233 -0.894 . . . . 1.4199999999999999 108.758 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.819 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 17.5 t -64.33 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 115.175 -0.921 . . . . 0.67000000000000004 110.273 168.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.3 p -65.03 -18.8 65.61 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.042 -0.411 . . . . 0.71999999999999997 111.887 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.95 40.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.384 1.253 . . . . 0.93000000000000005 114.384 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER 170.76 -166.61 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 124.054 0.941 . . . . 1.05 108.846 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -109.62 92.32 11.91 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.89 -0.781 . . . . 1.5 108.89 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.819 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 2.4 Cg_endo -120.42 5.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.199 3.266 . . . . 0.84999999999999998 114.661 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' O ' ' HD1' ' A' ' 77' ' ' TYR . . . 107.31 -26.98 16.91 Favored Glycine 0 C--O 1.222 -0.602 0 N-CA-C 109.716 -1.353 . . . . 0.67000000000000004 109.716 -161.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.792 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 62.57 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.509 1.3 . . . . 0.45000000000000001 114.509 165.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -122.41 -10.17 8.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.612 0.72 . . . . 1.1100000000000001 110.482 -159.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.4 154.06 16.54 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.489 -1.445 . . . . 0.39000000000000001 109.489 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -130.47 138.9 50.51 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 118.716 -1.194 . . . . 0.56000000000000005 111.893 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.79 ' HE ' ' HB3' ' A' ' 51' ' ' MET . 20.1 mtp180 -126.35 157.94 37.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.381 -1.34 . . . . 1.9399999999999999 107.381 159.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 25.4 p90 -154.34 160.21 41.59 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.435 -1.306 . . . . 1.1399999999999999 111.845 165.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 72' ' ' VAL . 15.0 ttm180 -107.57 136.24 47.68 Favored 'General case' 0 C--O 1.253 1.267 0 O-C-N 125.758 1.911 . . . . 2.7200000000000002 109.228 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.6 m120 -115.58 176.89 1.34 Allowed Pre-proline 0 C--O 1.211 -0.946 0 O-C-N 124.292 0.995 . . . . 3.04 111.908 -169.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' CD ' ' HB3' ' A' ' 45' ' ' ASN . 2.2 Cg_endo -94.53 1.93 2.83 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.206 2.604 . . . . 3.6200000000000001 112.594 167.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.887 HG13 ' H ' ' A' ' 48' ' ' SER . 2.4 p -103.42 -96.27 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.892 0.377 . . . . 4.4199999999999999 111.709 -174.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.887 ' H ' HG13 ' A' ' 47' ' ' VAL . 6.2 m -104.7 -4.29 22.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.687 0.756 . . . . 3.3199999999999998 109.868 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 32.4 mt-30 52.88 42.62 32.05 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 113.976 -1.466 . . . . 4.2000000000000002 113.879 170.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -67.88 124.56 23.68 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.877 -1.51 . . . . 1.72 108.861 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.79 ' HB3' ' HE ' ' A' ' 42' ' ' ARG . 18.2 mmt -69.67 80.05 0.43 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.997 -1.112 . . . . 2.3500000000000001 107.997 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 15.1 ttt180 -101.79 152.88 20.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.565 -1.198 . . . . 2.48 110.991 -166.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 161.02 19.83 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.288 -1.324 . . . . 0.40999999999999998 114.54 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.67 ' CG1' ' HG ' ' A' ' 61' ' ' LEU . 86.0 t -99.09 142.16 15.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 113.416 -1.392 . . . . 0.42999999999999999 110.158 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -64.4 136.2 56.87 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 112.05 0.389 . . . . 4.1100000000000003 112.05 -172.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -117.1 111.91 20.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.123 0.487 . . . . 1.53 110.567 175.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.748 HG12 ' HG3' ' A' ' 58' ' ' GLU . 35.6 t -127.97 117.25 45.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 116.26 -0.427 . . . . 0.53000000000000003 110.059 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.748 ' HG3' HG12 ' A' ' 57' ' ' VAL . 22.0 mt-10 54.83 35.7 24.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.687 0.28 . . . . 1.51 111.689 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.7 3.1 86.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.41 -0.9 . . . . 0.51000000000000001 112.933 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.1 mt -96.29 146.62 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 117.114 0.457 . . . . 0.48999999999999999 110.814 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.811 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.8 tp -103.83 117.89 35.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.268 -1.382 . . . . 1.0700000000000001 107.268 169.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -116.44 137.37 52.21 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.107 -0.637 . . . . 1.5 112.365 -169.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.48 163.74 17.6 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 114.564 -1.198 . . . . 0.82999999999999996 109.899 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.3 167.4 6.16 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.672 2.914 . . . . 1.29 111.79 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -44.1 3.58 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.821 0.701 . . . . 3.1200000000000001 112.66 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 -21.02 7.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.125 -0.943 . . . . 2.1400000000000001 110.93 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 153.53 19.73 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.567 -1.302 . . . . 1.5600000000000001 112.378 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.871 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.71 -49.89 35.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.441 -1.318 . . . . 3.6899999999999999 107.441 169.347 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.1 -81.48 0.08 OUTLIER Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 112.781 -2.009 . . . . 1.78 110.261 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.827 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.5 p30 -147.04 -61.73 0.29 Allowed 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.559 -0.821 . . . . 1.48 109.354 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.871 HD21 ' HB2' ' A' ' 68' ' ' TRP . 1.2 mm? 56.24 166.95 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.664 0 O-C-N 124.276 0.985 . . . . 0.90000000000000002 110.959 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 1.8 p -100.3 107.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 114.26 -1.336 . . . . 0.81999999999999995 109.493 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.846 ' HB3' HD11 ' A' ' 41' ' ' LEU . 19.0 m-85 -77.1 142.2 39.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.109 -0.95 . . . . 0.41999999999999998 112.041 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.725 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.3 t -110.88 167.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 113.629 -1.623 . . . . 0.34000000000000002 110.6 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' VAL . 5.7 p -99.03 105.02 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 112.641 0.608 . . . . 1.8400000000000001 112.641 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 0.3 OUTLIER -130.36 124.9 33.3 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 118.692 -1.203 . . . . 1.8799999999999999 111.506 163.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.294 -0.86 . . . . 1.3600000000000001 109.545 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 29.8 p90 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.379 . . . . 1.1699999999999999 107.278 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.955 HD12 ' HE1' ' A' ' 73' ' ' TYR . 23.6 pt -129.98 163.8 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.129 0.422 . . . . 1.0 111.123 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 134.28 55.14 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 109.506 -0.553 . . . . 2.73 109.506 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.652 HG13 ' HB2' ' A' ' 73' ' ' TYR . 1.6 t -136.83 142.87 36.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 O-C-N 121.499 -0.751 . . . . 1.45 110.883 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.898 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 t -154.13 151.74 29.61 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.01 -0.431 . . . . 0.56000000000000005 111.319 163.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.99 ' HA ' ' CB ' ' A' ' 75' ' ' VAL . 18.8 tt0 -65.96 -40.05 90.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.51 0.672 . . . . 2.9700000000000002 110.734 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -123.02 151.03 42.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.711 -1.588 . . . . 1.1399999999999999 106.711 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 11' ' ' GLU . 2.5 mt-10 -58.32 -30.5 66.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.553 -0.906 . . . . 1.48 108.553 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.69 31.19 6.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.284 -1.325 . . . . 2.02 111.031 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 27.0 t70 -84.84 -121.53 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.28 -1.378 . . . . 0.58999999999999997 107.28 167.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -122.19 92.95 48.81 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.373 -0.831 . . . . 2.1800000000000002 110.455 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.898 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 56.3 Cg_endo -67.57 136.3 38.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 110.997 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.511 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.86 143.94 39.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.351 -0.84 . . . . 0.51000000000000001 111.461 -169.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.676 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 23.8 mt-10 -97.35 125.66 42.1 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.888 -0.412 . . . . 1.6200000000000001 109.888 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 47.8 pt -140.77 139.08 19.13 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.155 -0.475 . . . . 1.52 111.527 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 7.6 Cg_exo -72.65 150.91 51.56 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.292 2.662 . . . . 0.67000000000000004 112.784 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -129.47 168.41 16.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.96999999999999997 111.019 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' THR . 26.8 tt0 -75.07 145.73 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.289 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.38 -21.37 9.42 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.611 -1.177 . . . . 2.1299999999999999 112.536 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 29.3 t70 -76.16 -7.04 53.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.292 1.044 . . . . 2.3199999999999998 108.709 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.98 53.99 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.021 -1.631 . . . . 0.56000000000000005 109.021 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -123.44 155.92 36.51 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.447 -1.376 . . . . 0.62 110.401 -166.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -147.31 152.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 122.568 0.347 . . . . 0.46999999999999997 110.811 177.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.103 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -68.9 94.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.129 -0.487 . . . . 1.9399999999999999 110.468 178.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -64.6 -49.69 70.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 110.006 -0.368 . . . . 0.96999999999999997 110.006 -171.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 32' ' ' THR . 16.7 p -62.66 -36.22 82.16 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.829 0.824 . . . . 1.4299999999999999 110.154 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.103 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.6 m -72.53 -33.6 66.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.913 -1.04 . . . . 1.4199999999999999 108.512 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.85 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 8.8 t -60.95 -48.52 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.482 -1.236 . . . . 0.67000000000000004 110.751 170.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -62.44 -17.7 60.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.095 0.776 . . . . 0.71999999999999997 113.095 -176.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.12 38.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.71 1.374 . . . . 0.93000000000000005 114.71 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 170.22 -164.72 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.194 0.998 . . . . 1.05 109.012 -173.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -107.97 92.09 8.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.85 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.76 6.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.86 3.707 . . . . 0.84999999999999998 115.318 176.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 1.126 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 109.2 -15.6 32.99 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 109.979 -1.249 . . . . 0.67000000000000004 109.979 -161.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 47.15 -91.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.984 1.314 . . . . 0.45000000000000001 114.148 171.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 t -131.02 6.74 4.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.404 0.621 . . . . 1.1100000000000001 110.282 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -144.69 147.8 19.2 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.341 -0.845 . . . . 0.39000000000000001 111.081 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -128.25 152.97 47.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.283 -1.367 . . . . 0.56000000000000005 113.093 177.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.811 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 77.7 mtt-85 -136.48 164.88 27.13 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.057 -2.201 . . . . 1.9399999999999999 105.057 158.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -155.94 163.65 39.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 119.928 1.24 . . . . 1.1399999999999999 112.502 168.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -114.79 125.5 53.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 124.48 1.112 . . . . 2.7200000000000002 113.329 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.39 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 119.935 3.309 . . . . 3.04 119.935 141.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 9.7 mt-30 . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 122.317 1.056 . . . . 4.2000000000000002 111.96 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 132.19 34.67 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.464 -1.698 . . . . 1.72 111.293 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 12.4 ptp -69.52 82.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.051 0.453 . . . . 2.3500000000000001 109.937 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HD3' ' OH ' ' A' ' 43' ' ' TYR . 18.3 ttt180 -115.95 150.3 37.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.652 0.739 . . . . 2.48 110.812 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.77 165.98 24.8 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.514 -1.221 . . . . 0.40999999999999998 115.243 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.7 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 70.5 t -99.43 146.19 9.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.856 -1.672 . . . . 0.42999999999999999 111.01 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 11.1 mtt180 -62.01 136.27 57.89 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.707 0.803 . . . . 4.1100000000000003 112.906 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -121.74 115.7 23.17 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.664 -0.495 . . . . 1.53 109.664 170.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 58' ' ' GLU . 10.3 t -130.22 114.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.535 -0.302 . . . . 0.53000000000000003 110.52 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 57' ' ' VAL . 15.3 mt-10 51.2 37.19 17.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.021 0.528 . . . . 1.51 112.289 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -2.04 66.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.681 -0.771 . . . . 0.51000000000000001 113.058 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -100.97 147.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.684 -0.304 . . . . 0.48999999999999999 111.586 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.997 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -103.8 114.56 28.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.836 -1.172 . . . . 1.0700000000000001 107.836 169.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.751 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 9.9 t-160 -114.58 136.13 53.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.889 -0.724 . . . . 1.5 112.203 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.69 162.05 39.99 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 0.82999999999999996 108.586 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.46 159.1 54.86 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 121.85 1.7 . . . . 1.29 110.504 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -47.38 -44.34 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.686 0.616 . . . . 3.1200000000000001 112.503 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.61 28.22 0.38 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.545 -0.752 . . . . 2.1400000000000001 109.813 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.14 -97.43 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.592 -0.813 . . . . 1.5600000000000001 113.267 -173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 1.016 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -107.71 -81.56 0.56 Allowed 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.748 0.308 . . . . 3.6899999999999999 110.543 -178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.1 -70.7 0.43 Allowed Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 119.604 -1.284 . . . . 1.78 114.709 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 11.4 p-10 -139.77 33.67 2.0 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.84 1.305 . . . . 1.48 109.724 -152.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -48.7 162.04 0.11 Allowed 'General case' 0 CA--C 1.477 -1.836 0 CA-C-N 112.147 -2.297 . . . . 0.90000000000000002 109.242 169.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.775 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.5 p -86.33 106.36 15.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.156 -1.383 . . . . 0.81999999999999995 107.284 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.955 ' HE1' HD12 ' A' ' 5' ' ' ILE . 19.8 m-85 -77.77 145.28 36.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.587 -0.733 . . . . 0.41999999999999998 111.258 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 3.1 t -97.0 150.68 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.85 -1.523 . . . . 0.34000000000000002 108.06 169.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.126 HG13 ' HA2' ' A' ' 37' ' ' GLY . 5.0 t -108.1 118.1 55.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.59 0.71 . . . . 1.8400000000000001 112.186 -165.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -127.64 130.22 48.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.697 -1.138 . . . . 1.8799999999999999 110.611 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 3.3 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.674 -0.679 . . . . 1.3600000000000001 110.856 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 44.6 p90 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 106.779 -1.563 . . . . 1.1699999999999999 106.779 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 14.8 pt -128.23 161.24 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 118.044 0.384 . . . . 1.0 111.557 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 10.1 ttt180 -119.83 132.17 55.5 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.165 -0.679 . . . . 2.73 109.165 171.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.516 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.6 p -137.28 140.46 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.632 -0.427 . . . . 1.45 111.596 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.757 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.8 t -152.81 171.23 18.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.542 -0.754 . . . . 0.56000000000000005 109.754 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.82 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 21.1 mt-10 -74.72 -53.92 8.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.864 0.84 . . . . 2.9700000000000002 109.091 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.49 150.4 29.96 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.304 -1.369 . . . . 1.1399999999999999 107.304 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 44' ' ' ARG . 43.4 mt-10 -63.94 -22.51 66.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.264 -1.334 . . . . 1.48 109.083 -170.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -122.3 23.57 9.72 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.448 -1.251 . . . . 2.02 111.53 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.6 t70 -74.28 -112.71 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.097 -1.075 . . . . 0.58999999999999997 108.097 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' HD13 ' A' ' 16' ' ' ILE . 33.2 tt0 -122.23 88.42 48.55 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.283 -0.871 . . . . 2.1800000000000002 109.873 165.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 91.4 Cg_endo -78.43 130.59 10.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.625 1.55 . . . . 0.57999999999999996 110.686 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.08 133.58 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.539 -0.755 . . . . 0.51000000000000001 111.841 -169.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.76 122.56 29.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.377 -0.601 . . . . 1.6200000000000001 109.377 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 37.4 pt -139.04 138.83 21.7 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.99 -0.55 . . . . 1.52 110.927 -171.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 16.2 Cg_exo -68.71 124.29 11.35 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.08 2.52 . . . . 0.67000000000000004 112.055 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -95.49 169.57 9.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 0.96999999999999997 110.533 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.0 tp10 -64.95 136.02 56.33 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.008 -0.738 . . . . 2.77 109.008 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.63 -16.97 7.16 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.239 -0.891 . . . . 2.1299999999999999 112.32 -175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -79.6 1.09 27.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.726 0.774 . . . . 2.3199999999999998 109.028 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.98 49.25 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 114.258 -1.337 . . . . 0.56000000000000005 110.587 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.19 159.46 36.77 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.32 -0.94 . . . . 0.62 110.884 -165.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.942 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.33 153.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 111.223 175.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -70.54 94.6 1.0 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.872 -0.604 . . . . 1.9399999999999999 110.749 -178.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.46 -50.32 65.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.527 -0.545 . . . . 0.96999999999999997 109.527 -173.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.718 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.6 p -61.55 -33.95 74.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.682 0.753 . . . . 1.4299999999999999 110.375 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.099 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 8.6 m -75.0 -33.14 61.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.071 -0.968 . . . . 1.4199999999999999 108.952 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.838 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 18.7 t -62.68 -47.62 92.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.227 -0.897 . . . . 0.67000000000000004 110.537 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -64.89 -16.96 63.89 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.775 0.657 . . . . 0.71999999999999997 112.775 -177.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.75 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.451 1.278 . . . . 0.93000000000000005 114.451 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 170.77 -166.53 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.484 1.114 . . . . 1.05 108.787 -172.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HD2' ' HH ' ' A' ' 77' ' ' TYR . 11.0 m-85 -109.88 92.15 12.13 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.838 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -121.27 4.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.558 3.505 . . . . 0.84999999999999998 115.017 176.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.41 30.95 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.167 -1.173 . . . . 0.67000000000000004 110.167 -161.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.68 -88.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.764 1.394 . . . . 0.45000000000000001 114.764 165.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 15.7 m -129.58 -1.54 4.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 110.966 -163.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.55 169.96 20.59 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.199 -1.16 . . . . 0.39000000000000001 110.199 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.814 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -148.43 140.28 23.82 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.332 -0.947 . . . . 0.56000000000000005 112.15 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.595 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.5 mtt180 -134.11 152.91 52.05 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 106.38 -1.711 . . . . 1.9399999999999999 106.38 159.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.797 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 50.0 p90 -153.37 164.81 37.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 120.71 1.596 . . . . 1.1399999999999999 113.483 169.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 11' ' ' GLU . 9.0 mtm180 -109.73 150.49 28.23 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.845 -1.525 . . . . 2.7200000000000002 110.201 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.02 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 t30 . . . . . 0 C--O 1.219 -0.55 0 CA-C-N 114.028 -1.442 . . . . 3.04 110.508 -166.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.02 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.1 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 115.331 1.604 . . . . 4.2000000000000002 115.331 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -60.97 126.04 25.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.339 -0.391 . . . . 1.72 110.243 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.83 92.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.928 0.871 . . . . 2.3500000000000001 110.221 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 74.1 ttt180 -105.24 149.78 25.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.869 -1.059 . . . . 2.48 112.168 -170.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -96.53 149.22 19.25 Favored Glycine 0 C--N 1.302 -1.32 0 CA-C-N 113.941 -1.481 . . . . 0.40999999999999998 114.502 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.814 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 76.0 t -98.78 143.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.514 -1.343 . . . . 0.42999999999999999 110.327 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.665 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -65.85 135.49 54.9 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 112.514 0.561 . . . . 4.1100000000000003 112.514 -170.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.05 111.22 22.16 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.192 -0.67 . . . . 1.53 109.192 169.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 58' ' ' GLU . 19.3 t -129.44 118.03 44.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.153 -0.476 . . . . 0.53000000000000003 110.699 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.944 ' HG2' HG12 ' A' ' 57' ' ' VAL . 3.9 mm-40 52.69 35.53 18.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.375 0.509 . . . . 1.51 112.375 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' C ' HD23 ' A' ' 28' ' ' LEU . . . 92.79 -0.87 70.55 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.588 -0.815 . . . . 0.51000000000000001 113.048 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -104.08 149.35 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.796 0.332 . . . . 0.48999999999999999 111.706 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.942 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.51 116.5 32.73 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.92 -1.511 . . . . 1.0700000000000001 106.92 166.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -115.09 133.59 55.9 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.598 0.713 . . . . 1.5 112.166 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 164.25 31.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 113.895 -1.502 . . . . 0.82999999999999996 110.46 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.84 168.01 9.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.551 2.834 . . . . 1.29 110.688 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -41.99 -42.99 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.436 0.902 . . . . 3.1200000000000001 113.436 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.91 -23.63 4.6 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.171 0.434 . . . . 2.1400000000000001 112.171 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 136.9 8.44 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 118.98 -1.581 . . . . 1.5600000000000001 114.054 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.434 ' CD2' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -81.37 -89.55 0.07 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.238 0.615 . . . . 3.6899999999999999 111.373 170.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.9 48.0 0.12 Allowed Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.671 -0.776 . . . . 1.78 113.918 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.851 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 87.04 -45.18 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 114.361 -0.92 . . . . 1.48 110.28 156.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.806 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 47.07 173.2 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.964 1.364 . . . . 0.90000000000000002 113.784 174.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -103.02 105.05 17.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 113.422 -1.717 . . . . 0.81999999999999995 109.145 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.797 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.0 m-85 -80.59 145.84 31.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.094 0.95 . . . . 0.41999999999999998 112.858 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -109.16 159.18 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 112.889 -1.959 . . . . 0.34000000000000002 110.151 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.82 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 p -87.93 103.78 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 1.8400000000000001 112.145 -165.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -129.03 127.2 41.1 Favored 'General case' 0 C--O 1.208 -1.08 0 C-N-CA 120.111 -0.636 . . . . 1.8799999999999999 109.423 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.489 -0.767 . . . . 1.3600000000000001 110.322 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.78 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 35.7 p90 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.813 -0.81 . . . . 1.1699999999999999 108.813 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.958 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -124.36 159.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 121.188 -0.205 . . . . 1.0 111.01 -178.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.79 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 2.9 ttt180 -120.52 134.35 55.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.756 -0.461 . . . . 2.73 109.756 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.688 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.4 p -138.16 148.5 24.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 O-C-N 121.786 -0.571 . . . . 1.45 111.57 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.5 t -152.57 171.21 18.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.494 -0.321 . . . . 0.56000000000000005 110.918 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 1.035 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.4 tm-20 -83.33 -33.02 25.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.807 0.813 . . . . 2.9700000000000002 110.036 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -132.18 150.0 52.26 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.15 -1.426 . . . . 1.1399999999999999 107.15 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' HH21 ' A' ' 44' ' ' ARG . 7.4 mm-40 -55.62 -25.3 38.05 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.981 0.801 . . . . 1.48 109.529 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -130.52 38.01 3.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.816 -1.084 . . . . 2.02 111.898 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 8.4 t70 -77.02 -111.6 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.69 -1.596 . . . . 0.58999999999999997 106.69 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -123.36 89.61 50.95 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.026 -0.988 . . . . 2.1800000000000002 109.944 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.857 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 55.5 Cg_endo -69.18 133.1 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.231 1.287 . . . . 0.57999999999999996 110.05 173.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.41 128.26 69.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.605 -0.725 . . . . 0.51000000000000001 111.138 -169.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.78 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.6 mp0 -84.13 121.73 27.85 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.715 -0.675 . . . . 1.6200000000000001 109.628 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 32.1 pt -140.64 143.61 33.11 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.496 -0.775 . . . . 1.52 111.537 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 2.9 Cg_exo -76.35 131.4 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.319 2.679 . . . . 0.67000000000000004 112.415 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 5' ' ' ILE . 7.2 p -103.59 171.35 7.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.768 -0.651 . . . . 0.96999999999999997 109.799 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.26 142.57 58.23 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.444 -0.576 . . . . 2.77 109.444 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.76 -28.86 24.2 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.952 1.407 . . . . 2.1299999999999999 112.347 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 6.3 p-10 -84.54 1.28 46.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.141 0.972 . . . . 2.3199999999999998 108.8 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 24.31 23.05 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 113.867 -1.515 . . . . 0.56000000000000005 110.234 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.48 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.35 151.81 38.74 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.827 -1.187 . . . . 0.62 111.622 -165.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.834 HG23 ' HB3' ' A' ' 61' ' ' LEU . 1.0 OUTLIER -147.31 148.7 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.667 -0.697 . . . . 0.46999999999999997 109.955 170.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.012 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -64.87 102.75 0.63 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.15 0.5 . . . . 1.9399999999999999 110.128 175.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -63.65 -50.63 68.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.45 -0.574 . . . . 0.96999999999999997 109.45 -172.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.69 ' HA ' HG23 ' A' ' 32' ' ' THR . 17.9 p -68.87 -37.34 79.01 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.614 0.721 . . . . 1.4299999999999999 110.201 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.5 m -70.88 -32.97 70.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 108.73 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.858 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.7 t -62.14 -44.77 99.46 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-N 114.821 -1.081 . . . . 0.67000000000000004 110.47 170.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -63.4 -19.24 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.71 0.633 . . . . 0.71999999999999997 112.71 -176.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.33 40.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.869 1.433 . . . . 0.93000000000000005 114.869 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 169.91 -164.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.503 0.721 . . . . 1.05 109.437 -171.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -109.08 91.46 9.37 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.216 -0.661 . . . . 1.5 109.216 166.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.78 1.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.387 3.391 . . . . 0.84999999999999998 115.116 175.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CG2' ' A' ' 75' ' ' VAL . . . 107.69 -10.95 38.57 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 110.065 -1.214 . . . . 0.67000000000000004 110.065 -161.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 51.09 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.603 1.561 . . . . 0.45000000000000001 114.521 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -133.97 -36.41 0.93 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.733 0.778 . . . . 1.1100000000000001 110.439 -161.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 76' ' ' ASN . . . -97.76 155.21 20.42 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-N 114.742 -1.117 . . . . 0.39000000000000001 110.399 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.718 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -132.69 150.54 52.15 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.666 -1.214 . . . . 0.56000000000000005 112.858 178.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB2' ' A' ' 51' ' ' MET . 50.9 mtt180 -136.95 149.6 47.66 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.939 -1.875 . . . . 1.9399999999999999 105.939 162.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.79 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 41.6 p90 -154.93 158.13 38.8 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 120.165 1.348 . . . . 1.1399999999999999 112.635 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HG2' ' HB2' ' A' ' 45' ' ' ASN . 10.2 ttp180 -114.44 132.97 56.07 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 113.687 0.995 . . . . 2.7200000000000002 113.687 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.279 18.5 t30 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 117.926 2.565 . . . . 3.04 117.926 144.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 10.6 tt0 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.55 0.69 . . . . 4.2000000000000002 112.348 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -105.98 136.11 46.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 1.72 109.46 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.73 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 22.4 ptt? -62.61 85.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.793 0.806 . . . . 2.3500000000000001 111.125 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 57.0 ttt180 -100.54 150.29 22.83 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.494 -0.776 . . . . 2.48 110.954 -176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -90.45 160.83 28.27 Favored Glycine 0 C--N 1.293 -1.81 0 CA-C-N 115.019 -0.991 . . . . 0.40999999999999998 114.796 175.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.718 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 69.2 t -99.2 142.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.417 -1.392 . . . . 0.42999999999999999 109.804 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.731 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 1.2 mpt_? -66.89 133.73 50.62 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.052 0.39 . . . . 4.1100000000000003 112.052 -168.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.655 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.99 115.15 28.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.26 0.552 . . . . 1.53 109.64 172.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.623 HG12 ' HG3' ' A' ' 58' ' ' GLU . 3.6 t -133.81 118.93 31.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-N 116.222 -0.445 . . . . 0.53000000000000003 109.972 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 57' ' ' VAL . 29.2 mt-10 56.43 36.11 27.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.82 0.343 . . . . 1.51 111.643 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.31 0.41 89.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.493 -0.861 . . . . 0.51000000000000001 112.828 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 mt -97.08 147.43 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 O-C-N 122.617 -0.343 . . . . 0.48999999999999999 111.465 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.834 ' HB3' HG23 ' A' ' 26' ' ' VAL . 12.7 tp -104.03 115.76 31.02 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.55 -1.278 . . . . 1.0700000000000001 107.55 167.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -116.42 133.55 55.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.232 -0.587 . . . . 1.5 111.48 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.66 162.31 36.58 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.282 -1.007 . . . . 0.82999999999999996 108.282 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.79 160.05 42.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 121.87 1.714 . . . . 1.29 110.921 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.5 -44.25 17.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.693 0.621 . . . . 3.1200000000000001 111.89 -171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.89 32.47 0.1 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.082 -0.963 . . . . 2.1400000000000001 108.854 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -88.68 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.919 -1.037 . . . . 1.5600000000000001 113.935 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.855 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -103.89 -77.86 0.57 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.137 -0.69 . . . . 3.6899999999999999 109.137 -172.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.02 -78.37 0.13 Allowed Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.846 -1.169 . . . . 1.78 113.462 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.958 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 3.2 p-10 -127.92 -56.95 1.26 Allowed 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 114.957 -0.622 . . . . 1.48 109.444 -169.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER 56.45 167.34 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 124.694 1.247 . . . . 0.90000000000000002 110.465 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 72' ' ' VAL . 1.9 p -95.07 104.39 15.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.858 -1.137 . . . . 0.81999999999999995 108.562 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.79 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.2 m-85 -80.2 145.06 32.46 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.885 0.85 . . . . 0.41999999999999998 111.845 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.3 t -108.76 154.52 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 113.519 -1.673 . . . . 0.34000000000000002 109.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.035 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -85.61 120.13 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.163 0.506 . . . . 1.8400000000000001 110.16 -167.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.579 ' HB3' ' C ' ' A' ' 40' ' ' GLY . 56.2 t30 -131.5 128.24 38.97 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.775 -0.578 . . . . 1.8799999999999999 111.01 172.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 118.999 -0.524 . . . . 1.3600000000000001 110.648 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 15.5 p90 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 108.668 -0.864 . . . . 1.1699999999999999 108.668 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 20.9 pt -116.47 163.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.646 0.26 . . . . 1.0 111.592 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.657 HH11 ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.31 131.48 56.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.853 -0.795 . . . . 2.73 108.853 179.298 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.34 146.35 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.98 -1.075 . . . . 1.45 111.365 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.891 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 t -152.25 168.56 24.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.674 -0.239 . . . . 0.56000000000000005 110.413 166.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.657 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 1.7 mp0 -77.42 -33.92 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.9700000000000002 111.247 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.23 152.56 51.94 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.569 -1.271 . . . . 1.1399999999999999 107.569 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 4.2 mt-10 -55.29 -39.62 70.08 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 122.555 1.169 . . . . 1.48 107.966 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -106.85 25.91 10.72 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.873 -1.967 . . . . 2.02 113.057 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -81.83 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.891 -1.151 . . . . 0.58999999999999997 107.891 170.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.96 91.05 50.07 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 115.754 -0.657 . . . . 2.1800000000000002 110.624 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.891 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 58.5 Cg_endo -70.7 134.65 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.551 1.501 . . . . 0.57999999999999996 110.379 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.29 153.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.364 -0.835 . . . . 0.51000000000000001 110.864 -169.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.775 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.8 mp0 -108.5 122.48 47.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.2 -0.454 . . . . 1.6200000000000001 110.849 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.63 138.67 17.54 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.902 -0.59 . . . . 1.52 112.006 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.04 148.34 21.71 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.957 2.438 . . . . 0.67000000000000004 112.231 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.9 m -122.6 169.24 11.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 0.96999999999999997 111.281 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -66.49 150.71 48.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.485 0.66 . . . . 2.77 111.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -52.38 -28.39 19.43 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.438 -1.71 . . . . 2.1299999999999999 111.903 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 33.6 t70 -77.74 -7.21 56.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.379 1.085 . . . . 2.3199999999999998 108.79 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.81 25.98 36.44 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 108.357 -1.897 . . . . 0.56000000000000005 108.357 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.18 151.08 39.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.874 -1.663 . . . . 0.62 112.179 -160.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 147.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.393 -0.821 . . . . 0.46999999999999997 110.519 173.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.077 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -65.19 96.51 0.22 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.258 0.623 . . . . 1.9399999999999999 110.247 178.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.63 -49.57 70.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.563 -0.289 . . . . 0.96999999999999997 110.254 -168.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.5 p -70.2 -34.35 72.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.002 0.906 . . . . 1.4299999999999999 109.895 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.077 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 15.8 m -70.81 -32.78 69.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.742 -1.117 . . . . 1.4199999999999999 108.085 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.877 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.5 t -65.12 -42.15 93.63 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 CA-C-N 114.11 -1.404 . . . . 0.67000000000000004 110.846 171.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -64.4 -20.32 66.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.855 -0.528 . . . . 0.71999999999999997 111.95 -175.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.826 1.417 . . . . 0.93000000000000005 114.826 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.15 -163.3 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 123.211 0.604 . . . . 1.05 109.988 -173.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -106.96 92.59 7.8 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.719 -0.845 . . . . 1.5 108.719 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.877 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -122.34 2.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.201 3.267 . . . . 0.84999999999999998 114.867 173.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . 106.92 -16.15 39.78 Favored Glycine 0 C--O 1.217 -0.923 0 N-CA-C 109.917 -1.273 . . . . 0.67000000000000004 109.917 -162.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 52.75 -92.12 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.907 1.283 . . . . 0.45000000000000001 113.542 172.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.9 m -122.69 4.16 9.52 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.672 0.749 . . . . 1.1100000000000001 110.243 -166.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.65 174.65 21.47 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 110.085 -1.206 . . . . 0.39000000000000001 110.085 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -153.19 143.71 22.58 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 120.128 -0.629 . . . . 0.56000000000000005 110.692 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.554 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.4 mtt180 -134.64 150.84 50.7 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 105.739 -1.949 . . . . 1.9399999999999999 105.739 160.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.69 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 45.9 p90 -152.54 165.23 35.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 121.181 1.809 . . . . 1.1399999999999999 113.125 170.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 11' ' ' GLU . 35.1 mtp85 -106.91 134.34 50.22 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.159 -1.837 . . . . 2.7200000000000002 108.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.141 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 56.8 t30 . . . . . 0 C--O 1.219 -0.544 0 CA-C-N 114.575 -1.193 . . . . 3.04 111.136 -164.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.141 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 5.0 tt0 . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 114.936 1.458 . . . . 4.2000000000000002 114.936 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -60.97 130.03 44.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.992 -0.373 . . . . 1.72 109.992 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -64.85 87.58 0.06 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.357 0.598 . . . . 2.3500000000000001 109.804 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 21.0 ttt180 -101.21 147.63 26.04 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.684 0.754 . . . . 2.48 112.288 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -93.7 154.61 21.74 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 113.715 -1.584 . . . . 0.40999999999999998 114.279 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 46.4 t -100.04 143.7 13.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 113.746 -1.227 . . . . 0.42999999999999999 111.525 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -62.52 138.04 58.39 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 124.477 1.111 . . . . 4.1100000000000003 113.517 -175.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.4 pp -115.74 124.22 50.26 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.041 -0.264 . . . . 1.53 110.405 169.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.609 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.3 t -134.94 122.95 39.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.125 0 CA-C-O 118.846 -0.597 . . . . 0.53000000000000003 109.609 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HG3' HG12 ' A' ' 57' ' ' VAL . 35.1 mt-10 56.88 36.46 27.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.651 0.659 . . . . 1.51 112.093 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.29 8.69 87.03 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.549 -0.834 . . . . 0.51000000000000001 112.408 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 57' ' ' VAL . 5.8 mt -104.04 149.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 122.351 0.26 . . . . 0.48999999999999999 110.785 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.08 116.02 31.78 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.974 -1.121 . . . . 1.0700000000000001 107.974 170.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.16 122.56 46.16 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.106 0.479 . . . . 1.5 111.734 -175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.01 163.6 22.41 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.82999999999999996 110.381 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.17 166.55 12.5 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.112 2.541 . . . . 1.29 111.875 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.78 -45.65 4.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.233 0.827 . . . . 3.1200000000000001 113.233 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.99 -29.96 7.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 2.1400000000000001 110.935 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.79 128.64 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 122.04 0.8 . . . . 1.5600000000000001 113.375 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.535 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 m95 -84.2 -42.66 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.391 1.091 . . . . 3.6899999999999999 108.877 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.79 -79.82 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 113.359 -1.746 . . . . 1.78 111.446 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.69 -59.07 0.48 Allowed 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 114.423 -0.888 . . . . 1.48 109.36 -172.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER 58.08 151.25 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.799 1.312 . . . . 0.90000000000000002 110.425 -177.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.6 p -91.33 106.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.395 -0.82 . . . . 0.81999999999999995 108.806 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.69 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.1 m-85 -78.63 144.16 35.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.141 -0.936 . . . . 0.41999999999999998 112.012 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.7 t -109.19 159.88 8.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.179 -1.828 . . . . 0.34000000000000002 109.625 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.657 ' HB ' ' O ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -91.95 113.09 26.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.76 0.791 . . . . 1.8400000000000001 111.257 -169.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -130.54 126.34 36.53 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.075 -0.966 . . . . 1.8799999999999999 108.922 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 118.23 -0.89 . . . . 1.3600000000000001 110.4 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 23.4 p90 . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 107.985 -1.117 . . . . 1.1699999999999999 107.985 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.021 ' HA ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -135.23 162.33 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.222 0.465 . . . . 1.0 111.473 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 1.077 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -117.98 132.67 56.37 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 119.715 -0.794 . . . . 2.73 109.889 -176.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 3.3 p -138.85 148.44 24.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.941 -0.474 . . . . 1.45 111.405 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.985 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -153.98 164.01 39.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.353 -0.385 . . . . 0.56000000000000005 109.99 165.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.4 mp0 -67.94 -32.95 73.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 2.9700000000000002 111.504 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' THR . 14.2 t70 -132.48 149.44 52.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.613 -1.625 . . . . 1.1399999999999999 106.613 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 3.0 mt-10 -54.44 -34.22 61.03 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 122.01 0.91 . . . . 1.48 108.653 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -110.19 28.65 8.42 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.502 -1.681 . . . . 2.02 111.867 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.668 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.3 t70 -83.7 -117.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.895 -0.78 . . . . 0.58999999999999997 108.895 171.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -121.4 89.61 47.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.555 -0.748 . . . . 2.1800000000000002 110.429 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.985 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 74.4 Cg_endo -75.06 140.56 25.42 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 C-N-CA 123.107 2.538 . . . . 0.57999999999999996 113.506 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.09 125.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 115.448 -0.796 . . . . 0.51000000000000001 110.509 -175.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.077 ' HG2' ' HG3' ' A' ' 6' ' ' ARG . 25.0 mt-10 -86.12 120.6 27.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.223 -0.658 . . . . 1.6200000000000001 109.223 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 19.7 pt -142.03 144.41 31.89 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.303 -0.862 . . . . 1.52 111.454 -168.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 72.2 Cg_endo -74.64 145.29 32.74 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.867 2.378 . . . . 0.67000000000000004 113.34 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.503 ' OG ' HD12 ' A' ' 5' ' ' ILE . 8.5 m -104.42 170.26 8.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 110.232 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.01 141.12 54.97 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.987 -0.746 . . . . 2.77 108.987 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.66 -19.14 5.52 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.354 1.034 . . . . 2.1299999999999999 112.689 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' A' ' 25' ' ' THR . 7.4 m-20 -75.95 -5.17 44.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.124 0.964 . . . . 2.3199999999999998 108.775 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.21 23.99 60.13 Favored Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 108.74 -1.744 . . . . 0.56000000000000005 108.74 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -122.38 154.03 38.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.1 -1.55 . . . . 0.62 111.238 -162.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -146.68 143.12 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.526 -0.761 . . . . 0.46999999999999997 109.741 172.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 3.5 mp -68.53 116.92 9.62 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.786 -0.45 . . . . 1.9399999999999999 109.786 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD13 HD21 ' A' ' 61' ' ' LEU . 15.6 tp -60.02 -51.36 69.96 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.206 0.316 . . . . 0.96999999999999997 110.697 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.706 ' HA ' HG23 ' A' ' 32' ' ' THR . 7.9 m -71.78 -44.86 63.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.428 -0.805 . . . . 1.4299999999999999 110.859 -174.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 2.7 m -63.67 -32.19 73.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.955 -0.566 . . . . 1.4199999999999999 109.721 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.848 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -59.43 -48.47 87.07 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.908 -0.587 . . . . 0.67000000000000004 110.262 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.11 -17.76 63.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.043 0.757 . . . . 0.71999999999999997 113.043 -176.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.63 37.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.542 1.312 . . . . 0.93000000000000005 114.542 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 171.48 -165.71 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.967 0.907 . . . . 1.05 108.993 -173.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -109.31 92.79 12.06 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 109.233 -0.654 . . . . 1.5 109.233 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.848 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.92 8.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.52 3.48 . . . . 0.84999999999999998 113.928 173.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.929 ' HA2' ' HB ' ' A' ' 75' ' ' VAL . . . 107.83 -26.7 16.79 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 110.078 -1.209 . . . . 0.67000000000000004 110.078 -162.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.72 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 61.1 -81.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.987 1.106 . . . . 0.45000000000000001 113.987 167.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 28' ' ' LEU . 36.5 t -120.28 -12.9 8.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.524 0.678 . . . . 1.1100000000000001 109.443 -165.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.65 157.51 24.15 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.897 -1.047 . . . . 0.39000000000000001 112.344 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -127.94 153.01 47.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.174 -0.61 . . . . 0.56000000000000005 111.502 174.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 95.1 mtt180 -138.52 146.52 42.06 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 106.743 -1.577 . . . . 1.9399999999999999 106.743 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.841 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 47.4 p90 -154.67 166.92 31.89 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 117.903 -1.519 . . . . 1.1399999999999999 113.946 169.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.64 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 73.8 ttt180 -102.32 137.69 40.23 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 113.857 -1.519 . . . . 2.7200000000000002 107.853 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.853 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.4 t-20 . . . . . 0 C--O 1.211 -0.927 0 N-CA-C 113.219 0.822 . . . . 3.04 113.219 -158.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.853 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 5.9 mt-30 . . . . . 0 CA--C 1.515 -0.369 0 N-CA-C 113.426 0.898 . . . . 4.2000000000000002 113.426 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -57.33 133.96 55.58 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.124 -0.944 . . . . 1.72 109.973 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -63.42 88.22 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.672 0.748 . . . . 2.3500000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -102.41 145.03 30.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.382 -0.826 . . . . 2.48 111.623 -173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 167.28 21.28 Favored Glycine 0 C--N 1.299 -1.512 0 CA-C-N 114.092 -1.413 . . . . 0.40999999999999998 114.216 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 55.9 t -97.43 140.16 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.036 -1.082 . . . . 0.42999999999999999 111.058 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.0 mpt_? -67.33 135.86 53.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.58 -0.736 . . . . 4.1100000000000003 112.402 -174.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.788 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -108.11 120.51 42.53 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.935 -0.706 . . . . 1.53 110.563 171.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.749 HG12 ' HG3' ' A' ' 58' ' ' GLU . 32.5 t -130.16 115.81 34.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 115.686 -0.688 . . . . 0.53000000000000003 109.774 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.749 ' HG3' HG12 ' A' ' 57' ' ' VAL . 16.4 mt-10 52.59 35.42 17.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.766 0.317 . . . . 1.51 111.504 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.87 4.65 75.11 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.835 -0.698 . . . . 0.51000000000000001 113.066 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.788 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 5.1 mt -100.64 148.98 6.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 O-C-N 122.586 -0.361 . . . . 0.48999999999999999 111.496 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.852 ' HB2' HG23 ' A' ' 26' ' ' VAL . 56.2 mt -101.36 118.17 36.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.253 -1.017 . . . . 1.0700000000000001 108.253 167.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 128.96 55.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.331 -0.547 . . . . 1.5 111.832 -174.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 161.35 57.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.83 -1.544 . . . . 0.82999999999999996 106.83 161.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 12.7 Cg_exo -69.19 146.69 64.54 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.624 1.549 . . . . 1.29 111.145 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -45.78 17.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.804 0.811 . . . . 3.1200000000000001 111.629 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.79 24.26 5.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.38 -1.282 . . . . 2.1400000000000001 109.356 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 64' ' ' PRO . . . -77.3 -119.48 0.19 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.707 -0.759 . . . . 1.5600000000000001 112.715 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.821 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.49 -172.94 2.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.454 -0.573 . . . . 3.6899999999999999 109.454 -175.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -175.13 86.47 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.861 -1.162 . . . . 1.78 112.042 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.021 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 3.5 t30 102.19 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 124.808 2.242 . . . . 1.48 108.946 171.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -86.72 -177.48 6.13 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 109.517 -3.492 . . . . 0.90000000000000002 106.396 167.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -99.28 101.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 124.546 1.154 . . . . 0.81999999999999995 108.697 176.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 19.5 m-85 -84.2 141.27 31.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.704 1.002 . . . . 0.41999999999999998 113.704 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.8 t -109.2 163.91 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 112.564 -2.107 . . . . 0.34000000000000002 107.593 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.929 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 21.5 m -118.9 127.74 75.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.59 -0.694 . . . . 1.8400000000000001 111.407 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.91 128.35 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.751 -0.78 . . . . 1.8799999999999999 110.341 169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.717 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.047 -0.977 . . . . 1.3600000000000001 110.306 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 70' ' ' ASN . 38.8 p90 . . . . . 0 N--CA 1.441 -0.882 0 N-CA-C 108.591 -0.892 . . . . 1.1699999999999999 108.591 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.849 HD12 ' HE1' ' A' ' 73' ' ' TYR . 15.0 pt -127.52 165.78 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 122.611 0.365 . . . . 1.0 110.792 -170.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.611 ' NH1' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -114.46 132.76 56.16 Favored 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 108.952 -0.758 . . . . 2.73 108.952 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 HG22 ' HD1' ' A' ' 73' ' ' TYR . 2.3 t -135.89 143.5 36.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 O-C-N 121.113 -0.992 . . . . 1.45 110.296 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.966 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 t -153.55 167.41 29.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.039 -0.356 . . . . 0.56000000000000005 110.039 162.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.927 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -72.48 -54.18 10.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.023 0.916 . . . . 2.9700000000000002 109.2 173.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 13.1 t70 -112.63 148.13 35.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.639 -1.245 . . . . 1.1399999999999999 107.639 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 74' ' ' VAL . 3.8 mt-10 -58.55 -26.38 63.5 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.869 -1.06 . . . . 1.48 108.414 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -119.8 29.19 7.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.636 -1.62 . . . . 2.02 111.158 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.483 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -84.31 -117.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.07 -1.085 . . . . 0.58999999999999997 108.07 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 31.0 mt-10 -121.52 90.87 48.19 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.136 -0.938 . . . . 2.1800000000000002 110.218 168.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.966 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.8 Cg_endo -72.47 134.21 22.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.649 1.566 . . . . 0.57999999999999996 110.82 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.526 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -129.72 144.2 38.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.269 -0.878 . . . . 0.51000000000000001 110.983 -168.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 16.9 mt-10 -90.76 122.12 33.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.768 -0.456 . . . . 1.6200000000000001 109.768 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.75 HD12 ' HD2' ' A' ' 19' ' ' PRO . 7.1 tp -140.85 131.73 13.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.469 -0.787 . . . . 1.52 111.175 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.75 ' HD2' HD12 ' A' ' 18' ' ' ILE . 55.4 Cg_endo -71.88 137.71 30.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.652 2.235 . . . . 0.67000000000000004 112.764 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.0 p -106.32 170.46 7.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.96999999999999997 110.297 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -65.46 140.83 58.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.963 -0.384 . . . . 2.77 109.963 178.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 24' ' ' GLY . 3.5 m-20 -54.99 -19.91 7.9 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.617 -1.174 . . . . 2.1299999999999999 111.987 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.78 0.92 13.79 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.866 0.841 . . . . 2.3199999999999998 108.8 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.09 24.64 73.19 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.687 -1.365 . . . . 0.56000000000000005 109.687 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -134.74 166.15 23.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.143 -1.028 . . . . 0.62 109.963 -168.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -146.18 148.21 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.415 -0.357 . . . . 0.46999999999999997 110.384 175.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -65.56 94.55 0.19 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.148 -0.478 . . . . 1.9399999999999999 109.861 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.61 -49.08 74.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.664 -0.495 . . . . 0.96999999999999997 109.664 -168.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.558 ' N ' ' HG ' ' A' ' 28' ' ' LEU . 5.4 p -65.5 -35.6 81.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.5 0.667 . . . . 1.4299999999999999 110.349 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.044 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 3.4 m -72.35 -33.72 67.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.316 -0.856 . . . . 1.4199999999999999 108.7 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.88 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 45.7 t -63.72 -39.71 86.37 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 115.159 -0.928 . . . . 0.67000000000000004 110.383 170.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.6 p -64.87 -20.15 66.27 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 112.142 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 41.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.56 1.319 . . . . 0.93000000000000005 114.56 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.08 -163.88 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.258 0.623 . . . . 1.05 110.021 -173.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.7 92.83 7.77 Favored Pre-proline 0 N--CA 1.436 -1.132 0 N-CA-C 108.649 -0.871 . . . . 1.5 108.649 165.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.88 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -122.25 3.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.639 2.892 . . . . 0.84999999999999998 114.561 171.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.826 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 106.99 -23.77 26.73 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 109.806 -1.317 . . . . 0.67000000000000004 109.806 -161.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.82 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.49 -89.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.031 1.333 . . . . 0.45000000000000001 114.106 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 32.1 t -125.4 -13.34 6.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.45 0.643 . . . . 1.1100000000000001 110.846 -161.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.23 15.79 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 109.633 -1.387 . . . . 0.39000000000000001 109.633 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -133.05 139.75 47.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.963 -1.095 . . . . 0.56000000000000005 111.871 175.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 67.6 mtt180 -132.69 154.2 50.39 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 106.313 -1.736 . . . . 1.9399999999999999 106.313 162.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.1 p90 -154.69 165.47 36.44 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 120.121 1.328 . . . . 1.1399999999999999 113.234 170.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.77 ' HB2' HG13 ' A' ' 72' ' ' VAL . 97.1 mtt180 -97.28 133.31 42.07 Favored 'General case' 0 C--O 1.253 1.268 0 O-C-N 125.684 1.865 . . . . 2.7200000000000002 109.142 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.117 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 2.8 t-20 . . . . . 0 C--O 1.22 -0.483 0 CA-C-N 114.081 -1.418 . . . . 3.04 110.848 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.117 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.5 tt0 . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 115.132 1.53 . . . . 4.2000000000000002 115.132 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -62.07 121.17 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.244 -0.889 . . . . 1.72 109.017 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 59.3 mtm -68.44 77.82 0.27 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.65 -0.87 . . . . 2.3500000000000001 108.65 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 14.0 ttt180 -103.88 156.78 17.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.469 -0.787 . . . . 2.48 111.54 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.589 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -98.16 158.21 20.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.496 -1.229 . . . . 0.40999999999999998 114.766 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.635 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 87.9 t -98.86 143.93 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.325 -1.437 . . . . 0.42999999999999999 109.854 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' A' ' 64' ' ' PRO . 82.0 mtt180 -64.48 135.25 55.87 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 111.56 0.207 . . . . 4.1100000000000003 111.56 -171.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -113.7 114.98 27.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.873 0.368 . . . . 1.53 110.031 170.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 60' ' ' ILE . 4.6 t -128.32 115.09 36.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.472 -0.331 . . . . 0.53000000000000003 110.296 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.634 ' HG3' HG12 ' A' ' 57' ' ' VAL . 23.0 mt-10 53.44 36.55 23.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.999 0.52 . . . . 1.51 112.383 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.1 0.91 73.39 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.402 -0.904 . . . . 0.51000000000000001 112.689 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 57' ' ' VAL . 1.9 mt -104.34 148.04 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 122.681 -0.305 . . . . 0.48999999999999999 111.163 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.952 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -102.39 114.95 29.58 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.797 -1.186 . . . . 1.0700000000000001 107.797 169.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -115.66 142.2 47.06 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.2 0.524 . . . . 1.5 111.891 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.28 160.85 29.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.091 -0.958 . . . . 0.82999999999999996 110.301 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 24.2 Cg_exo -64.16 166.06 17.8 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.912 3.075 . . . . 1.29 112.602 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.01 -46.57 5.56 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.908 0.861 . . . . 3.1200000000000001 112.804 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.18 -44.25 8.44 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.987 -1.46 . . . . 2.1400000000000001 110.043 -175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.2 133.64 0.48 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.369 -0.832 . . . . 1.5600000000000001 112.427 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.624 ' CG ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.52 -77.39 0.07 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.091 -0.555 . . . . 3.6899999999999999 109.787 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 176.24 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.663 -0.698 . . . . 1.78 112.101 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 4.9 p-10 -156.38 54.84 0.56 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.199 1.0 . . . . 1.48 109.697 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.624 HD11 ' CG ' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -52.92 162.51 0.61 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-N 113.465 -1.698 . . . . 0.90000000000000002 110.028 165.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.77 HG13 ' HB2' ' A' ' 44' ' ' ARG . 1.6 p -96.42 107.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 114.297 -1.319 . . . . 0.81999999999999995 108.656 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.849 ' HE1' HD12 ' A' ' 5' ' ' ILE . 17.1 m-85 -80.03 146.95 31.7 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.121 -0.945 . . . . 0.41999999999999998 112.638 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -110.28 158.8 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 113.386 -1.734 . . . . 0.34000000000000002 110.039 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.927 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 6.4 p -97.61 109.06 22.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.594 0.711 . . . . 1.8400000000000001 112.422 -165.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.453 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 0.9 OUTLIER -130.62 128.51 41.14 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 120.144 -0.623 . . . . 1.8799999999999999 111.399 165.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.764 0 CA-C-O 119.129 -0.462 . . . . 1.3600000000000001 110.652 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.517 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 20.5 p90 . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 107.613 -1.254 . . . . 1.1699999999999999 107.613 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 21.7 pt -121.45 162.38 20.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 120.645 0.26 . . . . 1.0 110.589 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.892 ' HG3' ' HA ' ' A' ' 72' ' ' VAL . 1.4 tpp85 -118.81 131.96 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.0 -1.111 . . . . 2.73 108.0 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.409 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.5 p -139.85 146.95 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 O-C-N 121.218 -0.926 . . . . 1.45 110.763 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 1.044 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -152.26 148.87 28.07 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.666 -0.243 . . . . 0.56000000000000005 110.408 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 1.07 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 47.9 mp0 -60.8 -36.21 78.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.145 0.498 . . . . 2.9700000000000002 111.593 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -128.35 153.41 47.06 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.972 -1.492 . . . . 1.1399999999999999 106.972 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.24 -30.67 64.82 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.718 0.771 . . . . 1.48 108.927 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -119.76 31.66 6.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.366 -1.288 . . . . 2.02 110.972 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 3.8 t70 -79.98 -118.26 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.26 -1.385 . . . . 0.58999999999999997 107.26 168.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 21.9 tt0 -120.45 91.88 47.04 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.72 -0.673 . . . . 2.1800000000000002 110.01 168.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.044 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 64.1 Cg_endo -71.56 133.45 22.34 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.201 1.934 . . . . 0.57999999999999996 111.555 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.52 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.44 -0.8 . . . . 0.51000000000000001 110.885 -170.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 26.6 mt-10 -97.77 121.98 40.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.053 -0.522 . . . . 1.6200000000000001 110.123 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 41.4 pt -141.28 143.36 30.21 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.843 -0.617 . . . . 1.52 111.295 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 8.2 Cg_exo -72.6 160.15 47.18 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.184 2.589 . . . . 0.67000000000000004 112.422 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.4 m -132.37 171.67 13.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 110.001 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' THR . 28.8 tt0 -64.03 142.09 58.54 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.262 -0.644 . . . . 2.77 109.262 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.21 -24.21 17.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 124.503 1.127 . . . . 2.1299999999999999 111.951 -168.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 16.0 t70 -74.38 -8.64 56.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.34 1.067 . . . . 2.3199999999999998 108.905 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.26 41.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.741 -1.744 . . . . 0.56000000000000005 108.741 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -120.62 154.89 34.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.052 -1.574 . . . . 0.62 111.518 -165.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -147.61 140.01 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.161 -0.927 . . . . 0.46999999999999997 109.138 169.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.8 mp -64.43 111.86 2.85 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.927 -0.768 . . . . 1.9399999999999999 108.927 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' THR . 30.0 tp -58.14 -51.71 68.58 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 120.756 0.313 . . . . 0.96999999999999997 110.193 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -67.18 -47.5 70.76 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.564 -0.744 . . . . 1.4299999999999999 110.626 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.632 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.0 m -65.55 -32.65 74.36 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 115.563 -0.744 . . . . 1.4199999999999999 109.81 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.872 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -61.48 -45.12 99.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 115.907 -0.588 . . . . 0.67000000000000004 110.478 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.5 p -64.36 -19.21 65.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.207 0.447 . . . . 0.71999999999999997 112.207 -176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.1 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.364 1.246 . . . . 0.93000000000000005 114.364 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 171.22 -164.35 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 123.406 0.682 . . . . 1.05 109.835 -173.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -107.79 92.81 9.42 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.55 -0.75 . . . . 1.5 109.214 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.872 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -120.32 6.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.322 3.348 . . . . 0.84999999999999998 113.924 171.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 1.068 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 107.47 -25.54 21.14 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.097 -1.201 . . . . 0.67000000000000004 110.097 -161.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 56.61 -91.81 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.029 1.332 . . . . 0.45000000000000001 113.735 173.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.469 ' HA ' HD11 ' A' ' 28' ' ' LEU . 19.5 m -115.78 -21.71 9.48 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 110.135 -160.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.57 147.8 18.74 Favored Glycine 0 N--CA 1.418 -2.557 0 CA-C-N 114.783 -1.099 . . . . 0.39000000000000001 111.005 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -128.22 142.34 51.19 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.335 -0.946 . . . . 0.56000000000000005 110.606 172.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.696 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 96.0 mtt180 -132.24 161.78 32.58 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.841 -1.911 . . . . 1.9399999999999999 105.841 165.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -157.4 166.66 32.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.038 -1.065 . . . . 1.1399999999999999 112.369 168.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 46.4 mtp180 -111.08 139.28 46.57 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.347 1.655 . . . . 2.7200000000000002 108.282 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.892 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.209 -1.033 0 CA-C-N 115.343 -0.844 . . . . 3.04 111.636 -161.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.892 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 6.2 mt-30 . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 113.494 0.924 . . . . 4.2000000000000002 113.494 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -46.88 121.68 3.8 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.262 -0.881 . . . . 1.72 110.207 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 15.8 ptm -63.6 86.21 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 2.3500000000000001 109.21 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 10.6 ttt180 -124.67 151.03 45.46 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.709 0.766 . . . . 2.48 111.079 -172.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.51 165.52 24.87 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 114.194 -1.366 . . . . 0.40999999999999998 115.124 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.685 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 78.5 t -83.73 141.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 112.879 -1.661 . . . . 0.42999999999999999 109.696 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mpt_? -64.96 134.53 54.12 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.485 0.18 . . . . 4.1100000000000003 111.485 -171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.8 pp -110.62 114.08 27.2 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.59 -0.444 . . . . 1.53 110.065 172.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.591 HG12 ' HG3' ' A' ' 58' ' ' GLU . 13.9 t -125.1 113.79 37.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 109.916 -0.401 . . . . 0.53000000000000003 109.916 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 57' ' ' VAL . 19.9 mt-10 52.19 36.6 19.68 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.837 0.455 . . . . 1.51 111.711 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.79 -1.71 75.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.38 -0.914 . . . . 0.51000000000000001 112.891 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -95.69 145.49 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 117.342 0.571 . . . . 0.48999999999999999 110.688 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 11.9 tp -104.38 115.82 31.05 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.65 -1.241 . . . . 1.0700000000000001 107.65 170.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.422 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 2.5 t-80 -116.05 133.57 55.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.162 -0.615 . . . . 1.5 112.081 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 162.24 37.23 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 107.684 -1.228 . . . . 0.82999999999999996 107.684 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.09 153.19 72.41 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.491 1.46 . . . . 1.29 110.835 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -46.92 -44.14 19.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.588 0.709 . . . . 3.1200000000000001 111.472 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.64 36.43 0.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.428 -1.26 . . . . 2.1400000000000001 108.646 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.34 -103.53 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.99 -1.005 . . . . 1.5600000000000001 113.885 -172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HD1' HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -86.57 -58.18 2.71 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.969 -0.752 . . . . 3.6899999999999999 108.969 -173.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.58 -69.71 0.34 Allowed Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.57 -1.196 . . . . 1.78 113.195 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -139.39 -56.06 0.58 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 114.628 -0.786 . . . . 1.48 109.107 -168.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.631 HD21 ' HD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER 55.25 161.78 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.72 0 O-C-N 124.375 1.047 . . . . 0.90000000000000002 110.544 -177.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.892 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 16.3 m -93.63 104.27 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 108.174 -1.047 . . . . 0.81999999999999995 108.174 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.754 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m-85 -78.58 138.91 38.6 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.884 -0.598 . . . . 0.41999999999999998 111.504 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -96.85 151.94 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.456 -1.247 . . . . 0.34000000000000002 108.687 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.07 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 4.0 t -114.86 115.23 48.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.342 0.591 . . . . 1.8400000000000001 112.265 -163.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.696 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -128.63 129.14 45.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.497 -0.774 . . . . 1.8799999999999999 111.351 178.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.658 -0.687 . . . . 1.3600000000000001 110.552 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.933 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 32.6 p90 . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 109.272 -0.64 . . . . 1.1699999999999999 109.272 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.985 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 25.4 pt -124.06 160.71 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.234 0.333 . . . . 1.0 110.516 -174.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.782 ' HD3' ' HB2' ' A' ' 15' ' ' PRO . 22.1 ttm180 -118.73 135.61 54.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.976 -0.69 . . . . 2.73 110.146 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.663 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.1 t -130.02 145.94 34.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 O-C-N 122.044 -0.41 . . . . 1.45 110.638 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.78 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.3 t -151.4 163.02 39.91 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.297 -0.252 . . . . 0.56000000000000005 110.417 163.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 1.047 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -68.87 -39.05 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.925 -0.71 . . . . 2.9700000000000002 111.011 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.26 154.84 50.78 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.875 -0.787 . . . . 1.1399999999999999 108.875 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -52.6 -39.34 61.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.454 1.121 . . . . 1.48 108.257 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.57 7.97 33.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.366 -1.743 . . . . 2.02 112.939 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 2.7 t70 -85.79 -127.01 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 118.861 -1.136 . . . . 0.58999999999999997 108.218 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.46 92.13 48.55 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.566 -0.743 . . . . 2.1800000000000002 110.315 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 60.1 Cg_endo -70.57 132.96 23.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.726 1.617 . . . . 0.57999999999999996 111.094 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.19 125.82 64.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.173 -0.921 . . . . 0.51000000000000001 110.692 -169.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.933 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 23.4 mt-10 -85.1 120.98 27.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.966 -0.561 . . . . 1.6200000000000001 110.453 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 21.4 pt -143.07 145.2 31.92 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.07 -0.968 . . . . 1.52 111.748 -171.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 16.5 Cg_exo -69.54 133.68 26.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.112 2.542 . . . . 0.67000000000000004 113.084 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 p -108.53 172.23 6.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 110.647 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.73 138.41 58.37 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.044 0.45 . . . . 2.77 110.018 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -53.48 -31.49 45.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.954 -1.476 . . . . 2.1299999999999999 112.183 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.4 p-10 -85.45 2.3 45.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.877 0.846 . . . . 2.3199999999999998 108.9 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 25.47 18.28 Favored Glycine 0 CA--C 1.497 -1.07 0 CA-C-N 114.336 -1.302 . . . . 0.56000000000000005 109.976 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.544 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.01 155.42 29.23 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.004 -1.098 . . . . 0.62 112.254 -165.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 138.49 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.121 -0.945 . . . . 0.46999999999999997 108.994 169.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.6 mp -64.08 112.09 2.83 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.942 -0.762 . . . . 1.9399999999999999 108.942 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.34 -50.01 69.44 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.193 -0.669 . . . . 0.96999999999999997 109.193 -174.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.8 p -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 1.4299999999999999 111.171 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.714 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.6 m -68.43 -32.95 73.34 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.181 -0.674 . . . . 1.4199999999999999 109.181 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.861 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.3 t -58.61 -53.41 47.41 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 CA-C-N 115.199 -0.91 . . . . 0.67000000000000004 110.383 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -61.94 -16.64 52.59 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.351 0.871 . . . . 0.71999999999999997 113.351 -175.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.375 1.25 . . . . 0.93000000000000005 114.375 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 172.32 -164.26 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.014 0.926 . . . . 1.05 109.259 -173.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -108.96 91.88 9.85 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 109.073 -0.714 . . . . 1.5 109.073 164.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.861 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.13 8.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.801 3.667 . . . . 0.84999999999999998 114.466 175.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.866 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 108.27 -21.16 29.39 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.137 -1.185 . . . . 0.67000000000000004 110.137 -163.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 58.51 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.755 1.02 . . . . 0.45000000000000001 113.755 170.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.9 m -130.77 -5.33 4.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.52 0.676 . . . . 1.1100000000000001 110.472 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.0 155.27 21.37 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 115.14 -0.936 . . . . 0.39000000000000001 111.86 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -132.41 154.59 49.67 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 119.8 -0.76 . . . . 0.56000000000000005 111.466 174.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.2 mtt180 -140.41 151.82 45.22 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.706 -1.961 . . . . 1.9399999999999999 105.706 161.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.698 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 36.3 p90 -157.63 165.03 36.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 120.188 1.358 . . . . 1.1399999999999999 112.699 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 45.3 mtm180 -110.89 150.38 29.27 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 125.601 1.813 . . . . 2.7200000000000002 109.554 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.837 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 23.4 t-20 . . . . . 0 C--O 1.214 -0.806 0 CA-C-N 114.148 -1.387 . . . . 3.04 111.115 -162.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.837 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 10.2 mt-30 . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 113.901 1.075 . . . . 4.2000000000000002 113.901 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.71 115.9 1.3 Allowed 'General case' 0 C--N 1.308 -1.223 0 O-C-N 123.813 0.696 . . . . 1.72 110.739 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 4.8 ptt? -62.43 92.43 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.378 0.608 . . . . 2.3500000000000001 110.222 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 7.6 ptp85 -122.31 161.42 23.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.573 -0.74 . . . . 2.48 109.691 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -116.13 167.26 12.43 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.085 -1.055 . . . . 0.40999999999999998 115.391 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.705 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 99.5 t -83.96 141.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.345 -1.427 . . . . 0.42999999999999999 111.391 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 3.3 mpt_? -72.29 135.64 46.03 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.643 -0.708 . . . . 4.1100000000000003 112.221 -171.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp -98.84 117.68 33.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.103 -0.639 . . . . 1.53 109.888 172.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.61 HG12 ' HG3' ' A' ' 58' ' ' GLU . 9.5 t -132.95 114.7 22.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 109.87 -0.419 . . . . 0.53000000000000003 109.87 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HG3' HG12 ' A' ' 57' ' ' VAL . 25.3 mt-10 53.9 39.5 30.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.092 0.405 . . . . 1.51 112.092 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 87.04 -1.37 86.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.42 -0.895 . . . . 0.51000000000000001 112.646 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.3 mt -100.75 149.33 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 122.734 -0.274 . . . . 0.48999999999999999 111.073 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.4 tp -102.09 114.83 29.3 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.507 -1.664 . . . . 1.0700000000000001 106.507 165.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -115.57 134.69 54.81 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.269 0.557 . . . . 1.5 112.322 -165.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.65 163.02 18.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.591 -1.186 . . . . 0.82999999999999996 108.572 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.82 163.76 15.33 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.687 2.258 . . . . 1.29 111.683 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.2 -45.79 8.59 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.71 0.766 . . . . 3.1200000000000001 112.834 -173.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.38 -39.12 8.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.296 -1.32 . . . . 2.1400000000000001 110.336 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.88 149.06 4.48 Favored Glycine 0 N--CA 1.426 -2.029 0 C-N-CA 120.556 -0.831 . . . . 1.5600000000000001 112.298 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.85 -52.43 36.82 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.934 -1.135 . . . . 3.6899999999999999 107.934 175.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 166.98 -83.76 0.1 OUTLIER Glycine 0 N--CA 1.417 -2.58 0 CA-C-N 113.79 -1.55 . . . . 1.78 111.427 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.985 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.2 p30 -142.25 -62.11 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 0 CA-C-N 114.58 -0.81 . . . . 1.48 109.922 -170.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 54.01 176.4 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.35 1.071 . . . . 0.90000000000000002 111.297 -177.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 72' ' ' VAL . 2.1 p -102.91 104.54 16.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 113.326 -1.761 . . . . 0.81999999999999995 108.427 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.8 ' HE1' HD12 ' A' ' 5' ' ' ILE . 20.4 m-85 -80.82 146.5 30.89 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.701 0.763 . . . . 0.41999999999999998 112.157 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -107.6 158.21 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.499 -1.682 . . . . 0.34000000000000002 107.933 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.047 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 t -113.93 110.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.56 0.695 . . . . 1.8400000000000001 111.383 -164.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -126.35 129.4 48.74 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.684 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.835 0 CA-C-O 118.587 -0.72 . . . . 1.3600000000000001 110.116 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 23.0 p90 . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.594 -1.632 . . . . 1.1699999999999999 106.594 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -127.49 160.76 36.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.661 -172.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 5.2 ttt180 -119.4 132.77 55.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.758 -0.777 . . . . 2.73 109.279 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.787 HG22 ' HD1' ' A' ' 73' ' ' TYR . 3.5 t -132.63 144.2 37.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 121.923 -0.485 . . . . 1.45 110.396 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.961 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 5.4 t -152.85 168.33 26.11 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.369 0.128 . . . . 0.56000000000000005 110.768 166.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.793 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 tm-20 -72.92 -56.4 5.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.058 0.932 . . . . 2.9700000000000002 108.624 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 14.0 t70 -110.01 148.31 31.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.822 -1.177 . . . . 1.1399999999999999 107.822 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 74' ' ' VAL . 1.5 mt-10 -63.11 -17.82 62.73 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.347 -1.297 . . . . 1.48 108.577 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.64 33.55 4.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.996 -1.456 . . . . 2.02 110.657 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 7.3 t70 -83.55 -118.09 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.697 -1.223 . . . . 0.58999999999999997 107.697 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 6.1 tp10 -121.5 90.76 48.1 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.067 -0.97 . . . . 2.1800000000000002 110.184 167.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 72.7 Cg_endo -74.69 133.43 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.056 1.837 . . . . 0.57999999999999996 110.879 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.28 136.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.021 -0.536 . . . . 0.51000000000000001 111.338 -169.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 34.2 mt-10 -86.07 122.0 29.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.84 -0.43 . . . . 1.6200000000000001 109.84 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 25.4 pt -140.49 141.1 24.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.789 -0.641 . . . . 1.52 111.031 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 47.6 Cg_endo -69.69 136.29 32.81 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.713 2.275 . . . . 0.67000000000000004 112.425 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.778 ' HB3' HD12 ' A' ' 5' ' ' ILE . 8.2 p -112.14 169.36 8.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.96999999999999997 110.518 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.91 136.73 53.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.333 -0.618 . . . . 2.77 109.333 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' GLY . 1.2 m-20 -55.1 -17.4 4.01 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.195 0.998 . . . . 2.1299999999999999 112.555 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -74.55 0.71 13.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.009 0.909 . . . . 2.3199999999999998 108.645 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.31 23.98 74.38 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 113.866 -1.516 . . . . 0.56000000000000005 110.973 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.43 166.74 21.32 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.406 -0.397 . . . . 0.62 110.775 -169.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -147.5 146.35 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.598 -0.728 . . . . 0.46999999999999997 110.04 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -67.62 109.71 3.4 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.007 -0.738 . . . . 1.9399999999999999 109.007 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -65.77 -48.95 70.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.17 -0.923 . . . . 0.96999999999999997 110.009 -169.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.567 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.5 m -58.86 -39.23 80.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.14 -0.936 . . . . 1.4299999999999999 110.771 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.776 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 2.5 t -68.61 -33.19 73.61 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.602 -1.259 . . . . 1.4199999999999999 107.602 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.856 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 19.8 t -66.89 -42.54 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 CA-C-N 114.292 -1.322 . . . . 0.67000000000000004 109.864 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -65.8 -19.09 65.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.366 0.506 . . . . 0.71999999999999997 112.366 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.7 41.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.51 1.3 . . . . 0.93000000000000005 114.51 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 173.51 -164.29 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 123.968 0.907 . . . . 1.05 108.981 -173.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.04 92.16 10.44 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 108.849 -0.797 . . . . 1.5 108.849 166.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.878 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -118.53 1.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.287 3.325 . . . . 0.84999999999999998 114.369 173.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 107.61 -20.09 32.61 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 110.1 -1.2 . . . . 0.67000000000000004 110.1 -161.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.878 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 63.45 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.226 1.01 . . . . 0.45000000000000001 113.504 170.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.4 t -128.87 -21.49 3.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.317 0.58 . . . . 1.1100000000000001 110.415 -165.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.508 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -112.97 155.51 16.24 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.485 -1.046 . . . . 0.39000000000000001 110.485 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.706 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.59 151.01 51.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 118.736 -1.186 . . . . 0.56000000000000005 112.984 176.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 mtt180 -133.82 161.0 35.92 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.187 -1.783 . . . . 1.9399999999999999 106.187 158.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.872 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.6 p90 -156.91 165.57 35.83 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 119.396 0.998 . . . . 1.1399999999999999 111.892 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -110.07 143.64 39.83 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 125.088 1.493 . . . . 2.7200000000000002 109.138 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.106 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 35.0 t30 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 114.995 -1.002 . . . . 3.04 111.343 -169.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.106 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 115.28 1.585 . . . . 4.2000000000000002 115.28 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.56 118.67 12.72 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.088 -0.96 . . . . 1.72 111.01 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 5.9 ptm -64.23 87.26 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.074 -0.713 . . . . 2.3500000000000001 109.074 170.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 7.3 ttt180 -121.19 156.21 32.88 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.934 -0.575 . . . . 2.48 110.432 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -100.48 164.81 19.04 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 121.975 0.764 . . . . 0.40999999999999998 113.951 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.694 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 91.0 t -98.53 140.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.545 -1.327 . . . . 0.42999999999999999 109.867 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -63.27 134.72 56.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.648 -0.705 . . . . 4.1100000000000003 112.642 -175.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.34 121.77 46.1 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.533 -0.467 . . . . 1.53 109.925 165.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.662 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.7 t -126.17 113.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.739 -0.467 . . . . 0.53000000000000003 109.739 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HG3' HG12 ' A' ' 57' ' ' VAL . 12.1 mt-10 51.13 36.5 15.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.067 0.547 . . . . 1.51 112.445 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.454 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 95.35 -3.23 66.04 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.729 -0.748 . . . . 0.51000000000000001 112.932 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.3 mt -100.81 148.16 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.726 -0.279 . . . . 0.48999999999999999 110.443 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' VAL . 16.4 tp -102.44 114.58 28.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.134 -1.061 . . . . 1.0700000000000001 108.134 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -111.65 122.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.711 0.767 . . . . 1.5 111.616 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.67 162.47 62.83 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 106.838 -1.541 . . . . 0.82999999999999996 106.838 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 22.2 Cg_exo -63.41 149.89 89.97 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 120.421 1.186 . . . . 1.29 109.594 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -45.95 -43.68 14.2 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.195 0.934 . . . . 3.1200000000000001 111.924 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.17 32.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.484 -0.932 . . . . 2.1400000000000001 108.484 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.11 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.004 -0.998 . . . . 1.5600000000000001 113.885 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.775 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.34 -76.93 0.6 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.538 0.685 . . . . 3.6899999999999999 109.897 -172.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.33 -76.49 0.12 Allowed Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 114.95 -1.023 . . . . 1.78 113.757 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.935 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -133.42 -59.03 0.88 Allowed 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.101 -0.549 . . . . 1.48 109.737 -167.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 51.06 172.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.439 1.087 . . . . 0.90000000000000002 111.648 -176.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 6' ' ' ARG . 2.0 p -99.56 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 113.99 -1.459 . . . . 0.81999999999999995 108.492 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.872 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.6 m-85 -79.86 144.81 33.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.827 0.822 . . . . 0.41999999999999998 112.671 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.715 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.5 t -110.38 164.11 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.356 -1.747 . . . . 0.34000000000000002 109.548 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.902 HG23 ' HA2' ' A' ' 37' ' ' GLY . 9.8 p -98.95 114.67 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.671 0.619 . . . . 1.8400000000000001 112.671 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.457 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 1.1 p30 -133.54 128.2 34.78 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 118.638 -1.225 . . . . 1.8799999999999999 110.533 158.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.38 -0.819 . . . . 1.3600000000000001 109.957 167.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 16.8 p90 . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 107.258 -1.386 . . . . 1.1699999999999999 107.258 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -121.86 162.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.88 0.309 . . . . 1.0 111.223 -172.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 1.081 ' HD2' ' HB2' ' A' ' 15' ' ' PRO . 1.9 tpp85 -117.83 132.45 56.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 2.7 p -138.81 147.2 25.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 O-C-N 121.411 -0.806 . . . . 1.45 111.503 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 2.1 t -153.49 171.13 19.18 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.494 -0.928 . . . . 0.56000000000000005 108.494 166.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.0 mt-10 -75.33 -54.9 6.3 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.834 -1.147 . . . . 2.9700000000000002 108.142 171.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 12.0 m-20 -103.38 142.11 34.78 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.845 -1.169 . . . . 1.1399999999999999 107.845 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 74' ' ' VAL . 4.3 mt-10 -57.71 -25.76 60.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 1.48 109.078 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.64 39.33 3.89 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.677 -1.601 . . . . 2.02 110.868 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.4 t70 -80.86 -114.48 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.042 -1.466 . . . . 0.58999999999999997 107.042 165.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -123.14 90.16 50.52 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.274 -0.875 . . . . 2.1800000000000002 109.668 165.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.081 ' HB2' ' HD2' ' A' ' 6' ' ' ARG . 72.5 Cg_endo -72.55 135.96 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.397 2.065 . . . . 0.57999999999999996 111.376 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -126.86 147.01 31.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.804 -0.635 . . . . 0.51000000000000001 110.928 -168.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.608 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 13.8 mt-10 -95.62 124.53 39.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.113 -0.494 . . . . 1.6200000000000001 110.857 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 35.8 pt -141.2 150.9 60.19 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.715 -0.675 . . . . 1.52 111.047 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.48 159.73 14.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.938 2.426 . . . . 0.67000000000000004 112.421 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.523 ' OG ' HD12 ' A' ' 5' ' ' ILE . 16.4 m -119.06 169.59 9.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.96999999999999997 110.277 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.15 145.31 55.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.054 -0.721 . . . . 2.77 109.054 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -23.74 14.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.281 -1.327 . . . . 2.1299999999999999 111.952 -171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 22.5 t70 -78.26 -8.46 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.213 1.006 . . . . 2.3199999999999998 109.171 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.1 31.67 Favored Glycine 0 CA--C 1.5 -0.873 0 N-CA-C 108.681 -1.767 . . . . 0.56000000000000005 108.681 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.56 149.81 40.02 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 112.893 -1.654 . . . . 0.62 110.915 -166.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.811 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -144.42 148.03 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.225 -0.443 . . . . 0.46999999999999997 110.725 173.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.071 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -70.61 94.69 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.48 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.58 -49.77 69.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.017 -0.538 . . . . 0.96999999999999997 110.461 -170.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.633 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.7 m -69.77 -31.04 68.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.618 0.723 . . . . 1.4299999999999999 109.719 -177.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.071 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.5 m -73.46 -32.36 64.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.233 -0.894 . . . . 1.4199999999999999 108.758 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.819 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 17.5 t -64.33 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 115.175 -0.921 . . . . 0.67000000000000004 110.273 168.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.3 p -65.03 -18.8 65.61 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.042 -0.411 . . . . 0.71999999999999997 111.887 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.95 40.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.384 1.253 . . . . 0.93000000000000005 114.384 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 170.76 -166.61 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 124.054 0.941 . . . . 1.05 108.846 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -109.62 92.32 11.91 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.89 -0.781 . . . . 1.5 108.89 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.819 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 2.4 Cg_endo -120.42 5.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.199 3.266 . . . . 0.84999999999999998 114.661 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' O ' ' HD1' ' A' ' 77' ' ' TYR . . . 107.31 -26.98 16.91 Favored Glycine 0 C--O 1.222 -0.602 0 N-CA-C 109.716 -1.353 . . . . 0.67000000000000004 109.716 -161.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.792 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 62.57 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.509 1.3 . . . . 0.45000000000000001 114.509 165.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -122.41 -10.17 8.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.612 0.72 . . . . 1.1100000000000001 110.482 -159.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.4 154.06 16.54 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.489 -1.445 . . . . 0.39000000000000001 109.489 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -130.47 138.9 50.51 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 118.716 -1.194 . . . . 0.56000000000000005 111.893 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.79 ' HE ' ' HB3' ' A' ' 51' ' ' MET . 20.1 mtp180 -126.35 157.94 37.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.381 -1.34 . . . . 1.9399999999999999 107.381 159.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 25.4 p90 -154.34 160.21 41.59 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.435 -1.306 . . . . 1.1399999999999999 111.845 165.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 72' ' ' VAL . 15.0 ttm180 -107.57 136.24 47.68 Favored 'General case' 0 C--O 1.253 1.267 0 O-C-N 125.758 1.911 . . . . 2.7200000000000002 109.228 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.6 m120 . . . . . 0 C--O 1.211 -0.946 0 O-C-N 124.292 0.995 . . . . 3.04 111.908 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 35.7 mt-30 . . . . . 0 CA--C 1.507 -0.673 0 N-CA-C 113.879 1.066 . . . . 4.2000000000000002 113.879 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -67.88 124.56 23.68 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.877 -1.51 . . . . 1.72 108.861 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.79 ' HB3' ' HE ' ' A' ' 42' ' ' ARG . 18.2 mmt -69.67 80.05 0.43 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.997 -1.112 . . . . 2.3500000000000001 107.997 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 15.1 ttt180 -101.79 152.88 20.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.565 -1.198 . . . . 2.48 110.991 -166.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 161.02 19.83 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.288 -1.324 . . . . 0.40999999999999998 114.54 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.67 ' CG1' ' HG ' ' A' ' 61' ' ' LEU . 86.0 t -99.09 142.16 15.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 113.416 -1.392 . . . . 0.42999999999999999 110.158 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -64.4 136.2 56.87 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 112.05 0.389 . . . . 4.1100000000000003 112.05 -172.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -117.1 111.91 20.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.123 0.487 . . . . 1.53 110.567 175.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.748 HG12 ' HG3' ' A' ' 58' ' ' GLU . 35.6 t -127.97 117.25 45.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 116.26 -0.427 . . . . 0.53000000000000003 110.059 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.748 ' HG3' HG12 ' A' ' 57' ' ' VAL . 22.0 mt-10 54.83 35.7 24.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.687 0.28 . . . . 1.51 111.689 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.7 3.1 86.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.41 -0.9 . . . . 0.51000000000000001 112.933 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.1 mt -96.29 146.62 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 117.114 0.457 . . . . 0.48999999999999999 110.814 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.811 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.8 tp -103.83 117.89 35.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.268 -1.382 . . . . 1.0700000000000001 107.268 169.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -116.44 137.37 52.21 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.107 -0.637 . . . . 1.5 112.365 -169.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.48 163.74 17.6 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 114.564 -1.198 . . . . 0.82999999999999996 109.899 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.3 167.4 6.16 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.672 2.914 . . . . 1.29 111.79 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -44.1 3.58 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.821 0.701 . . . . 3.1200000000000001 112.66 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 -21.02 7.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.125 -0.943 . . . . 2.1400000000000001 110.93 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 153.53 19.73 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.567 -1.302 . . . . 1.5600000000000001 112.378 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.871 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.71 -49.89 35.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.441 -1.318 . . . . 3.6899999999999999 107.441 169.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.1 -81.48 0.08 OUTLIER Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 112.781 -2.009 . . . . 1.78 110.261 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.827 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.5 p30 -147.04 -61.73 0.29 Allowed 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.559 -0.821 . . . . 1.48 109.354 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.871 HD21 ' HB2' ' A' ' 68' ' ' TRP . 1.2 mm? 56.24 166.95 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.664 0 O-C-N 124.276 0.985 . . . . 0.90000000000000002 110.959 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 1.8 p -100.3 107.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 114.26 -1.336 . . . . 0.81999999999999995 109.493 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.846 ' HB3' HD11 ' A' ' 41' ' ' LEU . 19.0 m-85 -77.1 142.2 39.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.109 -0.95 . . . . 0.41999999999999998 112.041 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.725 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.3 t -110.88 167.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 113.629 -1.623 . . . . 0.34000000000000002 110.6 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' VAL . 5.7 p -99.03 105.02 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 112.641 0.608 . . . . 1.8400000000000001 112.641 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 0.3 OUTLIER -130.36 124.9 33.3 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 118.692 -1.203 . . . . 1.8799999999999999 111.506 163.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.294 -0.86 . . . . 1.3600000000000001 109.545 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.986 -0.375 . . . . 5.8600000000000003 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -120.23 101.28 7.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 2.73 110.977 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.7 136.79 34.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.678 -0.49 . . . . 2.5 109.678 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 29.8 p90 -139.66 176.01 9.09 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.379 . . . . 1.1699999999999999 107.278 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.955 HD12 ' HE1' ' A' ' 73' ' ' TYR . 23.6 pt -129.98 163.8 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.129 0.422 . . . . 1.0 111.123 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 134.28 55.14 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 109.506 -0.553 . . . . 2.73 109.506 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.652 HG13 ' HB2' ' A' ' 73' ' ' TYR . 1.6 t -136.83 142.87 36.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 O-C-N 121.499 -0.751 . . . . 1.45 110.883 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.898 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 t -154.13 151.74 29.61 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.01 -0.431 . . . . 0.56000000000000005 111.319 163.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.99 ' HA ' ' CB ' ' A' ' 75' ' ' VAL . 18.8 tt0 -65.96 -40.05 90.95 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.51 0.672 . . . . 2.9700000000000002 110.734 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -123.02 151.03 42.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.711 -1.588 . . . . 1.1399999999999999 106.711 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 11' ' ' GLU . 2.5 mt-10 -58.32 -30.5 66.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.553 -0.906 . . . . 1.48 108.553 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -113.69 31.19 6.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.284 -1.325 . . . . 2.02 111.031 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 27.0 t70 -84.84 -121.53 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.28 -1.378 . . . . 0.58999999999999997 107.28 167.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -122.19 92.95 48.81 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.373 -0.831 . . . . 2.1800000000000002 110.455 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.898 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 56.3 Cg_endo -67.57 136.3 38.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.191 1.927 . . . . 0.57999999999999996 110.997 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.511 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.86 143.94 39.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.351 -0.84 . . . . 0.51000000000000001 111.461 -169.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.676 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 23.8 mt-10 -97.35 125.66 42.1 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.888 -0.412 . . . . 1.6200000000000001 109.888 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 47.8 pt -140.77 139.08 19.13 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.155 -0.475 . . . . 1.52 111.527 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 7.6 Cg_exo -72.65 150.91 51.56 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.292 2.662 . . . . 0.67000000000000004 112.784 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -129.47 168.41 16.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.96999999999999997 111.019 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' THR . 26.8 tt0 -75.07 145.73 42.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.141 -0.481 . . . . 2.77 110.289 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.38 -21.37 9.42 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.611 -1.177 . . . . 2.1299999999999999 112.536 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 29.3 t70 -76.16 -7.04 53.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.292 1.044 . . . . 2.3199999999999998 108.709 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.98 53.99 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.021 -1.631 . . . . 0.56000000000000005 109.021 -173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -123.44 155.92 36.51 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.447 -1.376 . . . . 0.62 110.401 -166.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.997 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -147.31 152.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 122.568 0.347 . . . . 0.46999999999999997 110.811 177.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.103 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -68.9 94.45 0.62 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.129 -0.487 . . . . 1.9399999999999999 110.468 178.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -64.6 -49.69 70.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 110.006 -0.368 . . . . 0.96999999999999997 110.006 -171.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 32' ' ' THR . 16.7 p -62.66 -36.22 82.16 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.829 0.824 . . . . 1.4299999999999999 110.154 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.103 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.6 m -72.53 -33.6 66.99 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.913 -1.04 . . . . 1.4199999999999999 108.512 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.85 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 8.8 t -60.95 -48.52 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.482 -1.236 . . . . 0.67000000000000004 110.751 170.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -62.44 -17.7 60.02 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.095 0.776 . . . . 0.71999999999999997 113.095 -176.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.12 38.53 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.71 1.374 . . . . 0.93000000000000005 114.71 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 170.22 -164.72 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.194 0.998 . . . . 1.05 109.012 -173.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -107.97 92.09 8.69 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 165.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.85 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.76 6.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.86 3.707 . . . . 0.84999999999999998 115.318 176.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 1.126 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 109.2 -15.6 32.99 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 109.979 -1.249 . . . . 0.67000000000000004 109.979 -161.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.778 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 47.15 -91.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 124.984 1.314 . . . . 0.45000000000000001 114.148 171.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.8 t -131.02 6.74 4.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.404 0.621 . . . . 1.1100000000000001 110.282 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -144.69 147.8 19.2 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.341 -0.845 . . . . 0.39000000000000001 111.081 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.7 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -128.25 152.97 47.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.283 -1.367 . . . . 0.56000000000000005 113.093 177.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.811 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 77.7 mtt-85 -136.48 164.88 27.13 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.057 -2.201 . . . . 1.9399999999999999 105.057 158.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.726 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -155.94 163.65 39.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 119.928 1.24 . . . . 1.1399999999999999 112.502 168.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.618 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 29.1 mmt180 -114.79 125.5 53.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 124.48 1.112 . . . . 2.7200000000000002 113.329 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.39 0.7 OUTLIER 98.66 -60.28 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.223 0 N-CA-C 119.935 3.309 . . . . 3.04 119.935 141.231 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.749 ' HB2' HD12 ' A' ' 71' ' ' LEU . 39.5 Cg_exo -61.94 -1.29 2.1 Favored 'Trans proline' 0 C--N 1.363 1.298 0 CA-C-N 123.82 2.4 . . . . 3.6200000000000001 113.787 -170.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.826 HG13 ' H ' ' A' ' 48' ' ' SER . 2.5 p -98.32 -101.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.322 -0.621 . . . . 4.4199999999999999 109.322 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.826 ' H ' HG13 ' A' ' 47' ' ' VAL . 37.7 m -111.86 14.13 20.97 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 116.109 -0.496 . . . . 3.3199999999999998 111.26 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.036 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 9.7 mt-30 62.45 22.3 13.16 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.317 1.056 . . . . 4.2000000000000002 111.96 -171.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 132.19 34.67 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 113.464 -1.698 . . . . 1.72 111.293 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 12.4 ptp -69.52 82.18 0.4 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.051 0.453 . . . . 2.3500000000000001 109.937 172.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HD3' ' OH ' ' A' ' 43' ' ' TYR . 18.3 ttt180 -115.95 150.3 37.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.652 0.739 . . . . 2.48 110.812 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.77 165.98 24.8 Favored Glycine 0 C--N 1.305 -1.192 0 CA-C-N 114.514 -1.221 . . . . 0.40999999999999998 115.243 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.7 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 70.5 t -99.43 146.19 9.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.856 -1.672 . . . . 0.42999999999999999 111.01 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 11.1 mtt180 -62.01 136.27 57.89 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.707 0.803 . . . . 4.1100000000000003 112.906 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -121.74 115.7 23.17 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.664 -0.495 . . . . 1.53 109.664 170.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 58' ' ' GLU . 10.3 t -130.22 114.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.535 -0.302 . . . . 0.53000000000000003 110.52 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 57' ' ' VAL . 15.3 mt-10 51.2 37.19 17.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.021 0.528 . . . . 1.51 112.289 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.64 -2.04 66.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.681 -0.771 . . . . 0.51000000000000001 113.058 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -100.97 147.62 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 122.684 -0.304 . . . . 0.48999999999999999 111.586 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.997 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -103.8 114.56 28.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.836 -1.172 . . . . 1.0700000000000001 107.836 169.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.751 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 9.9 t-160 -114.58 136.13 53.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.889 -0.724 . . . . 1.5 112.203 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.69 162.05 39.99 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.974 -1.012 . . . . 0.82999999999999996 108.586 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.46 159.1 54.86 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 121.85 1.7 . . . . 1.29 110.504 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -47.38 -44.34 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.686 0.616 . . . . 3.1200000000000001 112.503 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.61 28.22 0.38 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.545 -0.752 . . . . 2.1400000000000001 109.813 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.14 -97.43 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.592 -0.813 . . . . 1.5600000000000001 113.267 -173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 1.016 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -107.71 -81.56 0.56 Allowed 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.748 0.308 . . . . 3.6899999999999999 110.543 -178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.1 -70.7 0.43 Allowed Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 119.604 -1.284 . . . . 1.78 114.709 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 11.4 p-10 -139.77 33.67 2.0 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 122.84 1.305 . . . . 1.48 109.724 -152.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -48.7 162.04 0.11 Allowed 'General case' 0 CA--C 1.477 -1.836 0 CA-C-N 112.147 -2.297 . . . . 0.90000000000000002 109.242 169.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.775 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.5 p -86.33 106.36 15.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.156 -1.383 . . . . 0.81999999999999995 107.284 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.955 ' HE1' HD12 ' A' ' 5' ' ' ILE . 19.8 m-85 -77.77 145.28 36.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.587 -0.733 . . . . 0.41999999999999998 111.258 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 3.1 t -97.0 150.68 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.85 -1.523 . . . . 0.34000000000000002 108.06 169.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.126 HG13 ' HA2' ' A' ' 37' ' ' GLY . 5.0 t -108.1 118.1 55.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.59 0.71 . . . . 1.8400000000000001 112.186 -165.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -127.64 130.22 48.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 114.697 -1.138 . . . . 1.8799999999999999 110.611 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 3.3 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.674 -0.679 . . . . 1.3600000000000001 110.856 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.038 -0.726 . . . . 5.8600000000000003 109.038 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m 62.26 79.3 0.26 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.319 -0.993 . . . . 2.73 108.319 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.48 152.19 28.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.718 -0.674 . . . . 2.5 111.258 -168.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 44.6 p90 -130.21 176.23 8.27 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.779 -1.563 . . . . 1.1699999999999999 106.779 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.851 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 14.8 pt -128.23 161.24 37.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 118.044 0.384 . . . . 1.0 111.557 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.806 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 10.1 ttt180 -119.83 132.17 55.5 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.165 -0.679 . . . . 2.73 109.165 171.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.6 p -137.28 140.46 42.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.632 -0.427 . . . . 1.45 111.596 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.757 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.8 t -152.81 171.23 18.58 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.542 -0.754 . . . . 0.56000000000000005 109.754 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.82 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 21.1 mt-10 -74.72 -53.92 8.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.864 0.84 . . . . 2.9700000000000002 109.091 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -111.49 150.4 29.96 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.304 -1.369 . . . . 1.1399999999999999 107.304 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 44' ' ' ARG . 43.4 mt-10 -63.94 -22.51 66.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.264 -1.334 . . . . 1.48 109.083 -170.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -122.3 23.57 9.72 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.448 -1.251 . . . . 2.02 111.53 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.6 t70 -74.28 -112.71 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.097 -1.075 . . . . 0.58999999999999997 108.097 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' HD13 ' A' ' 16' ' ' ILE . 33.2 tt0 -122.23 88.42 48.55 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.283 -0.871 . . . . 2.1800000000000002 109.873 165.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 91.4 Cg_endo -78.43 130.59 10.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.625 1.55 . . . . 0.57999999999999996 110.686 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.08 133.58 66.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.539 -0.755 . . . . 0.51000000000000001 111.841 -169.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.76 122.56 29.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.377 -0.601 . . . . 1.6200000000000001 109.377 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 37.4 pt -139.04 138.83 21.7 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.99 -0.55 . . . . 1.52 110.927 -171.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 16.2 Cg_exo -68.71 124.29 11.35 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.08 2.52 . . . . 0.67000000000000004 112.055 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 m -95.49 169.57 9.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.741 -0.663 . . . . 0.96999999999999997 110.533 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' THR . 12.0 tp10 -64.95 136.02 56.33 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.008 -0.738 . . . . 2.77 109.008 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.63 -16.97 7.16 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.239 -0.891 . . . . 2.1299999999999999 112.32 -175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -79.6 1.09 27.38 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.726 0.774 . . . . 2.3199999999999998 109.028 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.98 49.25 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 114.258 -1.337 . . . . 0.56000000000000005 110.587 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.19 159.46 36.77 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.32 -0.94 . . . . 0.62 110.884 -165.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.942 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.33 153.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 120.826 0.346 . . . . 0.46999999999999997 111.223 175.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.099 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -70.54 94.6 1.0 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.872 -0.604 . . . . 1.9399999999999999 110.749 -178.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.46 -50.32 65.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.527 -0.545 . . . . 0.96999999999999997 109.527 -173.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.718 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.6 p -61.55 -33.95 74.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.682 0.753 . . . . 1.4299999999999999 110.375 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.099 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 8.6 m -75.0 -33.14 61.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.071 -0.968 . . . . 1.4199999999999999 108.952 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.838 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 18.7 t -62.68 -47.62 92.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.227 -0.897 . . . . 0.67000000000000004 110.537 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -64.89 -16.96 63.89 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.775 0.657 . . . . 0.71999999999999997 112.775 -177.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.75 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.451 1.278 . . . . 0.93000000000000005 114.451 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 170.77 -166.53 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.484 1.114 . . . . 1.05 108.787 -172.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HD2' ' HH ' ' A' ' 77' ' ' TYR . 11.0 m-85 -109.88 92.15 12.13 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.938 -0.764 . . . . 1.5 108.938 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.838 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -121.27 4.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.558 3.505 . . . . 0.84999999999999998 115.017 176.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.1 -20.41 30.95 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.167 -1.173 . . . . 0.67000000000000004 110.167 -161.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.68 -88.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.764 1.394 . . . . 0.45000000000000001 114.764 165.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 15.7 m -129.58 -1.54 4.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.32 0.581 . . . . 1.1100000000000001 110.966 -163.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.55 169.96 20.59 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 110.199 -1.16 . . . . 0.39000000000000001 110.199 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.814 ' HB3' ' H ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -148.43 140.28 23.82 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.332 -0.947 . . . . 0.56000000000000005 112.15 -178.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.595 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.5 mtt180 -134.11 152.91 52.05 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 106.38 -1.711 . . . . 1.9399999999999999 106.38 159.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.797 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 50.0 p90 -153.37 164.81 37.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 120.71 1.596 . . . . 1.1399999999999999 113.483 169.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 11' ' ' GLU . 9.0 mtm180 -109.73 150.49 28.23 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.845 -1.525 . . . . 2.7200000000000002 110.201 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.02 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 t30 -147.57 126.28 6.2 Favored Pre-proline 0 C--O 1.219 -0.55 0 CA-C-N 114.028 -1.442 . . . . 3.04 110.508 -166.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 45' ' ' ASN . 52.1 Cg_exo -57.81 9.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.757 2.971 . . . . 3.6200000000000001 116.585 -173.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.974 HG13 ' H ' ' A' ' 48' ' ' SER . 2.8 p -111.34 -94.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.544 -0.722 . . . . 4.4199999999999999 111.566 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.974 ' H ' HG13 ' A' ' 47' ' ' VAL . 82.7 p -93.53 -11.63 31.48 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.5 0.667 . . . . 3.3199999999999998 109.427 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.02 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.1 tt0 51.8 28.01 4.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.331 1.604 . . . . 4.2000000000000002 115.331 167.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -60.97 126.04 25.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.339 -0.391 . . . . 1.72 110.243 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -67.83 92.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.928 0.871 . . . . 2.3500000000000001 110.221 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 74.1 ttt180 -105.24 149.78 25.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.869 -1.059 . . . . 2.48 112.168 -170.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -96.53 149.22 19.25 Favored Glycine 0 C--N 1.302 -1.32 0 CA-C-N 113.941 -1.481 . . . . 0.40999999999999998 114.502 175.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.814 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 76.0 t -98.78 143.33 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.514 -1.343 . . . . 0.42999999999999999 110.327 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.665 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -65.85 135.49 54.9 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 112.514 0.561 . . . . 4.1100000000000003 112.514 -170.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.05 111.22 22.16 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.192 -0.67 . . . . 1.53 109.192 169.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 58' ' ' GLU . 19.3 t -129.44 118.03 44.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.153 -0.476 . . . . 0.53000000000000003 110.699 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.944 ' HG2' HG12 ' A' ' 57' ' ' VAL . 3.9 mm-40 52.69 35.53 18.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.375 0.509 . . . . 1.51 112.375 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' C ' HD23 ' A' ' 28' ' ' LEU . . . 92.79 -0.87 70.55 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.588 -0.815 . . . . 0.51000000000000001 113.048 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -104.08 149.35 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.796 0.332 . . . . 0.48999999999999999 111.706 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.942 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.51 116.5 32.73 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.92 -1.511 . . . . 1.0700000000000001 106.92 166.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -115.09 133.59 55.9 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.598 0.713 . . . . 1.5 112.166 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 164.25 31.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 113.895 -1.502 . . . . 0.82999999999999996 110.46 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.84 168.01 9.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.551 2.834 . . . . 1.29 110.688 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -41.99 -42.99 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.436 0.902 . . . . 3.1200000000000001 113.436 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.91 -23.63 4.6 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.171 0.434 . . . . 2.1400000000000001 112.171 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.59 136.9 8.44 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 118.98 -1.581 . . . . 1.5600000000000001 114.054 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.434 ' CD2' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -81.37 -89.55 0.07 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.238 0.615 . . . . 3.6899999999999999 111.373 170.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.9 48.0 0.12 Allowed Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.671 -0.776 . . . . 1.78 113.918 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.851 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 87.04 -45.18 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 114.361 -0.92 . . . . 1.48 110.28 156.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.806 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER 47.07 173.2 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.964 1.364 . . . . 0.90000000000000002 113.784 174.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -103.02 105.05 17.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 113.422 -1.717 . . . . 0.81999999999999995 109.145 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.797 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.0 m-85 -80.59 145.84 31.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.094 0.95 . . . . 0.41999999999999998 112.858 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -109.16 159.18 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 112.889 -1.959 . . . . 0.34000000000000002 110.151 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.82 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 p -87.93 103.78 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 1.8400000000000001 112.145 -165.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -129.03 127.2 41.1 Favored 'General case' 0 C--O 1.208 -1.08 0 C-N-CA 120.111 -0.636 . . . . 1.8799999999999999 109.423 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.489 -0.767 . . . . 1.3600000000000001 110.322 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.066 -0.346 . . . . 5.8600000000000003 110.066 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m 65.84 -178.41 0.19 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.712 0.632 . . . . 2.73 111.465 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -109.76 152.6 25.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 116.09 -0.504 . . . . 2.5 110.007 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.78 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 35.7 p90 -135.06 172.92 12.33 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.813 -0.81 . . . . 1.1699999999999999 108.813 -172.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.958 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -124.36 159.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 121.188 -0.205 . . . . 1.0 111.01 -178.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.79 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 2.9 ttt180 -120.52 134.35 55.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.756 -0.461 . . . . 2.73 109.756 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.688 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.4 p -138.16 148.5 24.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 O-C-N 121.786 -0.571 . . . . 1.45 111.57 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.5 t -152.57 171.21 18.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.494 -0.321 . . . . 0.56000000000000005 110.918 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 1.035 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.4 tm-20 -83.33 -33.02 25.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.807 0.813 . . . . 2.9700000000000002 110.036 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -132.18 150.0 52.26 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.15 -1.426 . . . . 1.1399999999999999 107.15 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HB3' HH21 ' A' ' 44' ' ' ARG . 7.4 mm-40 -55.62 -25.3 38.05 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.981 0.801 . . . . 1.48 109.529 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -130.52 38.01 3.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.816 -1.084 . . . . 2.02 111.898 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 8.4 t70 -77.02 -111.6 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.69 -1.596 . . . . 0.58999999999999997 106.69 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -123.36 89.61 50.95 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.026 -0.988 . . . . 2.1800000000000002 109.944 164.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.857 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 55.5 Cg_endo -69.18 133.1 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.231 1.287 . . . . 0.57999999999999996 110.05 173.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.41 128.26 69.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.605 -0.725 . . . . 0.51000000000000001 111.138 -169.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.78 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.6 mp0 -84.13 121.73 27.85 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.715 -0.675 . . . . 1.6200000000000001 109.628 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 32.1 pt -140.64 143.61 33.11 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.496 -0.775 . . . . 1.52 111.537 -172.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 2.9 Cg_exo -76.35 131.4 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.319 2.679 . . . . 0.67000000000000004 112.415 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 5' ' ' ILE . 7.2 p -103.59 171.35 7.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.768 -0.651 . . . . 0.96999999999999997 109.799 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.26 142.57 58.23 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.444 -0.576 . . . . 2.77 109.444 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.76 -28.86 24.2 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.952 1.407 . . . . 2.1299999999999999 112.347 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 6.3 p-10 -84.54 1.28 46.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.141 0.972 . . . . 2.3199999999999998 108.8 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 24.31 23.05 Favored Glycine 0 CA--C 1.499 -0.966 0 CA-C-N 113.867 -1.515 . . . . 0.56000000000000005 110.234 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.48 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.35 151.81 38.74 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.827 -1.187 . . . . 0.62 111.622 -165.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.834 HG23 ' HB3' ' A' ' 61' ' ' LEU . 1.0 OUTLIER -147.31 148.7 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.667 -0.697 . . . . 0.46999999999999997 109.955 170.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.012 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -64.87 102.75 0.63 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.15 0.5 . . . . 1.9399999999999999 110.128 175.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -63.65 -50.63 68.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.45 -0.574 . . . . 0.96999999999999997 109.45 -172.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.69 ' HA ' HG23 ' A' ' 32' ' ' THR . 17.9 p -68.87 -37.34 79.01 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.614 0.721 . . . . 1.4299999999999999 110.201 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 6.5 m -70.88 -32.97 70.11 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 108.73 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.858 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.7 t -62.14 -44.77 99.46 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 CA-C-N 114.821 -1.081 . . . . 0.67000000000000004 110.47 170.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -63.4 -19.24 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.71 0.633 . . . . 0.71999999999999997 112.71 -176.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.33 40.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.869 1.433 . . . . 0.93000000000000005 114.869 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 169.91 -164.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 123.503 0.721 . . . . 1.05 109.437 -171.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -109.08 91.46 9.37 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 109.216 -0.661 . . . . 1.5 109.216 166.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.858 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.78 1.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.387 3.391 . . . . 0.84999999999999998 115.116 175.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CG2' ' A' ' 75' ' ' VAL . . . 107.69 -10.95 38.57 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 110.065 -1.214 . . . . 0.67000000000000004 110.065 -161.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 51.09 -88.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.603 1.561 . . . . 0.45000000000000001 114.521 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -133.97 -36.41 0.93 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.733 0.778 . . . . 1.1100000000000001 110.439 -161.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 76' ' ' ASN . . . -97.76 155.21 20.42 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-N 114.742 -1.117 . . . . 0.39000000000000001 110.399 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.718 ' HB2' ' H ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -132.69 150.54 52.15 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 118.666 -1.214 . . . . 0.56000000000000005 112.858 178.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.73 ' HB3' ' HB2' ' A' ' 51' ' ' MET . 50.9 mtt180 -136.95 149.6 47.66 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 105.939 -1.875 . . . . 1.9399999999999999 105.939 162.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.79 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 41.6 p90 -154.93 158.13 38.8 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 120.165 1.348 . . . . 1.1399999999999999 112.635 171.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HG2' ' HB2' ' A' ' 45' ' ' ASN . 10.2 ttp180 -114.44 132.97 56.07 Favored 'General case' 0 C--O 1.256 1.424 0 N-CA-C 113.687 0.995 . . . . 2.7200000000000002 113.687 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' GLN 0.279 18.5 t30 105.88 -75.84 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 117.926 2.565 . . . . 3.04 117.926 144.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.603 ' CG ' HD12 ' A' ' 71' ' ' LEU . 56.0 Cg_exo -55.41 -3.23 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.132 1.888 . . . . 3.6200000000000001 114.484 -171.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.001 HG13 ' H ' ' A' ' 48' ' ' SER . 3.6 p -105.35 -94.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.663 -0.495 . . . . 4.4199999999999999 109.663 168.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 1.001 ' H ' HG13 ' A' ' 47' ' ' VAL . 17.6 t -110.89 7.01 21.62 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.326 -0.397 . . . . 3.3199999999999998 111.702 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 45' ' ' ASN . 10.6 tt0 52.4 25.55 3.57 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-O 121.55 0.69 . . . . 4.2000000000000002 112.348 -168.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -105.98 136.11 46.22 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 1.72 109.46 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.73 ' HB2' ' HB3' ' A' ' 42' ' ' ARG . 22.4 ptt? -62.61 85.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.793 0.806 . . . . 2.3500000000000001 111.125 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 57.0 ttt180 -100.54 150.29 22.83 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.494 -0.776 . . . . 2.48 110.954 -176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -90.45 160.83 28.27 Favored Glycine 0 C--N 1.293 -1.81 0 CA-C-N 115.019 -0.991 . . . . 0.40999999999999998 114.796 175.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.718 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 69.2 t -99.2 142.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.417 -1.392 . . . . 0.42999999999999999 109.804 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.731 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 1.2 mpt_? -66.89 133.73 50.62 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.052 0.39 . . . . 4.1100000000000003 112.052 -168.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.655 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -111.99 115.15 28.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.26 0.552 . . . . 1.53 109.64 172.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.623 HG12 ' HG3' ' A' ' 58' ' ' GLU . 3.6 t -133.81 118.93 31.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-N 116.222 -0.445 . . . . 0.53000000000000003 109.972 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 57' ' ' VAL . 29.2 mt-10 56.43 36.11 27.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.82 0.343 . . . . 1.51 111.643 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.31 0.41 89.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.493 -0.861 . . . . 0.51000000000000001 112.828 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 mt -97.08 147.43 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 O-C-N 122.617 -0.343 . . . . 0.48999999999999999 111.465 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.834 ' HB3' HG23 ' A' ' 26' ' ' VAL . 12.7 tp -104.03 115.76 31.02 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.55 -1.278 . . . . 1.0700000000000001 107.55 167.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -116.42 133.55 55.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.232 -0.587 . . . . 1.5 111.48 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.66 162.31 36.58 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.282 -1.007 . . . . 0.82999999999999996 108.282 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.79 160.05 42.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 121.87 1.714 . . . . 1.29 110.921 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.5 -44.25 17.53 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.693 0.621 . . . . 3.1200000000000001 111.89 -171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.89 32.47 0.1 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.082 -0.963 . . . . 2.1400000000000001 108.854 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -88.68 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.919 -1.037 . . . . 1.5600000000000001 113.935 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.855 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -103.89 -77.86 0.57 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.137 -0.69 . . . . 3.6899999999999999 109.137 -172.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.02 -78.37 0.13 Allowed Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.846 -1.169 . . . . 1.78 113.462 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.958 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 3.2 p-10 -127.92 -56.95 1.26 Allowed 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 114.957 -0.622 . . . . 1.48 109.444 -169.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER 56.45 167.34 0.03 OUTLIER 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 124.694 1.247 . . . . 0.90000000000000002 110.465 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 72' ' ' VAL . 1.9 p -95.07 104.39 15.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 118.858 -1.137 . . . . 0.81999999999999995 108.562 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.79 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.2 m-85 -80.2 145.06 32.46 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.885 0.85 . . . . 0.41999999999999998 111.845 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.3 t -108.76 154.52 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 113.519 -1.673 . . . . 0.34000000000000002 109.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.035 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -85.61 120.13 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.163 0.506 . . . . 1.8400000000000001 110.16 -167.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.579 ' HB3' ' C ' ' A' ' 40' ' ' GLY . 56.2 t30 -131.5 128.24 38.97 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.775 -0.578 . . . . 1.8799999999999999 111.01 172.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 118.999 -0.524 . . . . 1.3600000000000001 110.648 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.751 -0.463 . . . . 5.8600000000000003 109.751 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m 60.08 84.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.229 -0.656 . . . . 2.73 109.229 -173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -80.84 152.5 28.16 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.497 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 15.5 p90 -126.12 171.82 10.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.668 -0.864 . . . . 1.1699999999999999 108.668 -174.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 20.9 pt -116.47 163.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.646 0.26 . . . . 1.0 111.592 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.657 HH11 ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.31 131.48 56.33 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.853 -0.795 . . . . 2.73 108.853 179.298 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.34 146.35 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.98 -1.075 . . . . 1.45 111.365 178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.891 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.7 t -152.25 168.56 24.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.674 -0.239 . . . . 0.56000000000000005 110.413 166.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.657 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 1.7 mp0 -77.42 -33.92 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.461 0.648 . . . . 2.9700000000000002 111.247 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.23 152.56 51.94 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 107.569 -1.271 . . . . 1.1399999999999999 107.569 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.601 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 4.2 mt-10 -55.29 -39.62 70.08 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 122.555 1.169 . . . . 1.48 107.966 -173.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -106.85 25.91 10.72 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.873 -1.967 . . . . 2.02 113.057 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -81.83 -114.84 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.891 -1.151 . . . . 0.58999999999999997 107.891 170.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.96 91.05 50.07 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 115.754 -0.657 . . . . 2.1800000000000002 110.624 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.891 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 58.5 Cg_endo -70.7 134.65 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.551 1.501 . . . . 0.57999999999999996 110.379 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -127.29 153.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.364 -0.835 . . . . 0.51000000000000001 110.864 -169.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.775 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 1.8 mp0 -108.5 122.48 47.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.2 -0.454 . . . . 1.6200000000000001 110.849 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.63 138.67 17.54 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.902 -0.59 . . . . 1.52 112.006 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.04 148.34 21.71 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.957 2.438 . . . . 0.67000000000000004 112.231 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.9 m -122.6 169.24 11.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 0.96999999999999997 111.281 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -66.49 150.71 48.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.485 0.66 . . . . 2.77 111.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -52.38 -28.39 19.43 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 113.438 -1.71 . . . . 2.1299999999999999 111.903 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 33.6 t70 -77.74 -7.21 56.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.379 1.085 . . . . 2.3199999999999998 108.79 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.81 25.98 36.44 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 108.357 -1.897 . . . . 0.56000000000000005 108.357 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -120.18 151.08 39.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.874 -1.663 . . . . 0.62 112.179 -160.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 147.8 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.393 -0.821 . . . . 0.46999999999999997 110.519 173.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.077 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -65.19 96.51 0.22 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.258 0.623 . . . . 1.9399999999999999 110.247 178.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.63 -49.57 70.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.563 -0.289 . . . . 0.96999999999999997 110.254 -168.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.634 ' HA ' HG23 ' A' ' 32' ' ' THR . 9.5 p -70.2 -34.35 72.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.002 0.906 . . . . 1.4299999999999999 109.895 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.077 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 15.8 m -70.81 -32.78 69.97 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.742 -1.117 . . . . 1.4199999999999999 108.085 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.877 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.5 t -65.12 -42.15 93.63 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 CA-C-N 114.11 -1.404 . . . . 0.67000000000000004 110.846 171.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.9 OUTLIER -64.4 -20.32 66.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.855 -0.528 . . . . 0.71999999999999997 111.95 -175.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.826 1.417 . . . . 0.93000000000000005 114.826 173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.15 -163.3 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 123.211 0.604 . . . . 1.05 109.988 -173.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -106.96 92.59 7.8 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.719 -0.845 . . . . 1.5 108.719 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.877 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -122.34 2.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.201 3.267 . . . . 0.84999999999999998 114.867 173.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . 106.92 -16.15 39.78 Favored Glycine 0 C--O 1.217 -0.923 0 N-CA-C 109.917 -1.273 . . . . 0.67000000000000004 109.917 -162.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 52.75 -92.12 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.907 1.283 . . . . 0.45000000000000001 113.542 172.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.9 m -122.69 4.16 9.52 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.672 0.749 . . . . 1.1100000000000001 110.243 -166.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.65 174.65 21.47 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 110.085 -1.206 . . . . 0.39000000000000001 110.085 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -153.19 143.71 22.58 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 120.128 -0.629 . . . . 0.56000000000000005 110.692 178.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.554 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.4 mtt180 -134.64 150.84 50.7 Favored 'General case' 0 C--O 1.203 -1.369 0 N-CA-C 105.739 -1.949 . . . . 1.9399999999999999 105.739 160.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.69 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 45.9 p90 -152.54 165.23 35.79 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 121.181 1.809 . . . . 1.1399999999999999 113.125 170.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.601 ' HD2' ' OE2' ' A' ' 11' ' ' GLU . 35.1 mtp85 -106.91 134.34 50.22 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.159 -1.837 . . . . 2.7200000000000002 108.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.141 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 56.8 t30 -133.7 128.45 19.93 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 114.575 -1.193 . . . . 3.04 111.136 -164.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' A' ' 45' ' ' ASN . 86.9 Cg_exo -50.16 -13.04 0.54 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.802 3.001 . . . . 3.6200000000000001 115.996 -175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.002 HG13 ' H ' ' A' ' 48' ' ' SER . 2.8 p -94.73 -91.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 118.403 0.547 . . . . 4.4199999999999999 111.129 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 1.002 ' H ' HG13 ' A' ' 47' ' ' VAL . 80.0 p -97.26 -9.9 26.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.396 0.617 . . . . 3.3199999999999998 109.709 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.141 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 5.0 tt0 50.88 27.63 3.26 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.936 1.458 . . . . 4.2000000000000002 114.936 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -60.97 130.03 44.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.992 -0.373 . . . . 1.72 109.992 173.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -64.85 87.58 0.06 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.357 0.598 . . . . 2.3500000000000001 109.804 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' CE1' ' A' ' 43' ' ' TYR . 21.0 ttt180 -101.21 147.63 26.04 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.684 0.754 . . . . 2.48 112.288 -172.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -93.7 154.61 21.74 Favored Glycine 0 C--N 1.307 -1.062 0 CA-C-N 113.715 -1.584 . . . . 0.40999999999999998 114.279 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 46.4 t -100.04 143.7 13.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 113.746 -1.227 . . . . 0.42999999999999999 111.525 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -62.52 138.04 58.39 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 124.477 1.111 . . . . 4.1100000000000003 113.517 -175.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.4 pp -115.74 124.22 50.26 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.041 -0.264 . . . . 1.53 110.405 169.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.3 t -134.94 122.95 39.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.125 0 CA-C-O 118.846 -0.597 . . . . 0.53000000000000003 109.609 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HG3' HG12 ' A' ' 57' ' ' VAL . 35.1 mt-10 56.88 36.46 27.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.651 0.659 . . . . 1.51 112.093 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.29 8.69 87.03 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.549 -0.834 . . . . 0.51000000000000001 112.408 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 57' ' ' VAL . 5.8 mt -104.04 149.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 122.351 0.26 . . . . 0.48999999999999999 110.785 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.8 tp -102.08 116.02 31.78 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.974 -1.121 . . . . 1.0700000000000001 107.974 170.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.16 122.56 46.16 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.106 0.479 . . . . 1.5 111.734 -175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.01 163.6 22.41 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.82999999999999996 110.381 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.17 166.55 12.5 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.112 2.541 . . . . 1.29 111.875 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.78 -45.65 4.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.233 0.827 . . . . 3.1200000000000001 113.233 -170.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.99 -29.96 7.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.312 -0.858 . . . . 2.1400000000000001 110.935 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.79 128.64 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 122.04 0.8 . . . . 1.5600000000000001 113.375 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.535 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 m95 -84.2 -42.66 15.72 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 122.391 1.091 . . . . 3.6899999999999999 108.877 -174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.79 -79.82 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 113.359 -1.746 . . . . 1.78 111.446 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.69 -59.07 0.48 Allowed 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 114.423 -0.888 . . . . 1.48 109.36 -172.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER 58.08 151.25 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.799 1.312 . . . . 0.90000000000000002 110.425 -177.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' ARG . 1.6 p -91.33 106.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.395 -0.82 . . . . 0.81999999999999995 108.806 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.69 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 18.1 m-85 -78.63 144.16 35.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.141 -0.936 . . . . 0.41999999999999998 112.012 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.7 t -109.19 159.88 8.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.179 -1.828 . . . . 0.34000000000000002 109.625 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.657 ' HB ' ' O ' ' A' ' 9' ' ' GLU . 1.0 OUTLIER -91.95 113.09 26.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.76 0.791 . . . . 1.8400000000000001 111.257 -169.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -130.54 126.34 36.53 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.075 -0.966 . . . . 1.8799999999999999 108.922 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 118.23 -0.89 . . . . 1.3600000000000001 110.4 170.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.876 -0.416 . . . . 5.8600000000000003 109.876 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -93.82 114.94 27.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.074 -0.713 . . . . 2.73 109.074 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.28 147.5 28.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.088 0.471 . . . . 2.5 111.189 -172.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 23.4 p90 -138.69 174.73 10.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.985 -1.117 . . . . 1.1699999999999999 107.985 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.021 ' HA ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -135.23 162.33 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.222 0.465 . . . . 1.0 111.473 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 1.077 ' HG3' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -117.98 132.67 56.37 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 119.715 -0.794 . . . . 2.73 109.889 -176.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 3.3 p -138.85 148.44 24.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 O-C-N 121.941 -0.474 . . . . 1.45 111.405 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.985 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -153.98 164.01 39.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.353 -0.385 . . . . 0.56000000000000005 109.99 165.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.719 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.4 mp0 -67.94 -32.95 73.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.582 0.706 . . . . 2.9700000000000002 111.504 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' THR . 14.2 t70 -132.48 149.44 52.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.613 -1.625 . . . . 1.1399999999999999 106.613 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 3.0 mt-10 -54.44 -34.22 61.03 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 122.01 0.91 . . . . 1.48 108.653 -173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -110.19 28.65 8.42 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.502 -1.681 . . . . 2.02 111.867 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.668 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 10.3 t70 -83.7 -117.93 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.895 -0.78 . . . . 0.58999999999999997 108.895 171.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -121.4 89.61 47.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.555 -0.748 . . . . 2.1800000000000002 110.429 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.985 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 74.4 Cg_endo -75.06 140.56 25.42 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 C-N-CA 123.107 2.538 . . . . 0.57999999999999996 113.506 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.09 125.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 115.448 -0.796 . . . . 0.51000000000000001 110.509 -175.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.077 ' HG2' ' HG3' ' A' ' 6' ' ' ARG . 25.0 mt-10 -86.12 120.6 27.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.223 -0.658 . . . . 1.6200000000000001 109.223 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 19.7 pt -142.03 144.41 31.89 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.303 -0.862 . . . . 1.52 111.454 -168.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 72.2 Cg_endo -74.64 145.29 32.74 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.867 2.378 . . . . 0.67000000000000004 113.34 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.503 ' OG ' HD12 ' A' ' 5' ' ' ILE . 8.5 m -104.42 170.26 8.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 110.232 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.01 141.12 54.97 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.987 -0.746 . . . . 2.77 108.987 173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.66 -19.14 5.52 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.354 1.034 . . . . 2.1299999999999999 112.689 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' A' ' 25' ' ' THR . 7.4 m-20 -75.95 -5.17 44.98 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 122.124 0.964 . . . . 2.3199999999999998 108.775 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.21 23.99 60.13 Favored Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 108.74 -1.744 . . . . 0.56000000000000005 108.74 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -122.38 154.03 38.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.1 -1.55 . . . . 0.62 111.238 -162.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -146.68 143.12 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.526 -0.761 . . . . 0.46999999999999997 109.741 172.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 3.5 mp -68.53 116.92 9.62 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.786 -0.45 . . . . 1.9399999999999999 109.786 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD13 HD21 ' A' ' 61' ' ' LEU . 15.6 tp -60.02 -51.36 69.96 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.206 0.316 . . . . 0.96999999999999997 110.697 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.706 ' HA ' HG23 ' A' ' 32' ' ' THR . 7.9 m -71.78 -44.86 63.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.428 -0.805 . . . . 1.4299999999999999 110.859 -174.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 2.7 m -63.67 -32.19 73.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.955 -0.566 . . . . 1.4199999999999999 109.721 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.848 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -59.43 -48.47 87.07 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 CA-C-N 115.908 -0.587 . . . . 0.67000000000000004 110.262 169.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.11 -17.76 63.75 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.043 0.757 . . . . 0.71999999999999997 113.043 -176.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.63 37.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.542 1.312 . . . . 0.93000000000000005 114.542 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 171.48 -165.71 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.967 0.907 . . . . 1.05 108.993 -173.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -109.31 92.79 12.06 Favored Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 109.233 -0.654 . . . . 1.5 109.233 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.848 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -120.92 8.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 124.52 3.48 . . . . 0.84999999999999998 113.928 173.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.929 ' HA2' ' HB ' ' A' ' 75' ' ' VAL . . . 107.83 -26.7 16.79 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 110.078 -1.209 . . . . 0.67000000000000004 110.078 -162.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.72 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 61.1 -81.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.987 1.106 . . . . 0.45000000000000001 113.987 167.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 28' ' ' LEU . 36.5 t -120.28 -12.9 8.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.524 0.678 . . . . 1.1100000000000001 109.443 -165.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.65 157.51 24.15 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.897 -1.047 . . . . 0.39000000000000001 112.344 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.4 OUTLIER -127.94 153.01 47.18 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.174 -0.61 . . . . 0.56000000000000005 111.502 174.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 95.1 mtt180 -138.52 146.52 42.06 Favored 'General case' 0 C--O 1.208 -1.08 0 N-CA-C 106.743 -1.577 . . . . 1.9399999999999999 106.743 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.841 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 47.4 p90 -154.67 166.92 31.89 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 117.903 -1.519 . . . . 1.1399999999999999 113.946 169.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.64 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 73.8 ttt180 -102.32 137.69 40.23 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 113.857 -1.519 . . . . 2.7200000000000002 107.853 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.853 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 3.4 t-20 -142.68 111.95 5.83 Favored Pre-proline 0 C--O 1.211 -0.927 0 N-CA-C 113.219 0.822 . . . . 3.04 113.219 -158.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HD2' HD12 ' A' ' 71' ' ' LEU . 31.7 Cg_exo -20.89 -35.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.269 1 C-N-CA 126.783 4.989 . . . . 3.6200000000000001 118.105 -175.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.895 HG13 ' H ' ' A' ' 48' ' ' SER . 2.1 p -81.69 -83.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 118.871 0.759 . . . . 4.4199999999999999 110.821 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.895 ' H ' HG13 ' A' ' 47' ' ' VAL . 87.5 p -103.76 -9.64 18.92 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.109 -0.496 . . . . 3.3199999999999998 110.486 -177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.853 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 5.9 mt-30 50.66 25.59 2.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.961 -1.018 . . . . 4.2000000000000002 113.426 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 m -57.33 133.96 55.58 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.124 -0.944 . . . . 1.72 109.973 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -63.42 88.22 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.672 0.748 . . . . 2.3500000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -102.41 145.03 30.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.382 -0.826 . . . . 2.48 111.623 -173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 167.28 21.28 Favored Glycine 0 C--N 1.299 -1.512 0 CA-C-N 114.092 -1.413 . . . . 0.40999999999999998 114.216 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 55.9 t -97.43 140.16 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.036 -1.082 . . . . 0.42999999999999999 111.058 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 4.0 mpt_? -67.33 135.86 53.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.58 -0.736 . . . . 4.1100000000000003 112.402 -174.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.788 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -108.11 120.51 42.53 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.935 -0.706 . . . . 1.53 110.563 171.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.749 HG12 ' HG3' ' A' ' 58' ' ' GLU . 32.5 t -130.16 115.81 34.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 115.686 -0.688 . . . . 0.53000000000000003 109.774 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.749 ' HG3' HG12 ' A' ' 57' ' ' VAL . 16.4 mt-10 52.59 35.42 17.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.766 0.317 . . . . 1.51 111.504 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.87 4.65 75.11 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.835 -0.698 . . . . 0.51000000000000001 113.066 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.788 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 5.1 mt -100.64 148.98 6.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 O-C-N 122.586 -0.361 . . . . 0.48999999999999999 111.496 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.852 ' HB2' HG23 ' A' ' 26' ' ' VAL . 56.2 mt -101.36 118.17 36.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.253 -1.017 . . . . 1.0700000000000001 108.253 167.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 128.96 55.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.331 -0.547 . . . . 1.5 111.832 -174.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 161.35 57.84 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.83 -1.544 . . . . 0.82999999999999996 106.83 161.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 12.7 Cg_exo -69.19 146.69 64.54 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.624 1.549 . . . . 1.29 111.145 -172.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.35 -45.78 17.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.804 0.811 . . . . 3.1200000000000001 111.629 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.79 24.26 5.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.38 -1.282 . . . . 2.1400000000000001 109.356 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 64' ' ' PRO . . . -77.3 -119.48 0.19 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.707 -0.759 . . . . 1.5600000000000001 112.715 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.821 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.49 -172.94 2.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.454 -0.573 . . . . 3.6899999999999999 109.454 -175.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -175.13 86.47 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.861 -1.162 . . . . 1.78 112.042 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.021 ' HB2' ' HA ' ' A' ' 5' ' ' ILE . 3.5 t30 102.19 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 124.808 2.242 . . . . 1.48 108.946 171.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -86.72 -177.48 6.13 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 109.517 -3.492 . . . . 0.90000000000000002 106.396 167.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -99.28 101.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 124.546 1.154 . . . . 0.81999999999999995 108.697 176.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 19.5 m-85 -84.2 141.27 31.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.704 1.002 . . . . 0.41999999999999998 113.704 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.8 t -109.2 163.91 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 112.564 -2.107 . . . . 0.34000000000000002 107.593 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.929 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 21.5 m -118.9 127.74 75.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.59 -0.694 . . . . 1.8400000000000001 111.407 -169.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -127.91 128.35 44.97 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.751 -0.78 . . . . 1.8799999999999999 110.341 169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.717 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.047 -0.977 . . . . 1.3600000000000001 110.306 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.921 -0.4 . . . . 5.8600000000000003 109.921 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 61.59 92.22 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.312 -0.625 . . . . 2.73 109.312 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -78.86 140.51 38.14 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.068 -0.514 . . . . 2.5 110.862 -166.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 70' ' ' ASN . 38.8 p90 -133.6 172.2 13.07 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.591 -0.892 . . . . 1.1699999999999999 108.591 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.849 HD12 ' HE1' ' A' ' 73' ' ' TYR . 15.0 pt -127.52 165.78 25.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 122.611 0.365 . . . . 1.0 110.792 -170.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.611 ' NH1' ' HG3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -114.46 132.76 56.16 Favored 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 108.952 -0.758 . . . . 2.73 108.952 -178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 HG22 ' HD1' ' A' ' 73' ' ' TYR . 2.3 t -135.89 143.5 36.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 O-C-N 121.113 -0.992 . . . . 1.45 110.296 -177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.966 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 t -153.55 167.41 29.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.039 -0.356 . . . . 0.56000000000000005 110.039 162.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.927 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -72.48 -54.18 10.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 122.023 0.916 . . . . 2.9700000000000002 109.2 173.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 13.1 t70 -112.63 148.13 35.26 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.639 -1.245 . . . . 1.1399999999999999 107.639 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 74' ' ' VAL . 3.8 mt-10 -58.55 -26.38 63.5 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.869 -1.06 . . . . 1.48 108.414 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -119.8 29.19 7.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 113.636 -1.62 . . . . 2.02 111.158 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.483 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 4.4 t70 -84.31 -117.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.07 -1.085 . . . . 0.58999999999999997 108.07 170.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 31.0 mt-10 -121.52 90.87 48.19 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.136 -0.938 . . . . 2.1800000000000002 110.218 168.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.966 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 60.8 Cg_endo -72.47 134.21 22.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.649 1.566 . . . . 0.57999999999999996 110.82 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.526 ' C ' ' HD3' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -129.72 144.2 38.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.269 -0.878 . . . . 0.51000000000000001 110.983 -168.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.611 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 16.9 mt-10 -90.76 122.12 33.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.768 -0.456 . . . . 1.6200000000000001 109.768 174.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.75 HD12 ' HD2' ' A' ' 19' ' ' PRO . 7.1 tp -140.85 131.73 13.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.469 -0.787 . . . . 1.52 111.175 -169.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.75 ' HD2' HD12 ' A' ' 18' ' ' ILE . 55.4 Cg_endo -71.88 137.71 30.05 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.652 2.235 . . . . 0.67000000000000004 112.764 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.0 p -106.32 170.46 7.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 0.96999999999999997 110.297 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -65.46 140.83 58.64 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.963 -0.384 . . . . 2.77 109.963 178.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 24' ' ' GLY . 3.5 m-20 -54.99 -19.91 7.9 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.617 -1.174 . . . . 2.1299999999999999 111.987 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.78 0.92 13.79 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.866 0.841 . . . . 2.3199999999999998 108.8 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.09 24.64 73.19 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.687 -1.365 . . . . 0.56000000000000005 109.687 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -134.74 166.15 23.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.143 -1.028 . . . . 0.62 109.963 -168.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -146.18 148.21 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.415 -0.357 . . . . 0.46999999999999997 110.384 175.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.044 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -65.56 94.55 0.19 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.148 -0.478 . . . . 1.9399999999999999 109.861 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -63.61 -49.08 74.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.664 -0.495 . . . . 0.96999999999999997 109.664 -168.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.558 ' N ' ' HG ' ' A' ' 28' ' ' LEU . 5.4 p -65.5 -35.6 81.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.5 0.667 . . . . 1.4299999999999999 110.349 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.044 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 3.4 m -72.35 -33.72 67.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.316 -0.856 . . . . 1.4199999999999999 108.7 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.88 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 45.7 t -63.72 -39.71 86.37 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-N 115.159 -0.928 . . . . 0.67000000000000004 110.383 170.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.6 p -64.87 -20.15 66.27 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 112.142 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 41.34 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.56 1.319 . . . . 0.93000000000000005 114.56 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 172.08 -163.88 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.258 0.623 . . . . 1.05 110.021 -173.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.7 92.83 7.77 Favored Pre-proline 0 N--CA 1.436 -1.132 0 N-CA-C 108.649 -0.871 . . . . 1.5 108.649 165.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.88 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -122.25 3.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.639 2.892 . . . . 0.84999999999999998 114.561 171.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.826 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 106.99 -23.77 26.73 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 109.806 -1.317 . . . . 0.67000000000000004 109.806 -161.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.82 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 58.49 -89.74 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.031 1.333 . . . . 0.45000000000000001 114.106 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 32.1 t -125.4 -13.34 6.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.45 0.643 . . . . 1.1100000000000001 110.846 -161.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.23 15.79 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 109.633 -1.387 . . . . 0.39000000000000001 109.633 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -133.05 139.75 47.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 118.963 -1.095 . . . . 0.56000000000000005 111.871 175.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 67.6 mtt180 -132.69 154.2 50.39 Favored 'General case' 0 C--O 1.208 -1.096 0 N-CA-C 106.313 -1.736 . . . . 1.9399999999999999 106.313 162.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.1 p90 -154.69 165.47 36.44 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 120.121 1.328 . . . . 1.1399999999999999 113.234 170.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.77 ' HB2' HG13 ' A' ' 72' ' ' VAL . 97.1 mtt180 -97.28 133.31 42.07 Favored 'General case' 0 C--O 1.253 1.268 0 O-C-N 125.684 1.865 . . . . 2.7200000000000002 109.142 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.117 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 2.8 t-20 -128.54 122.53 21.79 Favored Pre-proline 0 C--O 1.22 -0.483 0 CA-C-N 114.081 -1.418 . . . . 3.04 110.848 -170.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 45' ' ' ASN . 77.5 Cg_exo -51.74 -15.42 2.93 Favored 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 124.027 3.151 . . . . 3.6200000000000001 116.467 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 48' ' ' SER . 0.8 OUTLIER -91.29 -90.47 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 118.792 0.724 . . . . 4.4199999999999999 111.383 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.646 ' N ' HG22 ' A' ' 47' ' ' VAL . 3.4 m -101.99 -2.57 29.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.746 0.784 . . . . 3.3199999999999998 110.765 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.117 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 2.5 tt0 51.02 47.91 24.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 115.132 1.53 . . . . 4.2000000000000002 115.132 171.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -62.07 121.17 12.36 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.244 -0.889 . . . . 1.72 109.017 169.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 59.3 mtm -68.44 77.82 0.27 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.65 -0.87 . . . . 2.3500000000000001 108.65 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 14.0 ttt180 -103.88 156.78 17.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.469 -0.787 . . . . 2.48 111.54 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.589 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -98.16 158.21 20.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.496 -1.229 . . . . 0.40999999999999998 114.766 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.635 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 87.9 t -98.86 143.93 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.325 -1.437 . . . . 0.42999999999999999 109.854 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' A' ' 64' ' ' PRO . 82.0 mtt180 -64.48 135.25 55.87 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 111.56 0.207 . . . . 4.1100000000000003 111.56 -171.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -113.7 114.98 27.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.873 0.368 . . . . 1.53 110.031 170.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 60' ' ' ILE . 4.6 t -128.32 115.09 36.79 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.472 -0.331 . . . . 0.53000000000000003 110.296 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.634 ' HG3' HG12 ' A' ' 57' ' ' VAL . 23.0 mt-10 53.44 36.55 23.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.999 0.52 . . . . 1.51 112.383 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.1 0.91 73.39 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.402 -0.904 . . . . 0.51000000000000001 112.689 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 57' ' ' VAL . 1.9 mt -104.34 148.04 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 122.681 -0.305 . . . . 0.48999999999999999 111.163 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.952 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.3 tp -102.39 114.95 29.58 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.797 -1.186 . . . . 1.0700000000000001 107.797 169.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -115.66 142.2 47.06 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.2 0.524 . . . . 1.5 111.891 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.28 160.85 29.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.091 -0.958 . . . . 0.82999999999999996 110.301 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 24.2 Cg_exo -64.16 166.06 17.8 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.912 3.075 . . . . 1.29 112.602 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.01 -46.57 5.56 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.908 0.861 . . . . 3.1200000000000001 112.804 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.18 -44.25 8.44 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.987 -1.46 . . . . 2.1400000000000001 110.043 -175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.2 133.64 0.48 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.369 -0.832 . . . . 1.5600000000000001 112.427 -176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.624 ' CG ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.52 -77.39 0.07 Allowed 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.091 -0.555 . . . . 3.6899999999999999 109.787 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 176.24 -85.62 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.663 -0.698 . . . . 1.78 112.101 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 4.9 p-10 -156.38 54.84 0.56 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.199 1.0 . . . . 1.48 109.697 -171.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.624 HD11 ' CG ' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -52.92 162.51 0.61 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-N 113.465 -1.698 . . . . 0.90000000000000002 110.028 165.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.77 HG13 ' HB2' ' A' ' 44' ' ' ARG . 1.6 p -96.42 107.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 114.297 -1.319 . . . . 0.81999999999999995 108.656 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.849 ' HE1' HD12 ' A' ' 5' ' ' ILE . 17.1 m-85 -80.03 146.95 31.7 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.121 -0.945 . . . . 0.41999999999999998 112.638 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -110.28 158.8 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 113.386 -1.734 . . . . 0.34000000000000002 110.039 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.927 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 6.4 p -97.61 109.06 22.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.594 0.711 . . . . 1.8400000000000001 112.422 -165.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.453 ' OD1' ' HG3' ' A' ' 42' ' ' ARG . 0.9 OUTLIER -130.62 128.51 41.14 Favored 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 120.144 -0.623 . . . . 1.8799999999999999 111.399 165.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.713 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.764 0 CA-C-O 119.129 -0.462 . . . . 1.3600000000000001 110.652 167.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 110.276 -0.268 . . . . 5.8600000000000003 110.276 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t 71.48 125.33 0.03 OUTLIER 'General case' 0 C--O 1.235 0.292 0 O-C-N 124.087 0.867 . . . . 2.73 110.397 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -80.83 153.16 27.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.848 -0.615 . . . . 2.5 109.596 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.517 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 20.5 p90 -120.51 166.84 13.06 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.613 -1.254 . . . . 1.1699999999999999 107.613 -176.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 21.7 pt -121.45 162.38 20.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 120.645 0.26 . . . . 1.0 110.589 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.892 ' HG3' ' HA ' ' A' ' 72' ' ' VAL . 1.4 tpp85 -118.81 131.96 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.0 -1.111 . . . . 2.73 108.0 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 1.5 p -139.85 146.95 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 O-C-N 121.218 -0.926 . . . . 1.45 110.763 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 1.044 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 3.2 t -152.26 148.87 28.07 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.666 -0.243 . . . . 0.56000000000000005 110.408 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 1.07 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 47.9 mp0 -60.8 -36.21 78.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.145 0.498 . . . . 2.9700000000000002 111.593 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -128.35 153.41 47.06 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.972 -1.492 . . . . 1.1399999999999999 106.972 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -57.24 -30.67 64.82 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.718 0.771 . . . . 1.48 108.927 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -119.76 31.66 6.44 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.366 -1.288 . . . . 2.02 110.972 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 3.8 t70 -79.98 -118.26 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.26 -1.385 . . . . 0.58999999999999997 107.26 168.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 21.9 tt0 -120.45 91.88 47.04 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.72 -0.673 . . . . 2.1800000000000002 110.01 168.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.044 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 64.1 Cg_endo -71.56 133.45 22.34 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.201 1.934 . . . . 0.57999999999999996 111.555 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.52 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.44 -0.8 . . . . 0.51000000000000001 110.885 -170.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 26.6 mt-10 -97.77 121.98 40.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.053 -0.522 . . . . 1.6200000000000001 110.123 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 41.4 pt -141.28 143.36 30.21 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.843 -0.617 . . . . 1.52 111.295 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' ILE . 8.2 Cg_exo -72.6 160.15 47.18 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.184 2.589 . . . . 0.67000000000000004 112.422 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.4 m -132.37 171.67 13.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 110.001 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' THR . 28.8 tt0 -64.03 142.09 58.54 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.262 -0.644 . . . . 2.77 109.262 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.21 -24.21 17.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 124.503 1.127 . . . . 2.1299999999999999 111.951 -168.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 16.0 t70 -74.38 -8.64 56.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.34 1.067 . . . . 2.3199999999999998 108.905 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.26 41.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.741 -1.744 . . . . 0.56000000000000005 108.741 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -120.62 154.89 34.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.052 -1.574 . . . . 0.62 111.518 -165.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.932 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -147.61 140.01 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 115.161 -0.927 . . . . 0.46999999999999997 109.138 169.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.8 mp -64.43 111.86 2.85 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.927 -0.768 . . . . 1.9399999999999999 108.927 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' THR . 30.0 tp -58.14 -51.71 68.58 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 120.756 0.313 . . . . 0.96999999999999997 110.193 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -67.18 -47.5 70.76 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.564 -0.744 . . . . 1.4299999999999999 110.626 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.632 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.0 m -65.55 -32.65 74.36 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 115.563 -0.744 . . . . 1.4199999999999999 109.81 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.872 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 t -61.48 -45.12 99.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.969 0 CA-C-N 115.907 -0.588 . . . . 0.67000000000000004 110.478 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.5 p -64.36 -19.21 65.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.207 0.447 . . . . 0.71999999999999997 112.207 -176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.1 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.364 1.246 . . . . 0.93000000000000005 114.364 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER 171.22 -164.35 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 123.406 0.682 . . . . 1.05 109.835 -173.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -107.79 92.81 9.42 Favored Pre-proline 0 N--CA 1.433 -1.276 0 CA-C-N 115.55 -0.75 . . . . 1.5 109.214 165.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.872 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -120.32 6.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.322 3.348 . . . . 0.84999999999999998 113.924 171.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 1.068 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 107.47 -25.54 21.14 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.097 -1.201 . . . . 0.67000000000000004 110.097 -161.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 56.61 -91.81 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.029 1.332 . . . . 0.45000000000000001 113.735 173.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.469 ' HA ' HD11 ' A' ' 28' ' ' LEU . 19.5 m -115.78 -21.71 9.48 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 110.135 -160.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.57 147.8 18.74 Favored Glycine 0 N--CA 1.418 -2.557 0 CA-C-N 114.783 -1.099 . . . . 0.39000000000000001 111.005 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -128.22 142.34 51.19 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.335 -0.946 . . . . 0.56000000000000005 110.606 172.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.696 ' HG3' ' ND2' ' A' ' 76' ' ' ASN . 96.0 mtt180 -132.24 161.78 32.58 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.841 -1.911 . . . . 1.9399999999999999 105.841 165.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.754 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -157.4 166.66 32.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.038 -1.065 . . . . 1.1399999999999999 112.369 168.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.496 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 46.4 mtp180 -111.08 139.28 46.57 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.347 1.655 . . . . 2.7200000000000002 108.282 172.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.892 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -137.49 120.82 11.6 Favored Pre-proline 0 C--O 1.209 -1.033 0 CA-C-N 115.343 -0.844 . . . . 3.04 111.636 -161.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' N ' HD22 ' A' ' 45' ' ' ASN . 82.1 Cg_exo -49.58 5.98 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 124.653 3.569 . . . . 3.6200000000000001 116.869 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.998 HG13 ' H ' ' A' ' 48' ' ' SER . 2.7 p -100.62 -86.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 121.797 -0.564 . . . . 4.4199999999999999 110.25 169.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.998 ' H ' HG13 ' A' ' 47' ' ' VAL . 68.5 p -107.28 -8.12 16.49 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.977 -0.556 . . . . 3.3199999999999998 110.911 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.892 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 6.2 mt-30 51.77 28.02 4.61 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 124.482 1.113 . . . . 4.2000000000000002 113.494 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -46.88 121.68 3.8 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.262 -0.881 . . . . 1.72 110.207 171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 15.8 ptm -63.6 86.21 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.21 -0.663 . . . . 2.3500000000000001 109.21 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 10.6 ttt180 -124.67 151.03 45.46 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.709 0.766 . . . . 2.48 111.079 -172.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -95.51 165.52 24.87 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 114.194 -1.366 . . . . 0.40999999999999998 115.124 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.685 ' H ' ' HB3' ' A' ' 41' ' ' LEU . 78.5 t -83.73 141.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 112.879 -1.661 . . . . 0.42999999999999999 109.696 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.6 mpt_? -64.96 134.53 54.12 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.485 0.18 . . . . 4.1100000000000003 111.485 -171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.8 pp -110.62 114.08 27.2 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.59 -0.444 . . . . 1.53 110.065 172.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.591 HG12 ' HG3' ' A' ' 58' ' ' GLU . 13.9 t -125.1 113.79 37.25 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 109.916 -0.401 . . . . 0.53000000000000003 109.916 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 57' ' ' VAL . 19.9 mt-10 52.19 36.6 19.68 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.837 0.455 . . . . 1.51 111.711 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.79 -1.71 75.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.38 -0.914 . . . . 0.51000000000000001 112.891 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 3.9 mt -95.69 145.49 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 117.342 0.571 . . . . 0.48999999999999999 110.688 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.932 ' HB3' HG23 ' A' ' 26' ' ' VAL . 11.9 tp -104.38 115.82 31.05 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.65 -1.241 . . . . 1.0700000000000001 107.65 170.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.422 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 2.5 t-80 -116.05 133.57 55.88 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.162 -0.615 . . . . 1.5 112.081 -171.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 162.24 37.23 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 107.684 -1.228 . . . . 0.82999999999999996 107.684 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.09 153.19 72.41 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.491 1.46 . . . . 1.29 110.835 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -46.92 -44.14 19.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.588 0.709 . . . . 3.1200000000000001 111.472 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.64 36.43 0.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.428 -1.26 . . . . 2.1400000000000001 108.646 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.34 -103.53 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.99 -1.005 . . . . 1.5600000000000001 113.885 -172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HD1' HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -86.57 -58.18 2.71 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.969 -0.752 . . . . 3.6899999999999999 108.969 -173.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.58 -69.71 0.34 Allowed Glycine 0 N--CA 1.432 -1.579 0 CA-C-N 114.57 -1.196 . . . . 1.78 113.195 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -139.39 -56.06 0.58 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 114.628 -0.786 . . . . 1.48 109.107 -168.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.631 HD21 ' HD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER 55.25 161.78 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.72 0 O-C-N 124.375 1.047 . . . . 0.90000000000000002 110.544 -177.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.892 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 16.3 m -93.63 104.27 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 108.174 -1.047 . . . . 0.81999999999999995 108.174 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.754 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 22.5 m-85 -78.58 138.91 38.6 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.884 -0.598 . . . . 0.41999999999999998 111.504 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.5 t -96.85 151.94 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.456 -1.247 . . . . 0.34000000000000002 108.687 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.07 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 4.0 t -114.86 115.23 48.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.342 0.591 . . . . 1.8400000000000001 112.265 -163.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.696 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -128.63 129.14 45.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.497 -0.774 . . . . 1.8799999999999999 111.351 178.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.748 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.2 p90 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.658 -0.687 . . . . 1.3600000000000001 110.552 170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.639 0.257 . . . . 5.8600000000000003 110.651 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -87.8 119.02 27.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.848 -0.427 . . . . 2.73 109.848 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.75 134.18 35.13 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.65 -0.5 . . . . 2.5 109.65 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.933 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 32.6 p90 -141.19 172.9 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.272 -0.64 . . . . 1.1699999999999999 109.272 -170.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.985 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 25.4 pt -124.06 160.71 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.234 0.333 . . . . 1.0 110.516 -174.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.782 ' HD3' ' HB2' ' A' ' 15' ' ' PRO . 22.1 ttm180 -118.73 135.61 54.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.976 -0.69 . . . . 2.73 110.146 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.663 ' HA ' ' HB2' ' A' ' 73' ' ' TYR . 2.1 t -130.02 145.94 34.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.726 0 O-C-N 122.044 -0.41 . . . . 1.45 110.638 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.78 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 1.3 t -151.4 163.02 39.91 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.297 -0.252 . . . . 0.56000000000000005 110.417 163.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 1.047 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 mp0 -68.87 -39.05 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.925 -0.71 . . . . 2.9700000000000002 111.011 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.26 154.84 50.78 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.875 -0.787 . . . . 1.1399999999999999 108.875 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -52.6 -39.34 61.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.454 1.121 . . . . 1.48 108.257 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.57 7.97 33.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.366 -1.743 . . . . 2.02 112.939 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 2.7 t70 -85.79 -127.01 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 118.861 -1.136 . . . . 0.58999999999999997 108.218 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.46 92.13 48.55 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.566 -0.743 . . . . 2.1800000000000002 110.315 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 60.1 Cg_endo -70.57 132.96 23.04 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.726 1.617 . . . . 0.57999999999999996 111.094 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.19 125.82 64.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.173 -0.921 . . . . 0.51000000000000001 110.692 -169.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.933 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 23.4 mt-10 -85.1 120.98 27.22 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.966 -0.561 . . . . 1.6200000000000001 110.453 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 21.4 pt -143.07 145.2 31.92 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.07 -0.968 . . . . 1.52 111.748 -171.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 4' ' ' TYR . 16.5 Cg_exo -69.54 133.68 26.56 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.112 2.542 . . . . 0.67000000000000004 113.084 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 p -108.53 172.23 6.96 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 110.647 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.73 138.41 58.37 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.044 0.45 . . . . 2.77 110.018 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -53.48 -31.49 45.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.954 -1.476 . . . . 2.1299999999999999 112.183 -170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.4 p-10 -85.45 2.3 45.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.877 0.846 . . . . 2.3199999999999998 108.9 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 25.47 18.28 Favored Glycine 0 CA--C 1.497 -1.07 0 CA-C-N 114.336 -1.302 . . . . 0.56000000000000005 109.976 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.544 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.01 155.42 29.23 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.004 -1.098 . . . . 0.62 112.254 -165.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -145.49 138.49 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 CA-C-N 115.121 -0.945 . . . . 0.46999999999999997 108.994 169.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.748 ' H ' HD12 ' A' ' 27' ' ' LEU . 2.6 mp -64.08 112.09 2.83 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.942 -0.762 . . . . 1.9399999999999999 108.942 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -64.34 -50.01 69.44 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.193 -0.669 . . . . 0.96999999999999997 109.193 -174.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' THR . 5.8 p -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 1.4299999999999999 111.171 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.714 ' HB ' ' CB ' ' A' ' 27' ' ' LEU . 3.6 m -68.43 -32.95 73.34 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.181 -0.674 . . . . 1.4199999999999999 109.181 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.861 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.3 t -58.61 -53.41 47.41 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 CA-C-N 115.199 -0.91 . . . . 0.67000000000000004 110.383 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -61.94 -16.64 52.59 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.351 0.871 . . . . 0.71999999999999997 113.351 -175.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.375 1.25 . . . . 0.93000000000000005 114.375 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 32' ' ' THR . 0.2 OUTLIER 172.32 -164.26 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 124.014 0.926 . . . . 1.05 109.259 -173.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -108.96 91.88 9.85 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 109.073 -0.714 . . . . 1.5 109.073 164.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.861 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -122.13 8.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.801 3.667 . . . . 0.84999999999999998 114.466 175.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.866 ' HA2' HG13 ' A' ' 75' ' ' VAL . . . 108.27 -21.16 29.39 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.137 -1.185 . . . . 0.67000000000000004 110.137 -163.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 77' ' ' TYR . . . 58.51 -81.45 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.755 1.02 . . . . 0.45000000000000001 113.755 170.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.9 m -130.77 -5.33 4.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.52 0.676 . . . . 1.1100000000000001 110.472 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.0 155.27 21.37 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 115.14 -0.936 . . . . 0.39000000000000001 111.86 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -132.41 154.59 49.67 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 119.8 -0.76 . . . . 0.56000000000000005 111.466 174.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.2 mtt180 -140.41 151.82 45.22 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.706 -1.961 . . . . 1.9399999999999999 105.706 161.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.698 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 36.3 p90 -157.63 165.03 36.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 120.188 1.358 . . . . 1.1399999999999999 112.699 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 45.3 mtm180 -110.89 150.38 29.27 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 125.601 1.813 . . . . 2.7200000000000002 109.554 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.837 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 23.4 t-20 -146.21 116.53 4.75 Favored Pre-proline 0 C--O 1.214 -0.806 0 CA-C-N 114.148 -1.387 . . . . 3.04 111.115 -162.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 71' ' ' LEU . 14.2 Cg_exo -25.6 -27.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 126.569 4.846 . . . . 3.6200000000000001 118.311 -172.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.982 HG13 ' H ' ' A' ' 48' ' ' SER . 2.5 p -83.9 -84.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 118.957 0.799 . . . . 4.4199999999999999 110.855 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.982 ' H ' HG13 ' A' ' 47' ' ' VAL . 22.7 t -107.12 -9.01 16.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 116.021 -0.536 . . . . 3.3199999999999998 110.151 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.837 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 10.2 mt-30 50.61 26.97 2.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 113.901 1.075 . . . . 4.2000000000000002 113.901 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.71 115.9 1.3 Allowed 'General case' 0 C--N 1.308 -1.223 0 O-C-N 123.813 0.696 . . . . 1.72 110.739 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 4.8 ptt? -62.43 92.43 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.378 0.608 . . . . 2.3500000000000001 110.222 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' CE1' ' A' ' 43' ' ' TYR . 7.6 ptp85 -122.31 161.42 23.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.573 -0.74 . . . . 2.48 109.691 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -116.13 167.26 12.43 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.085 -1.055 . . . . 0.40999999999999998 115.391 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.705 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 99.5 t -83.96 141.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 113.345 -1.427 . . . . 0.42999999999999999 111.391 -174.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 55' ' ' ARG . 3.3 mpt_? -72.29 135.64 46.03 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.643 -0.708 . . . . 4.1100000000000003 112.221 -171.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp -98.84 117.68 33.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.103 -0.639 . . . . 1.53 109.888 172.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.61 HG12 ' HG3' ' A' ' 58' ' ' GLU . 9.5 t -132.95 114.7 22.37 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.81 0 N-CA-C 109.87 -0.419 . . . . 0.53000000000000003 109.87 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HG3' HG12 ' A' ' 57' ' ' VAL . 25.3 mt-10 53.9 39.5 30.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.092 0.405 . . . . 1.51 112.092 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 87.04 -1.37 86.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.42 -0.895 . . . . 0.51000000000000001 112.646 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.3 mt -100.75 149.33 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 O-C-N 122.734 -0.274 . . . . 0.48999999999999999 111.073 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.4 tp -102.09 114.83 29.3 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.507 -1.664 . . . . 1.0700000000000001 106.507 165.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -115.57 134.69 54.81 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.269 0.557 . . . . 1.5 112.322 -165.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.65 163.02 18.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.591 -1.186 . . . . 0.82999999999999996 108.572 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.82 163.76 15.33 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.687 2.258 . . . . 1.29 111.683 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.2 -45.79 8.59 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.71 0.766 . . . . 3.1200000000000001 112.834 -173.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.38 -39.12 8.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.296 -1.32 . . . . 2.1400000000000001 110.336 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.88 149.06 4.48 Favored Glycine 0 N--CA 1.426 -2.029 0 C-N-CA 120.556 -0.831 . . . . 1.5600000000000001 112.298 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.738 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -67.85 -52.43 36.82 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.934 -1.135 . . . . 3.6899999999999999 107.934 175.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 5' ' ' ILE . . . 166.98 -83.76 0.1 OUTLIER Glycine 0 N--CA 1.417 -2.58 0 CA-C-N 113.79 -1.55 . . . . 1.78 111.427 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.985 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.2 p30 -142.25 -62.11 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 0 CA-C-N 114.58 -0.81 . . . . 1.48 109.922 -170.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 54.01 176.4 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.35 1.071 . . . . 0.90000000000000002 111.297 -177.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 72' ' ' VAL . 2.1 p -102.91 104.54 16.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 113.326 -1.761 . . . . 0.81999999999999995 108.427 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.8 ' HE1' HD12 ' A' ' 5' ' ' ILE . 20.4 m-85 -80.82 146.5 30.89 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.701 0.763 . . . . 0.41999999999999998 112.157 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 2.4 t -107.6 158.21 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.499 -1.682 . . . . 0.34000000000000002 107.933 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.047 ' HB ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 t -113.93 110.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.56 0.695 . . . . 1.8400000000000001 111.383 -164.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -126.35 129.4 48.74 Favored 'General case' 0 C--O 1.212 -0.88 0 CA-C-N 115.122 -0.945 . . . . 1.8799999999999999 110.684 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.835 0 CA-C-O 118.587 -0.72 . . . . 1.3600000000000001 110.116 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.863 0.363 . . . . 5.8600000000000003 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p -112.24 -81.05 0.59 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.965 0.412 . . . . 2.73 110.59 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -111.8 153.74 26.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.309 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 23.0 p90 -131.67 163.87 27.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.594 -1.632 . . . . 1.1699999999999999 106.594 173.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -127.49 160.76 36.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.661 -172.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 5.2 ttt180 -119.4 132.77 55.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 119.758 -0.777 . . . . 2.73 109.279 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.787 HG22 ' HD1' ' A' ' 73' ' ' TYR . 3.5 t -132.63 144.2 37.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 121.923 -0.485 . . . . 1.45 110.396 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.961 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 5.4 t -152.85 168.33 26.11 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.369 0.128 . . . . 0.56000000000000005 110.768 166.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.793 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 1.6 tm-20 -72.92 -56.4 5.22 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.058 0.932 . . . . 2.9700000000000002 108.624 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 14.0 t70 -110.01 148.31 31.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.822 -1.177 . . . . 1.1399999999999999 107.822 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.715 ' HG2' HG22 ' A' ' 74' ' ' VAL . 1.5 mt-10 -63.11 -17.82 62.73 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.347 -1.297 . . . . 1.48 108.577 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.64 33.55 4.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.996 -1.456 . . . . 2.02 110.657 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' HB3' ' OG1' ' A' ' 8' ' ' THR . 7.3 t70 -83.55 -118.09 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.697 -1.223 . . . . 0.58999999999999997 107.697 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 6.1 tp10 -121.5 90.76 48.1 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 115.067 -0.97 . . . . 2.1800000000000002 110.184 167.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 72.7 Cg_endo -74.69 133.43 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.056 1.837 . . . . 0.57999999999999996 110.879 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -128.28 136.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.021 -0.536 . . . . 0.51000000000000001 111.338 -169.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 34.2 mt-10 -86.07 122.0 29.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.84 -0.43 . . . . 1.6200000000000001 109.84 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 25.4 pt -140.49 141.1 24.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.789 -0.641 . . . . 1.52 111.031 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 4' ' ' TYR . 47.6 Cg_endo -69.69 136.29 32.81 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.713 2.275 . . . . 0.67000000000000004 112.425 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.778 ' HB3' HD12 ' A' ' 5' ' ' ILE . 8.2 p -112.14 169.36 8.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.96999999999999997 110.518 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.91 136.73 53.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.333 -0.618 . . . . 2.77 109.333 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' GLY . 1.2 m-20 -55.1 -17.4 4.01 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.195 0.998 . . . . 2.1299999999999999 112.555 -174.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -74.55 0.71 13.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.009 0.909 . . . . 2.3199999999999998 108.645 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' ASP . . . 74.31 23.98 74.38 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 113.866 -1.516 . . . . 0.56000000000000005 110.973 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.43 166.74 21.32 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.406 -0.397 . . . . 0.62 110.775 -169.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -147.5 146.35 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.598 -0.728 . . . . 0.46999999999999997 110.04 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.776 ' HG ' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -67.62 109.71 3.4 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.007 -0.738 . . . . 1.9399999999999999 109.007 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -65.77 -48.95 70.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.17 -0.923 . . . . 0.96999999999999997 110.009 -169.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.567 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.5 m -58.86 -39.23 80.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.14 -0.936 . . . . 1.4299999999999999 110.771 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.776 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 2.5 t -68.61 -33.19 73.61 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.602 -1.259 . . . . 1.4199999999999999 107.602 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.856 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 19.8 t -66.89 -42.54 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 CA-C-N 114.292 -1.322 . . . . 0.67000000000000004 109.864 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -65.8 -19.09 65.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.366 0.506 . . . . 0.71999999999999997 112.366 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.7 41.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.51 1.3 . . . . 0.93000000000000005 114.51 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 173.51 -164.29 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 123.968 0.907 . . . . 1.05 108.981 -173.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -109.04 92.16 10.44 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 108.849 -0.797 . . . . 1.5 108.849 166.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.878 ' HG2' ' H ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -118.53 1.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.287 3.325 . . . . 0.84999999999999998 114.369 173.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 75' ' ' VAL . . . 107.61 -20.09 32.61 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 110.1 -1.2 . . . . 0.67000000000000004 110.1 -161.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.878 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 63.45 -81.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.226 1.01 . . . . 0.45000000000000001 113.504 170.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.4 t -128.87 -21.49 3.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.317 0.58 . . . . 1.1100000000000001 110.415 -165.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.508 ' O ' HD22 ' A' ' 41' ' ' LEU . . . -112.97 155.51 16.24 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.485 -1.046 . . . . 0.39000000000000001 110.485 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.706 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.59 151.01 51.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 118.736 -1.186 . . . . 0.56000000000000005 112.984 176.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 mtt180 -133.82 161.0 35.92 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.187 -1.783 . . . . 1.9399999999999999 106.187 158.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.872 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 52.6 p90 -156.91 165.57 35.83 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 119.396 0.998 . . . . 1.1399999999999999 111.892 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -110.07 143.64 39.83 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 125.088 1.493 . . . . 2.7200000000000002 109.138 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.106 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 35.0 t30 -128.04 123.84 22.85 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.995 -1.002 . . . . 3.04 111.343 -169.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 71' ' ' LEU . 48.8 Cg_exo -38.01 -28.59 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.966 3.777 . . . . 3.6200000000000001 116.305 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.857 HG13 ' H ' ' A' ' 48' ' ' SER . 2.1 p -96.54 -90.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 118.074 0.397 . . . . 4.4199999999999999 111.461 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.857 ' H ' HG13 ' A' ' 47' ' ' VAL . 33.8 p -90.33 -8.83 49.82 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.666 0.746 . . . . 3.3199999999999998 110.798 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.106 ' HG3' ' H ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER 50.43 49.27 21.02 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 115.28 1.585 . . . . 4.2000000000000002 115.28 169.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.56 118.67 12.72 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.088 -0.96 . . . . 1.72 111.01 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 43' ' ' TYR . 5.9 ptm -64.23 87.26 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.074 -0.713 . . . . 2.3500000000000001 109.074 170.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 53' ' ' GLY . 7.3 ttt180 -121.19 156.21 32.88 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.934 -0.575 . . . . 2.48 110.432 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' HG2' ' A' ' 52' ' ' ARG . . . -100.48 164.81 19.04 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 121.975 0.764 . . . . 0.40999999999999998 113.951 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.694 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 91.0 t -98.53 140.48 18.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 113.545 -1.327 . . . . 0.42999999999999999 109.867 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HD2' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -63.27 134.72 56.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.648 -0.705 . . . . 4.1100000000000003 112.642 -175.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -110.34 121.77 46.1 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.533 -0.467 . . . . 1.53 109.925 165.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.662 HG12 ' HG3' ' A' ' 58' ' ' GLU . 2.7 t -126.17 113.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.739 -0.467 . . . . 0.53000000000000003 109.739 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.662 ' HG3' HG12 ' A' ' 57' ' ' VAL . 12.1 mt-10 51.13 36.5 15.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.067 0.547 . . . . 1.51 112.445 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.454 ' HA2' HD23 ' A' ' 28' ' ' LEU . . . 95.35 -3.23 66.04 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.729 -0.748 . . . . 0.51000000000000001 112.932 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.3 mt -100.81 148.16 7.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.726 -0.279 . . . . 0.48999999999999999 110.443 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' VAL . 16.4 tp -102.44 114.58 28.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.134 -1.061 . . . . 1.0700000000000001 108.134 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -111.65 122.51 48.01 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.711 0.767 . . . . 1.5 111.616 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.67 162.47 62.83 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 106.838 -1.541 . . . . 0.82999999999999996 106.838 166.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HG2' ' CE2' ' A' ' 68' ' ' TRP . 22.2 Cg_exo -63.41 149.89 89.97 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 120.421 1.186 . . . . 1.29 109.594 -174.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -45.95 -43.68 14.2 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.195 0.934 . . . . 3.1200000000000001 111.924 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.17 32.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.484 -0.932 . . . . 2.1400000000000001 108.484 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.11 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.004 -0.998 . . . . 1.5600000000000001 113.885 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.775 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -110.34 -76.93 0.6 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.538 0.685 . . . . 3.6899999999999999 109.897 -172.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.33 -76.49 0.12 Allowed Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 114.95 -1.023 . . . . 1.78 113.757 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.935 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -133.42 -59.03 0.88 Allowed 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 115.101 -0.549 . . . . 1.48 109.737 -167.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.775 ' O ' ' HB3' ' A' ' 6' ' ' ARG . 0.5 OUTLIER 51.06 172.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.439 1.087 . . . . 0.90000000000000002 111.648 -176.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 6' ' ' ARG . 2.0 p -99.56 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 113.99 -1.459 . . . . 0.81999999999999995 108.492 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.872 ' HD2' ' HB3' ' A' ' 43' ' ' TYR . 21.6 m-85 -79.86 144.81 33.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.827 0.822 . . . . 0.41999999999999998 112.671 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.715 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.5 t -110.38 164.11 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 113.356 -1.747 . . . . 0.34000000000000002 109.548 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.902 HG23 ' HA2' ' A' ' 37' ' ' GLY . 9.8 p -98.95 114.67 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.671 0.619 . . . . 1.8400000000000001 112.671 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.457 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 1.1 p30 -133.54 128.2 34.78 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 118.638 -1.225 . . . . 1.8799999999999999 110.533 158.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 1.5 p90 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.38 -0.819 . . . . 1.3600000000000001 109.957 167.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.614 0.245 . . . . 5.8600000000000003 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -80.91 73.69 7.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.364 0.602 . . . . 2.73 109.553 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -82.73 141.72 32.18 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.635 -0.711 . . . . 2.5 109.755 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 17' ' ' GLU . 16.8 p90 -138.64 162.54 34.36 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.258 -1.386 . . . . 1.1699999999999999 107.258 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.827 ' HA ' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -121.86 162.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 117.88 0.309 . . . . 1.0 111.223 -172.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 1.081 ' HD2' ' HB2' ' A' ' 15' ' ' PRO . 1.9 tpp85 -117.83 132.45 56.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.152 -0.684 . . . . 2.73 109.152 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' HB ' ' HD1' ' A' ' 73' ' ' TYR . 2.7 p -138.81 147.2 25.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 O-C-N 121.411 -0.806 . . . . 1.45 111.503 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' A' ' 15' ' ' PRO . 2.1 t -153.49 171.13 19.18 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.494 -0.928 . . . . 0.56000000000000005 108.494 166.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 14.0 mt-10 -75.33 -54.9 6.3 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 118.834 -1.147 . . . . 2.9700000000000002 108.142 171.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 12.0 m-20 -103.38 142.11 34.78 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.845 -1.169 . . . . 1.1399999999999999 107.845 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.725 ' HG2' HG22 ' A' ' 74' ' ' VAL . 4.3 mt-10 -57.71 -25.76 60.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 1.48 109.078 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.64 39.33 3.89 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.677 -1.601 . . . . 2.02 110.868 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 9.4 t70 -80.86 -114.48 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.042 -1.466 . . . . 0.58999999999999997 107.042 165.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -123.14 90.16 50.52 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-N 115.274 -0.875 . . . . 2.1800000000000002 109.668 165.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.081 ' HB2' ' HD2' ' A' ' 6' ' ' ARG . 72.5 Cg_endo -72.55 135.96 25.09 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.397 2.065 . . . . 0.57999999999999996 111.376 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -126.86 147.01 31.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.804 -0.635 . . . . 0.51000000000000001 110.928 -168.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.608 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . 13.8 mt-10 -95.62 124.53 39.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.113 -0.494 . . . . 1.6200000000000001 110.857 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 4' ' ' TYR . 35.8 pt -141.2 150.9 60.19 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.715 -0.675 . . . . 1.52 111.047 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.48 159.73 14.73 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.938 2.426 . . . . 0.67000000000000004 112.421 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.523 ' OG ' HD12 ' A' ' 5' ' ' ILE . 16.4 m -119.06 169.59 9.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.01 -0.541 . . . . 0.96999999999999997 110.277 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.15 145.31 55.95 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.054 -0.721 . . . . 2.77 109.054 171.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.05 -23.74 14.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.281 -1.327 . . . . 2.1299999999999999 111.952 -171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 25' ' ' THR . 22.5 t70 -78.26 -8.46 58.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.213 1.006 . . . . 2.3199999999999998 109.171 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.1 31.67 Favored Glycine 0 CA--C 1.5 -0.873 0 N-CA-C 108.681 -1.767 . . . . 0.56000000000000005 108.681 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.8 OUTLIER -117.56 149.81 40.02 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 112.893 -1.654 . . . . 0.62 110.915 -166.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.811 HG23 ' HB3' ' A' ' 61' ' ' LEU . 0.9 OUTLIER -144.42 148.03 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.225 -0.443 . . . . 0.46999999999999997 110.725 173.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.071 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -70.61 94.69 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.48 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -64.58 -49.77 69.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.017 -0.538 . . . . 0.96999999999999997 110.461 -170.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.633 ' HA ' HG23 ' A' ' 32' ' ' THR . 14.7 m -69.77 -31.04 68.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.618 0.723 . . . . 1.4299999999999999 109.719 -177.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.071 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.5 m -73.46 -32.36 64.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.233 -0.894 . . . . 1.4199999999999999 108.758 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.819 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 17.5 t -64.33 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 CA-C-N 115.175 -0.921 . . . . 0.67000000000000004 110.273 168.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 28' ' ' LEU . 1.3 p -65.03 -18.8 65.61 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.042 -0.411 . . . . 0.71999999999999997 111.887 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.95 40.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.384 1.253 . . . . 0.93000000000000005 114.384 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER 170.76 -166.61 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 124.054 0.941 . . . . 1.05 108.846 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -109.62 92.32 11.91 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.89 -0.781 . . . . 1.5 108.89 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.819 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 2.4 Cg_endo -120.42 5.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.199 3.266 . . . . 0.84999999999999998 114.661 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' O ' ' HD1' ' A' ' 77' ' ' TYR . . . 107.31 -26.98 16.91 Favored Glycine 0 C--O 1.222 -0.602 0 N-CA-C 109.716 -1.353 . . . . 0.67000000000000004 109.716 -161.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.792 ' H ' ' HG2' ' A' ' 36' ' ' PRO . . . 62.57 -92.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.509 1.3 . . . . 0.45000000000000001 114.509 165.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -122.41 -10.17 8.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.612 0.72 . . . . 1.1100000000000001 110.482 -159.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.4 154.06 16.54 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.489 -1.445 . . . . 0.39000000000000001 109.489 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -130.47 138.9 50.51 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 118.716 -1.194 . . . . 0.56000000000000005 111.893 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.79 ' HE ' ' HB3' ' A' ' 51' ' ' MET . 20.1 mtp180 -126.35 157.94 37.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.381 -1.34 . . . . 1.9399999999999999 107.381 159.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 73' ' ' TYR . 25.4 p90 -154.34 160.21 41.59 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.435 -1.306 . . . . 1.1399999999999999 111.845 165.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HB3' HG13 ' A' ' 72' ' ' VAL . 15.0 ttm180 -107.57 136.24 47.68 Favored 'General case' 0 C--O 1.253 1.267 0 O-C-N 125.758 1.911 . . . . 2.7200000000000002 109.228 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 1.6 m120 -115.58 176.89 1.34 Allowed Pre-proline 0 C--O 1.211 -0.946 0 O-C-N 124.292 0.995 . . . . 3.04 111.908 -169.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' CD ' ' HB3' ' A' ' 45' ' ' ASN . 2.2 Cg_endo -94.53 1.93 2.83 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.206 2.604 . . . . 3.6200000000000001 112.594 167.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.887 HG13 ' H ' ' A' ' 48' ' ' SER . 2.4 p -103.42 -96.27 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.892 0.377 . . . . 4.4199999999999999 111.709 -174.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.887 ' H ' HG13 ' A' ' 47' ' ' VAL . 6.2 m -104.7 -4.29 22.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.687 0.756 . . . . 3.3199999999999998 109.868 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' ASN . 35.7 mt-30 52.88 42.62 32.05 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 113.976 -1.466 . . . . 4.2000000000000002 113.879 170.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -67.88 124.56 23.68 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.877 -1.51 . . . . 1.72 108.861 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.79 ' HB3' ' HE ' ' A' ' 42' ' ' ARG . 18.2 mmt -69.67 80.05 0.43 Allowed 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.997 -1.112 . . . . 2.3500000000000001 107.997 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 15.1 ttt180 -101.79 152.88 20.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.565 -1.198 . . . . 2.48 110.991 -166.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 41' ' ' LEU . . . -99.33 161.02 19.83 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.288 -1.324 . . . . 0.40999999999999998 114.54 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.67 ' CG1' ' HG ' ' A' ' 61' ' ' LEU . 86.0 t -99.09 142.16 15.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 113.416 -1.392 . . . . 0.42999999999999999 110.158 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -64.4 136.2 56.87 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 112.05 0.389 . . . . 4.1100000000000003 112.05 -172.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -117.1 111.91 20.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.123 0.487 . . . . 1.53 110.567 175.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.748 HG12 ' HG3' ' A' ' 58' ' ' GLU . 35.6 t -127.97 117.25 45.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 116.26 -0.427 . . . . 0.53000000000000003 110.059 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.748 ' HG3' HG12 ' A' ' 57' ' ' VAL . 22.0 mt-10 54.83 35.7 24.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.687 0.28 . . . . 1.51 111.689 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.7 3.1 86.37 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.41 -0.9 . . . . 0.51000000000000001 112.933 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.1 mt -96.29 146.62 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 117.114 0.457 . . . . 0.48999999999999999 110.814 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.811 ' HB3' HG23 ' A' ' 26' ' ' VAL . 6.8 tp -103.83 117.89 35.4 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.268 -1.382 . . . . 1.0700000000000001 107.268 169.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -116.44 137.37 52.21 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.107 -0.637 . . . . 1.5 112.365 -169.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.48 163.74 17.6 Favored Pre-proline 0 N--CA 1.44 -0.942 0 CA-C-N 114.564 -1.198 . . . . 0.82999999999999996 109.899 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.3 167.4 6.16 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.672 2.914 . . . . 1.29 111.79 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -44.1 3.58 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.821 0.701 . . . . 3.1200000000000001 112.66 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 -21.02 7.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.125 -0.943 . . . . 2.1400000000000001 110.93 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 153.53 19.73 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.567 -1.302 . . . . 1.5600000000000001 112.378 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.871 ' HB2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.71 -49.89 35.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.441 -1.318 . . . . 3.6899999999999999 107.441 169.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.1 -81.48 0.08 OUTLIER Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 112.781 -2.009 . . . . 1.78 110.261 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.827 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 1.5 p30 -147.04 -61.73 0.29 Allowed 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.559 -0.821 . . . . 1.48 109.354 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.871 HD21 ' HB2' ' A' ' 68' ' ' TRP . 1.2 mm? 56.24 166.95 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.664 0 O-C-N 124.276 0.985 . . . . 0.90000000000000002 110.959 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' HG3' ' A' ' 6' ' ' ARG . 1.8 p -100.3 107.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 114.26 -1.336 . . . . 0.81999999999999995 109.493 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.846 ' HB3' HD11 ' A' ' 41' ' ' LEU . 19.0 m-85 -77.1 142.2 39.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.109 -0.95 . . . . 0.41999999999999998 112.041 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.725 HG22 ' HG2' ' A' ' 11' ' ' GLU . 3.3 t -110.88 167.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 113.629 -1.623 . . . . 0.34000000000000002 110.6 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' VAL . 5.7 p -99.03 105.02 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 112.641 0.608 . . . . 1.8400000000000001 112.641 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 0.3 OUTLIER -130.36 124.9 33.3 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 118.692 -1.203 . . . . 1.8799999999999999 111.506 163.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 2.4 p90 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.294 -0.86 . . . . 1.3600000000000001 109.545 166.939 . . . . . . . . 1 1 . 1 stop_ save_